https://www.healthtalk.no/hjertesykdom/ny-kolesterolpille-kan-utfordre-dagens-behandling/2099302026-04-03T10:44+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legemiddelselskaper-venter-med-a-lansere-i-europa-vil-beskytte-usa-priser/2099162026-04-03T10:59+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/a-prioritere-innebaerer-a-si-nei-til-nyttig-behandling/2098932026-04-01T12:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/meninger/befring-svarer-frich-systemet-vil-bli-endret/2098692026-04-01T08:34+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/frich-svarer-befring-kan-umulig-vite-hva-norge-er-tilbudt-sammenlignet-med-naboland/2098482026-03-31T09:02+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lilly-presser-britene-vil-ha-hoyere-legemiddelpriser-for-a-gjenoppta-investeringer/2098362026-03-31T11:51+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/prosjekt-x-skal-bane-vei-for-ny-helsereform-pasientene-skal-slippe-a-bli-kasteballer/2098162026-03-30T13:32+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/prisras-nar-ozempic-gar-av-patent-globalt-men-ikke-i-europa/2097962026-04-01T09:30+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/stor-studie-finner-ingen-effekt-av-tidspunktet-immunterapi-gis/2097352026-03-27T16:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/ny-adc-viser-sterke-overlevelsesdata-i-egfr-mutert-lungekreft/2097152026-03-27T11:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/befring-kritiserer-nye-metoder-etter-carvykti-avslag-mangler-legitimitet/2096782026-03-30T08:11+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legemiddelindustrien-stotter-frp-norge-kan-ga-glipp-av-nye-behandlinger/2096632026-03-27T07:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/frp-fremmer-forslag-om-a-justere-terskelverdien-anklager-regjeringen-for-trenering/2096522026-03-27T07:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/immunterapi-etter-straling-forsinker-tilbakefall-ved-tidlig-lungekreft-men-uten-effekt-pa-overlevelse/2096242026-03-27T11:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/ny-studie-etter-norsk-ja-disse-pasientene-har-storst-nytte-av-tagrisso-kombinasjon/2095932026-03-26T15:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/pfizer-vinner-bayer-taper-i-milliardanbud-pa-hjertemedisin/2095802026-03-26T13:06+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/over-halvparten-av-sakene-i-beslutningsforum-avgjores-na-uten-metodevurdering/2095652026-03-26T12:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/healthtalk-dekker-elcc-2026/2095282026-03-26T09:50+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/lungekreft/ny-adc-kombinasjon-gir-uvanlig-hoy-respons-i-smacellet-lungekreft-men-mangler-kontrollarm/2095202026-03-26T10:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehusinnkjop-bytter-anbudsplattform-gar-fra-mercell-til-ivalua/2094962026-03-25T11:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fhi-faerre-far-hjerneslag-men-ikke-blant-denne-aldersgruppen/2094822026-03-25T09:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/britene-snur-helsevesenet-norge-star-foran-de-samme-valgene/2094722026-03-25T13:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-om-ny-handlingsplan-for-kliniske-studier-tempoet-ma-opp/2094392026-03-23T14:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-handlingsplan-for-kliniske-studier-hoyere-ambisjoner-men-mye-er-kjent-fra-for/2094142026-03-23T15:44+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/novartis-kjoper-nytt-legemiddel-mot-brystkreft-for-opptil-3-milliarder-dollar/2093912026-03-23T12:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fda-vil-fase-ut-dyreforsok-satser-pa-ki-og-organer-pa-chip/2093442026-03-24T11:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/psoriasis/pasientforbund-krever-nye-psoriasis-retningslinjer-hvorfor-er-det-godt-nok-a-vaere-75-prosent-frisk/2093272026-03-23T08:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/eli-kari-gjengedal-om-menopause-vi-damer-holder-kjeft-og-lider-i-stillhet/2093002026-03-19T13:36+01:00https://image.healthtalk.no?imageId=209308&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/frp-topp-til-healthtalk-alternativkostnaden-ma-opp-na/2092852026-03-20T09:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nytt-prioriteringsrad-pa-plass/2092702026-03-20T08:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/roche-bygger-ai-fabrikk-med-nvidia-for-raskere-legemiddelutvikling/2092612026-03-19T08:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/schjesvold-om-car-t-nei-sier-nei-til-den-beste-behandlingen-vi-har/2092312026-03-17T14:21+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/verdens-dyreste-legemiddel-innfores-i-norge-en-engangsbehandling-til-43-millioner-kroner/2092202026-03-18T07:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/durvalumab-godkjent-i-eu-for-tidlig-magekreft/2092062026-03-19T11:52+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/milliardkamp-om-hjertemedisin-bayer-utfordrer-pfizers-dominans/2091902026-03-17T07:39+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/beslutningsforum-sier-ja-til-tagrisso-kombinasjon-ved-egfr-mutert-lungekreft/2091742026-03-16T13:09+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norske-tarmkreftleger-ba-om-ny-behandling-na-sier-beslutningsforum-ja/2091662026-03-17T11:12+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/abbvie-etter-elahere-nei-ma-vurdere-om-vi-vil-prove-igjen-i-norge/2091382026-03-18T16:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/jj-etter-carvykti-nei-vanskelig-a-akseptere/2091302026-03-16T12:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-sa-ja-til-tepmetko-etter-prisreduksjon/2091152026-03-16T12:05+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyresykdom/beslutningsforum-sa-ja-til-13-legemidler-nei-til-carvykti-og-elahere/2091012026-03-16T11:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/nye-behandlingsmetoder-og-mer-presisjonsmedisin-i-fokus-pa-gyn-onkologisk-vintermote/2090652026-03-13T12:41+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/leddgikt/bimekizumab-viser-bedre-effekt-enn-risankizumab-i-behandling-av-psoriasisartritt/2090512026-03-13T08:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/gynekolog-om-overgangsalder-kvinner-trenger-ikke-a-ga-rundt-med-plager/2090142026-03-12T14:48+01:00https://image.healthtalk.no?imageId=209022&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rekordmote-i-beslutningsforum-18-legemidler-skal-avgjores-kan-apne-for-ny-tarmkreftbehandling/2090062026-03-13T17:35+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ema-apner-for-manedlig-dosering-av-elfabrio-ved-fabrys-sykdom/2089922026-03-12T08:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/ny-legemiddelklasse-viser-lovende-effekt-mot-tilbakevendende-myelomatose/2089582026-03-11T08:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/lovende-brystkreftpille-feilet-i-nokkelstudie/2089442026-03-10T09:06+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/hodepine-norge-reagerer-pa-ous-praksis-helt-motsatt-av-stortingets-vedtak/2089282026-03-13T15:58+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/blodkreft/fda-gir-rekordrask-godkjenning-til-tecvayli-kombinasjon-kan-bli-ny-standard-ved-tilbakefall-av-myelomatose/2088992026-03-09T08:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/alvorlighet-alder-og-prioritering-et-gammelt-sporsmal-i-ny-drakt/2088802026-03-09T07:40+01:00https://image.healthtalk.no?imageId=208886&format=webp&width=1200https://www.healthtalk.no/migrene/frp-reagerer-pa-mulig-tvungen-migrenepause-vestre-avviser-generell-praksis/2088582026-03-06T12:10+01:00https://image.healthtalk.no?imageId=203654&format=webp&width=1200https://www.healthtalk.no/meninger/det-er-ingen-grunn-til-at-norge-skal-gjore-samme-feil-som-britene/2088342026-03-05T13:16+01:00https://image.healthtalk.no?imageId=203723&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/ms-ekspert-ny-medisin-kan-bli-et-viktig-gjennombrudd-men-frykter-for-norsk-tilgang/2088152026-03-10T07:49+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/rekordhoy-bruk-av-hormonbehandling-mot-overgangsplager-nytt-ostrogenplaster-kan-bidra-mot-mangel/2088022026-03-04T13:57+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/stortinget-vil-gi-dodssyke-als-pasienter-tidligere-tilgang-til-nye-legemidler/2087772026-03-03T15:52+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/esgo-2026-immunterapi-gir-lengre-overlevelse-ved-platinum-resistent-eggstokkreft/2087452026-03-02T12:20+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/ny-kombinasjon-reduserer-risiko-for-progresjon-med-30-prosent-ved-avansert-nyrekreft/2087052026-03-02T10:31+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/ema-anbefaler-godkjenning-av-ny-malrettet-behandling-for-barn-med-hjernesvulst/2086922026-03-03T12:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/ema-anbefaler-godkjenning-av-modernas-kombinasjonsvaksine-mot-covid-19-og-influensa/2086782026-03-04T08:52+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/prostatakreft/endelige-peace-3-data-xofigo-kombinasjon-gir-overlevelsesgevinst/2086592026-03-02T10:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/padcev-og-keytruda-reduserer-risiko-for-tilbakefall-og-dod-ved-muskelinvasiv-blaerekreft/2086422026-03-02T10:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/psoriasis/helsedirektoratet-vil-vurdere-behovet-for-psoriasis-retningslinjer-etter-healthtalk-sak/2086242026-03-03T07:21+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/espen-lahnstein-blir-ny-generalsekretaer-i-psoriasis-og-eksemforbundet/2086092026-02-26T13:02+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/strid-om-alternativkostnaden-bor-den-justeres-eller-sta-fast/2085912026-03-03T11:37+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/kreft/norge-i-europatoppen-pa-kreftoverlevelse-bruker-langt-mindre-enn-sveits-og-tyskland/2085762026-03-05T11:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helseministeren-vil-ikke-si-hvordan-stortingets-vedtak-om-alternativkostnaden-skal-folges-opp/2085632026-02-26T20:12+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/vil-fa-sykehus-og-kommune-til-a-snakke-bedre-sammen-malet-er-en-felles-informasjonsflyt/2085292026-02-26T09:48+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/nordlandssykehuset-kutter-ventetid-med-sproytebehandling-man-bommer-ikke-pa-et-lar/2085172026-02-25T09:32+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/nyrekreftpasient-vidar-larsen-64-og-kona-onsker-kreftbehandling-naermere-hjemmet/2085042026-02-25T09:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/dmp-foreslar-ny-modell-for-vurdering-av-legemidler-i-nye-metoder/2084852026-02-24T10:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/slik-folger-nordlandssykehuset-opp-barn-som-skal-do-noen-onsker-a-avslutte-livet-hjemme/2084742026-02-25T08:45+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisks-nye-fedmemedisin-nadde-ikke-malet-mot-konkurrent/2084602026-02-23T11:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/psoriasis/nesten-150-000-nordmenn-har-psoriasis-nasjonale-retningslinjer-eksisterer-likevel-ikke/2084382026-02-23T08:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vil-gi-gratis-medisiner-til-de-minste-barna-bred-stotte-men-ogsa-advarsler/2084272026-03-02T07:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/sverige-wegovy-beslutning-utsettes-pa-ubestemt-tid/2084142026-02-22T10:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/viste-healthtalk-reportasje-pa-25-arsjubileet-det-er-en-stolthet-i-avdelingen/2083912026-03-05T10:46+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hod-til-dmp-er-det-slik-at-vi-har-feilinformert-stortinget-og-bor-rette-opp/2083752026-02-20T12:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/ny-lancet-studie-kan-styrke-sanofis-rsv-sak-i-norge/2083542026-02-24T10:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/crohns/biomarkorstyrt-top-down-ga-ingen-gevinst-ved-nydiagnostisert-ibd-mulig-effekt-ved-crohns-sykdom/2083322026-02-20T14:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/crohns/rwe-data-pa-rinvoq-sterk-symptomlindring-og-hoy-respons-mot-ulceros-kolitt/2083212026-02-20T14:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/crohns/real-world-data-viser-hoy-remisjon-med-risankizumab-mot-crohns/2083102026-02-20T14:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/strid-om-martin-studien-dmp-erkjenner-upresis-formulering-fastholder-konklusjonen/2082872026-02-18T21:13+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/kjaere-helseminister-na-ma-videokonsultasjon-i-akuttfasen-bli-en-integrert-del-av-helsetjenesten/2082712026-02-19T12:04+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/professor-line-bjorge-er-nominert-til-kvinnehelseprisen-pa-her-awards/2082562026-02-18T10:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legeforeningen-vil-heve-alternativkostnaden-overleger-kaller-dmp-rapport-villedende/2082402026-02-18T07:28+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/500-kreftpasienter-i-nordland-far-digital-hjemmeoppfolging-dette-er-kjempeviktig/2082102026-02-25T09:34+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/deloitte-skal-granske-ordningen-for-sjeldne-og-alvorlige-sykdommer/2081892026-02-17T11:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/hoyre-vil-endre-vaksinesystemet-industrien-kritiserer-treg-politisk-behandling/2081702026-02-20T08:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/fhi-anbefaler-helvetesild-vaksine-til-65-aringer-men-dagens-pris-er-ikke-kostnadseffektiv/2081532026-02-20T08:51+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/eksperimentell-blodfortynner-reduserer-risikoen-for-nytt-slag-med-26-prosent/2081402026-02-16T08:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/fra-blodtrykk-til-helhet-forebygging-er-god-medisin-men-fortsatt-underprioritert/2081222026-02-13T12:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/ki-halverer-radiologenes-bildevurdering-men-okt-tilbakekalling-kan-spise-opp-hele-gevinsten/2080842026-02-12T10:53+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/pharma-toppene-advarer-uten-raskere-tilgang-og-mindre-byrakrati-flytter-innovasjonen/2080632026-02-11T15:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tidsbruken-i-nye-metoder-gar-ned-disse-tiltakene-er-innfort/2080242026-02-12T13:51+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/amerikanske-eksperter-slik-blir-forskning-investerbar-og-derfor-feiler-sa-mange-life-science-prosjekter/2080012026-02-10T14:55+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/undersokelse-viser-flere-barrierer-for-bruk-av-tilgangsordningen/2079862026-02-11T09:58+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fokus-slar-storrelse-ge-healthcares-globale-forskningssjefs-rad-til-norsk-life-science/2079722026-02-10T11:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/svettekjertelbetennelse/nei-til-cosentyx-mot-hs-trist-for-en-hardt-rammet-pasientgruppe/2079482026-02-09T11:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sa-nei-til-flere-nye-legemidler-prisen-er-rett-og-slett-for-hoy/2079262026-02-09T11:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/toppmote-bak-lukkede-dorer-om-legemiddelpriser-uten-regjeringen-til-stede/2079122026-02-09T07:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/trump-lanserer-trumprx-vil-presse-legemiddelprisene-ned/2078832026-02-06T12:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/beslutningsforum-9-februar-ny-car-t-konkurranse-og-mulig-ja-til-lenge-ventet-lungekreftmedisin/2078752026-02-09T09:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/gronberg-om-kliniske-studier-pasienter-far-behandling-de-ellers-matte-ventet-i-arevis-pa/2078552026-02-06T13:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/for-forste-gang-car-t-konkurranse-i-norge/2078372026-02-06T08:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/digital-forstehjelp-i-ambulansetjenesten/2078252026-02-11T18:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/beslutningsforum-har-ikke-et-kommunikasjonsproblem-det-har-politikerne/2078092026-02-05T16:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/oyesykdom/amd-pasient-astri-wold-om-oyebehandling-jeg-har-fatt-et-liv-jeg-kan-leve-med/2077482026-02-04T08:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oyesykdom/seksjonsleder-om-oyeprosjektet-i-molde-involvering-har-vaert-helt-avgjorende/2077352026-02-04T08:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oyesykdom/oyelegen-roser-effektivisering-ved-snr-sykehuset-jeg-har-ikke-vaert-bekymret/2077222026-02-04T08:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oyesykdom/slik-snudde-oyeavdelingen-kokrisen-kuttet-injeksjoner-med-20-prosent/2077092026-02-04T08:25+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/tid-er-den-knappeste-ressursen-i-helsetjenesten-na-ma-vi-bruke-den-bedre/2076802026-02-02T12:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/ny-rapport-immunterapi-under-huden-kan-halvere-kostnadene-i-sykehus/2076592026-02-02T12:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/tarmkreft/uvanlig-gjennomslag-for-fagmiljoet-bestillerforum-hopper-over-metodevurdering-ved-ny-tarmkreftbehandling/2076422026-02-05T09:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/nar-skal-kreft-behandles-darzalex-vurderes-for-myelomatose-blir-aktiv/2076302026-02-10T09:01+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/ny-norsk-studie-tester-trening-og-ernaering-som-del-av-lungekreftbehandling/2075902026-02-13T09:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/blodkreftforeningen-et-viktig-skritt-i-riktig-retning/2075732026-01-30T11:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/kreftforsker-aslaug-helland-er-arets-ildsjel-2025/2075292026-01-30T14:52+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/hjerteforsker-peder-langeland-myhre-er-arets-unge-forsker-2025/2075212026-01-30T14:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimers/ira-haraldsen-og-prosjektgruppen-ved-ous-er-arets-innovative-miljo/2075132026-01-30T14:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/ingerid-abrahamsen-og-bms-norge-vant-prisen-arets-industriinitierte-studie/2075052026-01-30T14:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oyesykdom/norsk-praksisendrende-blodpropp-studie-i-new-england-journal-of-medicine/2074912026-01-29T09:09+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/ms-forsker-oivind-torkildsen-ved-haukeland-star-bak-arets-forskerinitierte-studie/2074832026-01-30T14:55+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/oslo-myelomatosesenter-er-arets-senter-2025/2074692026-01-30T14:56+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/skal-styrke-tilliten-til-beslutningsforum-ny-kommunikasjonsplan-under-arbeid/2074572026-01-28T10:46+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/disse-kan-vinne-kliniske-studier-pris-for-arets-senter/2074362026-01-29T11:13+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/leddgikt/norsk-barneleddgikt-studie-endrer-praksis-unodvendig-a-injisere-ledd-ved-oppstart-av-biologisk-behandling/2074242026-01-28T07:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/svettekjertelbetennelse/hs-pasienter-har-bare-en-godkjent-biologisk-medisin-eksperten-vil-ha-tilgang-pa-flere/2074062026-01-27T07:43+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/psoriasis/over-halvparten-fikk-nesten-klar-hud-med-ny-tyk2-tablett/2073772026-01-26T08:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/psoriasis/ny-biotilsvarende-i-tnf-bio-anbudet-ekspert-tror-flere-kan-fa-biologisk-behandling/2073602026-01-23T10:20+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/frich-bare-16-soknader-i-tilgangsordningen-i-2025-tror-ordningen-er-for-lite-kjent/2073392026-01-26T07:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sanofi-og-novartis-dokumentasjon-kan-ikke-leveres-men-sakene-star-likevel-i-ventestatistikken/2072882026-02-03T08:13+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/de-glemte-legemidlene-har-ventet-nesten-20-ar-pa-metodevurdering-av-medisin/2072772026-02-03T09:24+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/raskere-kreftbehandling-med-sproyte-jeg-foler-meg-veldig-trygg/2072652026-01-22T16:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftsykepleier-pasientene-skal-ikke-tape-noe-pa-a-ga-over-til-subkutan-behandling/2072452026-01-22T16:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftsjefen-pa-kalnes-subkutan-behandling-frigir-masse-tid-per-behandling/2072302026-01-22T16:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/bristol-myers-og-microsoft-tar-i-bruk-ai-for-a-oppdage-lungekreft-tidligere/2072122026-01-22T08:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/kreftvaksine-gir-langvarig-effekt-ved-hoyrisiko-melanom/2072012026-01-21T08:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/kreftbehandling-pa-minutter-ikke-timer-et-helt-nodvendig-skifte/2071922026-01-22T16:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/keytruda-innfores-i-kurativ-behandling-av-lokalavansert-livmorhalskreft/2071702026-01-20T11:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/fredrik-wang-gierloff-blir-viseadministrerende-direktor-i-lmi/2071522026-01-19T12:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tezspire-fikk-ja-ganske-enkel-beslutning/2071332026-01-19T12:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/13-av-14-saker-fikk-ja-i-arets-forste-beslutningsforum-kun-jaypirca-fikk-nei/2071132026-01-19T12:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/domore-sjefens-frustrasjon-klinisk-studie-fem-ganger-dyrere-i-norge/2070952026-01-16T08:48+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/14-legemidler-skal-avgjores-i-beslutningsforum-mandag-dette-blir-de-viktigste-sakene/2070812026-01-19T10:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/eu-godkjenner-teizeild-forste-behandling-som-kan-utsette-type-1-diabetes/2070652026-01-14T09:25+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsenaeringen-etter-helsetalen-fine-ord-ma-folges-av-handling/2070502026-01-13T14:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vestre-varsler-stor-helsereform-kortere-ventetider-og-mer-pasientvalg/2070372026-01-13T13:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-bms-norge-sjef-markedstilgang-har-blitt-helt-essensielt/2069922026-01-12T12:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/skymoen-advarer-norge-kan-bli-for-lite-og-for-billig-for-nye-legemidler/2069712026-01-12T07:52+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/forsvarets-sanitetssjef-krig-er-en-folkehelsekatastrofe/2069552026-01-09T11:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsedirektoren-vi-kommer-til-a-matte-prioritere-og-vi-kommer-til-a-matte-dra-ned-aktivitet/2069412026-01-09T10:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftsjefen-pa-ous-om-schjesvold-pastander-det-er-ikke-riktig/2069252026-01-13T13:08+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/ahus-lykkes-med-kliniske-kreftstudier-schjesvold-etterlyser-endringer-ved-ous/2069172026-01-13T13:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/jens-torup-ostby-er-ny-sjef-i-bms-norge/2069032026-01-08T09:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fhi-studie-12-millioner-flere-fastlegekonsultasjoner-enn-ventet-i-2024/2068872026-01-07T11:41+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vil-ikke-justere-alternativkostnaden-lmi-krever-politisk-handling/2068512026-01-06T09:46+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/kraftig-okning-i-spiserorskreft-i-norge-livsstil-pekes-ut-som-viktig-arsak/2068352026-01-05T11:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/disse-lovendringene-pa-helseomradet-bor-du-vite-om-i-2026/2068182026-01-05T07:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ketamin-og-esketamin-fores-opp-pa-narkotikalisten-i-skyggen-av-misbruk-medisinsk-innovasjon-og-helsepolitisk-debatt/2067972025-12-29T13:30+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/usa-godkjenner-novo-nordisks-orale-wegovy-mot-fedme/2067772025-12-23T10:33+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/disputerte-for-doktorgraden-fortsetter-i-impress-og-matrix-rare/2067582025-12-22T14:51+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/kreft/ane-gerda-zahl-eriksson-blir-president-elect-i-esgo-i-2026-blir-president-i-2028/2067302025-12-19T14:47+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/astma/mild-astma-kan-vaere-misvisende-alle-skal-ha-betennelsesdempende-behandling/2067032026-02-03T15:02+01:00https://image.healthtalk.no?imageId=206709&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/thomas-axelsen-gar-fra-kreftforeningen-til-barneombudet/2066532025-12-17T09:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/legemidlet-ble-innfort-men-forst-etter-to-systemflaskehalser/2066262025-12-17T08:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/lhl-forsinkelser-i-innforingen-rammer-pasientenes-livskvalitet-og-tillit/2066102025-12-17T08:14+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/eu-anbefaler-ja-til-trippel-dose-med-wegovy-kan-ledsages-av-flere-bivirkninger/2066022025-12-17T09:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ottersen-om-eus-nye-regelverk-for-legemidler-kan-gi-bedre-tilgang-i-sma-markeder/2065882025-12-29T10:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ous-lofter-frem-forskning-med-pris-til-seks-fremragende-artikler/2065632025-12-30T10:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/thomas-fleischer-karet-til-arets-forsker-2025-ved-institutt-for-kreftforskning-pa-oslo-universitetssykehus/2065492025-12-18T09:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rootwelt-og-spreng-takker-av-etter-mer-enn-to-ar-i-beslutningsforum-ledelsen/2065272025-12-15T12:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/ny-studie-ny-hormonbehandling-forlenger-tiden-for-cellegift-ved-avansert-brystkreft/2065102025-12-16T08:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/ingen-overlevelsegevinst-med-palbociclib-nye-data-viser-klare-forskjeller-mellom-cdk4/6-hemmere/2064842025-12-17T09:05+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/emma-cerrone-tar-over-roret-i-msd-norge-og-finland/2064672025-12-12T08:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/tukysa-forlenger-progresjonsfri-overlevelse-med-over-atte-maneder/2064592025-12-12T12:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-slar-tilbake-mot-litfulo-kritikk-svaert-mangelfullt-dokumentert-fra-firma/2064382025-12-11T15:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/trodelvy-skuffer-i-hr-brystkreft-ingen-gevinst-som-forste-behandling-etter-endokrin-terapi/2064252025-12-12T07:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kritiserer-svak-metodevurdering-til-tross-for-litfulo-ja-i-beslutningsforum/2064062025-12-11T15:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/ny-brystkreftpille-reduserer-risiko-for-tilbakefall-med-30-prosent/2063842025-12-11T12:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/leger-og-sykepleier-vant-healthtalks-nyhetsbrev-konkurranse/2063722025-12-19T12:01+01:00https://image.healthtalk.no?imageId=206379&format=webp&width=1200https://www.healthtalk.no/myelomatose/ny-teknologi-lager-car-t-direkte-i-kroppen-de-forste-pasientene-viser-dype-responser/2063432025-12-11T08:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/ett-av-de-beste-resultatene-vi-har-sett-ved-tilbakefall-av-myelomatose/2063212025-12-10T09:46+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/eli-sihn-ble-arets-onkolog-jeg-ble-helt-fantastisk-overrasket/2062952026-01-02T08:08+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/alopecia-pasientene-jubler-for-litfulo-ja-en-julegave/2062672025-12-10T07:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/gir-langvarig-sykdomskontroll-ved-itp-halverer-risikoen-for-behandlingssvikt/2062592025-12-10T16:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/to-klinikere-og-to-brukerrepresentanter-skal-inn-i-beslutningsforum/2062482025-12-11T09:45+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/tepkinly-kombinasjon-viser-kraftig-effektforbedring-i-follikulaert-lymfom/2062292025-12-09T10:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/jaypirca-slar-kjemoimmunterapi-i-forstelinje-kll-kan-bli-ny-standard/2062142025-12-09T17:04+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/gsk-om-blenrep-ja-saken-har-loftet-viktige-problemstillinger/2061752025-12-08T12:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/jubeldag-for-pasienter-med-alvorlig-hartap-og-benmargskreft-ja-til-bade-litfulo-og-blenrep/2061542025-12-08T13:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/jaypirca-minst-like-effektiv-som-imbruvica-i-ny-kll-studie/2061362025-12-08T14:52+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/tidsbegrenset-behandling-likeverdig-med-livslang-btk-hemming-i-ny-kll-studie/2061052025-12-09T07:38+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/nye-ash-data-carvykti-gir-dype-og-varige-responser-vurderes-na-av-beslutningsforum/2060882025-12-08T07:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/ny-studie-viser-hoye-responsrater-nar-tepkinly-legges-til-forstelinjebehandling-for-dlbcl/2060642025-12-07T12:39+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/ny-teknologi-endrer-blodkreftbehandling-fire-ash-studier-peker-mot-mer-treffsikre-og-skansomme-terapier/2060342025-12-08T07:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/dobbeltmalrettet-car-t-gir-100-prosent-respons-hos-ny-diagnostiserte-myelomatosepasienter/2060112025-12-06T16:28+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/skropelige-myelomatosepasienter-har-ingen-nytte-av-intensiv-behandling/2060012025-12-11T09:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/scemblix-gir-bedre-livskvalitet-enn-tki-er/2059822025-12-06T18:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/dreamm-8-blenrep-kombinasjon-gir-dype-og-varige-responser/2059692025-12-06T14:39+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-8-desember-blenrep-tilbake-pa-bordet-og-hartap-medisinen-litfulo-kan-fa-ja/2058802025-12-05T11:56+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/180-pasienter-er-aktuelle-for-car-t-under-halvparten-vil-fa-tilgang/2058632026-03-11T10:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/carvykti-i-andrelinje-kan-bli-et-veiskille-i-norsk-myelomatosebehandling/2058512026-03-11T10:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/industrien-vil-nesten-doble-terskelverdien-advarer-om-at-norge-kan-havne-bakerst-i-koen-for-nye-medisiner/2058392025-12-05T08:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slar-alarm-om-okt-bruk-av-tramadol-i-norge-store-forskjeller-mellom-norge-og-nabolandene/2058252025-12-04T09:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legemiddelutgiftene-oker-men-prisene-er-ikke-hovedforklaringen/2058052025-12-02T11:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/otto-von-ubisch-blir-ny-juridisk-direktor-i-sykehusinnkjop/2057912025-12-02T07:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/usa-presser-storbritannia-til-a-oke-betalingsviljen-for-legemidler-hva-betyr-det-for-norge/2057722025-12-02T07:14+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/norske-klinikere-derfor-bor-leger-delta-i-industriens-advisory-boards/2057572025-12-01T07:46+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/fra-oslo-til-boston-norsk-hematolog-forsker-pa-myelomatose-ved-dana-farber-og-harvard/2057422025-11-28T11:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/eu-sier-ja-til-scemblix-i-forstelinje-kan-oke-sjansen-for-behandlingsfri-remisjon/2057262025-11-28T09:04+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/sigrid-skanland-far-dr-ragnar-morks-pris-for-fremragende-kreftforskning/2057072025-11-27T13:08+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/disse-kreftforskerne-far-millioner-fra-kreftforeningen/2056902025-11-27T08:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norge-far-nasjonal-standard-for-fosterovervakning-skal-redusere-risiko-for-alvorlige-fodselskomplikasjoner/2056702025-11-26T08:25+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/kurzrock-vi-ma-rive-ned-gamle-regler-for-a-gi-kreftpasienter-bedre-behandling/2056482025-11-26T09:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/ny-blodfortynner-med-fase-3-suksess-reduserer-risiko-for-nytt-hjerneslag/2056322025-11-25T09:30+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/semaglutid-skuffer-klarte-ikke-a-bremse-alzheimers-sykdom/2056162025-11-24T13:33+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/advarer-mot-urealistisk-studieambisjon-hele-systemet-ma-styrkes/2055952025-11-24T11:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/ny-strategi-i-behandling-av-brystkreft-esr1-mutasjon-avslorer-resistens-for-den-blir-synlig/2055752025-11-24T07:41+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/katrin-kleinmanns-tildelt-onkologisk-forums-ung-forsker-pris/2055602025-11-25T08:05+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/spreng-avviser-kritikken-soknadsprosessen-i-tilgangsordningen-er-ikke-for-krevende/2055252025-11-21T15:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/trening-kan-bli-standard-kreftbehandling-en-game-changer/2054722025-11-25T10:48+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/prostatakreft-har-utbetalt-40-mill-i-erstatning-til-64-menn/2054552025-11-20T07:27+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisk-sjefen-haper-politikerne-prioriterer-bla-resept-for-wegovy/2054182025-11-18T13:58+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/dmp-anbefaler-bla-resept-for-wegovy-etter-nytt-pristilbud-fra-novo-nordisk/2054022025-11-18T14:01+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/alt-tyder-pa-blenrep-innforing-for-jul-rootwelt-og-gsk-naermer-seg-losning/2053802025-11-18T08:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/nei-til-car-t-dobbelt-ja-til-keytruda/2053602025-11-17T10:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/studieapp-gjor-det-enkelt-for-onkologene-a-finne-kliniske-studier-til-pasientene/2053522025-11-25T13:32+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/prisvinner-karl-johan-malmberg-om-nk-cellene-kroppens-egne-seriemordere/2053442025-11-20T11:47+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/onkologisk-forum-samler-kreft-norge-moteplassen-med-stor-m/2053362025-11-20T10:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/pris-og-effekt-i-spill-nar-beslutningsforum-vurderer-tre-nye-kreftbehandlinger/2053222025-11-16T09:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/msds-orale-pcsk9-hemmer-viser-opptil-60-prosent-ldl-reduksjon-i-fase-3-studier/2053082025-11-18T12:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/fransk-ekspert-haper-pa-bedre-medisin-tilgang-for-norske-myelomatosepasienter/2052612025-11-13T10:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/yngre-med-benmargskreft-far-darligere-behandling-enn-eldre-en-merkelig-situasjon/2052482025-11-13T10:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/eldre-og-skropelige-pasienter-taler-omfattende-behandling-av-benmargskreft-godt/2052372025-11-13T10:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/gsk-svarer-rootwelt-haper-at-vi-sammen-skal-finne-en-losning/2052242025-11-12T12:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fagdirektor-om-tilgangsordningen-tunge-prosesser-og-uklare-begreper/2052102025-11-14T08:38+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/rootwelt-innrommer-beslutningsforum-baserte-blenrep-avslag-pa-utdatert-dosering/2051752025-11-10T17:14+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/prostatakreft/norsk-studie-skal-teste-car-t-mot-prostatakreft-rekrutterer-pasienter-fra-hele-landet/2051352025-11-11T08:42+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/departementet-sender-habilitetssak-til-helse-sor-ost-direktor-har-allerede-uttrykt-full-tillit-til-michael-vester/2051232025-11-10T13:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-har-ingen-mening-om-hva-michael-vester-publiserer-pa-sosiale-medier/2051122025-11-10T08:27+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/oppsummerte-gynkreft-hoydepunktene-fra-esmo/2050942025-11-10T10:27+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/blodkreft/sykehusinnkjop-peker-pa-beslutningsforum-for-vurdering-av-klinisk-relevans-i-blenrep-saken/2050752025-11-07T14:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kommunikasjonssjef-frode-nakkim-ferdig-i-bayer/2050582025-11-07T13:05+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vester-anklager-lmi-for-dobbeltmoral-etter-habilitetskritikk/2049902025-11-06T16:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/prostatakreft/screening-av-prostatakreft-kan-redde-liv-pilotprosjekt-pa-ahus-skal-gi-svar/2049732025-11-07T15:02+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/forebyggende-behandling-av-migrene-en-av-fire-trenger-det-kun-en-av-ti-far-det/2048702025-11-06T12:00+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helseindustrien-vokser-men-norges-eksport-hviler-pa-en-bedrift/2048522025-11-06T08:39+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/blodkreftforeningen-krever-gjennomgang-etter-blenrep-avslag-pasientene-blir-skadelidende-av-rot-og-uklarhet/2048242025-11-05T15:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/schjesvold-mener-sykehusinnkjop-har-regnet-feil-pa-blenrep/2047872025-11-05T08:28+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/frp-krav-fradrag-pa-selvangivelsen-for-legemidler-som-betales-privat/2047712025-11-04T12:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rootwelt-forsvarer-vester-har-full-tillit-til-jobben-som-gjores/2047402025-11-03T11:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/sykehusinnkjop-taus-om-de-ga-gsk-prisrad/2046742025-11-04T10:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kommentar/helseminister-vestre-lovet-hap-systemet-leverer-taushet/2046642025-11-03T10:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nye-metoder-lege-omtaler-legemiddelindustrien-som-gradige-og-skruppellose-gir-dmp-rad-om-terskelverdi/2046322025-11-01T15:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ibuprofen-far-bli-i-lua-ordningen-men-dmp-varsler-informasjonsloft/2045982025-10-30T14:09+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/parorende-ble-dobbelt-sa-tilfredse-og-ringte-mindre-ahus-avdeling-far-pris/2045812025-10-30T12:59+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/faerre-leger-melder-bivirkninger-relis-frykter-at-viktige-faresignaler-kan-glippe/2045732025-10-31T09:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/schjesvold-om-blenrep-saken-beslutningsforum-bryter-med-sine-egne-prinsipper/2045512025-10-29T08:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/vestre-ma-svare-om-helvetesild-vaksine-etter-mangel-pa-herpesmedisin/2045262025-10-28T08:52+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/flere-nye-metodevurderinger-pa-vei-gront-lys-for-behandling-av-ultrasjelden-blodsykdom/2044772025-10-28T11:31+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kun-byrakrater-og-okonomer-skal-radgi-dmp-om-terskelverdi-ingen-leger-pasienter-eller-industri/2044612025-10-27T10:53+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/gsk-etter-nei-til-blenrep-vi-har-forholdt-oss-til-prosessen/2044452025-10-24T14:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/mot-eksperten-egil-blix-om-monarche-studien/2044252025-10-24T10:07+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/healthtalk/mot-eksperten-marius-normann-om-keynote-905/2043772025-10-21T18:03+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rootwelt-gsk-gikk-inn-i-forhandlingene-med-en-uvanlig-hoy-prisforventning/2043662025-10-22T07:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/mot-eksperten-axel-heidenreich-om-molekylaer-testing-og-udekkede-behov-hos-pasienter-med-prostatakreft/2043232025-10-21T15:39+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/healthtalk/mot-eksperten-katarina-puco-om-impress-norway/2043112025-10-21T15:30+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/healthtalk/mot-eksperten-sigmund-brabrand-om-impress-norway/2042992025-10-21T15:25+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/healthtalk/mot-eksperten-bente-vilming-om-keynote-b96/2042872025-10-21T15:19+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/healthtalk/mot-eksperten-kristina-lindemann-om-keynote-b96/2042722025-10-21T15:12+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/kreft/gjennombrudd-for-ctdna-veiledet-behandling-ved-blaerekreft-veldig-viktig-studie/2042482025-10-23T12:32+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/imfinzi-og-bcg-immunterapi-ga-faerre-tilbakefall-for-hoyrisiko-blaerekreft-pasienter-lovende/2042322025-10-21T11:29+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/gsk-tilbakeviser-rootwelt-maksprisen-var-ikke-del-av-forhandlingene/2042162025-10-21T09:03+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/svangerskap-og-amming-gir-varig-beskyttelse-mot-trippel-negativ-brystkreft/2041972025-10-22T12:55+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/seks-metoder-innfores-blenrep-og-jaypirca-far-nei-i-beslutningsforum/2041702025-10-20T10:59+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/kinesisk-adc-og-immunterapi-doblet-overlevelsen-til-pasienter-med-her2-positiv-urinveiskreft-positiv-overraskelse/2041622025-10-20T13:43+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lymfekreft-spinal-muskelatrofi-og-cystisk-fibrose-disse-legemidlene-skal-opp-i-beslutningsforum-mandag-20-oktober/2041432025-10-20T09:21+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/kreftforsker-trodelvy-gir-historisk-forbedring-i-behandling-av-metastatisk-trippel-negativ-brystkreft/2041272025-10-20T09:12+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/lungekreft-bisepesifikt-antistoff-ga-nesten-dobbelt-sa-lang-tid-uten-tilbakefall-som-immunterapi/2041132025-10-19T18:55+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/blodtest-oppdaget-kreft-syv-ganger-oftere-enn-vanlig-screening/2040832025-10-19T15:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/pasienter-med-eggstokkreft-levde-lenger-med-immunterapi-haukeland-professor-er-storfornoyd/2040432025-10-19T14:44+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/enhertu-kan-endre-behandlingsforlopet-ved-tidlig-her2-positiv-brystkreft/2039992025-10-20T14:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/et-gjennombrudd-som-vil-endre-behandlingsstandarden-ved-blaerekreft/2039762025-10-18T22:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/giredestrant-kan-bli-et-nytt-effektivt-alternativ-etter-cdk4/6-behandling/2039572025-10-18T11:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/svaert-betydningsfulle-resultater-for-kreftpasienter/2039302025-10-18T09:34+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/lavere-dose-cellegift-ga-prostatakreft-pasienter-langt-faerre-alvorlige-bivirkninger-kan-bli-ny-standard/2039222025-10-18T08:58+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/verzenios-er-forste-cdk4/6-hemmer-som-viser-okt-overlevelse-i-adjuvant-behandling-av-brystkreft/2038982025-12-12T10:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/rekordmange-haukeland-leger-pa-arets-esmo-viktig-for-bade-rekruttering-og-faglig-utvikling/2038632025-10-18T08:27+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/reaksjoner-pa-statsbudsjettet-2026-ikke-pasientenes-budsjett/2038182025-10-16T10:27+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/esmo-2025-de-viktigste-studiene-og-norsk-rekord/2037952025-10-17T12:26+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/disse-onkologene-reiser-til-esmo-2025-flere-presenterer-ny-norsk-kreftforskning/2037872025-10-16T11:02+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-sjefen-om-terskelverdien-forventer-en-betydelig-oppjustering/2037652025-10-14T09:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nye-metoder-lege-advarer-a-oke-betalingsvilligheten-kan-gi-faerre-gode-levear-til-pasientene/2037152025-10-10T17:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/subkutan-keytruda-kan-tas-i-bruk-i-desember-2025-kortere-behandlingstid-men-samme-pris/2037042025-10-13T17:04+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/nevrolog-advarer-frykter-at-norge-ikke-tar-migrene-pa-alvor/2036562025-10-10T08:27+02:00https://image.healthtalk.no?imageId=203651&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-soker-norske-eksperter-til-europeisk-legemiddelarbeid/2035852025-10-15T09:40+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/storbritannia-planlegger-a-heve-terskelverdien-med-25-prosent/2035692025-10-08T16:50+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bard-hoksrud-er-ny-leder-av-transport-og-kommunikasjonskomiteen/2035532025-10-08T16:39+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vestre-erkjenner-fiasko-for-kliniske-studier-lover-forbedring/2035262025-10-08T06:45+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/crohns/nye-uegw-data-pa-rinvoq-kan-pavirke-debatten-om-jak-hemmere/2035062025-10-07T11:00+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/tarmkreft/lars-aabakken-hedret-med-pris-under-uegw-2025/2034832025-10-07T07:34+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/rwe-studie-pa-uegw-rinvoq-gir-rask-effekt-ved-ulceros-kolitt/2034732025-10-07T07:30+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nobelprisen-i-medisin-gar-til-forskerne-bak-oppdagelsen-av-immunsystemets-sikkerhetsvakter/2034482025-10-06T16:09+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/flertallspress-pa-myndighetene-vil-ha-oppdatert-terskelverdi-na/2034302025-10-09T11:03+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/erlend-svardal-boe-er-ny-helsepolitisk-talsperson-i-hoyre-troen-gar-til-ny-komite/2033962025-10-03T11:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/nye-europeiske-retningslinjer-wegovy-og-mounjaro-skal-vaere-forstevalg-ved-fedmebehandling/2033792025-10-02T15:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/astma/studie-apner-for-klimavennlige-inhalatorer/2033702025-10-06T10:49+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/healthtalk/lets-be-fire-preventers-not-just-firefighters-says-asthma-expert-simon-couillard-emphasizing-the-importance-of-early-intervention/2033002025-10-02T13:27+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/astma/vi-ma-vaere-brannforebyggere-ikke-bare-brannslukkere-astmaekspert-om-viktigheten-av-tidlig-intervensjon/2032842025-10-02T14:17+02:00https://image.healthtalk.no?imageId=202228&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vil-oke-antallet-kliniske-studier-og-korte-ned-tiden-til-rekruttering-av-pasienter/2032672025-10-02T08:53+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/pfizer-inngar-prisavtale-med-trump-kan-presse-fram-lignende-kutt-hos-roche-og-novartis/2032482025-10-01T19:06+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/tarmkreft/ny-norsk-studie-skal-teste-funksjonell-presisjonsmedisin-for-tarmkreft-med-spredning/2032252025-10-01T08:27+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/ny-kreftmedisin-far-samme-pris-som-i-usa/2032082025-09-30T12:04+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-besokte-medicinradet-i-danmark/2031892025-09-30T10:49+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tor-frostelid-forlater-novo-nordisk-begynner-i-sykehusinnkjop-1-januar/2031532025-09-29T14:40+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hvordan-vil-ola-nordmann-fordele-helsekronene-vare/2031392025-10-03T09:26+02:00https://image.healthtalk.no?imageId=203146&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-genterapi-viser-lovende-resultater-for-huntingtons-sykdom/2031042025-10-06T08:02+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/trump-truer-med-100-prosent-toll-pa-legemidler-lmi-advarer-om-konsekvensene/2030862025-09-29T07:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/eu-har-godkjent-kisunla-na-starter-norsk-vurdering-av-alzheimers-medisinen/2030712025-09-29T11:24+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helse-sor-ost-hever-avtalen-med-medi3/2030562025-09-26T15:38+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/kan-ki-hjelpe-oss-a-forsta-og-forebygge-effekten-av-sjokkartede-hendelser/2030282025-09-29T12:02+02:00https://image.healthtalk.no?imageId=203034&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kjersti-toppe-kan-bli-ny-leder-av-helse-og-omsorgskomiteen/2030082025-09-26T10:01+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vestre-svarer-troen-lover-rask-utredning-av-terskelverdi-innen-nyttar/2029852025-10-09T11:13+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftanbudet-endrer-behandlingslandskapet-dette-er-vinnerne-og-de-viktigste-endringene/2029772025-09-26T13:20+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/eli-lilly-sjefen-storbritannia-er-det-verste-landet-i-europa-for-legemiddelpriser/2029172025-09-24T12:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/ectrims-ocrevus-viser-effekt-ogsa-ved-avansert-ppms-og-som-subkutan-injeksjon/2028962025-10-01T10:55+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/trump-knytter-autisme-til-vaksiner-og-paracetamol-ema-fastholder-at-legemidlet-er-trygt-i-svangerskap/2028732025-10-01T10:56+02:00https://image.healthtalk.no?imageId=192413&format=webp&width=1200https://www.healthtalk.no/healthtalk/dmp-blokkerer-60-ulovlige-nettsteder-om-legemidler/2028502025-10-01T10:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/ms-er-en-erfaringssykdom-helene-wangberg-om-a-bli-eldre-med-multippel-sklerose/2028242025-09-24T10:36+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bekrefter-subkutan-opdivo-erstatter-intravenos-fra-1-november/2027942025-09-22T14:31+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/subkutan-opdivo-innfort-aktuell-for-et-stort-antall-pasienter/2027722025-09-22T13:09+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/mandag-kan-nok-en-sproytebasert-immunterapi-bli-innfort-hva-betyr-det-for-pasientene/2027552025-09-19T14:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/ectrims-nye-firearsdata-viser-varig-effekt-av-mavenclad-ved-ms/2026842025-10-01T10:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-verzenios-viser-for-forste-gang-okt-overlevelse-kan-endre-norske-retningslinjer/2026052025-09-18T08:36+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimers/blodprovetest-kan-apne-doren-til-nye-alzheimer-legemidler-behandles-i-bestillerforum-mandag/2024642025-09-21T13:29+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/perioperativ-pembrolizumab-gir-bedre-langtidsresultater-ved-operabel-lungekreft/2024122025-09-17T10:58+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/keynote-483-pembrolizumab-kan-bli-nytt-behandlingstilbud-ved-mesoteliom/2024022025-09-17T08:50+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/aldring-og-ms-slik-pavirker-sykdommen-eldre-pasienter-og-hva-fremtidens-behandling-kan-bli/2023822025-09-18T12:57+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norsk-lege-i-new-york-jeg-haper-a-kunne-ta-med-meg-det-beste-fra-to-verdener-hjem-til-norge/2023602025-09-19T08:49+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/se-odd-terje-brustugun-om-empower-lung-5-arsdata/2022652025-09-15T10:32+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/healthtalk/cathrine-meland-utnevnt-til-ny-departementsrad-i-helse-og-omsorgsdepartementet/2022342025-09-12T13:36+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sanofis-myndighetskontakt-bjorn-kristian-svendsrud-er-klar-for-stortinget/2022042025-09-12T09:04+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/femarsdata-bekrefter-langtidseffekt-av-libtayo-ved-avansert-lungekreft/2021842025-09-16T10:49+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/lungekreft/wclc-siste-nytt-om-adc-er-bispesifikke-antistoff-og-straleterapi/2021732025-09-11T10:55+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/duchenne-pasienter-lever-lenger-men-lege-peker-pa-manglende-oppfolging-av-voksne-pasienter/2021292025-09-10T14:36+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/lillys-jaypirca-viser-sterke-resultater-i-forstelinje-kll/2021142025-09-24T09:00+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/lovende-resultater-for-kras-hemmer-blir-veldig-spennende-a-se/2021002025-09-10T11:20+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/lungekreft/ti-maneders-lenger-overlevelse-ved-egfr-mutert-lungekreft-overraskende-og-imponerende/2020682025-09-09T07:32+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/kliniske-studier-norge-ma-spille-i-den-internasjonale-toppdivisjonen/2020522025-09-17T12:00+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/blodkreftforeningen-skal-vaere-en-trygg-havn-og-en-tydelig-stemme/2020202025-09-12T11:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kronisk-kostnad-eller-kronisk-losning/2019752025-09-04T15:21+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/diffia-henter-ny-toppsjef-for-a-styrke-vekst-og-innovasjon/2019382025-09-04T14:25+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/46-legemidler-under-metodevurdering-kreft-dominerer/2019252025-09-23T07:35+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-omradedirektor-for-legemiddelvurdering-i-dmp/2019022025-09-03T07:16+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/ny-studie-wegovy-knyttes-til-lavere-hjertesykdomsrisiko-enn-mounjaro/2018862025-09-03T12:05+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/prostatakreft/helsedirektoratet-advarer-mot-raske-konklusjoner-i-prostata-debatten/2018692025-09-04T10:16+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/beone-medicines-blir-med-i-matrix-rare-studien/2018502025-09-10T12:02+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/radiolog-haseem-ashraf-blir-professor-ved-universitetet-i-oslo/2018332025-09-01T09:25+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/ny-medisin-kan-bli-et-gjennombrudd-i-behandlingen-av-hoyt-blodtrykk/2018112025-08-31T00:15+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nho-geneo-kritiserer-helsereformutvalget-utelater-sentrale-aktorer/2017962025-08-29T14:58+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hjerneradet-lanserer-digitalt-vitensenter-om-hjernen/2017832025-09-08T07:43+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dette-mener-de-om-direktoratet-for-medisinske-produkter/2017652025-09-03T12:04+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kliniske-studier-malene-som-glapp/2017432025-08-29T12:43+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bekeng-vi-vil-videreutvikle-handlingsplanen-for-kliniske-studier/2017242025-09-02T11:47+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kristin-svanqvist-skal-lede-nansen-neuroscience-network/2017122025-08-29T08:31+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ber-om-innspill-til-alternativkostnad-terskelverdien-under-lupen/2016952025-08-29T08:14+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/er-det-for-mange-sykehus-som-tilbyr-robotkirurgi-for-prostatakreft/2016652025-08-28T08:46+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftforeningen-altfor-fa-far-hjelp-gjennom-tilgangsordningen/2016502025-11-03T08:25+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/eu-godkjenner-nytt-legemiddel-som-kan-forebygge-hiv/2016352025-08-28T10:24+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/kisqali-godkjent-i-beslutningsforum-gir-nytt-tilbud-til-pasienter-med-tidlig-brystkreft-og-hoy-risiko-for-tilbakefall/2015702025-08-25T14:40+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/astrazeneca-fikk-dobbelt-ja-pa-blaerekreft-og-blodkreft/2015532025-08-25T11:05+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-sier-ja-til-ketamin-men-kritikken-hagler-norge-verdsetter-ikke-innovasjon/2015212025-08-25T11:48+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ous-avviser-schjesvolds-kritikk-om-motvilje-til-industrisamarbeid/2014902025-08-26T08:44+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsedirektoratet-innrommer-malbrist-ikke-fornoyd-med-utviklingen-i-kliniske-studier/2014802025-08-27T10:13+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-avviser-kritikk-ingen-motvilje-mot-industrisamarbeid/2014722025-08-26T08:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/topp-forsker-fredrik-schjesvold-motvilje-i-ous-ledelsen-hemmer-kliniske-studier-i-norge/2014592025-08-26T08:45+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vestre-mislykkes-med-malene-for-kliniske-studier-ingen-dobling-og-pasientmalet-ryker/2014402025-08-26T08:53+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/utfordrer-norges-omdomme/2014202025-08-25T07:45+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lhl-ma-se-pa-betalingsvilje-i-et-storre-bilde/2013592025-10-09T11:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norge-ma-vaere-med-og-bidra-et-snylteland-er-det-ingen-av-oss-som-onsker/2013462025-10-09T11:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bms-direktor-systemet-mister-gradvis-relevans-ar-for-ar/2013332025-10-09T11:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kreftpasienter-venter-637-dager-pa-de-nyeste-legemidlene/2013202025-10-09T11:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/professor-tror-betalingsviljen-for-legemidler-vil-oke-etter-valget/2013062025-10-09T11:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bekeng-og-hoksrud-vi-blir-nok-aldri-enige/2012922025-10-09T11:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/rsv/risikerer-at-mellom-2000-og-4000-spedbarn-unodvendig-blir-lagt-inn-pa-sykehus/2012712025-08-19T14:28+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ni-har-sokt-tre-har-fatt-medisin-som-beslutningsforum-har-sagt-nei-til/2012482025-11-03T08:25+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/rsv/rsv-medisin-kan-hjelpe-spedbarn-vil-norge-vente-til-2027/2012312025-08-19T14:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/eli-lilly-oker-legemiddelprisene-i-europa-for-a-gjore-dem-lavere-i-usa/2012182025-08-18T08:18+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/meyer-ma-apne-for-mer-kapasitet-satse-pa-forskning-og-tenke-mer-tverrfaglig/2011832025-08-12T17:31+02:00https://image.healthtalk.no?imageId=190618&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/kombinasjonsbehandling-gir-bedre-overlevelse-ved-blaerekreft/2011532025-08-15T08:30+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/samlet-toppledere-til-hemmelig-mote-i-arendal-slik-vil-de-styrke-norsk-livsvitenskap/2011452025-08-12T16:30+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/krever-nasjonal-strategi-for-kronisk-syke-hod-lover-ingenting/2011252025-08-11T16:48+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/storbritannia-lytter-til-usa-vil-bruke-mer-penger-pa-legemidler/2011002025-10-09T11:15+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/rsv/hod-vil-ikke-delta-i-arendalsuka-debatt-om-rsv-forebygging-far-kritikk/2010822025-08-11T11:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/eli-lillys-nye-fedmepille-skuffer-aksjekursen-falt-med-100-milliarder-dollar/2010572025-08-08T11:13+02:00https://image.healthtalk.no?imageId=172915&format=webp&width=1200https://www.healthtalk.no/blodkreft/tepkinly-viser-lovende-resultater-i-fase-3-studie-for-follikulaert-lymfom/2010422025-08-11T11:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norgesgruppen-kjoper-nmd-far-386-apotek-og-3000-ansatte-pa-kjopet/2010202025-08-07T10:12+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/robert-steen-om-sonnen-mats-ibelin-steen-duchennes-muskeldystrofi-og-livet-som-parorende/2010022025-08-07T20:50+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/avtroppende-novo-direktor-advarer-kan-bli-oppsigelser/2009852025-08-07T09:16+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/ema-ber-om-ja-til-nytt-legemiddel-mot-hjernesvulst/2009522025-08-05T08:05+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/msd-kutter-6000-stillinger-skal-spare-30-milliarder-kroner/2009322025-08-04T14:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/moderna-kutter-10-prosent-av-arbeidsstyrken-et-vanskelig-men-nodvendig-grep/2009132025-08-01T10:51+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/abbvie-med-sterke-resultater-for-rinvoq-i-behandling-av-alvorlig-alopecia-areata/2008952025-08-06T08:12+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/eli-lillys-jaypirca-slar-imbruvica-i-ny-leukemi-studie/2008752025-08-04T16:24+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/smitteverndirektor-are-stuwitz-berg-har-gatt-bort/2008582025-07-30T12:45+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/novo-nordisk-bytter-toppsjef-og-kutter-salgsprognosen-kraftig-1/2008412025-07-29T20:24+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/15-prosent-toll-pa-legemidler-fra-europa-vil-koste-milliarder-norske-selskaper-rammes/2008292025-08-01T09:25+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kols/betaler-53-milliarder-kroner-i-forskudd-for-kinesiske-legemidler/2008162025-07-31T07:54+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/gsk-far-eu-godkjenning-for-blenrep-kan-bli-ny-standard-i-behandlingen-av-benmargskreft/2008012025-08-01T09:03+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/roche-skal-undersoke-om-ny-medisin-kan-forsinke-eller-forebygge-alzheimers/2007812025-07-31T08:21+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ema-anbefaler-godkjenning-av-gileads-langtidsvirkende-hiv-profylakse-yeytuo/2007682025-07-29T08:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/kisunla-far-gront-lys-fra-europeiske-legemiddelmyndigheter-for-tidlig-alzheimers-sykdom/2007522025-07-28T11:21+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kols/ny-miljovennlig-drivgass-anbefalt-godkjent-for-trixeo-spray/2007402025-07-28T08:50+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/studie-bekrefter-overlevelsesgevinst-med-tagrisso-i-kombinasjon-med-kjemoterapi/2007242025-07-23T09:01+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/prostatakreft/eu-godkjenner-nubeqa-for-ny-indikasjon-ved-avansert-prostatakreft/2007112025-07-21T10:23+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/amyloidosebehandling-mislyktes-i-senfase-studie/2006952025-07-18T11:22+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/msd-samarbeider-med-gates-foundation-om-stor-global-hiv-studie/2006812025-07-17T09:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-norsk-metode-for-a-male-livskvalitet-skal-sikre-bedre-helseprioriteringer/2006692025-07-16T09:22+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/baxdrostat-reduserer-hoyt-blodtrykk-hos-behandlingsresistente-pasienter/2006542025-07-14T11:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ema-advarer-kritisk-medisin-for-gravide-kan-bli-mangelvare/2006392025-07-09T11:54+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/gsk-kjoper-legemiddel-satser-stort-pa-neste-generasjon-bloderbehandling/2006212025-07-08T13:26+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slik-arbeider-norge-sverige-og-danmark-med-metodevurdering-og-prisavtaler-pa-medisiner/2006012025-10-09T11:15+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/novartis-stanser-studie-av-cosentyx-mot-kjempecellearteritt/2005832025-07-07T09:40+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/bergenbio-og-oncoinvent-vil-bli-ett-selskap-skal-hente-130-nye-millioner/2005412025-07-03T13:55+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ultrasjelden-blodsykdom-far-forste-godkjente-behandling-vi-har-ventet-lenge/2005272025-07-04T13:51+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oyesykdom/halvarlige-sproyter-kan-gi-ny-hverdag-for-pasienter-med-alvorlige-oyesykdommer/2005012025-07-02T13:47+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norge-sier-nei-til-litfulo-danmark-sier-ja-hvor-mye-er-haret-verdt/2004752025-07-07T11:39+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/t-cellereseptorer-kan-bli-neste-store-gjennombrudd-i-kreftbehandling/2004632025-07-02T09:03+02:00https://image.healthtalk.no?imageId=200447&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/iselin-dahlen-syversen-tar-steget-fra-sykehusinnkjop-til-departementet/2004502025-07-03T08:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/astrazeneca-vi-er-apne-for-nye-losninger/2004292025-07-02T08:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/truqap-avslag-skaper-reaksjoner-vurderingen-gjenspeiler-ikke-norsk-virkelighet/2004122025-07-02T08:29+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/imbruvica-kan-erstatte-transplantasjon-norske-leger-soker-tidlig-bruk/2003972025-06-30T09:13+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sveinung-stensland-til-eli-lilly-far-ansvar-for-nordisk-legemiddelpolitikk/2003792025-06-26T15:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsevalget-2025-bard-hoksrud-frp-vi-far-faerre-ufore-med-mer-penger-til-helse-og-legemidler/2003562025-06-26T12:06+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/lungekreft/ingen-forskjell-i-overlevelse-mellom-immunterapier-mot-lungekreft/2003332025-06-26T08:23+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/sarclisa-godkjent-som-forstelinjebehandling-av-myelomatose-ny-ema-anbefaling-kan-utvide-bruken-ytterligere/2002802025-06-24T16:30+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/blodkreft/forsker-pa-ultrasjelden-leukemi-kanskje-bare-en-nordmann-som-rammes-i-aret/2002152025-06-24T10:49+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/samme-medisin-ulik-konklusjon-derfor-ble-hartap-behandling-godkjent-i-danmark-men-avvist-i-norge/2001912025-07-07T11:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/tidlig-behandling-ved-tilbakefall-kan-bli-nokkelen-for-pasienter-med-benmargskreft/2001702025-06-23T06:37+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-om-bekengs-pekefinger-mot-industrien-ren-ansvarsfraskrivelse/2001512025-06-20T11:06+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/paradigmeskifte-i-blodkreft-behandling-vi-kan-komme-til-a-snakke-om-kurasjon/2001192025-06-19T14:24+02:00https://image.healthtalk.no?imageId=199964&format=webp&width=1200https://www.healthtalk.no/myelomatose/norsk-kreftvaksine-viser-lovende-resultater-hos-pasienter-med-myelomatose/2000962025-06-19T09:36+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oyesykdom/beslutningsforum-videreforer-luxturna-genterapi-for-sjelden-oyesykdom-far-varig-godkjenning/2000762025-06-18T13:18+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-innforer-15-nye-metoder-norge-forst-med-tre-kreftbehandlinger/2000282025-06-16T12:34+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/kll-pasienter-fikk-bedre-livskvalitet-med-ny-btk-hemmer/1999942025-06-17T08:58+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/ny-studie-tidsbegrenset-behandling-gir-bedre-overlevelse-ved-kll-na-innfort-i-norge/1999662025-06-15T09:44+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/ny-kombinasjonsbehandling-viser-lovende-effekt-ved-tilbakevendende-kll/1999472025-06-18T09:51+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/neste-generasjons-legemidler-gir-hap-for-kll-pasienter/1999222025-06-14T10:27+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/aml-nytt-mal-for-behandling-kan-gi-okt-hap-for-pasientene/1998802025-06-17T14:23+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/haper-a-kunne-forutsi-hvordan-kml-pasienter-responderer-pa-behandling-etter-kun-en-time/1998682025-06-13T10:37+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/eu-kommisjonen-godkjenner-duvyzat-for-behandling-av-duchennes-muskeldystrofi/1998422025-06-13T09:22+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/pelabresib-viser-varig-effekt-ved-myelofibrose-kan-bli-forste-nye-behandling-pa-over-ti-ar/1998242025-06-13T09:13+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/lovende-kombinasjon-mot-tilbakevendende-benmargskreft-veldig-spennende/1997862025-06-14T16:02+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slik-forhandler-norge-frem-prisen-pa-nye-legemidler/1997742025-06-12T14:30+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/lymfom/nesten-alle-pasientene-ble-kreftfrie-med-tepkinly-i-forstelinje-det-er-bingo/1997272025-06-16T08:09+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kols/kols-koster-norge-over-100-milliarder-na-etterlyses-nasjonalt-pakkeforlop/1997182025-06-11T08:42+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/lymfom/mantelcellelymfom-seks-av-ti-pasienter-ble-kreftfrie-med-malrettet-behandling/1996952025-06-15T09:35+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/kml-pasienter-fikk-faerre-bivirkninger-og-raskere-effekt-kan-bli-ny-forstelinjebehandling/1996852025-06-12T15:12+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/ny-studie-stotter-enklere-oyeoppfolging-av-pasienter-med-benmargskreft/1996162025-06-14T18:19+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/alle-benmargskreft-pasientene-fikk-effekt-av-ny-antistoff-behandling-den-storste-eha-nyheten/1996082025-06-14T14:01+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/ventetiden-vi-ikke-vil-telle/1995942025-06-11T08:12+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/pasientorganisasjoner-krever-ny-ventetidsmaling-statsekretaer-peker-pa-industrien/1995842025-06-10T08:02+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/blodkreft-medisiner-oker-behovet-for-immunglobuliner-mot-immunsvikt-det-skaper-store-utfordringer/1995692025-06-12T15:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/nordmenn-presenterer-blodkreftforskning-pa-europeisk-kongress/1995492025-06-12T15:17+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/helsevalget-2025-truls-vasvik-ap-om-prioriteringsmeldingen-terskelverdi-og-helsekoer/1995262025-06-04T13:43+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/prostatakreft/kreftmedisin-gir-prostatakreft-pasienter-bedre-livskvalitet-det-er-betryggende/1994872025-06-03T14:14+02:00https://image.healthtalk.no?imageId=109512&format=webp&width=1200https://www.healthtalk.no/brystkreft/enhertu-kan-bli-ny-forstelinjestandard-ved-her2-positiv-brystkreft/1994602025-06-03T08:41+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/lovende-for-norsk-kreftvaksine-i-kombinasjon-med-immunterapi-mot-livmorhalskreft/1994382025-06-02T15:56+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/immunterapi-i-sproyteform-eu-godkjenner-subkutan-opdivo/1994272025-06-05T12:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/immunterapi-reduserer-risiko-for-tilbakefall-ved-tidlig-magekreft-med-29-prosent/1994082025-06-02T14:45+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/ny-kombinasjonsbehandling-reduserer-risiko-for-sykdomsprogresjon-med-35-hos-brystkreftpasienter/1993852025-06-03T07:23+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/skuffende-resultat-av-studie-pa-adc-ved-lungekreft/1993712025-06-05T13:22+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/norskledet-lungekreft-studie-pa-asco-immunterapi-ga-ikke-forventet-effekt/1993512025-06-02T14:41+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/pasientorganisasjoner-raser-mot-ventetidstatistikk-ma-males-til-faktisk-tilgang/1993302025-06-04T07:57+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/sigrid-matthes-er-ny-leder-i-blodkreftforeningen/1993132025-05-30T10:51+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/msd-norges-toppsjef-forlater-selskapet/1993022025-05-30T08:33+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vasvik-ap-advarer-reell-fare-at-vi-ikke-far-flere-legemidler-bare-dyrere/1992802025-05-28T14:55+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/stortinget-ber-regjeringen-gjore-ny-vurdering-av-betalingsviljen/1992542025-05-28T14:49+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/asco-2025-norske-leger-presenterer-forskning-pa-verdens-storste-kreftkongress/1992272025-05-30T10:48+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/vaksine/msd-tapte-vaksine-rettsak-situasjonen-kunne-vaert-unngatt/1992082025-05-27T15:50+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/tommel-opp-til-blenrep-kan-endre-behandlings-landskapet-for-myelomatose/1991922025-05-27T12:23+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/gjennombrudd-for-blaerekreft-ny-livsforlengende-behandling-innfores-fra-1-juli/1991652025-05-26T15:06+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/danske-prisforhandlinger-pa-apoteklegemidler-sykehusinnkjop-sier-velkommen-etter/1991442025-05-26T07:33+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/saken-vil-bli-en-betydelig-stresstest-for-beslutningsforum/1991292025-05-23T11:39+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/tiarets-storste-gjennombrudd-for-blaerekreft-pasienter-kan-fa-ja-i-norge-pa-mandag/1990932025-05-22T07:55+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/lilly-soker-blaresept-for-mounjaro-et-ja-kan-koste-staten-milliarder/1990672025-05-23T07:35+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/dette-er-norges-dyreste-legemidler/1990542025-05-21T10:26+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/norsk-teknologi-fra-exact-therapeutics-ga-firedoblet-effekt-av-cellegift-mot-leverkreft/1990392025-05-20T13:26+02:00https://image.healthtalk.no?imageId=199045&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/professor-jan-terje-andersen-tildelt-uios-innovasjonspris-for-2025/1990182025-05-20T12:34+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftforeningen-frykter-pasienter-stenges-ute-av-ny-unntaksordning/1989782025-05-20T07:08+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/novo-nordisks-toppsjef-gar-av-etter-kraftig-kursfall/1989262025-05-16T15:36+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eksem/vil-ekspress-behandle-nytt-legemiddel-mot-atopisk-eksem/1989082025-05-21T12:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/jaypirca-gar-til-metodevurdering-kan-bli-nytt-behandlingsalternativ-for-kll-pasienter/1988912025-05-19T07:59+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/psykisk-helse/bestillerforum-sier-nei-ingen-ny-metodevurdering-av-spravato-mot-behandlingsresistent-depresjon/1988692025-05-19T13:01+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/38-811-nye-krefttilfeller-i-2024-markant-nedgang-i-livmorhalskreft/1988482025-05-15T15:45+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/cathrine-marie-lofthus-blir-ny-helsedirektor/1988352025-09-12T13:23+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/lungekreftforeningen-byrakrati-stopper-viktig-kreftbehandling/1987702025-05-15T07:50+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/ny-immunterapi-i-sproyteform-opdivo-kan-bli-innfort-denne-maneden/1987552025-05-15T07:39+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisk-til-eli-lilly-fedmebehandling-handler-ikke-bare-om-kilo/1987322025-05-13T08:10+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/hva-koster-et-godt-levear-frp-vil-oke-terskelverdien-dmp-advarer/1987092025-10-09T11:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/trekker-seg-som-styreleder-sonnen-fikk-toppjobb-ved-radiumhospitalet/1987012025-05-12T15:53+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/eli-lillys-mounjaro-slar-wegovy-i-direkte-sammenligningsstudie/1986872025-05-13T11:14+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nye-medisiner-pa-vei-for-pasienter-med-duchenne-slik-beskriver-eksperten-behandlingene/1986692025-05-12T09:04+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/nytt-hap-for-gutter-med-duchenne-ny-medisin-naer-godkjenning-i-eu/1986492026-02-17T11:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/brukinsa-innfort-som-forstelinjebehandling-for-kll-pasienter-i-norge/1986192025-05-21T12:33+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/healthtalk/svs-marian-hussein-vil-erstatte-beslutningsforum-og-stanse-veksten-i-privat-helseforsikring/1986012025-05-09T09:02+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/odd-erik-johansen-far-global-lederstilling-ved-hovedkontoret-til-roche-i-sveits/1985592025-05-08T07:46+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/to-rapporter-om-ventetider-to-virkeligheter/1985292025-05-07T14:52+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-og-nye-metoder-nye-tiltak-kutter-tid-til-saksbehandling-industrien-trekker-ut-tiden/1984972025-05-07T11:04+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/wait-rapporten-norske-pasienter-venter-524-dager-pa-tilgang-til-nye-medisiner/1984772025-05-07T15:02+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/professor-karl-johan-malmberg-fikk-kong-olav-vs-kreftforskningspris-for-2025/1984592025-05-07T06:33+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/nevrolog-hyller-ny-migrenemedisin-men-advarer-mot-a-droppe-eldre-behandling/1984112025-05-06T08:43+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ema-anbefaler-16-nye-legemidler-for-godkjenning-i-eu/1983712025-05-06T07:41+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/etter-mer-enn-to-ar-blir-migrene-tabletten-vydura-tilgjengelig-pa-bla-resept/1983432025-05-02T13:55+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/chicken-game-i-legemiddelforhandlingene-staten-blunker-sist/1982912025-04-30T15:24+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehusinnkjop-topp-nicolai-maric-bjornaes-gar-til-ny-eu-stilling-flytter-til-brssel/1982622025-05-05T11:46+02:00https://image.healthtalk.no?imageId=192805&format=webp&width=1200https://www.healthtalk.no/lymfom/innforer-kreftmedisin-etter-ni-ars-ventetid-men-omstridt-anbudspraksis-fortsetter/1982542025-05-05T12:05+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/trumps-tolltrusler-kan-ramme-pasienter-og-investeringer-i-industrien/1982362025-05-02T07:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/disse-vil-bli-ny-helsedirektor/1982202025-04-30T08:53+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/disse-20-legemiddelselskapene-hadde-hoyest-omsetning-i-2024/1982012025-05-15T11:07+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/endelig-ja-til-fintepla-men-epilepsiforbundet-er-kritisk-til-lang-saksbehandling/1981852025-04-29T08:55+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ja-til-nye-lungekreftbehandlinger-immunterapi-gir-hap-om-lengre-overlevelse/1981582025-04-28T13:39+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/nevrolog-om-dobbelt-ms-ja-i-beslutningsforum-etter-syv-ar-et-alternativ-for-noen-fa/1981402025-04-28T13:06+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-sier-ja-til-behandling-av-ms-lungekreft-og-blodkreft-men-nei-til-medisin-mot-alvorlig-haravfall/1981162025-04-29T08:50+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kapplop-i-stortinget-for-prioriteringsmeldingen/1980722025-04-30T08:09+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-bruker-i-82-dager-pa-a-finne-eksperter-til-metodevurderinger-vet-ikke-hvorfor/1980192025-04-28T12:09+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rekordstort-mote-i-beslutningsforum-disse-25-sakene-skal-opp-til-behandling/1979962025-04-25T12:52+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-leder-i-gynkreftforeningen-jorun-stallemo-tar-over-stafettpinnen/1979652025-04-25T09:59+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/europeiske-legemiddelselskaper-krever-hoyere-medisinpriser-i-europa-etter-trusler-om-amerikanske-tollbarrierer/1979482025-04-24T11:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hod-om-ny-prioriteringsmelding-ryggdekning-for-prioritering-i-hele-helsetjenesten/1979302025-04-24T10:43+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tone-troen-h-helsekoene-krever-mer-enn-skippertak-og-kortsiktige-avtaler/1979092025-04-24T14:40+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/brystkreft/over-en-million-kroner-skiller-norsk-og-svensk-prisvurdering-av-brystkreftmedisin/1978832025-04-23T11:41+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/cecilie-wendt-er-ny-leder-i-blaerekreftforeningen/1978252025-04-22T14:10+02:00https://image.healthtalk.no?imageId=197831&format=webp&width=1200https://www.healthtalk.no/brystkreft/ny-studie-trodelvy-i-kombinasjon-med-keytruda-bremser-svulstvekst-i-aggressiv-brystkreft/1977962025-04-22T10:20+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/100-200-benmargskreft-pasienter-kan-vaere-aktuelle-for-blenrep-gjennom-compassionate-use/1977882025-04-23T06:43+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/ny-pille-fra-eli-lilly-gir-like-stort-vekttap-som-wegovy/1977712025-04-21T17:16+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/storbritannia-godkjenner-kombinasjonsbehandlinger-med-gsks-blodkreftlegemiddel-blenrep/1977562025-04-19T10:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/alzheimer-medisin-godkjent-i-eu-og-norge-men-usikkert-om-norske-pasienter-far-den/1977292025-04-16T13:33+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/hjertelegemiddel-skuffer-i-stor-studie/1977082025-04-15T13:36+02:00https://image.healthtalk.no?imageId=168207&format=webp&width=1200https://www.healthtalk.no/blodkreft/ny-behandling-for-aggressiv-blodkreft-godkjent-i-eu/1976922025-04-15T11:09+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/pfizer-stanser-utviklingen-av-fedmepille-etter-leverskade/1976692025-04-14T16:21+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/kommentar/norge-har-store-handelsbarrierer-pa-legemidler-hva-gjor-vi-med-det/1976402025-04-22T08:43+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nye-metoder-lege-med-krass-kritikk-mot-sjeldenkoalisjon-slik-svarer-ucb-sjefen/1976192025-04-14T08:23+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hoyre-og-ap-vil-gjore-norge-til-ledestjerne-for-helsenaering-men-er-de-enige-om-veien-dit/1976012025-04-11T08:53+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-kaller-prioriteringsmeldingen-en-falitterklaering-fra-regjeringen/1975842025-04-10T13:16+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/ms-anbudet-tysabri-gjor-comeback-velges-foran-kopi-medisinen-tyruko/1975492025-04-09T15:00+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/godkjenner-rinvoq-for-behandling-av-kjempecellearteritt/1975202025-04-09T14:41+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tidligere-pfizer-topp-erik-hjelvin-blir-partner-i-first-house/1974972025-04-09T10:50+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ahus-lykkes-med-forskningssatsing-8-av-10-leger-deltar-i-kliniske-studier/1974652025-04-09T11:26+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/leverte-syv-forslag-til-prisavtaler-for-enighet-lmi-krever-bedre-veiledning-fra-sykehusinnkjop/1974482025-04-08T12:51+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/heder-til-forskere-innen-hjerte-og-demens-pris-til-sigrun-halvorsen-og-jens-pahnke/1974342025-04-08T07:59+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/tidligere-bayer-norge-sjef-jan-borge-jakobsen-blir-sjef-for-thorium-norway/1974102025-04-08T11:11+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/vaksine/ny-pneumokokk-vaksine-eu-godkjent-beskytter-mot-21-undertyper-av-bakterie/1973952025-04-07T11:51+02:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/lymfom/norge-innforte-viktig-lymfekreft-medisin-for-danmark-og-sverige/1973532025-04-04T14:35+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehusinnkjop-mange-nei-i-beslutningsforum-kunne-vaert-unngatt/1973412025-04-07T11:35+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/gir-seg-ikke-i-kampen-for-livsvitenskapsstrategi-na-mobiliserer-hoyre-tungvekterne/1973132025-04-04T08:30+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/novartis-trekker-ms-medisin-fra-norsk-anbud-deltar-ikke-pa-like-vilkar/1972932025-04-04T09:09+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/norsk-studie-dodelighet-etter-hjerteinfarkt-faller-men-en-gruppe-har-svaert-darlig-prognose/1972362025-04-07T08:50+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norge-implementerer-nye-eu-regler-om-medisinske-metodevurderinger/1971912025-04-01T07:34+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimers/eli-lilly-far-avslag-i-europa-for-alzheimers-medisin-risiko-vurderes-som-for-hoy/1971612025-03-31T14:14+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vil-forby-gentesting-av-barn-utenfor-helsevesenet/1971252025-03-28T13:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dette-sier-industrimeldingen-om-helsenaering-livsvitenskap-og-legemiddelindustri/1971112025-03-28T13:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/dropper-metodevurdering-av-kll-behandling-kan-bli-priskonkurranse/1970952025-04-01T13:07+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nordby-lunde-h-om-norsk-helsenaering-vi-blir-slatt-ned-i-stovlene-av-danmark-og-sverige/1970622025-03-28T08:40+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/styret-og-ledelsen-gar-av-i-nykode-therapeutics/1970442025-03-27T14:47+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lovende-resultater-for-ungdom-med-alvorlig-haravfall-na-skal-beslutningsforum-ta-stilling-for-voksne/1970292025-04-02T07:41+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ge-healthcare-star-for-halve-helseeksporten-i-norge-hva-skjer-hvis-de-flytter/1969942025-03-26T14:41+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/bayer-utfordrer-pfizers-monopol-pa-hjertemedisin/1969772025-03-28T12:57+01:00https://image.healthtalk.no?imageId=101216&format=webp&width=1200https://www.healthtalk.no/myelomatose/norsk-studie-pa-benmargskreft-far-plass-i-europeiske-retningslinjer-aldri-skjedd-for/1969472025-03-26T13:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/tepkinly-skal-metodevurderes-for-follikulaert-lymfom/1969332025-03-28T13:00+01:00https://image.healthtalk.no?imageId=189425&format=webp&width=1200https://www.healthtalk.no/blodkreft/akutt-mangel-pa-medisin-mot-blodkreft-krever-hasteinnforing-av-nytt-legemiddel/1969202025-03-27T11:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oyesykdom/stor-ettersporsel-etter-ferdigfylt-oyemedisin-kan-skape-forsinkelser-i-norge/1968982025-03-25T10:41+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/ny-teknologi-skal-gi-bedre-oppfolging-av-hjertepasienter/1968612025-03-28T12:58+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/kommentar/fastlegekrise-mer-samarbeid-er-losningen-ikke-problemet/1968342025-03-25T06:50+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/danmark-apner-for-alternative-avtaler-sikrer-pasienter-nye-legemidler-raskere/1967792025-04-04T10:59+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/ny-immunterapi-godkjenning-gir-hap-for-norske-lungekreftpasienter/1967602025-03-21T09:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsedata-i-kliniske-studier-trenger-ikke-lenger-ta-10-12-ar-a-utvikle-et-legemiddel/1967272025-03-28T13:01+01:00https://image.healthtalk.no?imageId=196733&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helseministeren-sier-nei-til-a-evaluere-fast-track-na-far-kritikk-fra-kreftforeningen-og-hoyre/1967152025-03-24T07:58+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helse-sor-ost-og-hod-krever-ikke-okt-apenhet-fra-sykehusinnkjop-holder-fast-ved-kritisert-praksis/1966862025-03-20T10:21+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/na-far-svenske-pasienter-tilgang-til-velsipity-nesten-ett-ar-etter-nabolandene/1966502025-03-20T13:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eksem/eksem-medisin-med-lovende-resultater/1966322025-03-28T13:01+01:00https://image.healthtalk.no?imageId=196610&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/big-pharma-ber-om-fritak-for-medisiner-i-handelskrigen/1966182025-03-28T13:01+01:00https://image.healthtalk.no?imageId=192140&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nytt-lmi-styre/1965572025-03-28T13:03+01:00https://image.healthtalk.no?imageId=196566&format=webp&width=1200https://www.healthtalk.no/lymfom/beslutningsforum-om-lymfom-ja-apenbart-viktig-a-innfore/1965522025-03-17T15:45+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-godkjenner-atte-nye-legemidler-for-sykehusbruk/1965342025-03-17T12:39+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sivilombudet-einnsyn-gjor-offentlig-sektor-mer-apen/1964832025-03-19T10:16+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/forvalter-milliarder-av-helsekroner-svekker-innsyn-med-tungvint-system/1964732025-03-19T07:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/233-000-ventet-pa-helsehjelp-i-februar-laveste-niva-siden-mai-2022/1964572025-03-14T14:35+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/norsk-alzheimer-forskning-far-90-millioner-fra-eu/1964352025-03-28T13:03+01:00https://image.healthtalk.no?imageId=195844&format=webp&width=1200https://www.healthtalk.no/healthtalk/beslutningsforum-ville-ha-i-pose-og-sekk/1964182025-03-14T12:52+01:00https://image.healthtalk.no?imageId=196414&format=webp&width=1200https://www.healthtalk.no/lungekreft/studie-norske-helseregistre-kan-erstatte-kontrollgrupper-i-kliniske-studier/1964042025-03-17T09:13+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/vaksine/norge-sier-ja-sverige-sier-nei-hvorfor-ma-norske-pasienter-likevel-vente-pa-helvetesildvaksine/1963802025-03-18T09:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nevrolog-utfordrer-helseministeren-hvem-skal-ikke-fa-behandling/1963582025-03-17T12:44+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/det-er-pasientene-vi-jobber-for/1963422025-03-13T15:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/wegovy-er-na-pa-svenske-apotek-novo-nordisk-soker-om-refusjon-i-sverige/1963182025-03-28T13:04+01:00https://image.healthtalk.no?imageId=188313&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/roche-satser-57-milliarder-pa-nytt-dansk-fedmelegemiddel/1962952025-03-28T13:04+01:00https://image.healthtalk.no?imageId=195844&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/over-halvparten-strok-i-farmasi-uvanlig/1962632025-03-28T13:05+01:00https://image.healthtalk.no?imageId=195844&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsejurist-reagerer-kan-vaere-brudd-pa-offentlighetsloven/1962512025-03-19T07:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/utfordrer-helseministeren-hvorfor-ma-300-kreftpasienter-vente-pa-livsviktig-behandling/1962012025-03-11T08:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisk-aksjen-faller-etter-skuffende-studiedata-for-neste-generasjons-fedmebehandling/1961822025-03-28T13:05+01:00https://image.healthtalk.no?imageId=196188&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norske-ms-eksperter-vil-bli-rektor-og-viserektor-ved-uio-og-uib/1961592025-03-12T06:32+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyresykdom/flere-med-nyresykdom-far-legemiddel-pa-bla-resept/1961372025-03-28T13:05+01:00https://image.healthtalk.no?imageId=196143&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slapphet-og-trotthet-er-ikke-nodvendigvis-en-tilstrekkelig-diagnose-for-a-bli-ufor/1961012025-03-07T14:25+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/anbefaler-godkjenning-av-columvi-i-ny-behandling-for-aggressiv-blodkreft/1960772025-03-10T08:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/spreng-forsvarer-avslaget-pa-prisavtale-peker-tilbake-pa-msd/1959952025-03-05T09:13+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vi-kunne-fjernet-skatt-pa-arbeid-for-alle-med-inntekt-under-en-million-kroner/1959752025-03-04T17:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kreftforeningen-sterkt-beklagelig-om-partene-ikke-finner-en-raskere-losning/1959642025-03-05T11:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rinvoq-anbefalt-for-godkjenning-i-europa-for-behandling-av-kjempecellearteritt/1959562025-03-10T09:31+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/enhertu-anbefalt-for-godkjenning-i-europa-for-her2-lav-og-her2-ultralav-brystkreft/1959402025-03-06T09:39+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/overrasket-over-nei-til-lavere-pris-ved-rask-innforing-av-immunterapi/1959292025-03-05T09:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/ous-forsker-kalte-kll-data-et-gjennombrudd-na-blir-det-nytt-ja-i-eu/1959172025-03-07T15:31+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ord-duell-om-helsekoene-et-politisk-fluepapir/1958732025-03-03T16:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/danmark-innforer-verzenios-for-brystkreft-etter-nye-data-og-lavere-pris/1958532025-03-04T09:13+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/casper-lorentzen-er-ny-journalist-i-healthtalk/1958372025-03-03T13:40+01:00https://image.healthtalk.no?imageId=195844&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lars-kittilsen-er-ny-kommunikasjonsdirektor-i-helse-sor-ost/1957752025-03-03T08:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fire-nye-legemidler-anbefalt-for-godkjenning-i-europa/1957482025-03-03T11:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/toppmote-pharma-sjefenes-aerlige-mening-om-den-nye-dmp-sjefen/1957262025-02-28T14:46+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/blodkreft-leger-haper-kll-ja-kan-apne-for-nye-medisiner-i-fremtiden/1957072025-02-28T09:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorkreft/norsk-gynkreft-studie-fokus-pa-helsemestring-gir-bedre-oppfolging/1956692025-02-27T08:00+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreftscreening-nesten-30-pasienter-kunne-opereres-etter-tidlig-oppdagelse/1956542025-02-26T14:28+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bergenbio-satset-alt-mislyktes-med-hovedstudien/1956362025-02-26T10:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/oslo-og-tromso-leger-slakter-relis-artikkel-om-hpv-vaksine-ensidig-og-problematisk/1956062025-02-25T14:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/vaksine/vaksinering-mot-helvetesild-oker-kraftig-femdobling-siden-2023/1955872025-02-25T07:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oyesykdom/oyemedisin-viser-god-effekt-og-sikkerhet-etter-tre-ar/1955642025-02-24T08:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/prostatakreft/markant-nedgang-i-dodelighet-av-prostatakreft-norge-i-spissen/1955452025-02-26T09:38+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tre-tiltak-norge-ma-gjore-for-a-tiltrekke-seg-big-pharma/1955022025-02-21T13:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norske-pasienter-ventet-lenger-pa-nye-legemidler-i-2024-enn-i-2021/1954812025-02-22T20:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/mange-norske-pasienter-i-global-lungekreft-studie-banebrytende/1954512025-02-21T08:42+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/meninger/hjertet-og-hjernen-organene-som-er-sterkest-knyttet-til-hverandre/1954292025-02-19T13:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/photocure-med-sterk-vekst/1954102025-02-19T08:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kraftig-vekst-i-bruken-av-adhd-medisiner/1953832025-02-18T12:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kreftforeningen-investerer-millioner-i-legemidler-satser-pa-ny-kreftbehandling/1953712025-02-19T08:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-ikke-opioid-smertebehandling-godkjent-i-usa/1953352025-03-03T07:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/hjertelege-arnljot-tveit-far-aerespris-fra-lhl-hjerneslag-og-afasi/1953272025-02-17T13:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/prostatakreft/gjennombrudd-for-pasienter-med-prostatakreft-bemerkelsesverdig/1953142025-02-18T07:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/regjeringen-overkjores-trolig-flertall-for-a-utrede-skroting-av-helseplattformen/1952802025-02-16T19:58+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sier-nei-til-norsk-livsvitenskapsstrategi-lover-ikke-godt-for-bransjen/1952652025-02-17T08:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/regjeringen-vil-innfore-lungekreftscreening-kreftlege-politiker-og-pasientforening-ber-om-rask-handling/1952442025-02-14T15:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/regjeringen-vil-innfore-screening-av-lungekreft-og-prostatakreft/1952312025-02-14T11:41+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/michael-vester-om-lmi-sjefen-fremsetter-regelmessig-alternative-sannheter/1952032025-02-14T09:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-sjefen-svarer-dmp-sjefen-skjonner-ikke-hva-selskapene-skal-tjene-pa-det/1951852025-02-13T06:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/eksportvekst-i-helseindustrien-men-produksjon-og-innovasjon-svekkes/1951612025-02-11T16:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/astrazenecas-sjef-for-europa-og-canada-derfor-har-jeg-hap-for-norge/1951392025-02-11T11:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/etter-to-avslag-beslutningsforum-sier-ja-til-behandling-av-kronisk-lymfatisk-leukemi/1951212025-02-11T08:18+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norges-nye-medisinsjef-vil-ha-raskere-metodevurderinger-og-bedre-beredskap/1950942025-02-10T08:28+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorkreft/sannsynlig-innforing-av-immunterapi-mot-livmorkreft-pa-mandag/1950702025-02-07T12:22+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ett-ar-pa-a-behandle-rapport-om-lungekreftscreening-helt-uakseptabelt/1950532025-02-06T13:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/ny-rapport-roykere-mellom-50-79-ar-bor-fa-tilbud-om-lungekreftscreening/1950162025-02-04T15:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norsk-ketaminstudie-kan-gi-bedre-dokumentasjon/1949992025-02-05T09:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/relis-cervarix-gir-like-god-beskyttelse-mot-kreft-som-gardasil-9/1949782025-02-04T13:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ingen-ny-metodevurdering-for-depresjon-medisin-uten-ny-dokumentasjon/1949502025-02-05T11:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/26-europeiske-land-har-sagt-ja-til-ny-behandling-av-depresjon-norge-sier-nei/1949422025-02-05T09:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tidligere-pfizer-norge-sjef-sissel-lonning-andresen-blir-sjef-for-nomvec/1949102025-02-03T13:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/martin-grotnes-forlater-sykehusapotekene-blir-konsulent-i-teriak/1948922025-02-03T12:43+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/vi-har-fatt-et-samfunn-som-er-ekstremt-fedmefremkallende/1948422025-01-31T14:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/millioner-av-nordmenn-vil-ned-i-vekt-frykter-klasseskille-pa-slankemedisin/1948192025-01-30T08:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/dorejd-kastrati-er-ny-medisinsk-direktor-hos-boehringer-ingelheim-danmark-og-norge/1948052025-01-30T07:35+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slakter-naeringsfiendtlig-rapport-bekrefter-var-kritikk-av-utvalget/1947862025-01-29T12:55+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/norsk-studie-ai-kan-oppdage-brystkreft-flere-ar-for-diagnose/1947782025-02-03T08:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/inhabile-disse-legene-fikk-ikke-delta-i-metodevurderinger-i-2024/1947402025-01-30T12:16+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fhi-veteran-frode-forland-til-utenriksdepartementet/1946922025-01-27T11:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/bergen-forskere-tar-opp-kampen-mot-eggstokkreft-med-ny-immunterapi/1946582025-01-27T06:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordiskneste-generasjons-fedmebehandling-viser-lovende-resultater-gir-22-prosent-vekttap-i-tidlig-studie/1946432025-01-24T14:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorkreft/jemperli-kombinasjon-utvides-til-flere-pasienter-med-livmorkreft/1946242025-01-24T09:30+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lang-ventetid-pa-nye-legemidler-nytt-dialogmote-ga-ingen-svar/1945922025-01-24T20:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/derfor-stoppet-farmastat-a-rapportere-apne-salgstall-pa-legemidler/1945712025-01-22T10:41+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ous-lege-om-hpv-avgjorelse-vi-er-ekstremt-skuffet/1945502025-01-21T10:48+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/gsks-cervarix-vant-hpv-anbudet-kjemperabatt-utgjorde-forskjellen/1945092025-01-20T13:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/columvi-godkjent-som-behandling-av-agressiv-blodkreft/1944902025-01-21T16:01+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-sier-ja-til-syv-og-nei-til-fem-legemidler/1944732025-01-27T09:12+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/fda-godkjenner-ny-adc-medisin-mot-brystkreft/1944532025-01-20T08:12+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ozempic-og-wegovy-inkludert-i-prisforhandlinger-med-medicare-i-usa/1944282025-01-21T10:24+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-vurderer-nye-priser-pa-medisiner-mot-lungekreft-og-blodkreft/1944152025-01-17T15:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nho-sjef-langer-ut-mot-vestres-helsetale-dobbelt-budskap-om-private-aktorer/1943822025-01-17T13:05+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slik-skal-dmp-kartlegge-alle-norske-apotek/1943492025-01-22T07:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/denne-presisjonsmedisinen-har-endret-behandlingen-av-brystkreft/1943162025-01-16T12:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vestre-lover-at-helsekoene-skal-markant-ned-vil-se-pa-kapasitet-hos-private/1943082025-01-15T15:24+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/oyehelseproblemer-koster-samfunnet-opp-mot-12-milliarder-kroner-arlig/1942592025-01-16T08:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/han-blir-ny-smittevernoverlege-ved-oslo-universitetssykehus/1942392025-01-23T18:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/mario-klesse-blir-nordensjef-i-johnson-johnson/1942262025-01-17T08:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/wegovy-er-norges-storste-medisin-omsatte-for-15-milliarder-kroner-i-2024/1942022025-01-15T18:28+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/se-opp-for-disse-11-legemidlene-i-2025/1941892025-01-16T08:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/pfizers-blaerekreftbehandling-oppnar-hovedmalet-i-senfase-studie/1941612025-01-17T08:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/ane-gerda-zahl-eriksson-er-ny-leder-for-gyn-onkologene-pa-radiumhospitalet/1941392025-01-13T07:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/unik-mulighet-norsk-lege-til-memorial-sloan-kettering-cancer-center-for-kreftkirurgisk-spesialisering/1941292025-01-15T08:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/gilead-inngar-partnerskap-med-danske-leo-pharma-for-a-utvikle-legemidler-mot-inflammatoriske-sykdommer/1941162025-01-12T20:43+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/ny-bergenbio-sjef-om-kritiske-data-i-2025-blir-en-viktig-avlesing-for-oss/1940822025-01-13T13:56+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/novo-og-valo-health-gar-sammen-utvikler-medisiner-mot-kardiometabolske-sykdommer/1940682025-01-09T10:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/ny-medisin-mot-lungekreft-kan-utfordre-dagens-standardbehandling/1940432025-01-09T08:06+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/jonas-amthor-en-dedikert-leder-og-forkjemper-for-nyrekreftpasientene/1940282025-01-14T08:04+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nykode-aksjen-hopper-etter-livmorhalskreft-data-men-hvor-viktige-er-resultatene/1940002025-01-08T15:40+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/thor-medical-far-gront-lan-pa-90-millioner-til-produksjon-av-alfaemittere/1939712025-01-08T09:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/forste-pasient-innrullert-i-bergenbio-studie/1939562025-01-07T11:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/eivind-jorgensen-er-ny-partner-i-oslo-economics/1939482025-01-07T14:45+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/prostatakreft/norsk-car-t-kan-bli-en-potent-behandling-for-pasientene/1939142025-01-28T14:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/immunterapi-og-stralebehandling-gir-ikke-bedre-utfall-ved-tidlig-lungekreft/1939032025-01-07T07:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/novartis-vil-na-flere-sma-pasienter-med-zolgensma-via-injeksjon-i-ryggmargen/1938912025-01-07T08:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/podcast-vil-eli-lilly-eller-novo-nordisk-vinne-krigen-om-slankemedisin/1938662025-01-07T10:43+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsedirektor-krever-kreftadvarsel-pa-alkohol/1938262025-01-06T13:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slik-velges-legene-ut-som-eksperter-til-metodevurderinger/1937732025-01-03T08:16+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/eirik-tjonnfjord-blir-blod-konsulent-for-frst/1937562025-01-02T13:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/usa-godkjenner-subkutan-versjon-av-immunterapien-opdivo/1937392024-12-30T09:54+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/fedmemedisin-godkjent-for-behandling-av-obstruktiv-sovnapne/1937252024-12-28T09:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/vaksinering-av-voksne-er-sendt-ut-pa-horing/1937102024-12-27T08:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/kombinasjonsbehandling-nar-hovedmal-i-eggstokkreftstudie-norske-pasienter-i-nokkelrolle/1936812024-12-22T21:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-sjefen-vi-har-ikke-lenger-saksbehandlingsko-for-metodevurderinger/1936632025-01-22T10:25+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisks-nye-slankemedisin-leverte-ikke-godt-nok-selskapet-stuper-pa-borsen/1936452025-01-06T11:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/unilabs-tapte-milliardanbud-tar-staten-til-retten/1936302024-12-20T12:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/zelluna-tar-kontroll-over-ultimovacs-i-strategisk-sammenslaing-toppsjef-gar-pa-dagen/1936042024-12-18T08:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/de-viktigste-studiene-fra-ash-2024-norske-blodkreft-leger-oppsummerer/1935802024-12-17T13:16+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/legemiddel-fortsetter-a-beskytte-pasienter-mot-tilbakefall-av-brystkreft/1935652024-12-17T11:30+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/medisin-forlenger-tiden-for-brystkreft-kommer-tilbake-kan-endre-behandlingspraksis/1935482024-12-16T10:46+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/anette-weyergang-karet-til-arets-kreftforsker-pa-ous/1935062024-12-11T23:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/schjesvold-svarer-pa-kritikk-det-fremstar-underlig/1934682024-12-18T13:42+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/gjor-comeback-i-benmargskreft-svaert-effektiv-behandling/1934352025-04-19T10:21+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/beslutningsforum-godkjenner-ny-behandling-for-tidlig-brystkreft/1933782024-12-09T16:33+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/fra-tromso-til-san-diego-dette-ser-lymfom-ekspert-martin-maisenholder-frem-til-pa-ash/1933262024-12-09T20:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/st-olavs-lege-trekker-seg-fra-metodevurderinger-etter-nye-dmp-krav/1933042024-12-08T02:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/norske-eksperter-har-inntatt-san-diego-og-ash-kongressen-ny-rekord-i-ar/1932722024-12-09T20:21+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/ash-2024-nye-gjennombrudd-skaper-fremtidens-behandling-av-blodsykdommer/1932462024-12-09T20:24+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/spadom-etter-sterke-ash-data-kml-blir-snart-var-storste-leukemi-sykdom/1932322024-12-09T20:28+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/nye-studiedata-pa-kll-behandling-overrasker-ahus-overlege/1932212025-01-30T12:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/norsk-hematolog-tror-ny-kll-behandling-kan-bli-forstevalg-for-2030/1932062024-12-13T13:20+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/ny-og-viktig-behandling-for-kronisk-lymfatisk-leukemi/1931962024-12-13T12:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/frida-bugge-askeland-vinner-pris-pa-ash-kongressen-for-andre-ar-pa-rad/1931772024-12-10T07:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/eldre-pasienter-med-mantelcellelymfom-kan-behandles-uten-cellegift/1931682024-12-10T00:50+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/ous-hematolog-ikke-overrasket-over-sterke-car-t-data-pa-mantelcellelymfom/1931602024-12-10T14:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/disse-legene-reiser-til-ash-verdens-storste-blodsykdom-kongress-i-san-diego/1931252024-12-05T08:44+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/ny-behandling-av-ulmende-myelomatose-en-oppsiktsvekkende-gevinst/1931162024-12-09T19:54+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norges-mektigste-helsebyrakrat-vi-skal-bygge-en-sterkere-helsenaering-gjennom-offentlig-privat-samarbeid-og-kulturendring/1930972024-12-04T08:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/car-t-er-like-god-i-virkeligheten-som-i-kliniske-studier/1930512024-12-08T19:43+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/roche-immunterapi-mislykkes-i-lungekreftstudie/1930242024-12-03T10:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/godkjenner-ny-behandling-for-tidlig-brystkreft-moter-konkurranse/1929682024-11-29T15:54+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/to-ar-med-car-t-behandling-mot-lymfom-dette-er-overlegenes-erfaring/1929432024-11-28T15:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/eksklusivt-intervju-med-mercks-globale-sjef-norge-ma-handle-na/1929212024-12-01T21:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rootwelt-om-ny-rapport-vi-vurderer-allerede-bade-levetid-og-livskvalitet/1928852024-11-27T12:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kan-totaloverlevelse-erstattes-som-mal-i-kliniske-studier-ny-rapport-gir-svar/1928632024-11-26T21:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehusinnkjop-ber-om-granskning-av-israelske-teva/1928402024-11-25T14:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/anbefaler-nasjonal-screening-for-lungekreft-noe-norge-bor-satse-pa/1928152024-12-05T15:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/sykehusinnkjop-avlyste-kreftanbud-seminar-far-sterk-kritikk/1927932024-11-25T08:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftlegene-deler-dette-er-vare-storste-utfordringer-i-den-kliniske-hverdagen/1927342024-11-22T09:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftsjefen-pa-haukeland-slik-skal-vi-lofte-behandling-og-forskning/1927252024-11-22T11:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/ny-faggruppe-for-presisjonsmedisin-ma-mote-fremtidens-behov/1927012025-05-12T10:00+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/norske-onkologer-om-kreftanbudet-milliardbelop-som-frigjores/1926602025-05-12T10:03+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/olav-hellebo-blir-ny-administrerende-direktor-i-bergenbio/1926402024-11-20T21:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/kamp-om-alzheimer-behandling-to-nye-legemidler-endrer-spillet/1926292024-11-28T08:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/eu-godkjenner-ny-malrettet-behandling-for-eggstokkreft/1926142024-11-20T10:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/europeisk-forskerteam-ledet-av-sigrid-skanland-far-17-millioner-fra-eu/1926012024-11-22T08:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/advarer-gravide-medisin-kan-fore-til-alvorlige-fosterskader/1925582024-11-20T08:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/prover-pa-ny-car-t-godkjenning-st-olavs-lege-tror-det-blir-vanskelig/1925352024-11-20T07:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/trygve-ottersen-tar-over/1925132024-11-20T07:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-sa-ja-til-alle-behandlingene/1925002024-11-18T10:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreftlege-odd-terje-brustugun-trekker-seg-fra-kreftanbudet/1924832025-05-12T10:04+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/myelomatose-medisin-danket-ut-standardbehandling-overgikk-alle-forventninger/1924612024-11-18T07:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/tre-av-fire-voksne-i-usa-er-na-overvektige-eller-har-fedme/1924232024-11-19T08:28+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rfk-jr-vil-rense-opp-i-fda-og-gjor-seg-klar-til-konflikt-med-big-pharma/1924042024-11-15T15:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/anbefaler-godkjenning-av-alzheimermedisin-et-viktig-steg-fremover/1923692024-11-18T10:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/endringer-i-rasjoneringen-av-ozempic-pasienter-kan-fa-lengre-utlevering/1923512024-11-15T11:52+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/den-sjeldne-blodkreft-sykdommen-er-en-av-de-vanskeligste-a-behandle/1923422024-11-15T14:59+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hpv-beslutning-utsettes-med-fire-uker/1923272024-11-14T14:12+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/malrettet-cellegift-kan-revolusjonere-kreftbehandlingen-slik-fungerer-teknologien/1922862024-11-18T07:54+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/tarmkreft/ahus-forsker-far-millioner-presisjons-onkologi-for-immunterapi/1922652025-01-28T14:39+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/norske-krefteksperter-far-millioner-i-stotte-dette-skal-de-forske-pa/1922402024-11-13T09:49+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kols/sanofi-jakter-pa-kols-godkjenning-eksperter-strides-om-antall-pasienter/1921962024-11-12T07:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/frykter-for-gravide-na-blir-reseptfri-medisin-mot-soppinfeksjon-reseptpliktig/1921822024-11-11T13:01+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hva-blir-trumps-helsepolitikk-vil-han-kopiere-den-norske-prismodellen-for-legemidler/1921332024-11-11T09:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehusinnkjop-unngar-a-svare-pa-kritikk-om-kreftanbudet/1921132024-11-08T12:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nykode-kollapser-etter-tap-av-viktig-partner/1920962025-01-02T11:41+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helse-sor-ost-skal-redusere-ventetiden-for-oyebehandling/1920742024-11-07T11:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/car-t-blir-snart-landsdekkende-et-paradigmeskifte/1920482024-11-07T07:55+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/kritiserer-anbudsprosessen-for-kreftlegemidler-en-bekymringsfull-utvikling/1920192024-11-12T09:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/prover-pa-ny-godkjenning-av-millionbehandling/1920042024-11-06T14:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-medisin-doblet-tiden-for-tilbakefall-kan-bli-den-nye-standardbehandlingen/1919862024-11-06T07:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/immunterapi-har-betydelig-forbedret-overlevelse-for-lungekreft-pasienter/1919702024-11-06T08:09+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legemiddel-gikk-av-patent-vant-likevel-anbudskonkurranse/1919402024-11-08T10:21+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tnf-bio-anbudet-for-lettvint-a-kalle-dette-en-glipp/1919192024-11-11T08:45+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/nordmenn-sparer-tusenvis-pa-a-kjope-slankemedisiner-i-sverige/1918552024-11-01T14:51+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehusinnkjop-boter-pa-feil-forlenger-tnf-bio-anbudet-med-tre-maneder/1917972024-10-31T11:25+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/novo-nordisk-og-astrazeneca-er-nordens-to-storste-selskaper/1917842024-10-31T09:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/anne-karin-rime-onsker-gjenvalg-som-legepresident-mott-med-staende-applaus/1917522024-10-29T15:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/stortingspolitikere-med-hpv-krav-til-helseministeren-na-blir-det-debatt/1917142024-10-29T15:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/mounjaro-blir-dyrere-enn-wegovy-forventer-likevel-stor-ettersporsel/1917062024-10-31T09:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/dette-er-vinnerne-av-norges-storste-legemiddelanbud/1916822024-11-06T08:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/disse-poliklinikkene-for-hjertesvikt-er-best-og-darligst-i-landet/1916682024-10-31T09:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/na-far-wegovy-hard-konkurranse-mounjaro-klar-for-salg-denne-uken/1916302024-10-28T12:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tipper-at-beslutningsforum-puster-lettet-ut-etter-den-beslutningen/1915942024-10-28T09:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/nytt-antistoff-mot-rsv-gir-effektiv-beskyttelse-og-reduserer-sykehusinnleggelser-hos-spedbarn/1915812024-10-30T13:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/mange-tarm-pasienter-sliter-med-utmattelse-selv-i-remisjon/1915692024-11-01T11:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/industrien-reagerer-pa-feil-i-anbud-overraskende-og-bekymringsfullt/1915582024-10-30T11:50+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/en-glipp-fra-sykehusinnkjop-kan-ha-gitt-betydelige-tap-for-legemiddelselskaper/1915422024-10-30T09:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimers/informerte-ikke-om-hoy-risiko-i-alzheimer-studier/1915162024-10-25T09:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norske-pasienter-kan-fa-medisinsk-behandling-i-utlandet-betalt-av-staten/1915012024-10-25T09:25+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimers/storbritannia-alzheimermedisinen-donanemab-er-ikke-kostnadseffektiv/1914712024-10-24T09:45+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helseministeren-vil-kutte-ventelistene-varsler-rekordkjop-fra-private-helseforetak/1914572024-10-23T12:57+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dramatisk-nedgang-kliniske-studier-forsvinner-fra-europa-til-usa-og-kina/1914382024-10-23T07:57+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/gir-ikke-opp-etter-nei-til-haravfall-medisin-vi-skal-kjempe-videre/1913902024-10-21T22:06+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/nei-til-kombo-behandling-mot-blodkreft-for-hoy-pris-pa-de-to-legemidlene/1913782024-10-21T14:35+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/ms-forbundet-en-veldig-god-og-viktig-nyhet/1913602024-10-22T08:22+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/na-beslutningsforum-sier-ja-til-ni-og-nei-til-seks-legemidler/1913332024-10-21T11:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/crohns-tidlig-aggressiv-behandling-avgjorende-for-a-forhindre-ytterligere-skade-pa-tarmen/1913232024-10-24T10:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/kan-hiv-medisin-virke-pa-ms-pasienter-norske-forskere-vil-finne-det-ut/1913102025-01-28T14:40+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/inflammatorisk-tarmsykdom-mange-far-ikke-kontroll-pa-sykdommen/1912852024-10-21T08:13+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehusinnkjop-avlyser-milliardanbud/1912572024-10-20T19:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/kolesterolsenkende-medisin-amgen-er-ny-vinner-av-kontroversielt-anbud/1912362024-10-18T12:59+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-ny-vurdering-av-ms-medisin-og-blir-det-ja-til-behandling-av-alvorlig-haravfall/1912042024-10-17T18:11+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/crohns/inflammatorisk-tarmsykdom-norske-funn-kan-revolusjonere-diagnostisering-av-ibd/1911972024-10-18T08:48+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/meninger/et-svaert-alvorlig-prinsippbrudd/1911672024-10-17T10:52+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ulceros-kolitt-ekspertene-deler-innsikt-om-effektiv-behandling/1911352024-10-22T09:58+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/10-ar-med-kliniske-studier-pa-benmargskreft-dette-vil-fredrik-schjesvold-fa-til-de-neste-ti-arene/1911172024-10-16T08:54+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norsk-studie-overforing-av-avforing-er-like-bra-som-antibiotika-mot-alvorlig-bakterieinfeksjon/1910792024-11-04T10:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/dmp-om-hpv-kritikken-vi-tar-det-med-oss-videre/1910572024-10-14T15:03+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/flere-med-coliaki-kan-forbli-udiagnostisert-ved-bruk-av-dagens-screeningsmetoder/1910412024-10-14T07:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/cathrine-meland-blir-ekspedisjonssjef-i-ny-avdeling-i-helse-og-omsorgsdepartementet/1910222024-10-12T17:12+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vil-gjore-det-lettere-a-forske-pa-helse/1910072024-10-12T17:01+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/clostridium-difficile-infeksjon-denne-bakterien-kan-vaere-dodelig-men-far-liten-oppmerksomhet/1909942024-10-13T09:57+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/parkinsons/ny-parkinsonmedisin-reduserer-sykdomsbyrden/1909832024-10-14T09:08+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/politikerne-ma-pa-banen-hvis-hpv-vaksinene-skal-vurderes-pa-en-annen-mate/1909622024-10-11T14:36+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/gar-til-toppstilling-i-europa/1909522024-10-19T15:20+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/krever-hpv-avklaring-fra-helseministeren/1909372024-10-11T11:31+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/ingen-eksterne-eksperter-i-spesialistgruppe-for-anbud-pa-hpv-vaksine/1909132024-10-10T16:57+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nobelprisen-i-kjemi-tildeles-tre-forskere-for-deres-arbeid-med-a-forutsi-og-skape-proteiner/1908992024-10-10T15:01+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/dyrere-hpv-vaksine-vil-bli-billigere-for-samfunnet-pa-sikt/1908062024-10-09T11:38+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hudlege-hardt-ut-mot-direktoratet-undervurderer-alvorligheten-av-hartap/1907802024-10-08T09:12+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/500-millioner-kroner-til-direktoratet-for-medisinske-produkter/1907662024-10-07T13:47+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/regjeringen-lanserer-nytt-akseleratorprogram-for-helseinnovasjon/1907522024-10-07T11:15+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/regjeringen-styrker-det-sikkerhetspsykiatriske-tilbudet-med-136-millioner-kroner/1907382024-10-07T10:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/regjeringen-etablerer-voksenvaksinasjonsprogram/1906942024-10-07T15:18+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/statsbudsjettet-2025-kreftforeningen-krever-at-regjeringen-innfrir-loftene/1906542024-10-04T14:53+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hartap-pasientene-opplever-sosial-isolasjon-og-psykiske-utfordringer/1906262024-10-08T12:04+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vestre-om-kvinnehelse-selvsagt-har-kvinner-krav-pa-like-god-og-tilpasset-behandling-som-menn/1906072024-10-03T15:35+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/alarmerende-okning-i-antibiotikaresistens-kan-fore-til-39-millioner-dodsfall-innen-2050/1905922024-10-04T11:07+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/regjeringen-med-milliardlofte-til-sykehusene-skal-fa-ned-ventetidene/1905672024-10-02T13:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/prinsipper-for-fall/1905372024-10-02T09:20+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ozempic-gir-milliardvekst-for-apotekene/1904962024-09-30T17:49+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/arrdannelse-er-mer-enn-et-kosmetisk-problem/1904862024-10-01T12:49+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/trygve-ottersen-blir-ny-direktor-i-direktoratet-for-medisinske-produkter/1904232024-10-07T13:45+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-innsikt-i-genenaktivitet-kan-forbedre-behandling-av-sar/1904122024-09-30T09:44+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/dette-er-de-viktigste-fremskrittene-innen-forskning-pa-multippel-sklerose-ms/1904052024-10-03T08:54+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/radforsk-fortsetter-storsalg-av-aksjer-i-nykode/1903822024-09-27T09:52+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eksem/atopisk-eksem-opprettholdt-klar-hud-etter-tre-ar-med-antistoff-behandling/1903242024-09-26T14:25+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/svettekjertelbetennelse/svettekjertelbetennelse-nye-legemidler-gir-nye-anbefalinger-for-behandling/1902872024-09-26T14:03+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/enhertu-oppfolger-bommet-i-klinisk-studie-skaper-tvil-om-godkjenning/1902482024-09-25T11:13+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/immunterapi-star-sterkt-mer-enn-ti-ar-etter-forste-godkjenning-en-enorm-utvikling/1902342024-09-25T11:43+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/melanom/ny-forskning-viser-at-antistoffer-kan-oppdage-foflekkreft-i-tidlige-stadier/1902292024-09-27T09:36+02:00https://image.healthtalk.no?imageId=190366&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/jj-om-kontroversielt-anbud-lite-tillitsvekkende-og-uforutsigbart/1902052024-09-24T11:43+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oyesykdom/ja-til-medisin-for-pasienter-med-blodpropp-i-oyet/1901802024-09-23T14:29+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/ny-forskning-ozempic-kan-forbedre-en-vanlig-og-kronisk-hudsykdom/1901732024-09-26T08:20+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/derfor-sa-beslutningsforum-ja-til-kontroversielt-anbud-pa-medisiner/1901552024-09-23T15:54+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/na-beslutningsforum-sier-ja-til-atte-av-ni-saker/1901402024-09-23T12:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kari-jussie-lonning-blir-ny-sykehusdirektor-ved-diakonhjemmet/1900642024-09-23T13:51+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/kjoper-inn-hpv-vaksiner-for-692-millioner-kroner-effekt-teller-mer-enn-pris/1900552024-09-20T12:24+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/nye-firears-resultater-pa-ms-medisin-dette-er-gode-data/1900342024-09-19T13:46+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/beslutningsforum-ja-til-car-t-avhenger-av-anbud-pa-ikke-godkjente-legemidler/1900042024-09-19T08:29+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/prostatakreft/prostatakreft-nye-esmo-data-kan-utvide-bruken-av-nubeqa/1899882024-09-18T08:57+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/elahere-med-positive-resultater-i-eggstokkreft-studie/1899762024-09-22T16:45+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/lovende-tidligdata-for-mrna-vaksine-mot-hjernekreft/1899582024-09-20T11:43+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/ny-type-medisin-mot-lungekreft-jeg-ble-positivt-overrasket/1899432024-09-17T12:10+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/tre-sykehus-fikk-forbedringspris/1899332024-09-19T09:58+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/reduserer-risikoen-for-tilbakefall-hos-pasienter-med-tidlig-brystkreft-en-bekreftende-og-viktig-studie/1899052024-09-16T16:59+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fagdirektoren-stotter-anbud-pa-ikke-godkjente-legemidler-vi-ma-sette-pasientene-forst/1898852024-09-18T08:58+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nye-data-skuffer-ultimovacs-vaksine-oker-ikke-overlevelsen/1898242024-09-15T17:09+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/ahus-leger-ble-imponert-av-blaerekreft-data-dette-er-praksisendrende/1898172024-09-15T22:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/tarmkreft/er-immunterapi-mot-tarmkreft-kostnadseffektivt-biomarkorer-kan-vaere-nokkelen/1898012024-09-15T12:21+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/ny-kombinasjonsbehandling-gir-hap-for-pasienter-med-analkreft/1897882024-09-15T10:32+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/livmorhalskreft-bor-bli-standardbehandling-sa-raskt-som-mulig/1897572024-09-19T11:47+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/dmp-pa-esmo-slik-jobber-norge-med-vurdering-og-innforing-av-legemidler/1897302024-09-15T11:17+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/mage-og-spiserorskreft-gode-nyheter-for-uhelbredelige-pasienter/1897152024-09-14T14:41+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/esmo-studiertrygt-a-amme-etter-brystkreft/1896982024-09-14T12:10+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/prostatakreft/nye-xofigo-data-pa-prostatakreft-en-renessanse-for-var-norske-baby/1896852024-09-14T16:49+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/malrettet-cellegift-er-effektiv-mot-hjernemetastaser-hos-brystkreftpasienter-dette-blir-na-forstevalget/1896452024-09-15T22:59+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/sarkom/billig-eller-kjempedyrt-dette-er-de-viktigste-fremskrittene-innen-behandling-av-sarkom/1896322024-09-14T16:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/melanom/immunterapi-professor-hedret-for-banebrytende-arbeid/1896172024-09-13T16:04+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisks-nye-slankepille-gir-betydelig-vekttap-i-tidlig-studie/1895862024-09-13T08:17+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/esmo-2024-praksisendrende-kreftdata-og-et-comeback-for-norsk-kreftmedisin/1895772024-09-13T10:35+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/stopper-rekruttering-til-lungekreftstudie/1895652024-09-12T15:21+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bekymret-for-anbud-det-blir-mindre-aktuelt-a-legge-kliniske-studier-til-norge/1895452024-09-11T15:07+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sterke-reaksjoner-pa-anbud-med-ikke-godkjente-medisiner-fokuset-er-kun-pa-lavest-mulig-pris/1895052024-09-11T10:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/apner-doren-for-ikke-godkjente-legemidler-etter-sammenbrudd-i-prisforhandling/1894962024-09-11T10:15+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/disse-norske-kreftlegene-inntar-esmo-i-barcelona-europas-storste-kreftkongress/1894752024-09-12T08:25+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/to-organisasjoner-kjemper-na-for-fokus-pa-sjeldne-sykdommer/1894312024-09-10T14:24+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/eu-gir-gront-lys-til-ny-immunterapi-mot-lymfom/1894162024-09-09T08:48+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nykode-ledelsen-har-gjort-flere-strategiske-feilvurderinger/1893772024-09-09T08:51+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/pasienter-pa-blodtrykkssenkende-medisiner-bor-ha-lavere-blodtrykk/1893632024-09-06T13:26+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/studiestopp-tvinger-nykode-til-omfattende-nedbemanning/1893402024-09-05T08:09+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/blaerekreft-medisin-som-dobler-overlevelsen-er-na-eu-godkjent/1893172024-09-04T08:34+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-bayer-sjef-har-vel-en-litt-annen-vei-inn-i-legemiddelindustrien-enn-de-fleste/1892922024-09-03T08:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/starter-med-car-t-pa-haukeland-i-2025/1892742024-09-02T13:49+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/eu-godkjenning-av-medisin-mot-hoyt-blodtrykk-i-lungene/1892472024-08-30T14:00+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/radforsk-i-pengenod-vi-havnet-i-en-situasjon-hvor-vi-matte-selge/1892192024-09-02T13:49+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/hjertesvikt-poliklinikkene-brukes-for-lite/1891932024-08-30T11:30+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/oppfattet-immunterapi-kombo-mot-spiserorskreft-som-uaktuell-a-innfore/1891822024-09-04T09:05+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/det-skal-veldig-mye-til-for-at-investorene-skal-kaste-penger-etter-det-selskapet/1891682024-08-30T08:39+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/studie-pasienter-foretrekker-digital-hjemmeoppfolging/1891522024-08-28T08:47+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/ozempic-rasjonering-i-apotek-har-mer-enn-halvert-omsetningen/1891292024-08-27T11:12+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/ja-til-medisin-mot-benmargskreft-en-av-de-store-vi-har-manglet/1891022024-08-26T14:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-godkjenner-praksisendrende-immunterapi-til-nyrekreftopererte/1890542024-08-28T12:36+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/viktig-nyrekreftvedtak-pa-mandag-har-potensial-til-a-kurere/1890212024-08-23T13:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/disse-vil-bli-direktor-i-dmp/1889922024-08-22T16:00+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/abelia-direktor-oystein-eriksen-soreide-slik-forandrer-vi-norges-sardinboks-okonomi/1889752024-08-22T13:58+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nykode-sjefen-innrommer-avbrytelse-av-studie-er-et-tilbakeslag/1889562024-08-21T12:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/leukemi-studier-har-spart-nordiske-land-for-655-millioner-kroner/1889372024-08-21T08:25+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/gentest-kan-spare-brystkreft-pasienter-for-unodvendig-kjemoterapi-mandag-blir-det-ja-eller-nei-i-beslutningsforum/1889262024-08-22T12:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/bergenbio-inngar-samarbeid-med-tempus-for-a-fremskynde-utviklingen-av-bemcentinib/1889122024-08-20T10:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/ms-forskerne-apner-for-fremtidig-kur-men-det-blir-langt-frem-i-tid/1888982024-08-19T13:22+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-sjefen-frustrert-over-pastander-om-ensidig-prisfokus/1888712024-08-20T13:31+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/veikart-for-helsenaeringen-begynner-a-lukte-veldig-vondt-nykodesjefen-etterlyser-tiltak-og-handling/1888252024-08-16T14:11+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/nykode-sikrer-viktig-patent-i-usa-vi-er-glade-og-lettet/1888082024-08-14T14:48+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ekspertene-roper-varsko-om-hodepine-lidelser-i-norge/1887902024-08-14T13:53+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ht-debatt-slik-skal-ungdomspolitikerne-sikre-bedre-tilgang-pa-legemidler/1887632024-08-14T08:31+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helhetlig-pasientforlop-er-nokkelen-til-bedre-helsetjenester/1887362024-08-13T14:40+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/apotekforeningen-annenhver-pasient-har-opplevd-medisinmangel/1887232024-08-13T14:07+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ventetid-pa-nye-medisiner-koster-liv-over-6000-pasienter-rammet-i-2023/1887022024-08-13T14:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/aktiv-mot-kreft-disse-kickstartet-arendalsuka-med-13-mil-pa-sykkelsetet/1886722024-08-12T15:26+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/er-arendalsuka-en-demokratifest-eller-en-lobbyfest-kjor-debatt/1886642024-08-12T15:29+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/barbara-suter-gar-til-lmi/1886492024-08-12T13:14+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-podcast-de-som-kjorer-etter-veikart-for-helsenaeringen-de-havner-i-grofta/1886232024-08-09T12:24+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/gjenvinning-av-injeksjonspenner-vil-ikke-gronnvaske-legemiddelindustrien/1886072024-08-08T08:54+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/video-suksess-pa-some-lofter-healthtalk-til-nye-hoyder/1885852024-08-06T16:12+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/ultimovacs-mislykkes-med-nok-en-kreftstudie-analytiker-tror-det-er-slutten-for-selskapet/1885722024-08-06T10:04+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hoyaktuell-som-ny-dmp-direktor-dette-sier-trygve-ottersen-om-spekulasjonene/1885402024-08-05T11:31+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kliniske-studier-sparer-staten-for-flere-hundre-millioner-kroner/1885202024-08-06T08:17+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/eli-lillys-slankelegemiddel-zepbound-viser-fordeler-for-pasienter-med-hjertesvikt/1884972024-08-02T11:00+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/kari-rolfsjord-forlater-novartis-gar-til-menon-economics/1884712024-08-01T13:05+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimers/gammel-slankemedisin-bremser-alzheimers-i-liten-studie/1884402024-07-31T14:40+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-podcast-hvem-blir-ny-toppsjef-i-dmp-og-klarer-den-nye-helseministeren-a-fa-ned-ventetiden-pa-medisiner/1884212024-07-31T14:13+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-sjefen-skal-ga-av-farmasoyter-spilles-inn-som-mulige-arvtakere/1884022024-07-31T10:29+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/eu-nei-til-ny-wegovy-indikasjon-har-ingen-praktiske-konsekvenser/1883832024-07-29T14:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimers/derfor-sier-eu-nei-til-alzheimer-medisin/1883712024-07-29T10:41+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/wegovy-godkjent-i-storbritannia-for-a-redusere-risikoen-for-hjerte-og-karsykdommer/1883582024-07-23T23:48+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/ny-immunterapikombinasjon-kan-endre-kreftbehandlingen/1883432024-07-17T16:07+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/analyse-novo-nordisk-blir-verdens-storste-legemiddelselskap-i-2030/1883192024-07-16T11:09+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/skal-vurdere-om-wegovy-skal-fa-bla-resept-pa-nytt/1883062024-07-16T10:57+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/75-prosent-slutter-med-slankemedisiner-som-wegovy-for-det-er-gatt-to-ar/1882922024-07-10T22:40+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/klar-til-metodevurdering-av-alzheimersmedisin/1882652024-07-13T12:13+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/lillys-mounjaro-gir-mer-vekttap-enn-novos-ozempic-viser-studie/1882502024-07-13T12:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/apner-for-at-pasienter-kan-fa-medisin-selv-om-beslutningsforum-har-sagt-nei/1882292024-07-08T14:47+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slik-vil-vestre-redusere-ventetiden-pa-medisiner/1882102024-07-31T11:01+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/studie-diabetesmedisiner-som-ozempic-reduserer-kreftrisiko/1881862024-07-09T12:41+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kritiseres-for-unodig-omfattende-metodevurderinger-slik-svarer-dmp/1881562024-07-04T13:17+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/studie-knytter-ozempic-og-wegovy-til-okt-risiko-for-oyeslag-som-kan-forarsake-synstap/1881432024-07-04T11:53+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kols/forste-malrettede-kols-medisin-eu-godkjent-viktig-for-noen-fa-pasienter/1881232024-07-04T09:39+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fjerner-tre-legemidler-denne-typen-juks-aksepteres-ikke/1881102024-07-03T15:04+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/usa-godkjenner-donanemab-mot-tidlig-alzheimers-sykdom/1880942024-07-04T10:33+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hoyre-funderer-kan-bade-offentlige-og-private-aktorer-utfore-metodevurderinger/1880572024-07-02T15:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sjefsonkolog-kritiserer-lang-ventetid-i-nye-metoder-systemet-men-advarer-mot-nedlegging/1880372024-07-02T10:57+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bard-hoksrud-frp-om-beslutningsforum-utspill-jeg-blir-provosert/1880162024-07-01T17:40+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sanofi-norge-sier-opp-flere-ansatte/1879802024-06-28T14:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/melanom/derfor-har-hovedutproveren-fortsatt-tro-pa-kreftvaksinen-fra-norske-ultimovacs/1879362024-06-27T17:08+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legemiddelforbruket-oker-jevnt/1879222024-06-27T10:29+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/big-pharma-selskap-tar-i-bruk-ai-for-a-bekjempe-multiresistente-bakterier/1879092024-06-26T14:12+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nyfodtscreening-utvides-na-skal-alle-nyfodte-testes-for-flere-alvorlige-sykdommer/1878552024-06-26T10:24+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/dette-ma-du-vite-om-blodkreft/1878242024-08-01T15:59+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/private-kreftklinikker-far-rabatter-pa-medisiner-fra-legemiddelselskaper/1878082024-06-25T10:30+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ordkrig-om-legemiddel-korrupsjon-svaert-problematisk/1877752024-11-20T21:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vi-diskuterer-vinnerne-og-taperne-fra-siste-mote-i-beslutningsforum/1877392024-06-20T14:07+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/jan-frich-er-ny-administrerende-direktor-i-helse-midt-norge-dette-er-hans-prioriteringer/1877252024-06-20T11:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/migrenetablett-far-blaresept-vi-har-ventet-lenge-pa-dette/1877072024-06-21T09:22+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/nyrekreftforeningen-lanseres-vi-skal-bli-en-tydelig-stemme-for-pasienter-og-parorende/1876722024-06-20T11:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/blodkreftforeningen-om-lymfom-nei-gambler-med-pasientenes-liv-og-helse/1876412024-06-18T15:23+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/forskningsjefen-pa-sykehuset-ostfold-deltok-pa-eha-med-flere-studier-pa-blodsykdommer/1876302024-06-19T09:52+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/sjokkert-etter-nei-til-ny-medisin-vi-strakk-oss-langt-pa-pris/1876042024-06-18T08:56+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slik-begrunner-rootwelt-og-spreng-ja-og-nei-vedtakene-i-beslutningsforum/1875862024-06-19T12:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/den-storste-nyheten-for-norske-myelomatose-pasienter-kanskje-noensinne/1875672024-06-17T10:54+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/imponerende-kml-resultater-pasientene-far-rask-effekt/1875402024-06-16T12:09+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/ostfold-overlege-om-ny-studie-dette-er-beste-behandling-av-kll/1875102024-06-15T14:14+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/beslutningsforum-avgjor-pa-mandag-holder-nye-lymfekreft-data-til-et-ja-for-tepkinly/1874972024-06-15T11:55+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/lovende-resultater-for-kll-pasienter-med-hoy-risiko/1874722024-06-15T14:10+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/norske-hanne-presenterer-eha-studie-med-kreftvaksine-fra-norske-circio/1874592024-06-14T15:52+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/norges-storste-studie-pa-benmargskreft-frida-presenterer-nye-data-pa-eha-i-madrid/1874432024-06-14T15:47+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/schjesvold-tror-ny-car-t-er-like-effektiv-som-carvykti-og-gir-faerre-bivirkninger/1874322024-06-15T17:34+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/celleterapi-er-kostnadseffektiv-klokt-valg-av-helsemyndighetene/1874182024-06-14T09:22+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/eha-podcast-dette-er-fantastiske-resultater-de-er-overraskende-bra/1873942024-06-17T09:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/hematologi-flere-norske-leger-reiser-til-blod-kongressen-eha-i-madrid/1873812024-06-14T15:37+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/magne-wang-fredriksen-blir-ny-generalsekretaer-i-lhl/1873612024-06-12T12:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/norske-kreftpasienter-venter-nesten-600-dager-for-tilgang-pa-nye-medisiner/1873452024-06-12T10:11+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/nyhet-om-gammel-studie-sender-utbombet-biotek-aksje-til-vaers/1873152024-06-11T20:23+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/banebrytende-kreftstudier-pa-asco-2024-og-kunstig-intelligens-i-helsevesenet/1872962024-06-10T12:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/privat-kreftlege-vil-starte-behandlinger-basert-pa-asco-studier-umiddelbart/1872602024-06-06T16:38+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/aslaug-helland-og-kjetil-tasken-fremmer-impress-og-prime-rose-pa-asco/1872262024-06-04T18:35+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/tarmkreft/de-fleste-ble-kvitt-tarmkreften-med-immunterapi-for-operasjon/1871942024-06-07T08:40+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/ny-kreftmedisin-utfordrer-etablert-behandling-av-trippel-negativ-brystkreft/1871682024-06-04T10:34+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/avdekket-kritiske-uenigheter-pasienter-kan-ga-glipp-av-kurativ-behandling/1871612024-06-03T21:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/blodkreftlegemiddel-halverer-nesten-risikoen-for-sykdomsprogresjon-eller-dod/1871352024-06-03T08:54+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-de-aller-fleste-pasientene-vil-na-fa-behandling-med-enhertu-veldig-tidlig/1871102024-06-03T16:43+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/norske-tora-solheim-holdt-asco-presentasjon-om-vekt-og-muskeltap-hos-kreftpasienter/1870922024-06-03T16:47+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/kreftleger-fra-levanger-med-to-asco-studier-kan-sikre-tidligere-oppdagelse-av-lungekreft/1870582024-06-02T21:28+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/ny-behandling-forlenger-tiden-til-forverring-hos-pasienter-med-brystkreft/1870442024-06-02T22:08+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/malrettet-cellegift-mot-lungekreft-ma-tilbake-til-tegnebrettet/1870252024-06-03T16:39+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/norsk-lungekreftlege-aldri-sett-sa-gode-data/1869982024-06-03T16:39+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/asco-podcast-nye-kreftgjennombrudd-med-onkolog-marius-normann/1869812024-06-03T16:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-styreleder-i-lmi-cathrine-thomassen-tar-over/1869672024-05-31T14:36+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/oyesykdom/msd-kjoper-eyebio-for-a-styrke-pipelinen/1869462024-05-31T05:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/digital-helseomsorg-er-nodvendig-for-a-bekjempe-fedme/1869092024-05-30T08:47+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/fortsetter-a-folge-planen-og-kutter-kostnader/1868892024-05-29T08:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/dette-er-verdens-10-storste-legemidler-og-de-10-storste-i-norge/1868742024-05-30T09:30+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kunstig-intelligens-hjelper-flere-pasienter-a-mote-opp-til-koloskopiavtaler/1868562024-05-30T08:38+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/de-fleste-kvinner-kan-oppna-vellykkede-graviditeter-etter-brystkreftbehandling/1868392024-05-29T08:35+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/hpv-vaksinasjon-reduserer-risikoen-for-flere-krefttyper-hos-menn-og-kvinner/1868202024-05-29T08:34+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/medisin-mot-brystkreft-fikk-nei-veldig-skuffet/1867872024-05-27T15:23+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/beslutningsforum-nei-til-blodkreft-medisin-et-slag-i-ansiktet-for-pasientene/1867722024-05-27T13:23+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-sier-ja-til-atte-og-nei-til-fire-legemidler/1867592024-05-28T16:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyresykdom/ozempic-reduserer-risikoen-for-alvorlig-sykdom-og-dod-ved-kronisk-nyresykdom/1867272024-05-24T14:14+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-avgjor-skjebnen-til-to-kreftlegemidler-og-vi-tar-en-forhandstitt-pa-kreftnyhetene-som-kommer-pa-asco-1/1867032024-05-27T08:06+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legemiddelselskapene-slik-far-vi-flere-kliniske-studier-til-norge/1866512024-05-23T09:45+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/disse-norske-legene-reiser-til-verdens-storste-kreftkongress-i-chicago/1866382024-05-27T08:23+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/astrazeneca-med-ambisiose-vekstplaner/1866122024-05-22T08:27+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sanofi-inngar-samarbeid-med-openai/1865922024-05-21T14:41+02:00https://image.healthtalk.no?imageId=186602&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/eli-lilly-vokser-raskere-enn-novo-nordisk/1865722024-05-21T12:22+02:00https://image.healthtalk.no?imageId=185048&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-blodkreft-og-cystisk-fibrose-disse-legemidlene-skal-opp-i-neste-beslutningsforum/1865652024-05-22T09:42+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/i-danmark-gjenvinnes-25-prosent-av-medisinske-penner-arlig-na-jobbes-det-for-a-fa-ordningen-til-norge/1865602024-06-19T12:36+02:00https://image.healthtalk.no?imageId=185048&format=webp&width=1200https://www.healthtalk.no/healthtalk/vil-ta-blaresepten-fra-norges-mest-brukte-legemiddel-uklart-om-unntaksordningen-og-etter-bare-tre-uker-ble-ap-kurert-for-allergien-mot-private-sykehus/1865172024-05-16T15:53+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/oppfordrer-forskere-og-legemiddelindustri-til-a-beregne-klimaavtrykk-i-kliniske-studier/1865062024-05-21T07:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fagdirektor-om-blaerekreft-behandling-ikke-anledning-til-a-forskrive-denne-na/1864642024-05-15T16:08+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/diabetesforbundet-om-blaresept-nekt-til-ozempic-vi-er-bekymret/1864572024-05-15T14:25+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/novo-nordisk-et-inngripende-tiltak/1864342024-05-14T13:53+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/regjeringen-vil-fjerne-blaresept-pa-ozempic-gir-individuell-stonad-til-diabetes-tablett/1864212024-05-14T11:44+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ventetidene-skal-ned-vestre-far-tommel-opp-for-a-apne-for-private-aktorer/1863902024-05-13T13:47+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/250-millioner-kroner-til-helse-nord/1863742024-05-13T10:28+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/melanom/norsk-hudkreftlege-har-aldri-for-fatt-sa-rask-tilgang-pa-immunterapi/1863532024-05-13T09:47+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreftstudie-nadde-ikke-malet/1863262024-05-15T10:55+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vaksine/sykehusinnkjop-starter-anbudsrunde-for-pneumokokkvaksine-og-andre-viktige-vaksiner/1863122024-05-14T09:02+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/krav-om-ny-og-bedre-vaksine-mot-hpv-virus-hoyre-krever-svar-fra-helseministeren/1862952024-05-11T20:32+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-podcast-blaerekreft-gjennombrudd-krefttall-for-2023-og-nipu-publikasjon/1862672024-05-10T16:06+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/blaerekreftforeningen-krever-rask-handling-for-livsforlengende-behandling/1862212024-05-10T08:32+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/melanom/foflekkreft-oker-mest-vi-er-fortsatt-ikke-gode-nok-pa-sunt-solvett/1861972024-05-08T13:43+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/borshavari-medforte-kostnadslette-i-arets-forste-kvartal-for-ultimovacs/1861492024-05-07T11:44+02:00https://image.healthtalk.no?imageId=179685&format=webp&width=1200https://www.healthtalk.no/kreft/fhi-faerre-tilfeller-av-prostata-bryst-og-lungekreft-i-2023/1861312024-05-08T09:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/ber-kreftlegene-ta-i-bruk-ny-blaerekreft-medisin-som-dobler-overlevelsen-na-haster-det/1861052024-05-13T20:15+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/banebrytende-resultater-med-ny-behandling-bemerkelsesverdig/1860912024-05-07T12:26+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-podcastdet-foregar-et-strategisk-spill-om-innforing-av-immunterapi-mot-kreft/1860742024-05-08T10:29+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/disse-legene-sikrer-at-kvinner-med-livmorhalskreft-kan-fa-barn-etter-operasjon/1860492024-05-07T21:58+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/novartis-styrker-sin-posisjon-i-radiofarmasi-med-oppkjopet-av-mariana-oncology/1860192024-05-06T08:14+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/ny-utfordrer-i-behandlingen-av-fedme-amgens-maritide-med-lovende-resultater/1860092024-05-06T09:06+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/stadig-faerre-far-eller-dor-av-kreftsykdommen-dette-peker-ous-legen-pa-som-arsakene/1859802024-05-06T13:51+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nekter-a-gi-seg-kjerkol-klager-pa-fuskedommen/1859562024-05-02T13:20+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/janssen-kaster-navnet-blir-hetende-johnson-johnson-fra-i-dag/1859432024-05-02T12:52+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nye-data-fortsatt-hoy-beskyttelse-mot-helvetesild-ti-ar-etter-vaksinering/1859152024-05-02T09:51+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/svettekjertelbetennelse/godkjenner-effektiv-behandling-av-tabubelagt-hudsykdom-viktig-for-pasientene/1859042024-05-02T11:02+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/meninger/innovasjon-norge-svarer-inven2-vi-er-enige-i-diagnosen-men-ikke-i-behandlingen/1858792024-05-02T10:18+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eksem/eksem-hudlege-positiv-til-nye-rinvoq-data-men-tror-ikke-pa-stor-betydning-for-klinisk-praksis/1858212024-04-30T09:12+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/meninger/helsesektoren-trenger-mer-enn-mer-penger-den-trenger-ny-teknologi/1857742024-05-02T10:00+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ultimovacs-ledelsen-beholder-millionlonningene-40-prosent-av-ansatte-mister-jobben/1857692024-04-29T12:30+02:00https://image.healthtalk.no?imageId=177316&format=webp&width=1200https://www.healthtalk.no/oyesykdom/snarlig-avgjorelse-ventet-for-hoydoseversjonen-av-eylea/1857602024-04-29T15:26+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/hoy-oppslutning-om-barnevaksinasjonsprogrammet/1857372024-04-29T15:18+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/privat-kreftlege-derfor-provde-han-ut-medisinen-som-forlenget-tinas-liv/1856982024-04-30T11:53+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/kreftsyke-tina-la-for-doden-forlenget-livet-med-medisin-som-ikke-er-godkjent-mot-sykdommen/1856802024-04-30T11:56+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/regeneron-sier-ja-til-hurtiggodkjenning-av-sin-immunterapi/1856532024-04-26T14:32+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/lytix-biopharma-setter-i-gang-fase-ii-studie-i-oslo/1856372024-04-25T16:55+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norge-styrker-klimaforpliktelser-gjennom-internasjonalt-samarbeid/1856172024-04-25T14:48+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/eli-lilly-far-eu-godkjenning-for-a-benytte-tirzepatid-som-injeksjonspenn-mot-type-2-diabetes-og-overvekt/1855982024-04-25T13:42+02:00https://www.healthtalk.no/nyheter-og-politikk/slutter-som-toppsjef-i-helse-midt-norge/1855752024-04-25T11:49+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/msd-toppene-om-fremtidens-kreftbehandling-og-styrking-av-norsk-helsenaering/1855512024-04-25T16:14+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sa-mye-tjente-nykode-ledelsen-i-2023/1855462024-04-25T14:17+02:00https://image.healthtalk.no?imageId=185048&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/island-slutter-seg-til-nordisk-samarbeid-pa-metodevurderinger-pa-legemidler/1855312024-04-25T09:59+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/melanom/msd-med-kritikk-mot-beslutningsforum-stiller-sporsmal-ved-forklaring-etter-nei-til-keytruda-mot-foflekkreft/1855012024-04-25T11:07+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/strategisk-veivalg-astrazeneca-tar-fast-track-msd-velger-a-sta-i-ko/1854942024-04-29T15:39+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vestres-selskap-innforte-avtale-om-privat-helseforsikring-mens-han-var-daglig-leder/1854642024-04-22T21:25+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hurtigspor-sikrer-godkjenning-i-beslutningsforum/1854122024-04-23T08:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/prostatakreft/halleluja-dobbelt-prostatakreft-ja-i-beslutningsforum-sendte-daniel-i-skyene/1854042024-04-22T15:51+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dette-er-vedtakene-i-beslutningsforum/1853832024-04-23T09:39+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/eggstokkreft-slik-vurderer-ous-kirurgen-diagnostikk-og-behandling-av-sykdommen/1853532024-04-23T08:13+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/emisjonen-i-curida-elverum-kommune-sitter-igjen-med-smuler-svarer-ikke-pa-sporsmal-om-eierskap/1853452024-04-23T10:18+02:00https://image.healthtalk.no?imageId=184945&format=webp&width=1200https://www.healthtalk.no/healthtalk/flere-husker-timen-sin-pa-sykehuset/1853322024-04-22T08:48+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vestre-ny-helseminister-myrseth-blir-naeringsminister-og-sivertsen-naess-blir-fiskeriminister/1853072024-04-19T15:29+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/nykode-starter-ny-livmorhalskreft-studie-med-sin-kreftvaksine-og-immunterapi-fra-roche/1852912024-04-19T15:05+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-roche-test-kan-plukke-ut-her2-lave-pasienter-til-enhertu-behandling/1852782024-04-19T11:45+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/slankemedisin-kan-redusere-alvorlighetsgraden-av-sovnapne-1/1852382024-04-19T08:32+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/jan-christian-vestre-blir-trolig-helseminister/1852152024-04-19T08:45+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/domore-diagnostics-bruker-kunstig-intelligens-for-a-forutse-fremtiden-til-kreftpasienter/1852082024-04-19T09:06+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/hap-i-horisonten-for-ultimovacs-fokus-pa-focus-og-dovacc-studiene/1851942024-04-18T14:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/blodkreft-og-prostatakreft-disse-legemidlene-kan-bli-innfort-pa-mandag/1851732024-04-17T12:18+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/analytiker-til-dn-frykter-for-ultimovacs-fremtid/1851562024-04-17T11:21+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-sjef-om-curida-aksjene-etter-emisjon-sa-godt-som-helt-utvannet/1851312024-04-18T11:21+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/bergenbio-sikrer-fremtidig-finansiering-med-vellykket-kapitalinnhenting/1850942024-04-16T21:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/astrazeneca-bekrefter-imfinzi-med-i-hurtiginnforing-av-immunterapi-mot-kreft/1850732024-04-16T16:23+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kronprinsesse-mette-marit-hedret-vinnere-av-forskningspriser/1850262024-04-15T15:26+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/eu-ingen-tegn-til-sammenheng-mellom-slankemedisiner-og-selvmord/1850102024-04-15T13:03+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/verdien-pa-radforsks-borsportefolje-har-blitt-halvert-i-ar-blir-med-pa-bade-opp-og-nedturene/1850042024-04-16T08:29+02:00https://image.healthtalk.no?imageId=184513&format=webp&width=1200https://www.healthtalk.no/healthtalk/studie-bekrefter-at-migrenetablett-er-effektiv-og-trygg/1849672024-04-16T12:49+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/curida-sikrer-seg-250-millioner-kroner-i-ny-kapital-na-far-selskapet-mere-muskler/1849262024-04-12T12:44+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/ingvild-kjerkol-gar-av-som-helseminister/1848972024-04-12T11:48+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/anerkjent-kreftlege-ut-mot-protonsentrene-er-dette-riktig-prioritering/1848792024-04-12T09:36+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kraftig-kritikk-mot-regjeringens-helsestrategi-gar-i-helt-feil-retning/1848642024-04-15T11:44+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/felt-for-fusk-masteroppgaven-underkjennes/1848202024-04-11T14:49+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/abbvie-satser-tungt-flere-oppkjop-og-partnerskap-pa-kort-tid/1848002024-04-11T10:22+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norske-forskere-leder-banebrytende-internasjonal-studie-utforsker-behandling-av-hjerneslag-i-oyet/1847872024-04-11T13:21+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/lytix-oker-sitt-handlingsrom-med-ny-emmisjon/1847702024-04-10T13:03+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/svensk-fedmeapp-har-kommet-til-norge/1847502024-04-10T08:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/politikerne-om-fremtidens-kreftbehandling-og-helsenaering-teknologi-blir-kjempeviktig/1847142024-04-10T10:13+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/usikre-tider-for-norske-kreftvaksiner-vil-teknologien-bli-viktig-i-fremtidens-kreftbehandling/1846842024-04-29T15:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/usa-starter-prisforhandlinger-med-legemiddelselskapene/1846342024-04-08T15:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/ozempic-mangel-koster-staten-dyrt-dmp-ber-novo-nordisk-ta-sitt-samfunnsansvar/1846022024-04-05T11:42+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/diabetes/novo-nordisk-om-ozempic-mangel-vi-tar-denne-situasjonen-svaert-alvorlig/1845902024-04-05T14:02+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fda-godkjenner-nytt-antibiotikum-for-behandling-av-tre-infeksjoner/1845582024-04-08T08:50+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-undersokelse-helse-er-viktigste-politiske-sak/1845352024-04-04T14:07+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/stor-omstrukturering-i-msd-norge-blir-snart-100-ansatte/1845242024-04-05T10:28+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/styreleder-i-ultimovacs-avslorer-disse-nye-studiene-vurderer-selskapet/1845052024-04-04T12:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/lifecare-med-gjennombrudd-skyter-opp-55-prosent/1844922024-04-03T12:23+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/en-av-fire-kreftpasienter-har-fatt-tilbud-om-ny-behandling-gjennom-impress-studien/1844692024-04-03T09:43+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/norske-apotek-omsatte-for-50-milliarder-kroner-i-2023/1844502024-04-02T11:35+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/novo-kjoper-tysk-legemiddelfirma/1844012024-03-26T08:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/etter-ultimovacs-kollapsen-bransjeaktorer-har-fortsatt-tro-pa-norsk-biotek-men-mener-innsatsen-ma-okes/1843572024-03-25T08:43+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/multippel-sklerose/norske-ms-pasienter-bruker-billig-kreftmedisin-sparer-staten-for-en-halv-milliard-kroner-i-aret/1843422025-04-01T12:47+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/ms-multippel-sklerose/ms-et-av-verdens-vanligste-virus-kan-gi-svar-pa-gaten-bak-den-nevrologiske-sykdommen/1843162024-03-21T15:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/astma/glad-for-gront-lys-til-ny-biologisk-astmamedisin/1843012024-03-20T16:01+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorkreft/livmorkreft-ekspert-om-jemperli-ja-en-milepael-for-vare-pasienter/1842542024-03-19T14:34+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/beslutningsforum-godkjente-blodkreftlegemiddel-pa-rekordtid/1842332024-03-19T11:14+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/oyesykdom/hoydose-versjon-av-oyemedisin-er-godkjent-i-norge/1842182024-04-29T15:29+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hurtiginnforing-av-immunterapi-astrazeneca-og-beigene-blir-med/1841872024-03-18T16:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/beslutningsforum-godkjenner-injiserbar-immunterapi-for-alle-indikasjoner-en-milepael/1841742024-03-18T15:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-godkjenner-10-legemidler-7-fikk-nei/1841612024-03-18T15:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/demens/europeisk-nevrologi-sjef-slik-vurderer-han-utviklingen-innen-nevrologisk-medisin/1841252024-03-15T11:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/norske-helseklynger-fra-oslo-og-trondheim-pa-prestisjefull-financial-times-liste/1841132024-03-15T09:44+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kjerkol-onsker-snarlig-avklaring-fra-nord-universitet-om-masteroppgaven/1840942024-03-14T13:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/norsk-gynekolog-leder-stort-europeisk-prosjekt-kirurgi-som-fjerner-all-svulst-er-nokkelen-til-okt-overlevelse/1840772024-03-14T09:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rekordhoyt-antall-saker-i-neste-beslutningsforum-mote/1840622024-03-13T14:01+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/hva-betyr-ultimovacs-kollapsen-for-norsk-biotek-bransje/1840122024-04-29T15:48+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/fedme-og-overvekt-dette-bor-du-vite-om-bmi-slankemedisin-helserisiko-og-ernaering/1840012024-03-12T13:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningssystemet-ma-vaere-sa-robust-at-vi-sjelden-ma-gjore-unntak/1839902024-03-13T13:39+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/fedmelegemiddelet-wegovy-plusser-pa-hjerte-kar-fordeler-pa-indikasjonen-i-usa/1839682024-03-11T10:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/pop-up-poster-presentasjon-en-plattform-for-unge-forskere/1839302024-03-14T09:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/to-gode-nyheter-for-norske-pasienter-med-livmorhalskreft/1839092024-03-14T09:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorkreft/prisvinneren-helga-var-en-inspirator-for-mange-og-en-pioner-innen-gynekologisk-kreftforskning/1838922024-03-14T09:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/eggstokkreft-planlegger-inngrepet-med-bildediagnostikk/1838622024-03-14T09:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nymo-helli-om-styreleder-rollen-i-finnmarkssykehuset-et-kultursjokk/1838372024-03-11T11:55+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bildeserie-helse-og-fremtid-konferansen-2024/1837692024-03-08T13:21+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorkreft/livmorkreft-mange-vil-bli-sykdomsfrie-og-kurert/1837272024-03-07T21:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/esgo-flere-norske-bidrag-pa-europas-viktigste-gynkreft-kongress/1837092024-03-07T22:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/melanom/ultimovacs-initium-studien-med-uv1-vaksinen-mot-foflekkreft-var-negativ-veldig-overrasket-og-skuffet/1836852024-03-07T10:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lager-ikke-vi-farmasoyter-nok-stoy-rundt-jobben-vi-gjor/1836542024-04-09T16:17+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftforeningen-roser-180-dagers-krav-men-roper-varsko-om-dmps-ressurser/1836382024-03-06T10:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dmp-om-hods-180-dagers-krav-vi-vil-fortsette-a-jobbe-med-forbedringer/1836032024-03-05T14:13+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ordningen-med-nyfodtscreening-kan-bli-utvidet/1835782024-03-04T17:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hod-metodevurderinger-skal-fullfores-innen-180-dager/1835552024-03-05T15:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/melanom/dette-sa-ultimovacs-toppene-fa-dager-for-studie-svikten-og-aksjefallet/1835482024-03-11T12:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/migrene-nevrolog-mener-fastlegene-bor-forskrive-cgrp-hemmere-og-botox/1835132024-03-04T11:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legeforeningen-riktig-kurs-men-viktige-tiltak-uteblir/1834842024-03-02T13:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/en-milliard-mennesker-i-verden-lever-na-med-fedme-viser-ny-studie/1834652024-03-05T13:51+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/lover-bedre-finansiering-og-mer-samarbeid/1834432024-03-01T14:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nyfodtscreening-slik-oppdages-potensielt-sjeldne-sykdommer-hos-nyfodte/1834302024-03-01T11:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dette-nettstedet-onsker-a-bli-fremtidens-oppslagsverk-for-sjeldne-diagnoser/1834102024-03-01T10:52+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/31-mister-jobben-i-pfizer-norge-inkludert-medisinsk-direktor/1833982024-02-29T15:50+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vester-om-nye-medisiner-det-tjenes-ogsa-gode-penger-pa-det-som-ikke-virker/1833552024-02-28T10:48+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorkreft/livmorkreft-dette-bor-du-vite-om-symptomer-diagnose-og-behandling/1833492024-03-20T14:18+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/hege-edvardsen-er-ny-styreleder-i-connect/1833382024-02-27T15:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/rootwelt-om-immunterapi-kritikk-et-raskere-ja-er-positivt/1832872024-03-06T13:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/jusprofessor-kritiserer-hurtiginnforing-av-immunterapi-systemet-bor-endres/1832812024-02-26T13:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/leddgikt/betennelsessykdommer-ny-norsk-forskning-kan-sikre-bedre-behandling/1832542024-02-26T09:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bor-ikke-norske-pasienter-fa-tilgang-til-nye-medisiner/1832302024-04-09T16:15+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/svarer-pa-kritikken-aldri-for-har-vi-hatt-sa-mange-leveranser-til-nye-metoder/1832002024-02-22T12:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nye-metoder-lege-usikker-dokumentasjon-og-astronomiske-priser-pa-nye-legemidler/1831762024-02-22T09:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-reagerer-pa-lang-saksbehandling-det-gar-for-sakte/1831512024-02-22T11:46+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/benmargskreft-naermest-tredoblet-progresjonsfri-overlevelse-spennende/1831342024-02-21T10:21+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/crohns/ulceros-kolitt-forste-avanserte-orale-medisin-godkjent-i-norge-og-eu/1831192024-02-20T13:47+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorkreft/vaktpostlymfeknute-teknikk-med-robot-gir-lavere-kostnader-og-bedre-helse-hos-kvinner-med-livmorkreft/1831112024-03-08T16:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/pilotstudie-ved-ntnu-viser-positive-resultater-for-migrenesykdommer/1830982024-02-20T08:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/samfunnsokonom-om-fedme-og-overvekt-ujevnt-fordelt-i-befolkningen/1830452024-02-16T14:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/hoyt-kolesterol-professor-vil-behandle-unge-og-friske-personer-for-de-blir-syke-1/1830332024-02-20T16:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ekspertgruppe-vil-ogsa-prioritere-pasienter-som-kan-bidra-til-verdiskapingen-i-samfunnet/1829972024-02-16T08:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vil-ha-fire-nye-inn-i-beslutningsforum/1829782024-02-15T17:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/hjerneslag-norsk-konferanse-om-symptomer-diagnoser-behandling-og-forebygging/1829552024-02-15T13:41+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vil-innfore-ny-sjanse-etter-avslag-pa-medisiner-i-beslutningsforum/1829492024-02-15T21:53+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/kan-ta-ozempic-av-bla-resept-etter-reseptjuks/1829332024-02-15T08:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hurtiginnforing-av-immunterapi-disse-selskapene-har-blitt-med/1829152024-02-14T15:28+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/prisreduksjon-pa-kreftbehandling-kuttet-saksbehandlingstid-til-kun-fire-dager/1828862024-02-13T14:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/folketrygden-betalte-ut-14-milliarder-kroner-i-refusjoner-til-populaer-diabetesmedisin-i-fjor/1828732024-02-13T08:41+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ventetiden-pa-nye-medisiner-har-blitt-enda-lengre/1828522024-02-13T13:01+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/fire-ja-og-tre-nei-i-beslutningsforum/1828282024-02-13T13:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/cmv-jubler-for-ja-til-medisin-mot-infeksjon-etter-transplantasjon/1828222024-02-12T10:28+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-etter-forskningsavsloring-industrien-publiserer-studieresultater/1828102024-02-12T08:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/onsker-storre-eksport-av-helsenaering-dette-mener-aktorene-om-ny-strategi/1827762024-02-09T14:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vi-skal-doble-helseksporten-fra-22-til-50-milliarder-kroner-innen-2030/1827622024-02-09T13:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/lungekreft-pasienter-kan-fa-immunterapi-for-operasjon-foflekkreft-pasienter-kan-fa-etter/1827432024-02-08T14:53+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/epilepsi-krever-ja-til-medisin-mot-sjelden-epileptisk-sykdom/1827312024-02-08T14:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nesten-12-000-norske-pasienter-deltok-i-studier-som-ikke-har-blitt-publisert-sjokkerende-tall/1827192024-02-07T13:42+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/novo-nordisk-sjefen-overrasket-over-forbrukernes-betalingsvillighet-for-slankemedisin/1826772024-02-06T10:53+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/fedmeepidemien-slik-forklarer-de-arsaker-trender-og-forebygging/1826712024-02-06T13:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/fedmeekspert-joran-hjelmesaeth-politikerne-har-ikke-ryggrad/1826452024-02-05T09:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/takedas-hyqvia-med-eu-godkjenning-for-den-sjeldne-nevromuskulaere-lidelsen-cidp/1826212024-02-05T15:33+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/andreea-mocofan-blir-ny-sjef-i-msd-norge/1826092024-02-02T14:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/brystkreftmedisinen-enhertu-kan-fa-godkjenning-for-alle-typer-her2-positiv-kreft-er-allerede-i-bruk-pa-privat-norsk-kreftklinikk/1825712024-02-06T13:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/stopper-salg-og-utvikling-av-omstridt-alzheimermedisin/1825492024-02-01T10:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/mari-mette-har-levd-med-fedme-og-overvekt-du-blir-ekstremt-synlig-men-samtidig-usynlig/1825072024-02-01T10:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/rekordar-for-novo-nordisk/1824432024-01-31T10:25+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nei-vi-skal-ikke-prioritere-de-rike-og-friske-framfor-fattige-og-syke/1823992024-01-31T10:35+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/urinsyregikt-ny-forskning-viser-sterk-sammenheng-mellom-livsstil-og-smerte/1823872024-01-30T15:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/skal-vi-virkelig-prioritere-rike-og-friske-framfor-fattige-og-syke/1823502024-04-09T16:18+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/koronahandteringen-skal-granskes-pa-stortinget/1823442024-01-29T13:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/sas-vant-storkontrakt-med-spesialhelsetjenesten/1823312024-01-29T13:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nytt-legemiddel-mot-flekkvis-hartap-tilgjengelig-i-norge/1823012024-01-29T09:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/roche-om-immunterapi-onsker-okt-prioritering-til-nyvinninger/1822862024-01-26T13:47+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/prioriteringsmeldingen-nodvendig-at-vi-prioriterer-helsehjelp-til-pasienter-i-arbeidsfor-alder/1822652024-01-26T12:43+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/brukte-reseptpliktige-legemidler-for-352-milliarder-kroner/1822532024-01-25T13:35+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/injiserbar-immunterapi-trenger-ikke-metodevurdering-med-lik-eller-lavere-pris/1822312024-01-25T11:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/trodelvy-nadde-ikke-hovedmalet-i-lungekreftstudie/1822152024-02-06T12:38+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/klepp-karet-til-mest-demensvennlige-kommune/1822022024-01-24T15:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/blodkreftforeningen-om-car-t-ma-ses-som-en-investering-ikke-kun-en-kostnad/1821832024-02-06T14:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vil-ha-moms-pa-helseforsikring-men-stotter-ikke-rodt-forslag/1821692024-01-23T11:31+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kjerkol-kaller-plagiatpastander-absurde/1821432024-01-22T13:13+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-nei-til-fire-og-ja-til-tre-legemidler/1821142024-02-06T14:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/prostatakreft/prostatakreft-derfor-sa-beslutningsforum-ja-til-en-medisin-og-nei-til-en-annen/1821042024-02-06T15:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/flere-tekstlikheter-i-helseministerens-masteroppgave/1820862024-01-21T12:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/legemiddel-aret-2023-dette-var-hoydepunktene/1820602024-01-19T11:22+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/leddgikt/dette-er-de-nye-behandlingsanbefalingene-for-hofteartrose-og-kneartrose/1820422024-01-19T16:12+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/prostatakreft/prostatakreft-pasientene-ber-beslutningsforum-og-novartis-bli-enige-om-pris-pa-medisin/1820192024-02-06T15:44+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/prostatakreft/blir-ikke-enig-om-pris-dette-er-uenigheten-mellom-beslutningsforum-og-novartis/1820122024-02-06T15:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/aslaug-helland-eu-godkjenning-av-immunterapi-som-sproyte-vil-bety-mye-for-pasientene/1820012024-01-17T11:28+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/2024-blir-et-toft-ar-pa-legemiddelfronten/1819782024-04-29T15:50+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/freder-akuttkirurgien-og-fodetilbudet-i-lofoten-og-narvik/1819602024-01-16T13:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehustalen-2024-vil-gi-sykehusene-mer-penger-og-redusere-ventetidene/1819402024-01-16T14:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rekordmange-apotek-ble-lagt-ned-i-2023-apotekforeningen-er-bekymret/1819302024-01-16T13:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/43-milliarder-grunner-til-bedre-legemiddelbruk-i-norge/1819022024-04-09T16:19+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/utnevnelsen-av-nye-styrer-i-helseforetakene-utsatt-til-tirsdag/1818892024-01-15T09:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/benmargskreft-norske-gunhild-betalte-fem-millioner-kroner-for-genterapi-i-tyskland/1818612024-02-06T14:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/benmargskreft-norske-kreftpasienter-betaler-millioner-for-genterapi-i-utlandet/1818512024-02-06T14:35+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sjur-lehmann-utnevnt-som-ny-direktor-for-statens-helsetilsyn/1818372024-01-12T13:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/nakstad-forlater-helsedirektoratet-det-har-vaert-en-fin-tid/1818202024-01-12T12:52+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-podcast-episode-vi-diskuterer-prioriteringer-og-hurtiginnforing-av-immunterapier/1818132024-01-12T13:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/statsbygg-kjoper-forskningsutstyr-for-13-milliarder-til-livsvitenskapsbygget/1817992024-01-11T13:13+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/helseministeren-holder-fast-pa-fristen-for-sykehusplan-i-nord/1817652024-01-10T13:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/oyesykdom/godkjenner-hoy-dose-versjon-av-bayers-oyemedisin-eylea/1817562024-04-29T15:29+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helse-nord-trekker-omstridte-kuttforslag-ma-bruke-tiden-de-har-kjopt-seg/1817272024-01-09T17:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsetopp-advarer-mot-a-innfore-et-a-og-b-lag-blant-norske-pasienter/1817132024-01-10T09:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-systemet-ma-ikke-bli-et-prisforhandlingsverktoy-for-kun-legemidler/1816972024-01-10T08:51+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/apotekansatte-kan-gjore-oppgaver-som-i-dag-gjores-av-andre-i-helsetjenesten/1816832024-01-09T14:40+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/na-helseministeren-far-innspill-fra-helsebransjen-i-arbeidet-med-ny-prioriteringsmelding/1816712024-01-09T17:06+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/omstridt-kuttforslag-pa-styrebordet-i-helse-nord/1816502024-01-08T14:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/legemidler-salget-okte-med-nesten-9-milliarder-kroner-i-2023/1816382024-01-08T16:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-krever-enda-lavere-priser-for-raskere-innforing-av-immunterapi-mot-kreft/1816222024-01-11T11:41+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisk-inngar-milliardsamarbeid-med-amerikanske-biotekselskaper/1816072024-01-05T09:54+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/norske-christian-far-global-rolle-i-selskap-med-over-100-000-ansatte/1815792024-01-04T14:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorkreft/livmorkreft-gsks-kreftkombinasjon-nar-hovedmalet-i-senfase-studie/1815652024-02-06T14:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/nytt-rekordar-for-oslo-myelomatosesenter-nesten-150-pasienter-inkludert-i-kliniske-studier/1815522024-02-06T14:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/disse-biotek-selskapene-kjopte-big-pharma-opp-for-nyttar/1815402024-01-03T09:01+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/frp-vil-betale-mer-for-et-godt-levear/1814202024-02-06T14:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/guri-rortveit-blir-ny-fhi-direktor/1814002023-12-20T12:51+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorkreft/mener-gsk-kan-fa-medisin-mot-livmorkreft-hurtiginnfort-trenger-ikke-ta-lang-tid/1813342024-02-06T15:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/nyrekreft-forbedret-overlevelse-med-immunterapi-etter-operasjon-norsk-nyrekreft-lege-avventer-data/1813152024-02-06T15:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/det-beste-fra-ash-2023-verdens-storste-hematologikongress/1813082024-02-06T15:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/gir-gront-lys-for-den-forste-genredigeringsterapien/1812972024-02-06T15:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/arets-forsker-2023-vil-skreddersy-behandling-for-blodkreft-pasienter/1812582024-02-06T15:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/tarmkreft/nykode-vil-utvikle-vaksiner-mot-tarmkreft/1812402024-02-06T15:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/ny-podcast-de-viktigste-legemiddelsakene-i-2023-og-forventninger-for-2024/1812342024-01-02T09:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorkreft/livmorkreft-frykter-sen-innforing-av-medisin-2025-er-helt-uakseptabelt/1812102024-02-06T15:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/stamcelletransplantasjon-ferske-data-pa-medisin-mot-komplikasjon-etter-transplantasjon/1811982024-02-06T15:13+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/b-cellelymfom-8-av-10-ble-kvitt-kreften-helt-med-yescarta-som-forste-behandling/1811642024-02-06T15:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/norsk-industri-er-pa-plass-i-san-diego-for-ash-en-ypperlig-plattform/1811182024-11-15T10:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/leukemi-ny-kombinasjon-gir-bedre-og-lengre-effekt/1811082024-02-06T15:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/ny-car-t-mot-lymfom-nesten-alle-ble-kreftfrie/1810902024-02-06T15:18+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/beslutningsforum-vil-hurtiggodkjenne-immunterapi/1810722024-02-06T15:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/lymfekreft-ous-forsker-ga-muntlig-ash-presentasjon-om-tumor-mikromiljo/1810522024-02-06T15:21+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/car-t-utsetter-tilbakefall-men-uklart-om-overlevelsen-oker/1810352024-02-06T15:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/8-ars-data-viser-leukemibehandling-med-scemblix-er-effektiv-og-trygg/1810112024-02-06T15:24+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/benmargskreft-stavanger-lege-med-ash-studie-pa-hoydose-cellegift-i-eldre-pasienter/1809972024-02-06T15:25+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/norsk-blodkreftlege-vant-pris-pa-ash-dette-har-hun-forsket-pa/1809852024-02-06T15:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/deltar-med-10-studier-pa-verdens-storste-kongress-for-blodsykdommer/1809652024-02-06T15:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/car-t-mot-mantelcellelymfom-real-world-data-bekrefter-effekt-og-sikkerhet/1809472024-02-06T15:28+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/reduserer-risiko-for-tilbakefall-i-tidlig-brystkreft-etter-operasjon/1809332024-02-06T15:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/floskelsvar-frp-langer-ut-mot-blaresept-forsikringer-fra-hod/1809082024-02-06T15:46+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-malrettet-cellegift-forlenget-tid-til-sykdomsprogresjon-eller-dod/1808842024-02-06T15:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/tucatinib-og-kadcyla-forlenger-progresjonsfri-overlevelse-ved-avansert-her2-positiv-brystkreft/1808732024-02-06T15:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/diabetesforbundet-er-bekymret-mener-mye-er-uklart-om-blaresept-anbud/1808412024-02-06T15:48+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-i-forstelinje-verzenios-bommet-harfint-pa-mal-for-totaloverlevelse/1808262024-02-06T15:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/norsk-studie-pa-sabcs-epigenetiske-forandringer-tidlig-i-fosterlivet-kan-gi-brystkreft/1808022024-02-06T15:50+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/hod-om-blaresept-anbud-pasienter-har-ingenting-a-frykte/1807862024-02-06T15:51+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/dette-sier-industrien-om-flertall-for-blaresept-anbud/1807692024-02-06T15:52+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sjokkerende-pfizer-norge-reagerer-pa-svs-ja-til-blaresept-anbud/1807422024-02-06T15:55+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-podcast-sv-sikrer-flertall-for-blareseptanbud-car-t-trobbel-og-uenighet-om-hemmelige-priser/1807362024-02-06T15:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/rsv/rs-virus-potensielt-store-konsekvenser-men-mangel-pa-data-er-utfordrende/1807242024-02-06T15:56+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sv-gir-regjeringen-flertall-for-anbud-pa-blareseptlegemidler/1807022024-02-06T15:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/alle-piler-peker-oppover-slik-sa-salget-av-legemidler-ut-i-november/1806902024-02-06T15:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/rsv/ny-rsv-vaksine-na-tilgjengelig-i-norge/1806782024-02-06T15:58+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legemiddelverkets-sjef-skal-lede-nytt-direktorat-fra-nyttar-slik-blir-endringene/1806552024-02-06T15:59+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kols/norsk-lungelege-om-dupixent-mot-kols-kan-bli-behandling-for-liten-gruppe-pasienter/1806382024-02-06T16:00+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/flere-overlever-lunge-bryst-og-endetarmskreft/1806232024-02-06T16:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/myelomatose/begrenset-kapasitet-star-i-veien-for-banebrytende-terapi-mot-blodkreft/1805832024-02-06T16:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/lmi-sjefen-apne-priser-vil-gi-pasientene-darligere-tilgang-pa-medisiner/1805772024-02-06T16:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehusinnkjop-fastslar-uaktuelt-med-apne-priser-pa-patenterte-medisiner/1805662024-02-06T16:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/myelomatose/blodkreftlegene-har-sitt-beste-ar-pa-verdens-storste-kongress-for-blodsykdommer/1805512024-02-06T16:05+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/apotek-sjef-reagerer-pa-oppblast-statistikk-foreslar-tidsbegrensning-pa-hemmelige-priser/1805362024-02-06T16:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/prostatakreft/kreftkirurgi-kreftforeningen-gir-24-millioner-til-forskning-pa-operasjon-av-kreft/1805222024-02-06T16:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helseberedskapsmeldingen-dette-er-de-viktigste-punktene-til-regjeringen/1804942024-02-06T16:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisk-vil-investere-milliarder-i-frankrike/1804812024-02-06T16:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/msd-styrker-satsing-pa-nevrodegenerative-sykdommer-kjoper-nytt-selskap/1804522024-02-06T16:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-podcast-hvorfor-blir-immunterapi-mot-kreft-kanskje-snart-hurtiginnfort/1804342024-02-06T16:08+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eksem/eu-godkjenner-lebrikizumab-for-behandling-av-moderat-til-alvorlig-atopisk-eksem/1804162024-02-06T16:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/anerkjent-patolog-fra-md-anderson-i-usa-slik-vil-patologien-forme-fremtiden-pa-kreftfeltet/1804002024-02-06T16:09+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/den-11-desember-faller-dommen-beslutningsforum-avgjor-om-immunterapi-skal-hurtiginnfores/1803482024-02-06T16:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/leukemi-pasienter-far-tilgang-pa-ny-behandling-spesielt-gledelig/1803362024-02-06T16:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-disse-fikk-ja-og-disse-fikk-nei-i-dag/1803252024-02-19T11:13+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreftmedisin-mot-sjelden-genetisk-mutasjon-fikk-usa-ja/1802822024-02-19T11:13+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/verdens-forste-crispr-medisin-godkjent-for-sigdcelleanemi-og-beta-talassemi/1802642024-02-19T11:14+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legemiddelverket-snur-dette-er-legemidlene-de-vil-ha-pa-anbud/1802282024-02-19T11:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/helland-om-utviklingen-av-lungekreft-behandling-flere-pasienter-vi-na-kan-gjore-mye-for/1802122024-02-19T11:16+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kongens-fortjenstmedalje-til-johanne-sundby/1801972024-02-19T11:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rask-saksbehandling-av-immunterapi-lar-vente-pa-seg/1801692024-02-19T11:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreft-fase-3-studie-med-imfinzi-og-cellegift-samtidig-nadde-ikke-malet/1801582024-02-19T11:20+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/fresenius-kabi-fabrikken-i-halden-solgt-produksjonen-fortsetter/1801262024-02-19T11:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ny-takeda-sjef-apnet-nye-lokaler-i-asker-vil-sikre-innovative-medisiner-til-norske-pasienter/1801172024-02-19T11:22+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/utgiftene-til-legemidler-er-mye-lavere-enn-det-mange-tror/1800972024-01-02T11:31+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/8-millioner-kroner-til-forskning-fra-ous-pa-persontilpasset-immunterapi-mot-brystkreft/1800802024-02-19T11:22+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/wegovy-reduserer-risikoen-for-hjerteinfarkt-i-kardiovaskulaer-studie/1800492024-04-02T10:24+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/anbefaler-at-diabetesmedisinen-mounjaro-godkjennes-som-slankemiddel-i-europa/1800382024-02-19T11:27+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/migrene-apotek-1-tester-ut-migrenesamtaler-pa-nytt/1800202024-02-19T11:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ikke-bare-utdeling-av-medisin-disse-helsetjenestene-tilbys-i-norske-apotek/1799872024-02-19T11:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/vil-ultimovacs-gi-opp-kampen-om-brysthinnekreft/1799762024-02-19T11:31+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/fda-godkjenner-ny-slankemedisin-som-vil-konkurrere-med-wegovy/1799592024-02-19T11:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/forste-pasient-med-alvorlig-hemofili-er-behandlet-med-genterapien-roctavian/1799342024-02-19T11:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/car-t-kreftleger-ved-st-olavs-og-haukeland-venter-utalmodig-pa-oppstart/1799142024-02-19T11:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/kjetil-tasken-fra-ous-far-svensk-pris-for-fremragende-arbeid-pa-kreftfeltet/1798912024-02-19T11:35+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sv-om-blaresept-pa-anbud-uheldig-at-regjeringen-tar-et-slikt-grep/1798732024-02-19T11:35+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/ozempic-wegovy-og-saxenda-sikrer-rekordvekst-for-novo-nordisk/1798582024-02-19T11:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/han-er-ny-sjef-i-takeda-norge-og-norden/1798462024-02-19T11:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/aksjefall-for-moderna/1798152024-02-19T11:38+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-podcast-sterk-motstand-mot-blareseptanbud-og-vinn-eller-forsvinn-for-ultimovacs/1797942024-02-19T11:41+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/duchennes-muskeldystrofi-medisin-nadde-ikke-malet-i-klinisk-studie/1797822024-02-19T11:43+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/falske-slankemedisiner-slik-forhindrer-eu-landene-at-de-blir-solgt-i-apotekene/1797382024-02-19T11:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/astma/astma-og-allergiforbundet-om-blaresept-anbud-piloten-er-darlig-evaluert/1797182024-02-19T11:46+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/gsk-norge-om-blaresept-anbud-dagens-ordning-fungerer/1796922024-02-19T11:47+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/melanom/ultimovacs-har-fatt-klarsignal-til-alternativ-avlesning-av-foflekkreftstudien/1796732024-02-19T11:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/hodepine-ekspert-om-blaresept-anbud-virker-som-om-de-tror-at-alle-pasienter-er-like/1796572024-02-19T11:50+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kommentar/blareseptdebatt-uten-elefanten-i-rommet/1796292024-04-29T15:51+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bard-hoksrud-skuffet-over-at-regjeringen-droppet-debatt-om-anbud-pa-blaresept/1796122024-02-19T11:51+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-dette-var-de-viktigste-studiene-pa-esmo-kongressen/1795732024-02-19T11:52+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/urologisk-kreft-dette-var-de-viktigste-nyhetene-pa-esmo/1795622024-09-03T12:52+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/gynekologisk-kreft-dette-var-de-viktigste-studiene-pa-esmo-kongressen/1795412024-09-03T13:04+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftforeningen-pa-esmo-opptatt-av-hva-som-kan-ha-betydning-for-pasientene/1795292024-02-19T11:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/prostatakreft/prostatakreft-positive-data-fra-internasjonal-biomarkor-studie-med-norsk-deltakelse/1795112024-02-19T11:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-ny-malrettet-cellegift-gir-bedre-effekt-enn-vanlig-cellegift/1794852024-09-03T12:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/melanom/norsk-kreftlege-presenterte-norsk-medisin-pa-europas-storste-kreftkongress/1794732024-02-19T11:56+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/nykode-skattesmell-og-emisjon-sender-aksjen-ned/1794602024-02-19T11:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/sigrid-bratlie-i-kreftforeningen-far-naturviterprisen-for-2023/1794442024-02-19T11:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/testikkelkreft/testikkelkreft-norsk-kreftforsker-fra-alesund-undersokte-dodsarsaker-gjennom-30-ar/1794322024-02-19T11:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/blaerekreft-doblet-overlevelsen-med-ny-kombinasjon-ny-standardbehandling/1794012024-09-03T13:34+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/ultimovacs-sjefen-bekrefter-big-pharma-moter-pa-esmo-men-er-stille-om-studie-kritikk/1793852024-02-19T12:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-sier-ja-til-tre-av-seks-metoder-og-terje-rootwelt-fortsetter/1793682024-02-19T12:06+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/over-20-norske-lis-leger-deltar-pa-esmo-i-madrid-kreftlegene-spanderer-turen/1793232024-02-19T12:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/mange-viktige-lungekreftnyheter-vi-trenger-nye-behandlinger/1793102024-02-19T12:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreft-alectinib-holder-tilbakefall-i-sjakk-etter-operasjon/1792902024-02-19T12:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/ultimovacs-aslaug-helland-svarer-pa-kritikk-mot-nipu-studien-pa-esmo-i-madrid/1792642024-02-19T12:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/ous-forskere-leder-eu-prosjekt-pa-pasientfokusert-behandling-presenterte-fremgangen-pa-esmo/1792522024-02-19T12:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorkreft/livmorkreft-nye-data-fra-studie-imponerte/1792352024-02-19T12:12+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorkreft/sykepleiere-fulgte-opp-seksualitet-hos-gynkreft-pasienter-slik-opplevde-de-samtalene/1792222024-02-19T12:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/viser-for-forste-gang-en-betydelig-fordel-med-immunterapi-i-hr-positiv-tidlig-brystkreft-for-operasjon/1791962024-09-04T15:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-femarsdata-pa-medisin-fra-lilly-gir-hap-om-okt-overlevelse/1791792024-02-19T12:14+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/ahus-lege-jan-oldenburg-om-kreftforskning-blir-bare-bedre-og-bedre/1791552024-02-19T12:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreft-norske-eksperter-har-ankommet-esmo-i-madrid-dette-ser-de-frem-til/1791412024-02-19T12:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/immunterapi-i-kombinasjon-med-kjemoterapi-oker-overlevelsen-for-pasienter-med-blaerekreft/1791312024-02-19T12:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/rsv/voksenvaksinasjon-legemiddelindustri-og-apotek-er-samstemte-om-hastebehov/1791172024-02-19T12:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/healthtalk/behandling-av-lungekreft-innleder-en-ny-tidsalder/1791112024-02-19T12:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/rsv/manglende-vaksinering-kan-koste-samfunnet-mange-milliarder-kroner-i-aret/1790922024-02-19T12:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/pasienter-med-brysthinnekreft-lever-43-maneder-lenger-med-kreftvaksinen-til-ultimovacs/1790722024-02-19T12:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/gynekologisk-kreft-tror-forskningsfremskritt-vil-endre-behandlingspraksis/1790622024-02-19T12:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livmorkreft/livmorkreft-ema-anbefaler-utvidelse-av-indikasjonen-for-jemperli/1790492024-02-19T12:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/langtidsdata-pa-utprovende-ms-medisin-knyttet-stor-spenning-til-btk-hemmere/1790372024-02-19T12:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eksem/atopisk-eksem-dette-antistoffet-kan-vaere-et-alternativ-til-cyklosporin/1790072024-02-19T12:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/psoriasis/stadig-nye-behandlinger-av-hudsykdommer-norsk-hudlege-mener-det-finnes-noe-for-alle/1789912024-02-19T12:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ms-pasienter-byttet-fra-medisin-inn-i-venen-til-under-huden-spesielt-attraktive-data/1789792024-02-19T12:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/psoriasis/alopecia-areata-legemidlet-er-en-gamechanger-i-behandlingen-av-sykdommen/1789412024-02-19T12:39+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/ms-assosiert-med-hoyere-rater-av-kreft-i-ny-studie/1789272024-02-19T12:39+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eksem/atopisk-eksem-langtidsstudie-viser-vedvarende-effekt-og-sikkerhet-med-rinvoq/1788932024-02-19T12:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/psoriasis/health-talk-gir-deg-nyhetene-fra-dermatologi-og-venerologikongressen-i-berlin/1788722024-02-19T12:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ms-og-ocrevus-sproyte-under-huden-er-ikke-darligere-enn-intravenos-infusjon/1788602024-02-19T12:51+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/psoriasis/nesten-halvparten-av-pasientene-med-hudsykdom-lider-av-sovnforstyrrelser/1788462024-02-19T12:52+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eksem/studie-belyser-sterke-fordommer-til-akne-hos-voksne-kvinner/1788362024-02-19T12:54+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/melanom/ny-studie-avdekker-hudkreft-tar-livet-av-flere-enn-foflekkreft/1788252024-02-19T12:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/bristol-myers-squibb-kjoper-mirati-for-a-sikre-seg-malrettet-legemiddel-mot-lungekreft/1787972024-02-19T12:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/tilbudet-til-kreftpasienter-i-den-offentlige-helsetjenesten-er-av-hoy-kvalitet/1787822024-02-19T12:57+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/ruller-ut-den-rode-loperen-for-ultimovacs/1787582024-02-19T12:58+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/20-millioner-til-blaresept-refusjon-av-to-legemidler-mot-hjertesvikt/1787402024-02-19T12:59+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/kraftig-okning-i-spiseforstyrrelser-blant-unge-kvinner-under-pandemien/1787122024-02-19T13:01+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kommentar/statsbudsjettet-privat-helsevesen-er-den-storste-vinneren/1786912024-04-29T15:51+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/lmi-sjefen-uheldig-a-innfore-anbud-i-stor-skala/1786642024-02-19T13:02+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/novartis-om-blaresept-pa-anbud-regjeringen-har-vaert-lite-inkluderende/1786502024-02-19T13:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/anbud-pa-blarepseptlegemidler-pfizer-og-bms-kan-tape-flere-hundre-millioner-kroner/1786342024-02-19T13:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/astma/astma-og-allergiforbundet-om-blareseptanbud-regjeringen-bryter-lofter/1786202024-02-19T13:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/innforer-permanent-anbudsordning-pa-patenterte-legemidler-kan-spare-600-millioner-kroner-arlig/1786012024-02-19T13:04+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsenaeringen-kan-fa-150-millioner-kroner-i-statsbudsjettet/1785932024-02-19T13:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/statsbudsjettet-gratis-kikhostevaksine-til-gravide/1785772024-02-19T13:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/benskjorhet/sykehuset-i-vestfold-har-undersokt-om-sykepleiere-kan-gjore-en-av-anestesilegens-oppgaver-1/1785432024-02-19T13:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/na-er-den-forste-effektive-behandlingen-for-alzheimer-her-vil-norske-pasienter-fa-den/1785032024-02-19T13:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/benskjorhet/hofteprotese-ved-larhalsbrudd-er-hel-eller-halv-det-beste-valget/1784972024-02-19T13:09+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/benskjorhet/hoftebrudd-hos-eldre-dette-er-viktigst-for-pasientene/1784762024-02-19T13:08+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-nye-sterke-data-kan-gi-ja-i-beslutningsforum/1784542024-02-19T13:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreft-medisin-trekkes-tilbake-etter-skuffende-studiedata/1784432024-02-19T13:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/nobelprisen-i-medisin-til-oppdagelsen-av-mrna-vaksinen/1784182024-02-19T13:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/merck-siri-boro-er-ny-medisinsk-direktor-i-norge/1784022024-02-19T13:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/lymfekreft-medisin-fra-abbvie-har-fatt-eu-godkjenning/1783662024-02-19T13:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eksem/atopisk-eksem-ny-medisin-kan-bli-eu-godkjent/1783552024-02-19T13:13+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/tone-troen-h-om-privat-kreftbehandling-disse-historiene-bekymrer-meg/1783362024-02-19T13:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/privat-kreftbehandling-slik-reagerer-politikere-pa-pasienthistoriene-og-okt-bruk-av-privat-helse/1783122024-02-19T13:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/ultimovacs-kraftig-opp-pa-borsen-etter-nyhet-om-kreftstudie/1782862024-02-19T13:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/proverorsbefruktning-er-i-vekst-aleris-satser-med-egen-fertilitetsklinikk/1782652025-05-08T14:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/bard-hoksrud-frp-provoseres-av-avsloringer-om-privat-helse-skylder-pa-regjeringen/1782442024-02-19T13:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreft-ja-til-medisin-som-kan-forhindre-tilbakefall/1781952024-02-19T13:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/norge-tidlig-ute-med-godkjenning-av-enhertu-mot-her2-lav-brystkreft-jeg-er-overrasket/1781812024-02-19T13:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/tommel-opp-for-enhertu-disse-behandlingene-sa-beslutningsforum-ja-til/1781672024-02-19T13:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ny-studie-slik-opplever-pasienter-med-oyesykdom-behandling-i-norge/1781572024-02-19T13:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/lmi-rekrutterer-fra-the-life-science-cluster-ase-solberg-blir-ny-radgiver/1781392024-02-19T13:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/pa-mandag-kan-denne-medisinen-bli-en-av-norges-dyreste-eller-skape-politisk-hodepine/1781082024-02-19T13:31+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helseokonom-lanserte-nytt-sykdomsbegrep-tror-det-kan-provosere-noen/1780832024-02-19T13:32+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsetjenesten-betaler-opptil-tre-ganger-mer-for-et-godt-levear-enn-tidligere-antatt/1780582024-02-19T13:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/nukleaermedisin-fra-nord-norge-sprenger-kreftcellene-i-fillebiter/1780412024-02-19T13:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/tarmkreft/senskader-etter-tarmkreft-lasse-er-ikke-den-samme-som-han-var-for/1780222024-02-19T13:34+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-hadde-jeg-ikke-hatt-sparepenger-ville-jeg-vaert-dod-na/1779782024-09-03T13:13+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/orkla-gir-helseforsikring-til-alle-ansatte-blir-satt-veldig-pris-pa/1779592024-02-19T13:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/dette-pakkeforlopet-skal-sikre-forutsigbarhet-for-kreftpasienter-slik-fungerer-ordningen/1779392024-02-19T13:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/disse-kreftmedisinene-dekker-de-norske-forsikringsselskapene/1779142024-02-19T13:39+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreft-immunterapi-og-cellegift-sikret-flere-overlevende-etter-fem-ar-oppmuntrende/1778912024-02-19T13:40+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreft-behandling-bremser-forverring-men-bivirkninger-bekymrer-lege/1778732024-02-19T13:41+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/helseforsikring-gir-kreftpasient-tina-schau-mer-tid-dette-handler-om-a-overleve/1778502024-02-19T13:43+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/usa-vil-betale-mindre-for-legemidler-hvorfor-er-det-viktig-for-norge/1777922024-02-19T13:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/lise-ostlund-skal-lede-arbeidet-med-baerekraft-i-apotek-1/1777722024-02-19T13:44+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/haper-pa-car-t-behanding-mot-kreft-pa-haukeland-sterkt-onske-om-a-komme-i-gang/1777582024-02-19T13:45+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ultimovacs-sikre-pa-finanser-til-tross-for-forsinkelser-i-kreftstudie/1777292024-02-19T13:46+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ema-vil-stoppe-gravides-bruk-av-medisin-mot-epilepsi/1776962024-02-19T13:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/helland-om-nyhet-for-pasienter-med-tidlig-lungekreft-lovende/1776702024-02-19T13:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/norges-to-private-kreftklinikker-har-rekordvekst/1776602024-02-19T13:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/melanom/foflekkreft-godkjenner-immunterapi-etter-operasjon/1776402024-02-19T13:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/et-veldig-stort-fremskritt-for-pasienter-med-lymfekreft-og-brystkreft/1776342024-02-19T13:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/moderna-tar-sjansen-pa-norden-marianne-og-mattias-skal-lede-satsingen/1775992025-08-01T10:29+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/leddgikt/slik-gikk-det-med-leddgikt-pasienter-som-trappet-ned-medisinbruken/1775852024-02-19T13:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/leddgikt/revma-spesialist-dette-bor-du-vite-om-lupus-og-graviditet/1775652024-02-19T13:59+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/leddgikt/anerkjent-revmatolog-om-mr-bilder-fint-at-ogsa-revmatologer-kan-litt-om-dette/1775492024-02-19T13:59+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/rootwelt-om-ja-til-celleterapi-dataene-har-vaert-litt-sprikende/1775202024-02-19T13:59+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/beslutningsforum-sier-ja-til-medisin-mot-trippel-negativ-brystkreft-og-lymfekreft/1775062024-02-19T14:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/leddgikt/skandinavisk-lansering-av-medisin-mot-revmatiske-sykdommer-potensiell-gamechanger/1774642024-02-19T14:00+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/arendalsuka-2023-dette-var-det-viktigste-innen-helse/1774442024-02-19T14:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/leddgikt/har-undersokt-fysioterapeuters-forhold-til-digitale-hjelpemidler-dette-fant-han-ut/1774222024-02-19T14:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/rsv/rsv-eu-godkjenner-forste-vaksine-for-gravide-for-a-beskytte-nyfodte/1773992024-02-19T14:05+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/leddgikt/revmatolog-guro-lovik-goll-vant-pris-pa-scr-stolt-glad-og-inspirert/1773842024-02-19T14:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/leddgikt/norsk-ekspert-pa-leddgikt-dette-er-de-viktigste-nyhetene-innen-behandling/1773632024-02-19T14:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/pa-mandag-avgjor-beslutningsforum-skal-yescarta-erstatte-30-ars-standardbehandling-for-lymfekreftpasienter/1773432024-02-19T14:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nykode-sjefene-mye-bra-men-veikartet-mangler-to-viktige-tiltak/1773102024-08-16T09:03+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftforeningen-opplever-dette-som-en-milepael/1772862024-08-16T09:05+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/veikart-for-helsenaeringen-vi-skal-ha-skyhoye-ambisjoner-og-gjennomforingsevne/1772702024-08-16T09:33+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/veikartet-for-helsenaeringen-kommer-onsdag-dette-vil-bransjetoppene-ha/1772322024-02-19T14:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/aml-nye-pasienter-med-blodkreft-far-ikke-bli-med-i-studier-med-medisin-fra-gilead/1772192024-02-19T14:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/migrene-nevrolog-mener-leger-ma-bli-bedre-pa-a-stille-diagnosen/1772032024-02-19T14:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/migrene-rammer-unge-arbeidsfore-dette-er-konsekvensene/1771762024-02-19T14:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-er-dette-enhertus-neste-store-utfordrer/1771232024-02-19T14:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/ja-til-ny-effektiv-migrentablett-men-far-den-bla-resept/1771072024-02-19T14:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/kan-persontilpasset-medisin-bidra-til-a-lose-ressurskrisen-i-helsevesenet/1770832024-02-19T14:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/nykode-grnder-dette-ma-vi-laere-av-danmark-for-a-tiltrekke-oss-kompetanse/1770562024-02-19T14:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/multippel-sklerose-ms-koster-samfunnet-12-milliarder-i-aret-disse-pasientene-koster-mest/1770372024-02-19T14:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/migrene-slik-endret-sykdommen-livet-til-therese/1770162024-02-19T14:20+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/opplever-et-betydelig-bedre-samarbeid-og-mindre-mistro/1769922024-02-19T14:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/de-viktigste-helsemotene-pa-arendalsuka-og-wegovy-gjor-seg-klar-for-bla-resept/1769452024-02-19T14:24+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/slv-tror-pa-ny-diskusjon-med-novo-nordisk-om-blaresept-for-wegovy-ganske-snart/1769152024-02-19T14:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisk-kjoper-biotekselskap-for-10-milliarder-kroner-og-legger-frem-rekordoverskudd/1768962024-02-19T14:30+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/sigdecellesykdom-medisin-trekkes-fra-markedet/1768812024-02-19T14:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/forventer-nye-partier-av-roykeslutt-medisin-i-lopet-av-2024/1768652024-02-19T14:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/wegovy-reduserer-alvorlige-hjertekomplikasjoner-med-20-prosent-dette-er-veldig-gode-nyheter/1768342024-02-19T14:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/usa-godkjenner-den-forste-pillen-for-behandling-av-fodselsdepresjon/1768212024-02-19T14:35+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/salgsboom-pa-legemidler-pilene-peker-oppover-pa-alle-omrader/1768032024-02-19T14:35+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/diabetes-og-slankemedisin-dominerte-salgstallene-i-juli/1767692024-02-19T14:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/finnes-det-en-kur-for-arvelige-sykdommer/1767522024-06-26T10:03+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/nyoppdaget-bakterie-kan-bidra-til-a-utrydde-malaria/1766992024-02-19T14:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/tarmkreft/tarmkreft-studiesuksess-for-medisin-fra-amgen/1766712024-02-19T14:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/den-persontilpassede-revolusjon-slik-blir-dine-immunceller-oppgradert-til-banebrytende-medisin/1766452024-06-26T11:11+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/biogen-kutter-1000-jobber-usikkert-om-konsekvensene-for-biogen-norge/1766282024-02-19T14:41+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/msd-norge-brukte-50-millioner-kroner-pa-forskning-sa-mye-brukte-de-andre-selskapene/1765892024-02-19T14:42+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/et-eureka-oyeblikk-skapte-immunterapien/1765752024-06-26T11:00+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/presisjonsmedisin-skreddersys-til-behandling-av-kreftsvulstene/1765622024-06-26T11:05+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/kan-dette-vaere-arsaken-til-overraskende-eu-nei-til-ny-kreftmedisin/1765382024-02-19T14:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/historien-om-dine-geniale-gener/1765212024-06-26T11:07+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/legemiddelselskapene-brukte-159-millioner-kroner-pa-forskning-men-annen-pengebruk-okte-mest/1765092024-02-19T14:46+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreft-immunterapi-viser-gode-resultater-for-kirurgi/1764792024-02-19T14:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/moderna/merck-starter-senfasestudie-av-mrna-kreftvaksine/1764632024-02-19T14:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/hiv-gsk-far-gront-lys-i-eu-for-forebyggende-medisin/1764492024-02-19T14:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/130-leger-varsler-soksmal-mot-staten/1764292024-02-19T14:50+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/melanom/foflekkreft-anbefaler-immunterapi-i-tidlige-stadier/1764172024-02-19T14:51+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/lymfekreft-nytt-legemiddel-naermer-seg-eu-godkjenning/1763972024-02-19T14:53+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/godkjenner-14-nye-legemidler-overraskende-avslag-for-lungekreftbehandling/1763772024-02-19T14:54+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/rsv/rsv-klarsignal-for-vaksine-fra-pfizer-for-sma-barn-og-eldre-voksne/1763632024-02-19T14:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/pfizer-og-flagship-gar-sammen-for-a-utvikle-10-nye-legemidler/1763472024-02-19T14:58+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/rsv/rs-virus-flere-eldre-blir-syke-na-kommer-vaksinen-til-norge/1763322024-02-19T14:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/alzheimerlegemiddel-bremser-sykdom-med-60-prosent-for-pasienter-i-tidlig-fase/1763182024-02-19T15:01+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/omsetningen-doblet-pa-ett-ar-for-vektreduserende-legemidler/1762832024-02-19T15:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/personer-med-diabetes-kan-miste-rett-til-ozempic-pa-bla-resept/1762682024-02-19T15:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/det-pagar-en-revolusjon-i-kreftbehandlingen/1762472024-06-26T11:03+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/forste-reseptfrie-p-pille-er-godkjent-i-usa/1762332024-02-19T15:04+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes/legemiddelverket-varsler-mangel-pa-diabetesmedisin-en-god-stund-framover/1762112024-02-19T15:05+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreft-eu-godkjenner-behandling-for-operasjon-kan-ikke-overvurderes/1761932024-02-19T15:06+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/de-fleste-slutter-med-slankemedisiner-som-wegovy-for-det-er-gatt-ett-ar/1761732024-07-15T09:10+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/pfizer-okonom-mener-staten-ikke-kun-bor-fokusere-pa-kortsiktige-migrene-kostnader/1761482024-02-19T15:08+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/globale-myndigheter-covid-19-vaksinene-er-trygge-a-bruke/1761342024-02-19T15:09+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/statssekretaer-om-migrene-kritikken-samfunnet-har-begrensede-ressurser/1761162024-02-19T15:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/helsepolitikere-om-krav-for-a-fa-ny-migrenemedisin-uholdbart/1760912024-02-19T15:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/stadig-bedring-for-barn-med-sjelden-muskelsykdom-fire-ar-etter-medisinstart/1760782024-02-19T15:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/hodepine-norge-om-nei-til-migrenetablett-kjempeskuffet-pa-vegne-av-pasientene/1760442024-02-19T15:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyresykdom/ny-podcast-varsko-om-nyresykdom-skepsis-til-nordiske-prisforhandlinger-og-strenge-regler-stopper-migrenepille/1760202024-02-19T15:13+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/nevrolog-frykter-strenge-krav-kan-gjore-pasienter-med-migrene-enda-sykere/1760042024-02-19T15:13+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/diabetes/eli-lilly-kjoper-sigilon-utvikler-celleterapi-mot-diabetes/1759872024-02-19T15:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/derfor-tror-lmi-selskapene-kan-vaere-skeptiske-til-nordiske-prisforhandlinger/1759732024-02-19T15:14+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/skal-gjore-ny-vurdering-av-legemiddel-mot-alvorlig-blodsykdom/1759452024-02-19T15:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/slv-om-blaresept-nei-til-migrenemedisin-har-ikke-levert-dokumentasjon-som-viser-effekt/1759332024-02-19T15:16+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/styrker-nordiske-prisforhandlinger-pa-medisiner-vil-ha-mer-interesse-fra-industrien/1759192024-02-19T15:16+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/blankt-nei-til-blaresept-for-migrenetablett-fra-pfizer/1758942024-02-19T15:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/prioritering-og-industribygging-pa-dagsorden-under-arendalsuka/1758752024-02-19T15:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyresykdom/fastlege-sjef-om-nyre-kritikken-synspunktene-til-en-spesialist/1758472024-02-19T15:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/godkjenner-forste-genterapi-i-usa-mot-sjelden-muskelsykdom/1758352024-02-19T15:20+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ventetiden-og-fristbrudd-oker/1758132024-02-19T15:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/gun-peggy-knudsen-tar-over-ledelsen-i-fhi/1758012024-02-19T15:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/dette-var-de-viktigste-norske-studiene-pa-asco-i-ar/1757572024-02-19T15:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/pfizer-haper-pa-snarlig-svar-om-refusjon-pa-smeltetablett-mot-migrene/1757372024-02-19T15:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyresykdom/roper-varsko-om-nyresykdom-mener-fastlegene-ma-folge-opp-tidligere/1755742024-02-19T15:25+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/beslutningsforum-ja-i-omstridt-brystkreftsak-og-fedmerapport-med-skremmende-utsikter/1755542024-02-19T15:27+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/norsk-nevrolog-om-ny-studie-tror-migrene-tablett-vil-brukes-mer-i-fremtiden/1754892024-02-19T15:28+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/enhertu-er-lovende-i-enda-flere-krefttyper-privat-klinikk-bruker-medisinen-allerede/1753732024-02-19T15:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/leder-i-kreftforeningen-refser-helseministeren-for-treg-innforing-av-nye-legemidler/1753582024-02-19T15:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyresykdom/ny-studie-svaert-fa-blir-diagnostisert-med-kronisk-nyresykdom-stort-behov-for-bedre-screening/1753362024-02-19T15:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/trodelvy-saken-i-dag-feller-jeg-tarer-i-glede-og-sorg/1752942024-02-19T15:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/sa-nei-immunterapi-kombo-mot-sjelden-kreft/1752882024-02-19T15:33+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/bryne-om-brystkreft-ja-til-trodelvy-vi-har-delt-utalmodigheten/1752762024-02-19T15:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/beslutningsforum-sier-ja-til-trodelvy-og-genterapi/1752542024-02-19T15:35+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/banebrytende-migrene-studie-sammenlignet-daglig-tablett-og-manedlig-injeksjon/1752242024-02-19T15:35+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/krever-godkjenning-av-ny-medisin-mot-brystkreft/1752102024-02-19T15:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/pasientene-far-styrket-sin-rolle-i-beslutningsforum-og-bestillerforum/1751942024-02-19T15:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/thomas-smedsrud-blir-ny-konsernsjef-i-kernel-og-daglig-leder-i-dips/1751582024-02-19T15:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/ny-studie-lavere-sjanse-for-nytt-hjerneslag-ved-tidligere-antikoagulerende-behandling/1751522024-02-19T15:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/dette-mener-kristina-lindemann-var-de-viktigste-gynkreft-nyhetene-pa-asco/1751362024-02-19T15:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/debatt-med-pondus-om-fedme-som-samfunnssykdom/1751122024-02-19T15:39+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/fedmeekspert-hyllet-nye-slankemedisiner-men-ingen-fikk-vite-hva-de-heter/1750762024-02-19T15:39+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/rsv/den-forste-rsv-vaksinen-blir-klar-til-hostens-sykdomssesong-men-du-ma-betale-selv/1750652024-02-19T15:40+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/fedme-og-overvekt-koster-oss-238-milliarder-kroner-i-aret-nesten-like-mye-som-kreft/1750472024-02-20T10:49+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/slik-svarer-healthtalk-pa-radforsk-kritikk-om-ultimovacs-studie/1750212024-02-20T10:50+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/leddgikt/godkjenner-ny-behandling-av-psoriasisartritt-og-bekhterev/1750092024-02-20T10:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/sarkom/ous-overlege-kjetil-boye-har-undersokt-hvorfor-menn-med-gist-har-darligere-utfall-enn-kvinner/1749982024-02-20T10:59+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/dette-var-hoydepunktene-for-de-norske-uro-onkologene-pa-asco-2023/1749462024-02-20T11:00+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kronisk-lymfatisk-leukemi/venclyxto-opprettholdt-progresjonsfri-overlevelse-i-pasienter-med-leukemi/1749342024-02-20T11:00+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/melanom/har-forskerne-funnet-en-vaksine-mot-kreft-denne-teknologien-kan-vaere-losningen/1748992024-02-20T11:01+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/asco-oppsummert-kongressen-viste-fram-overlevelses-gevinsten-til-nye-kreftmedisiner/1748872024-02-20T11:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/vaksine-fra-ultimovacs-feilet-i-studie-pa-sjelden-kreft-faller-kraftig-pa-oslo-bors/1748442024-02-20T11:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/tarmkreft/ous-kirurg-stein-larsen-presenterte-studie-pa-norsk-medisin-for-andre-ar-pa-rad/1747992024-02-20T14:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/aslaug-helland-derfor-er-asco-viktig-for-a-fa-legemidler-til-impress-studien/1747802024-02-20T14:34+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/asco-oppsummert-podcast-lytt-til-de-viktigste-studiene-fra-verdens-storste-kreftkongress/1747742024-02-20T14:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/anne-karin-rime-gjenvalgt-som-president-i-legeforeningen/1747622024-02-20T14:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/dette-er-de-store-linjene-i-asco-forskningen/1747232024-02-20T14:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/tarmkreft/kreftlege-anne-hansen-ree-fra-ahus-presenterte-ny-forskning-pa-kolorektalkreft-pa-asco/1747132024-02-20T14:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/gileads-car-t-terapi-forlenger-overlevelse-i-viktig-blodkreftstudie/1746682024-02-20T14:39+01:00https://image.healthtalk.no?imageId=174682&format=webp&width=1200https://www.healthtalk.no/lungekreft/medisinstudent-evgenia-taranova-presenterte-egen-poster-pa-verdens-storste-kreftkongress/1746612024-02-20T14:41+01:00https://image.healthtalk.no?imageId=174560&format=webp&width=1200https://www.healthtalk.no/lungekreft/hovedutprover-for-stor-asco-studie-en-stor-seier-for-lungekreftpasientene/1746172024-02-20T14:41+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/testikkelkreft/tandstad-etter-asco-presentasjon-blir-sannsynligvis-en-del-av-standardbehandlingen-internasjonalt/1745762024-02-20T14:42+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/enhertu-behandler-her2-kreft-effektivt-uavhengig-av-svulstens-plassering/1745542024-02-20T14:43+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/aslaug-helland-om-osimertinib-etter-operasjon-en-apenbar-fordel/1745342024-02-20T14:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/prostatakreft/onkolog-jan-oldenburg-fra-ahus-med-asco-studie-pa-psa-som-test-for-prostatekreft/1745222024-02-20T14:45+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/tagrisso-etter-operasjon-halverer-risikoen-for-dod-hos-lungekreftpasienter/1745062024-02-20T14:51+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/tarmkreft/stor-oppmerksomhet-rundt-presentasjon-fra-ous-kirurg-knut-jorgen-labori-pa-asco-om-kreft-i-bukspyttkjertelen/1744712024-02-20T14:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreftlege-om-nye-kisqali-data-reduserer-tilbakefall-men-til-en-hoy-kostnad/1744542024-02-20T14:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/aslaug-helland-om-keynote-studie-pa-lungekreft-kjempeviktig-for-pasientene/1744372024-02-20T14:56+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lungekreft/keytruda-for-og-etter-kirurgi-av-lungekreft-reduserer-risiko-for-tilbakefall-med-42-prosent/1744152024-02-20T14:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/dette-ser-norske-kreftleger-mest-frem-til-pa-arets-asco-kongress/1743792024-02-20T14:57+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/legemiddel-fra-novartis-reduserer-risikoen-for-tilbakefall-i-brystkreft/1743732024-02-20T14:59+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lungekreft/lungekreft-bjorn-henning-gronberg-fra-st-olavs-hospital-med-viktig-studie-pa-asco-om-straling/1743672024-02-20T15:00+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/testikkelkreft/testikkelkrefttorgrim-tandstad-fra-st-olavs-hospital-holdt-muntlig-innlegg-pa-asco/1743612024-02-20T15:01+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eggstokkreft/eggstokkreft-ous-onkolog-kristina-lindemann-har-kartlagt-behandling-bekymringsverdig/1743552024-02-20T15:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/urologisk-kreft/testet-prediksjonsmodell-for-lungekreft-pa-blaerekreft-dette-fant-forskerne-ut/1743492024-02-20T15:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/prisdryss-fra-inven2-jan-terje-andersen-ble-arets-innovator-ideprisen-gikk-til-dogbite/1743122024-02-20T15:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/blodkreft/medisin-mot-blodkreft-fikk-fem-nei-i-beslutningsforum-men-ous-lege-tar-avslag-med-fatning/1743002024-02-20T15:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/asco-setter-fokus-pa-fremskrittene-med-malrettet-cellegift/1742902024-02-20T15:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/asco-forventninger-til-studier-i-behandling-av-bryst-og-lungekreft-i-tidlig-fase/1742542024-02-20T15:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/beslutningsforum-ga-motbud-i-prisforhandlingen-med-legemiddelselskap-det-gikk-ikke-sa-bra/1742262024-02-20T15:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/disse-norske-kreftlegene-reiser-til-verdens-storste-kreftkongress-asco-i-chicago/1742202024-02-20T15:11+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/kun-to-nye-anbefalinger-om-eu-godkjente-legemidler/1742042024-02-20T15:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/derfor-stemte-de-mot-frp-forslag-om-finansiering-for-behandling-av-sjeldne-sykdommer/1741592024-02-20T15:13+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/marianne-aasen-blir-ny-leder-i-bioteknologiradet/1741462024-02-20T15:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/stemte-ned-forslag-om-sjeldne-sykdommer-i-dag-sviktet-stortinget-en-liten-gruppe-mennesker/1741232024-02-20T15:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livmorhalskreft/imfinzi-lynparza-kombinasjon-forbedret-progresjonsfri-overlevelse-av-kreft-i-livmorslimhinnen/1741112024-02-20T15:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/novartis-sjefen-inn-i-life-science-cluster-styret-og-ny-styreleder-er-pa-plass/1740912024-02-20T15:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/nytt-samarbeid-for-norske-authera-skal-jobbe-med-the-jackson-laboratory/1740742024-02-20T15:20+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-utsetter-leukemi-sak-novo-utvikler-ny-slanketablett-og-fda-godkjenner-genterapi/1740622024-02-20T15:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/novo-nordisk-og-life-edit-therapeutics-skal-samarbeide-om-genredingering/1740422024-02-20T15:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/dnb-forsterker-satsingen-pa-den-globale-helseindustrien-kjoper-seg-inn-i-amerikansk-radgivningsselskap/1740222024-02-20T15:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/over-80-prosent-av-ansatte-i-legemiddelverket-er-kvinner-vurderer-a-oppfordre-menn-til-a-soke/1740102024-02-20T15:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/fda-godkjenner-nesespray-pa-resept-mot-opioidoverdose/1739792024-02-20T15:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/oral-versjon-av-wegovy-gir-15-prosent-vekttap/1739602024-02-20T15:25+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/utsetter-blodkreft-vedtak-etter-legekritikk-glad-for-at-vi-blir-hort/1739232024-02-20T15:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningsforum-sa-ja-til-15-legemidler-to-saker-med-venclyxto-utsettes/1738882024-02-20T15:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/fda-godkjenner-verdens-forste-genterapi-som-pafores-huden/1738822024-02-20T15:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/studie-viser-at-en-medisin-kan-redusere-opphopning-av-skadelige-proteiner-i-hjertet/1738392024-02-20T15:28+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/novo-nordisk-pauser-annonseringen-av-slankemedisinen-wegovy/1738272024-02-22T11:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ny-podcast-frykter-det-blir-nei-i-beslutningsforum-arctic-bioscience-med-stor-studie-og-lovende-kreftvaksine/1738062024-02-22T11:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/gilead-og-arcus-utvider-samarbeid-legger-til-inflammatoriske-sykdommer/1737892024-02-22T11:09+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/astma/skal-stoppe-bruk-av-astmainhalatorer-med-klimagasser-i-sykehusene/1737652024-02-22T11:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/usa-godkjenner-pille-for-behandling-av-hetetokter-i-overgangsalderen/1737332024-02-22T11:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/sykehusene-klarer-ikke-a-spare-inn-penger-som-kan-brukes-til-nye-kreftlegemidler/1736982024-02-22T11:27+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blodkreft/kreftlege-frykter-beslutningsforum-vil-si-nei-til-leukemi-medisin-mener-slv-bruker-feil-prisestimat/1736822024-02-22T11:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/bergenbio-presenterer-nye-data-styrker-utvilsomt-optimismen-til-studien/1736702024-02-22T11:30+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/lovende-mrna-vaksine-mot-bukspyttkjertelkreft/1736382024-02-22T11:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/omradedirektor-i-slv-veldig-fornoyde-med-det-nye-navnet/1736152024-02-22T11:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/psoriasis/sterk-konkurranse-innen-psoriasis-derfor-tror-arctic-sjefen-de-kan-hevde-seg-i-markedet/1735942024-02-22T11:33+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/regjeringen-omorganiserer-helseforvaltningen-norge-er-sen-til-a-innfore-legemidler/1735812024-02-22T11:35+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/psoriasis/arctic-biosciences-har-startet-den-storste-norske-kliniske-studien-noensinne/1735702024-02-22T11:35+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/legemiddelverket-far-nytt-navn-disse-direktoratene-slas-sammen/1735482024-02-22T11:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/medisin-fra-astrazeneca-mot-sjelden-oyesykdom-godkjent-i-eu/1735302024-02-22T11:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/photocure-faller-pa-gode-salgstall/1734882024-02-22T11:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/takeda-reagerer-pa-uttalelse-fra-fagdirektor-i-helse-vest-overrasket-og-skuffet/1734722024-02-22T11:51+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/nord-europa-sjefen-i-roche-dypt-bekymret-over-eus-reformforslag/1734572024-02-22T11:51+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft/rekordmange-fikk-brystkreft-og-foflekkreft-i-fjor/1734362024-02-22T11:52+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/crohns/eli-lilly-med-nye-data-pa-mirikizumab-mot-ulceros-kolitt-i-bade-barn-og-voksne/1734072024-02-22T11:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/beslutningstakere-er-kritiske-til-wait-rapporten-sammenligner-epler-og-paerer/1733302024-02-22T11:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/lmi-sjef-om-wait-rapport-norge-bruker-lenger-tid-enn-andre-land/1733212024-02-22T11:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rapport-norge-godkjenner-faerre-nye-legemidler-og-bruker-lenger-tid-enn-nabolandene/1732992024-02-22T11:55+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kjetil-tasken-far-innovasjonsprisen-fra-universitetet-i-oslo/1732882024-02-22T11:56+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/ous-onkolog-kritisk-mot-nei-til-medisin-mot-sjelden-lymfekreft-noen-pasienter-har-blitt-desperate/1732682024-02-22T11:57+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/lymfom/fagdirektor-om-kritikk-mot-beslutningsforum-nei-forstaelse-for-at-dette-er-vanskelig/1732592024-02-22T11:57+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/oslo-cancer-cluster-med-i-stort-eu-prosjekt/1732442024-02-22T11:58+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/nettapoteket-farmasiet-saksoker-staten/1731912024-02-22T12:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/rsv/usa-godkjenner-den-forste-rsv-vaksinen/1731642024-02-22T12:01+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimers/alzheimer-medisin-i-stor-studie-bremset-kognitiv-nedgang-med-35-prosent/1731292024-02-22T12:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/marianne-arnemo-blir-forste-ansatte-i-moderna-norge/1731172024-02-22T12:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/norsk-kundebarometer-apotek-1-er-bransjevinner-for-12-aret-pa-rad/1731052024-02-22T12:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/chatgpt-gir-bedre-og-mer-empatiske-svar-enn-leger/1730862024-02-22T12:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehusene-far-62-milliarder-kroner-mer-i-revidert-budsjett/1730732024-02-22T12:08+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/duarte-marchand-har-forlatt-takeda-har-blitt-norden-og-sverige-sjef-i-janssen/1730612024-02-22T12:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/leddgikt/psoriasisartritt-vil-gi-bimzelx-to-nye-indikasjoner/1730522024-02-22T12:13+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eksem/eksem-syv-av-ti-pasienter-fikk-forbedret-eller-klar-hud/1730292024-02-22T12:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/fda-vil-ikke-godkjenne-danske-ascendis-hormonbehandling/1730122024-02-22T12:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/lymfom/bms-lyktes-i-to-studier-med-car-t-mot-ulike-lymfekreft-typer/1730002024-02-22T12:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/fastlegene-far-pasienttilpasset-grunntilskudd/1729892024-02-22T12:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/anders-neijber-blaerekreft-cystoskopi/anders-neijber-i-photocure-presisjonsmedisin-oker-behovet-for-presisjonsdiagnostikk/1729482023-05-09T10:52+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/bms-bristol-myers-squibb-ema/bms-naermer-seg-eu-godkjenning-av-medisin-mot-arvelig-hjertesykdom/1729372023-04-28T15:01+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/truls-vasvik-ap-blir-ny-statssekretaer-i-helse-og-omsorgsdepartementet/1729252024-02-22T12:21+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/mounjaro-ga-16-prosent-vektnedgang-hos-personer-med-diabetes-type-2/1729092024-02-22T12:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/pfizer-far-usa-godkjent-20-valent-pneumokokk-vaksine-for-spedbarn-og-barn/1728972024-02-22T12:22+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/astrazeneca-med-en-god-start-pa-aret-skal-vokse-med-nye-legemidler/1728642024-02-22T12:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/innen-2030-vil-100-legemidler-ga-av-patent-de-generiske-konkurrentene-er-klare/1728582024-02-22T12:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brystkreft/brystkreftforeningen-skuffet-og-oppgitt-over-nei-i-beslutningsforum/1728362024-02-22T12:25+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/aslaug-helland-hedres-med-kong-olav-vs-kreftforskningspris/1728222024-02-26T08:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/rsv/ema-anbefaler-godkjenning-av-syv-nye-legemidler-i-eu/1728122024-02-22T12:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/eu-reform-hisser-pa-seg-legemiddelindustrien/1727972024-02-22T12:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/har-fatt-66-millioner-kroner-fra-eu-dette-skal-prime-rose-prosjektet-jobbe-med/1727742024-02-22T12:29+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/prostatakreft/prostatakreft-janssen-fikk-eu-godkjent-kombinasjonstablett/1727612024-02-22T12:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/bergenbio-vil-ha-250-millioner-kroner-til-a-utvikle-bemcentinib/1727502024-02-22T12:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/novartis-venter-okt-vekst/1727352024-02-22T12:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/stoltenberg-om-samfunnsoppdrag-pa-kreft-for-snevert-med-fokus-kun-pa-behandling/1727122024-02-22T12:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/stortingshoring-vil-ha-rekvireringsrett-til-pneumokokkvaksiner-og-utvidet-medisinstart/1726962024-02-22T12:38+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/dette-mener-fagfolkene-om-mission-som-metode-pa-kreftfeltet-et-klart-og-tydelig-mal/1726842024-02-22T12:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreftvaksine-ultimovacs-uv1/resultatene-fra-melanomstudien-til-ultimovacs-er-forsinket-positivt-for-pasientene/1726592023-04-25T11:48+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/eli-lilly-starter-sammenlikningsstudie-med-wegovy-til-novo-nordisk/1726322023-12-18T10:05+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ikke-smittsomme-sykdommer-legemiddelindustrien-leif-rune-skymoen/skymoen-om-voksenvaksinasjon-lavthengende-frukt-som-regjeringen-na-ma-plukke/1726162023-04-24T14:26+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/anna-maria-hoffmann-vold-beslutningsforum-kronisk-lungefibrose/glad-for-at-beslutningsforum-vil-tilby-ny-behandling-til-pasienter-med-dodelig-lungesykdom/1726052023-04-24T14:36+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/camilla-stoltenberg-direktor-fhi/camilla-stoltenberg-slutter-i-fhi-blir-konsernsjef-i-forskningskonsernet-norce/1725932023-04-24T13:47+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-inger-cathrine-bryne-trodelvy/sa-nei-til-to-brystkreftmedisiner-vil-ha-nye-prisforhandlinger-med-produsentene/1725792023-04-27T10:23+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/relis-utelukker-ikke-at-deler-av-vekttapet-fra-wegovy-skyldes-bivirkninger/1725262024-04-02T10:20+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/abbvie-ategopant-episodisk-migrene/nytt-usa-ja-til-abbvies-qulipta-forste-forebyggende-orale-cgrp-hemmer-mot-alle-former-for-migrene/1725142023-04-21T13:00+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-brystkreft-malrettet-behandling/skal-beslutte-om-brystkreftpasienter-skal-fa-malrettet-legemiddel-etter-operasjon/1725002023-04-21T11:02+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/angelina-maniaol-c5-hemmer-myasthenia-gravis/ous-nevrolog-er-medforfatter-i-lancet-studie-pa-sjelden-nevrologisk-sykdom-haper-medisinen-blir-tilgjengelig/1724852023-04-21T09:27+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/ny-studie-viser-stor-effekt-av-celleterapi-hap-om-at-noen-kreftpasienter-kan-bli-kurert/1724792023-04-24T09:15+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fastlege/nytt-tilskudd-skal-lokke-flere-leger-inn-i-fastlegeordningen/1724472023-04-20T14:32+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/dette-er-verdens-20-storste-legemiddelselskaper/1724352024-01-02T10:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/antistoff-legemiddelkonjugat-dlbcl-fda/polivy-far-usa-godkjenning-for-forstelinjebehandling-av-lymfom/1724212023-04-20T11:32+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alfred-bjorlo-guri-melby-nomy/alfred-bjorlo-v-om-livsvitenskap-en-av-de-store-nye-naeringene-vi-skal-leve-av-i-fremtiden/1723862023-04-19T14:57+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/helseplattformen-st-olavs-hospital/helsetilsynet-helseplattformen-har-fort-til-okt-risiko-for-svikt-i-pasientbehandlingen/1723692023-04-19T13:29+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alfred-bjorlo-authera-guri-melby/venstre-leder-guri-melby-motte-life-science-selskaper-potensialet-for-naeringene-er-kjempestort/1723492023-04-19T12:37+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/gsk-kronisk-hoste-oppkjop/gsk-kjoper-bellus-health-for-2-milliarder-dollar-far-legemiddel-mot-kronisk-hoste/1723352023-04-19T13:54+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreftvaksine-livmorhalskreft-michael-engsig/nykode-gjor-borsbyks-etter-nye-data-fra-kreftvaksinestudie/1723212023-04-19T13:53+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/dan-atar-forskning-nasjonalforeningen-for-folkehelsen/professor-dan-atar-forskermiljoet-er-mye-viktigere-enn-den-enkelte-forskeren/1722732023-04-18T17:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/dan-atar-hjerteforskningsprisen-ingvild-kjerkol/kongen-hyllet-dan-atar-og-evandro-fei-fang-med-forskningspriser-innen-hjertehelse-og-demens/1722382023-04-18T17:25+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/anbud-astma-astma-og-allergiforbundet/hadde-alle-land-vaert-som-norge-sa-hadde-vi-ikke-fatt-noen-nye-legemidler/1722262023-04-18T11:52+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fastlege-fastlegeordningen-ingvild-kjerkol/fastleger-bor-slutte-a-skrive-sykemelding-for-korttidsfravaer-i-arbeidslivet-mener-utvalg/1722072023-04-18T11:43+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/crohns-sykdom-merck-msd/merck-kjoper-prometheus-biosciences-for-110-milliarder-kroner/1721812023-04-17T16:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/antibiotika-antibiotikaresistens-eccmid/utprovende-antibiotika-fra-gsk-mot-urinveisinfeksjon-kan-bli-forste-nye-pa-over-20-ar/1721562023-04-17T14:58+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hadean-ventures-halvard-gronlien-ingrid-teigland-akay/full-kapitaltorke-men-dette-mener-de-er-oppskriften-pa-a-skape-en-sterk-norsk-helsenaering/1721352023-04-19T15:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/foflekkreft-keytruda-kreftvaksine/spennende-data-fra-studie-pa-msd-og-modernas-kreftvaksine-mot-foflekkreft/1721132023-04-17T13:20+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/abbvie-crohns-crohns-sykdom/rinvoq-eu-godkjent-mot-crohns-abbvie-haper-pa-avgjorelse-i-beslutningsforum-for-sommeren/1720972023-04-17T10:52+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/bard-hoksrud-fremskrittspartiet-frp/bard-hoksrud-frp-ma-fa-ny-finansieringslosning-for-sjeldne-sykdommer/1720352023-04-14T14:12+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/bard-hoksrud-ffo-frp/ffo-lederen-trenger-gjennomgang-av-prioriteringskriteriene/1720252023-04-14T12:58+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-bard-hoksrud-fredrik-arneberg/koalisjonen-for-sjeldne-sykdommer-mange-pasienter-falt-mellom-to-stoler/1720152023-04-14T14:30+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/bard-hoksrud-frp-kristine-juvet/lise-klaveness-pa-sjelden-mote-banebrytende-behandlinger-som-ikke-blir-tilgjengelig-i-norge/1720012023-04-14T12:59+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-fedmelegemiddel-liraglutid/novo-spar-rekord-i-salg-og-overskudd/1719942023-04-14T14:28+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eli-lilly-ulceros-kolitt/vil-ikke-godkjenne-nytt-legemiddel-mot-inflammatorisk-tarm/1719722023-04-14T10:11+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-lmi-nye-metoder/na-ma-legemiddelselskapene-selv-be-om-metodevurdering-malet-er-raskere-saksbehandling/1719362023-04-13T15:15+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/oyesykdom/roche-med-nye-data-fra-oye-portefoljen-nye-og-positive-funn-for-vabysmo/1719082024-04-29T15:30+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/aspect-biosystems-bioprinting-celleterapi/novo-nordisk-blir-partner-med-kanadisk-selskap-skal-utvikle-bioprintede-vevsterapier-for-diabetes-og-fedme/1718962023-04-13T10:35+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/chatgpt-kunstig-intelligens-store-sprakmodeller/chatgpt-er-flink-til-a-besvare-enkle-pasientsporsmal/1718822023-05-03T09:29+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/merck-ms/fda-pauser-pasientstudie-av-ms-medisin/1718482023-04-12T15:12+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ibrutinib-imbruvica-janssen/janssen-trekker-lymfekreft-indikasjoner-for-imbruvica-i-usa/1718352023-04-12T10:29+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-morten-lofthus-tangnes-sma/utrolig-glad-for-at-voksne-med-sma-endelig-har-fatt-behandlingen-de-fortjener/1717742023-04-11T15:42+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eisai-fase-3-keytruda/nedtur-for-msd-og-eisai-i-to-fase-3-kreftstudier-en-feilet-og-en-stoppes-tidlig/1717642023-04-11T15:29+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/apotekfarmasoyt-apotekforeningen-farmasoyt/stadig-flere-nordmenn-onsker-fornyet-resept-i-apotek-fastlegene-mener-det-ikke-er-losningen/1717302023-04-11T13:01+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/bjornar-angell-direktor-for-myndighetskontakt-novartis/bjornar-angell-har-blitt-vikarierende-direktor-for-myndighetskontakt-i-novartis-norge/1717162023-04-11T09:33+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-inger-cathrine-bryne-spinraza/na-beslutningsforum-innforer-spinraza-til-voksne-med-spinal-muskelatrofi/1717022023-04-11T10:18+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreftvaksine-moderna-pfizer/koronapandemien-har-gitt-hap-om-kreftvaksine/1716892023-04-10T18:48+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/svettekjertelbetennelse/legemiddel-fra-ucb-viser-langvarig-effekt-mot-inflammatorisk-hudsykdom/1716792024-04-30T15:50+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/astrazeneca-durvalumab-eggstokkreft/lynparza/imfinzi-kombo-forbedret-progresjonsfri-overlevelse-i-pasienter-med-eggstokkreft/1716622023-04-06T09:38+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/slankere-salgstall-for-saxenda-etter-innstramming-av-refusjon-nesten-halvering-fra-januar/1716442023-12-18T10:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-biogen-ekstramote/utsatte-spinraza-avgjorelse-na-skal-beslutningsforum-ha-ekstramote-om-sma-behandlingen/1715912023-04-04T12:21+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimer-jan-terje-andersen-leo-james/norske-forskere-fikk-publisert-alzheimer-studie-i-prestisje-tidsskriftet-science/1715732023-04-04T11:06+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/egil-store-blix-hege-russnes-impress/to-ar-med-impress-dette-er-nokkeltallene-fra-den-nasjonale-kliniske-kreftstudien/1715342023-04-03T19:13+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/chmp-ema/anbefaler-at-ni-nye-legemidler-godkjennes-i-europa/1714752023-04-03T09:53+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/folkehelseinstituttet-folkehelsemeldingen-ingvild-kjerkol/lmi-sjefen-vil-jobbe-for-et-stortingsflertall-for-voksenvaksinasjonsprogram/1714202023-03-31T17:51+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/helseministeren-strammer-inn-roykeloven-men-kreftforeningen-vil-ha-20-arsgrense-og-markedsforingsforbud-mot-solarium/1714042023-03-31T17:09+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/astrid-telhaug-karlsson-hjernemetastaser-ikke-smacellet-lungekreft/ous-lege-med-norsk-forskningsbidrag-om-lungekreftpasienter-med-hjernemetastaser/1713942023-03-31T17:03+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/bard-hoksrud-folkehelsemeldingen-ingvild-kjerkol/frp-om-folkehelsemeldingen-et-mageplask/1713792023-03-31T15:12+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/regjeringen-sier-nei-til-omfattende-vaksinasjonsprogram-for-voksne/1713662024-01-02T10:24+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/atezolizumab-cabozantinib-doceteaxel/nok-en-negativ-fase-3-studie-pa-elcc-men-amerikansk-onkolog-ser-spennende-tegn-i-subgrupper-av-pasientene/1713482023-03-31T11:44+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/se-helseministeren-presenterer-folkehelsemeldingen/1713352023-03-31T14:19+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/charles-rudin-liposomal-irinotecan-memorial-sloan-kettering-cancer-center/motte-ikke-malet-i-fase-3-studie-pa-smacellet-lungekreft-topotecan-er-toffere-a-sla-enn-vi-trodde/1713072023-03-30T18:12+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/bavencio-merck-kga/merck-og-pfizer-gar-hver-sin-vei/1712972023-04-03T08:04+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/astrazeneca-elcc-european-lung-cancer-congress/5000-tyskere-har-deltatt-i-studie-pa-lungekreft-screening-kjent-onkolog-anbefaler-ordning-til-norden/1712742023-03-30T14:40+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/christina-aamelfot-drammen-sykehus-elcc/norske-overleger-i-kobenhavn-derfor-drar-vi-pa-lungekreft-kongress/1712472023-03-30T13:31+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/undersokelse-nordmenn-tror-ikke-helsevesenet-klarer-seg-uten-private-aktorer/1712282023-03-30T11:23+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diakonhjemmet-jan-frich/jan-frich-blir-ny-sykehusdirektor-pa-diakonhjemmet-en-stilling-jeg-har-dromt-om/1712112023-03-30T10:46+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fda-immunterapi-keytruda/usa-gir-full-godkjenning-av-keytruda-for-behandling-av-tumoragnostisk-kreft-tar-uforholdsmessig-lang-tid-i-norge/1711982023-03-31T09:52+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/david-waterhouse-elcc-european-lung-cancer-congress/presenterte-pasientrapporterte-utfall-fra-fase-3-studie-med-sotorasib-vil-bli-viktigere-i-fremtidens-studier/1711612023-03-30T13:32+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/elcc-european-lung-cancer-congress-ikke-smacellet-lungekreft/tysk-onkolog-vil-ha-mer-molekylaertesting-av-pasienter-med-lungekreft-dette-er-hans-rad-til-onkolog-kolleger/1711472023-03-30T13:33+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/norsk-forskere-noen-leddgiktpasienter-kan-klare-seg-uten-medisiner/1711262023-03-30T08:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/markedsforingstillatelse-plakkpsoriasis-psoriasis/sotyktu-er-godkjent-for-behandling-av-plakkpsoriasis/1711122023-04-04T08:37+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/navamedic/navamedic-vil-kjope-svensk-selskap-for-75-millioner-et-viktig-skritt-fremover/1710992023-03-29T11:47+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/elcc-european-lung-cancer-congress-konferanse/lungekreft-kongressen-elcc-er-i-gang-healthtalk-er-pa-plass/1710762023-03-30T13:35+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/daniel-waernes-gar-fra-legeforeningen-til-pfizer/1710702024-01-02T10:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vil-ha-strengere-reaksjoner-der-helsepersonell-begar-overgrep/1710572023-03-29T10:17+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/dupixent-kols/dupixent-motte-alle-mal-i-kols-studie-for-tidlig-a-si-hva-det-kan-bety-for-norske-pasienter/1710442023-03-29T10:24+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/andre-bregard-lmi-veronika-barrabes/her-er-det-nye-styret-i-lmi/1710222023-03-28T15:40+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/helse-og-omsorgsdepartementet-hemmelige-priser-karl-kristian-bekeng/statssekretaer-ga-sniktitt-inn-i-arbeidet-med-ny-prioriteringsmelding/1709972023-03-28T14:49+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/immunterapi-mot-livmorkreft-imponerer-forskere-dette-er-den-nye-behandlingsstandarden/1709792024-01-02T10:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ingrid-stenstadvold-ross-livmorhalskreft/flere-kvinner-ma-vente-14-uker-pa-svar-pa-livmorhalsprove/1709662023-03-27T21:56+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/brystkreft-kisqali-verzenio/kisqali-reduserer-risiko-for-tilbakefall-hos-pasienter-med-tidlig-brystkreft/1709542023-03-28T09:08+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-per-aabakken-podcast/vil-ikke-a-satse-penger-pa-at-helseministeren-til-fredag-sier-ja-til-et-vaksinasjonsprogram-for-voksne/1709222023-04-19T15:44+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/erik-magnus-saether-erland-skogli-hans-olav-melberg/dette-sier-helseokonomene-om-prioritering-i-helsevesenet/1709102023-03-27T13:55+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol-jon-magnussen-sykehusutvalget/sykehusutvalgets-rapport-far-blandede-reaksjoner/1708932023-03-27T12:44+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/utvalg-foreslar-a-legge-om-maten-sykehusene-finansieres/1708762023-03-27T15:30+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/helse-vest-sykehusapotek/ny-styreleder-i-sjukehusapoteka-vest/1708572023-03-27T10:25+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/vil-stille-hoyere-krav-til-studier-for-a-gi-kreftlegemidler-akselerert-godkjenning/1708432023-03-27T09:47+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/direkte-se-overleveringen-av-sykehusutvalgets-rapport-her/1708362023-03-27T11:14+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/antibiotika/antibiotika-reduserer-ikke-dodsrisikoen-blant-pasienter-med-virusinfeksjon/1707972023-03-25T15:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helse-vest-anbefaler-ansatte-a-fjerne-tiktok-og-telegram/1707852024-01-02T10:58+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/dupilumab-dupixent-jan-cezary-sitek/ous-hudlege-om-ny-eksem-indikasjon-for-dupilumab-et-potensielt-gode-for-vare-pasienter/1707682023-03-24T15:54+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/abbvie-fase-3-inflammatoriske-sykdommer/abbvies-skyrizi-lyktes-i-fase-3-studie-pa-ulceros-kolitt/1707412023-03-24T14:57+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/satser-pa-nukleaermedisin-i-nytt-forskningssenter/1707242024-01-02T10:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/are-stuwitz-berg-fhi-folkehelseinstituttet/blir-det-bla-resept-pa-vaksine-mot-helvetesild-dette-svarer-fhi-og-slv/1707062023-03-24T11:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/helge-lund-gjenvalgt-som-styreleder-i-novo-nordisk-veldig-fornoyd-med-selskapets-resultater/1706902023-03-23T17:16+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/flere-jenter-enn-gutter-bruker-antidepressiver-sovemedisin-og-antipsykotika/1706792023-03-23T16:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/dupilumab-dupixent-sanofi/na-er-sanofis-blockbuster-eu-godkjent-mot-alvorlig-eksem-hos-barn-fra-seks-maneders-alder/1706452023-03-23T13:41+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/karsten-bruins-slot-lytix-biopharma-medisinsk-direktor/karsten-bruins-slot-om-ny-jobb-i-lytix-far-mer-ansvar-i-den-kliniske-utviklingen/1706162023-03-23T09:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/rapport-varslingsvilkaret-for-uonskede-pasienthendelser-bor-vurderes/1706092023-03-23T08:51+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/abbvie-adalimumab-amgen/nytt-usa-ja-til-biotilsvarende-humira-i-ar-far-abbvie-hard-konkurranse/1705892023-03-22T15:19+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-car-t-celleterapi/nye-data-celleterapi-gir-bedre-overlevelse-enn-de-siste-30-ars-standardbehandling-overlege-haper-pa-innforing/1705602023-03-22T12:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimer-blodtest-diagnostikk/roche-og-eli-lilly-skal-samarbeide-vil-styrke-tidlig-diagnostisering-av-alzheimers/1705412023-03-22T11:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/oslo-universitetssykehus-aslaug-helland/aslaug-helland-valgt-inn-i-vitenskapsakademi-en-anerkjennelse/1705352023-03-23T11:38+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/gilead-kreft-leddgikt/gilead-sikrer-rettighetene-til-potensiell-leddgikt-medisin-fra-nurix/1705062023-03-21T15:49+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ikke-hoyere-risiko-for-svangerskapskomplikasjoner-for-kvinner-unnfanget-med-assistert-befruktning/1704962024-01-02T11:33+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol/kjerkol-far-fornyet-tillit-som-fylkeslagsleder-i-trondelag-arbeiderparti/1704842023-03-21T14:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/biogen-evrysdi-novartis/11-norske-barn-har-fatt-diagnosen-sma-7-har-fatt-genterapien-zolgensma-na-er-langtidsdataene-her/1704592023-03-21T12:31+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/apotek-apotekforeningen-jostein-soldal/innlandet-og-nordland-brukte-mest-reseptlegemidler-i-2022/1704222023-03-21T10:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/astellas-daniel-heinrich-kastrasjonsbehandling/positive-data-pa-medisin-mot-prostatakreft-men-kreftlege-tror-innforing-kan-bli-vanskelig/1703972023-03-20T18:39+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/anna-winge-main-foflekkreft-malignt-melanom/na-kan-danske-pasienter-med-foflekkreft-fa-behandling-med-t-celleterapi-ikke-aktuelt-i-norge/1703842023-03-21T09:50+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/abortpille/amerikansk-delstat-forbyr-abortpiller/1703722023-03-20T12:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/argenx-authera-fcrn/norske-authera-gar-inn-i-forskningssamarbeid-med-nederlandske-argenx/1703572023-03-20T11:57+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/christine-meyer-hjertesykdom-kvinnehelse/ny-studie-middelhavskost-forebygger-hjerte-og-karsykdommer-og-dod-hos-kvinner/1703402023-03-19T13:17+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol-ventelister/okte-ventetider-vi-er-saerlig-bekymret-for-ventetider-knyttet-til-psykisk-helse/1703052023-03-17T15:15+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/luftambulansen/luftambulansen-i-tromso-star-pa-grunn-av-streik/1702902023-03-17T14:05+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/coronavaksine-covid-19-vaksine/eldre-og-sykehjemsbeboere-anbefales-ny-oppfriskningsdose-mot-covid-19/1702702023-03-17T13:26+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pfizer-brukte-flest-reklamekroner-pa-arets-oscar-utdeling/1702582023-03-17T13:11+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/sanofi-reduserer-prisen-pa-insulin-folger-lilly-og-novo/1702422023-03-17T11:06+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ulik-modenhet-mellom-gutter-og-jenter-kan-fore-til-sosial-ulikhet-og-darlig-helse/1702282023-03-17T09:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/folkehelseinstituttet/fhi-kvinner-er-overrepresentert-blant-de-som-lever-med-langvarig-smerte/1701982023-03-16T13:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/gsk-hjernehinnebetennelse-meningokokk/positive-fase-3-data-for-gsks-5-i-1-vaksine-mot-meningokokk/1701852023-03-16T11:32+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/novo-nordisk-saxenda-wegovy/novo-nordisk-suspendert-fra-britisk-bransjeforening-for-alvorlige-brudd/1701722023-03-16T12:33+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/cepi-coalition-for-epidemic-preperadness-innovations-covid-19/cepi-direktor-slik-vil-vi-utvikle-vaksine-mot-neste-sykdom-x-pa-100-dager/1700952023-04-19T15:44+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/helseplattformen/gar-pa-som-midlertidig-administrerende-direktor-i-helseplattformen-jobber-med-a-ansette-en-ny/1700832023-03-15T15:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/novo-nordisk-sier-de-vil-kutte-prisen-pa-insulin/1700542023-03-17T10:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/britt-moe-flatla-per-aabakken-sanofi/britt-moe-flatla-om-sanofi-exiten-vil-fortsette-a-jobbe-for-en-baerekraftig-helseindustri/1700402023-03-15T12:25+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/britt-moe-flatla-per-aabakken-sanofi/per-aabakken-er-ny-sjef-i-sanofi-norge/1700182023-03-15T08:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-legemiddelverket-statens-legemiddelverk/beslutningsforumsjefen-legemiddelselskapene-ma-ta-sin-del-av-ansvaret-for-tidsbruken/1699852023-03-15T09:52+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/abbott-farmaceutene-farmasoyt/urd-andestad-forlater-lederjobben-i-farmaceutene-na-blir-hun-konsulent-i-teriak/1699672023-03-14T14:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fastlegeordningen-ingvild-kjerkol-legeforeningen/allmenlegeforeningen-ingen-har-etterlyst-denne-endringen/1699502023-03-14T11:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fastlege-fastlegeordningen-ingvild-kjerkol/regjeringen-lover-historisk-satsing-pa-fastlegene/1699352023-03-14T10:55+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/aedes-aegypti-aedes-albopictus-brasil/takeda-har-fatt-godkjent-denguefeber-vaksine-i-brasil/1699162023-03-14T09:39+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/migrene/migrene-nesespray-er-godkjent-i-usa-veldig-effektiv-behandling-av-migreneanfall/1698992023-12-15T16:12+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-folkehelseinstituttet/gar-i-tenkeboksen-med-avansert-screening-av-svangerskapsforgiftning/1698812023-03-13T20:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/oyesykdom/behandling-som-forbedrer-og-opprettholder-synet-er-tilgjengelig-for-norske-pasienter/1698662024-04-29T15:31+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-brystkreft-trippel-negativ-brystkreft/sa-nei-til-malrettet-cellegift-mot-trippel-negativ-brystkreft-vi-onsker-oss-et-tilbud-med-en-lavere-pris/1698492023-03-13T20:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/antistofflegemiddelkonjugat-kreft-pfizer/pfizer-kjoper-seagen-for-430-milliarder-kroner/1698232023-03-13T13:43+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/psykisk-helse/26-prosent-flere-barn-henvist-til-psykiatri-etter-pandemien/1698102023-03-13T12:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/diabetes-type-1-diabetes-type-1-legemiddelindustrien/sanofi-kjoper-provention-bio-sikrer-medisin-mot-type-1-diabetes/1697962023-03-13T12:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/immunterapi-keytruda-ultimovacs/byr-pa-konkurranse-i-sjelden-lungekreft/1697652023-03-15T11:27+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/beslutningsforum-fikk-rett-tagrisso-forlenger-livet-til-pasienter-med-lungekreft/1697562023-12-15T16:00+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/crohns/nye-langtidsdata-pa-janssen-medisin-mot-ulceros-kolitt-styrker-den-varige-effekten-til-stelara/1697162023-12-18T09:58+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/helvetesild-oker-risiko-for-slag-norsk-hjertelege-ser-positivt-pa-vaksinering/1697022023-12-15T16:08+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-folkehelseinstituttet-gravid/ny-metode-kan-hjelpe-legen-til-a-forutsi-risiko-for-svangerskapsforgiftning/1696772023-03-11T16:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/curida-legemiddelindustrien-leif-rune-skymoen/ny-lmi-sjef-om-satsingen-pa-helsenaering-vi-ma-vaere-flinkere-pa-a-fjerne-noen-rode-lys/1696632023-04-19T15:45+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/skal-avgjore-om-malrettet-cellegift-skal-tilbys-pasienter-med-aggressiv-brystkreft/1696552023-03-10T11:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-biogen-morten-lofthus-tangnes/utsetter-sma-vedtak-veldig-overraskende-og-utrolig-leit-for-pasientene/1696402023-03-10T10:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/helse-midt-norge-helseplattformen-stig-slordahl/helseplattform-sjef-gar-av-tillitsvalgte-vil-la-flere-hoder-rulle/1696262023-03-09T16:51+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/alzheimer-alzheimers-donanemab/eli-lilly-feilet-i-alzheimer-studie-med-solanezumab-satser-videre-pa-andre-kandidater/1696072023-03-09T14:42+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/bergenbio-har-dosert-forste-pasient-i-forstelinje-lungekreftsstudie/1695932024-01-02T09:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-bjorn-egil-vikse-spinraza/beslutningsforum-utsetter-spinraza-vedtak-for-voksne/1695812023-03-09T10:02+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/lytix-biopharma-sjefen-ser-lyse-tider-for-selskapets-utprovende-kreftmedisiner/1695672023-12-15T15:56+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/abbott-anette-kilander-fhi/ny-omradedirektor-i-slv-aktorenes-kjennskap-og-etterlevelse-av-regelverk-er-grunnleggende/1695332023-03-08T15:03+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/anemi-beta-thalassemi-betatalassemi/bms-har-fatt-ny-eu-godkjenning-av-medisin-for-voksne-med-arvelig-blodsykdom/1695162023-03-08T10:43+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/anette-kilander-audun-haga-einar-andreassen/anette-kilander-er-ny-omradedirektor-for-legemiddeltilgang-i-legemiddelverket/1694982023-03-07T16:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/norske-pasienter-har-testet-ut-ny-lovende-kolesterolpille/1694742024-01-02T10:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/helseteknologi-nho-sykepleierforbundet/etterlyser-investeringer-i-helseteknologi/1694572023-03-07T09:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/acc-dan-atar-kardiologi/inspirerende-pa-mange-mater/1694442023-03-07T12:14+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/patientsky-selskaper-far-danske-eiere/1694152023-03-06T14:14+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ahus-akershus-universitetssykehus-inven2/kraftig-okning-i-industristudier-pa-legemidler-marsjordren-har-fungert/1693882023-03-07T07:44+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/astrazeneca-daiichi-sankyo-enhertu/kreftmedisinen-enhertu-med-lovende-resultater-pa-nye-krefttyper/1693822023-03-06T13:41+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/acc-konferanse-stop-ca/statin-beskytter-hjertet-til-pasienter-med-lymfekreft-som-behandles-med-antibiotikabasert-cellegift/1693402023-03-13T10:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/acc-konferanse/bempedoinsyre-har-klare-kliniske-fordeler-for-statin-intolerante/1693212023-03-13T10:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/acc-bayer-blodfortynner/skal-teste-ut-ny-blodfortynner-pa-nesten-50-000-pasienter/1693122023-03-13T10:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/crispr-intellia/fda-gir-gront-lys-til-genterapistudie/1692712023-03-03T15:51+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/bayer-darolutamide-europakommisjonen/bayer-far-eu-ja-til-nubeqa-mot-ny-prostatakreft-indikasjon/1692622023-03-03T15:55+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/acc-hormonbehandling-kjonssdysfori/hormonbehandling-for-kjonnsdysfori-oker-kardiovaskulaer-risiko/1692502023-03-05T19:08+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/acc-hjertesvikt-kardiologi/acc-ser-sammenheng-mellom-hoy-temperatur-og-kardiovaskulaer-dodelighet/1692382023-03-13T11:28+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/acc-hjerteattakk/pasienter-med-brystsmerter-som-har-en-psykiatrisk-diagnose-far-darligere-helsehjelp/1692162023-03-05T12:06+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/sykepleiere-tjener-mer-utenfor-helsevesenet/1692022023-03-03T09:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ema-esmo-gynaecological-cancers-podcast/podcast-anbefalinger-om-nye-legemidler-gynkreft-kongress-i-barcelona-og-sjeldne-sykdommer/1691902023-04-19T15:46+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/christine-meyer-ingvild-kjerkol-kvinnehelse/ekspertutvalg-vil-ha-en-milliard-kroner-til-kvinnehelse/1691772023-03-02T11:25+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/gsk-rs-virus-rsv/gsk-et-steg-naermere-godkjenning-av-rsv-vaksine-for-voksne/1691572023-03-02T10:34+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/godkjenningsfritak-melatonin-uregistrerte-legemidler/mange-leger-forskriver-uregistrerte-legemidler-dette-gjor-slv-for-a-bremse-utviklingen/1691372023-03-01T16:31+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/diabetes-diabetes-type-2-eli-lilly/kutter-prisen-pa-eli-lilly-insulin-med-70-prosent-i-usa/1691212023-03-01T15:04+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/acc-cannabis-konferanse/daglig-cannabisbruk-oker-risikoen-for-hjertesykdom-viser-studie/1691152023-03-13T11:29+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/keytruda-lungekreft-prostatakreft/keytruda-skuffer-msd-skroter-sin-fjerde-prostatakreftstudie/1690882023-03-01T13:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/erytritol-hjerteinfarkt-sukrin/studie-overraskende-sammenheng-mellom-sukkererstatning-og-risiko-for-hjerteinfarkt-og-slag/1690662023-02-28T17:22+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eksem/almirall-lanserer-psoriasis-medisin-i-norge-satser-med-ny-organisasjon-i-norden/1690542023-12-18T09:45+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/bard-hoksrud-duarte-marchand-sjeldne-sykdommer/samler-folk-fra-hele-europa-til-sjelden-konferanse-i-stockholm/1689862023-02-28T13:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/eggstokkreft-esmo-gynaecological-cancers-livmorhalskreft/esmo-gyn-er-en-vitenskapelig-suksess/1689712023-02-28T10:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/amgen-torbjorn-solsnaes/torbjorn-solsnaes-blir-pr-sjef-i-amgen/1689522023-02-28T09:49+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/apotek-apotekforeningen-apotekstatistikk/dette-var-de-ti-mest-brukte-legemidlene-i-norge-i-2022/1689342023-02-28T08:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pompes-sykdom-sanofi-sjeldne-sykdommer/sanofi-om-data-pa-medisin-mot-pompes-sykdom-styrker-potensial-som-ny-standardbehandling/1689122023-02-27T15:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/ema-lagevrio-molnupiravir/vil-ikke-gi-markedsforingstillatelse-til-msds-koronapille/1689012023-02-27T14:50+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ema-vil-godkjenne-atte-nye-medisiner/1688742024-01-02T09:32+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pfizer-seagen/wall-street-journal-pfizer-vil-kjope-kreftselskapet-seagen/1688122023-02-27T13:07+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/abbvie-crohns-sykdom-ema/ema-anbefaler-godkjenning-av-abbvies-jak-hemmer-rinvoq-mot-crohns-sykdom/1687962023-02-27T17:38+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kronikk-nasjonal-kompetansetjeneste-for-sjeldne-diagnoser-rebecca-tvedt-skarberg/europa-satser-pa-sjeldne-diagnoser-er-vi-klare-i-norge/1687842023-02-28T16:01+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/esmo-gynaecological-cancers-livmorhalskreft/professor-gentesting-er-avgjorende-for-a-utvikle-ny-behandling-men-ikke-glem-at-livmorhalskreft-kan-forebygges/1687592023-02-24T14:23+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/antonio-gonzalez-martin-esmo-gynaecological-cancers-niraparib/ny-studie-zejula-har-langvarig-effekt-pa-kvinner-med-eggstokkreft-flere-vil-bli-kurert/1687382023-02-28T15:27+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/antistoff-antistofftest-glioblastom/roche-med-to-nye-antistoff-tester-vil-finne-viktige-mutasjoner-hos-pasienter-med-hjernekreft/1687272023-02-23T15:32+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/astrazeneca-ema-eu/immunterapi-kombo-fra-astrazeneca-godkjent-i-eu-mot-lever-og-lungekreft/1687052023-02-23T11:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/esmo-gynaecological-cancers-kreft/hun-skal-holde-foredrag-pa-esmo-gynaecological-cancers-dette-blir-hoydepunktene/1686822023-02-23T09:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/kreft/tablettversjon-av-leukemi-medisin-fra-astrazeneca-eu-godkjent/1686702024-01-02T11:43+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/asco-gu-astellas-pfizer/talzenna-xtandi-kombo-mot-prostatakreft-potensial-som-ny-standardbehandling/1686592023-02-22T11:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-hemgenix-hemofili/forste-genterapi-som-behandler-hemofili-b-er-godkjent-i-europa/1686222023-02-21T23:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-blaerekreft-bristol-myers-squibb/adjuvant-immunterapi-fortsetter-a-gi-effekt-for-blaerekreftpasienter-etter-tre-ar/1685832023-02-21T11:36+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ous-ulleval-sykehus/leger-slar-alarm-om-ous-kutt/1685702023-02-20T21:54+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/blalys-cystoskopi-cysview-hexvix/asco-gu-redusert-risiko-for-tilbakefall-av-blaerekreft-med-photocures-blalys-cystoskopi/1685542023-02-21T09:45+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/norges-arktiske-universitet-uit/norges-arktiske-universitet-produserer-rekordmange-sykepleiere/1685392023-02-20T13:57+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/esmo-gynaecological-cancers-lynparza-olaparib/lynparza-oker-overlevelsen-til-pasienter-med-mutert-eggstokkreft-uavhengig-av-risiko-for-tilbakefall/1685272023-02-24T16:48+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-inger-cathrine-bryne-ms/beslutningsforum-sier-ja-til-ms-medisinen-kesimpta/1685162023-02-20T21:35+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/direktoratet-for-e-helse-helseanalyseplattformen/direktoratet-for-e-helse-vraker-it-prosjekt-etter-a-ha-brukt-200-millioner-kroner/1685062023-02-21T07:42+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/healthtalk/forste-legemiddel-er-godkjent-for-behandling-av-geografisk-atrofi-en-vanlig-arsak-til-blindhet-hos-eldre/1684922024-03-01T14:20+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/rsv/ny-vaksine-beskytter-eldre-mot-rs-virus/1684762023-12-18T09:53+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/apotek-apotek-1-apotekforeningen/apoteksjefen-apotekene-ma-brukes-mer-til-a-avlaste-andre-deler-av-helsevesenet/1684472023-04-19T15:50+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/ous-ulleval-sykehus/hagler-inn-med-oppsigelser-fra-intensivsykepleiere/1684362023-02-16T17:30+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/bergenbio-ma-hente-penger-men-sier-de-har-gjort-store-kliniske-fremskritt/1684242024-01-02T09:37+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/bavarian-nordic-med-milliardoppkjop-av-reisevaksiner-varsler-rekordoverskudd/1684072023-02-15T14:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/helsetilsynet-mener-helseplattformen-har-fort-til-okt-risiko-for-pasienter/1683952023-02-16T09:34+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/bill-gates-med-helseskryt-av-norske-politikere/1683492024-01-02T10:19+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nyresykdom/kerendia-far-utvidet-nyreindikasjon/1683372024-01-02T10:56+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/migrene/sier-nei-til-migrenelegemiddel/1683222024-01-02T09:47+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/leddgikt/glad-for-ja-til-medisin-mot-barneleddgikt/1682972024-01-02T10:10+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-inger-cathrine-bryne-kreft/beslutningsforum-vil-at-kreftmedisin-innfores-midlertidig-med-solid-rabatt/1682852023-02-13T19:09+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/bp-equinor-helge-lund/novo-styreleder-dette-ma-norge-gjore-for-a-bli-store-innen-livsvitenskap/1682632023-02-13T17:24+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/forxiga-far-utvidet-hjertesviktsindikasjon/1682522024-01-02T10:04+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/arnaldo-frigessi-bjorn-atle-bjornbeth-legemiddelindustrien/norway-life-science-skymoen-tror-norge-kan-bli-store/1682402023-02-13T14:55+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/celleterapi-heartseed-hjertesvikt/novo-nordisk-studie-pa-celleterapi-mot-avansert-hjertesvikt/1682292023-02-15T08:41+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/bms-offentliggjor-nye-myelomatosedata-pa-abecma/1681972024-01-02T10:03+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/ema-skal-vurdere-hvor-trygge-pseudoefedrin-medisiner-er/1681852024-01-02T09:35+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/keytruda-livmorkreft-msd/immunterapi-pluss-kjemoterapi-bedre-enn-kjemoterapi-i-forstelinje-livmorkreft/1681722023-02-13T08:44+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/oyesykdom/roche-medisin-forbedret-syn-hos-pasienter-med-blodpropp-i-oyet/1681612024-04-29T15:29+02:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/astrazeneca/astrazeneca-vokser-med-nye-legemidler/1681462023-02-10T14:06+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/helsepersonellkommisjonen-kols-medisinbytte/ny-podcast-helsepersonellkommisjonen-kols-novo-nordisk-og-medisinbytte/1681212023-04-19T15:47+02:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/fentanyl-legemiddelverket-narkotika/slv-vil-ha-gruppe-av-opioider-pa-narkotikalisten-stort-misbrukspotensiale/1681052023-02-10T14:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-epilepsi-fintepla/fintepla-er-godkjent-til-behandling-av-epileptiske-anfall/1680962023-02-13T10:18+01:00https://image.healthtalk.no?imageId=166974&format=webp&width=1200https://www.healthtalk.no/nimbus-therapeutics-oppkjop-psoriasis/takeda-med-milliardoppkjop-sikrer-utprovende-medisin-mot-immun-medierte-sykdommer/1680802023-02-09T13:48+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/bayer-bill-anderson-kreft/bayer-utnevner-ny-toppsjef-etter-press-fra-aksjonaerer/1680332023-02-09T13:49+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/antistoff-ema-fast-track/lovende-data-for-antistoff-mot-autoimmun-sykdom-hos-foster-og-nyfodt/1680122023-02-09T09:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/car-t-eggstokkreft-immunterapi/lovende-resultater-for-immunterapi-ved-eggstokkreft/1680002023-02-09T14:30+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/barnemedisin-ema-europakommisjonen/slik-har-eu-myndigheter-jobbet-for-a-sikre-flere-nye-legemidler-til-barn/1679892023-02-09T09:13+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/positive-roche-data-for-medisin-mot-sjelden-og-livstruende-blodsykdom/1679292024-01-02T09:37+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/angioodem-antistoff-fda/takeda-far-usa-godkjent-antistoff-mot-arvelig-genetisk-sykdom/1679192023-02-09T09:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/digital-hjemmeoppfolging-helse-sor-ost-lena-nymo-helli/seks-selskaper-fikk-avtale-om-a-levere-digital-hjemmeoppfolging-til-helse-sor-ost/1678992023-02-09T09:24+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/byttelisten-generisk-bytte-ingrid-ass/slv-disse-legemidlene-kan-koste-staten-unodvendig-mye-penger/1678952023-02-07T17:02+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/trodelvy-far-sin-andre-bryskreftgodkjenning/1678572023-12-15T15:55+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/eva-hofsli-podcast-st-olavs-hospital/videopod-nye-lovende-behandlinger-av-tarmkreft-med-fjernspredning/1677932023-04-19T15:52+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/vil-endre-smittevernloven-og-helseberedskapsloven/1677752024-01-02T10:00+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/kols/lungelege-dette-er-risikofaktorene-for-utvikling-av-kols/1677532023-12-18T09:51+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/helle-grottum-kols-kolspasienter/lhl-leder-om-symptomer-pa-kols-ga-til-legen-tidlig/1677452023-02-09T09:26+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kols/lungelege-om-kolsmedisiner-ofte-er-effekten-svaert-beskjeden/1677342023-12-18T09:50+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/apotek-1-apoteklovutvalget-boots-apotek/ny-podcast-fremtidens-apotek-topplisten-og-omorganisering-i-legemiddelverket/1676852023-04-19T15:47+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-fda-ikke-smacellet-lungekreft/usa-godkjenner-immunterapi-etter-operasjon-av-ikke-smacellet-lungekreft/1676712023-02-09T09:35+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/christian-gilhuus-moe-farmastat-keytruda/farmastat-sjef-novo-nordisk-er-i-realiteten-storst-i-norge/1676522023-02-09T09:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/gunnar-bovim-helsepersonellkommisjonen-ingvild-kjerkol/gunnar-bovim-en-situasjon-vi-ikke-kan-betale-oss-ut-av/1676252023-02-09T09:37+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/helsepersonellkommisjonen-ingvild-kjerkol/helseministereren-viktigere-enn-noen-gang-at-helsepersonell-far-brukt-kompetansen-sin-riktig/1676122023-02-09T09:39+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/helsepersonellkommisjonen-det-blir-faerre-ansatte-per-pasient/1675932024-01-02T10:16+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/autoimmune-sykdommer-belimumab-benlysta/gsk-medisin-far-spesiell-status-i-usa-utvikles-mot-sjelden-autoimmun-sykdom/1675832023-02-09T09:40+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/bergenbio-far-med-seg-internasjonale-lungekrefteksperter/1675712024-01-02T10:05+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/direkte-kl-11-se-overleveringen-av-helsepersonellkommisjonens-rapport-her/1675622024-01-02T09:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/det-er-dejlig-a-vaere-dansk-sykepleier-i-norge/1675342023-02-01T12:53+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/dansk-gigant-med-rekordoverskudd/1675072024-01-02T09:57+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/apoteklovutvalget-farmasiet-helseminister/farmasiet-om-dagens-apotekkrav-ikke-saerlig-fremtidsrettet/1674912023-02-01T11:10+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/psoriasis/arctic-bioscience-forste-pasient-inkludert-i-psoriasistudie/1674802024-01-02T10:21+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/bispesifikke-antistoffer-emicizumab-eu/ny-hemofili-indikasjon-i-eu-for-bispesifikt-antistoff-fra-roche/1674712023-02-01T09:07+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/apotek-1-apoteklovutvalget-boots-apotek/apoteklovutvalget-behov-for-okt-konkurranse-i-apotekmarkedet/1674392023-01-31T17:07+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/bms-bristol-myers-squibb-darzalex/dette-var-de-storste-legemiddelselskapene-og-de-storste-legemidlene-i-2022/1674292023-03-06T13:18+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/chmp-diabetes-type-2-ema/disse-legemidlene-vil-ema-ha-godkjent-i-eu/1674192023-01-31T10:34+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/haper-trenden-har-snudd-stor-okning-i-antall-sokte-kliniske-studier-i-2022/1674032023-01-30T17:42+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/btk-hemmer-fda-jaypirca/usa-godkjenning-for-btk-hemmer-mot-sjelden-form-for-lymfekreft/1673662023-01-30T14:45+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/campus-radiumhospitalet-cancer-crosslinks-innovasjonspark/lanserte-modell-for-campus-radiumhospitalet-ma-se-inn-i-fremtiden/1673542023-01-30T11:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/plakkpsoriasis-psoriasis/sotyktu-ett-steg-fra-eu-godkjenning-for-plakkpsoriasis/1673442023-01-31T10:16+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/audun-haga-legemiddelverket-omorganisering/slv-direktor-om-ny-organisering-bedre-uten-a-miste-det-vi-har-oppnadd/1672142023-01-27T14:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol-pasientrettigheter/foreslar-endringer-i-pasient-og-brukerrettighetsloven/1672102023-01-27T12:39+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ingunn-hatlevoll-lonsurf-tarmkreft/overlege-overraskende-gode-overlevelsesdata-for-pasienter-med-metastatisk-tarmkreft/1671822023-01-30T08:39+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/kreft/brystkreftlege-dette-er-et-stort-gjennombrudd-for-svaert-mange-pasienter-med-metastatisk-brystkreft/1671652023-12-15T15:56+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/anna-winge-main-bms-bristol-myers-squibb/norske-onkologer-om-cancer-crosslinks-viktig-arena-for-a-bygge-nettverk/1671462023-01-27T10:23+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/bms-cancer-crosslinks-douglas-hanahan/15-ar-med-cancer-crosslinks-slik-har-arrangorene-sikret-vekst/1671302023-01-27T10:28+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/eldreomsorg-ingvild-kjerkol/kjerkol-om-eldreomsorgen-krevende-okonomisk-situasjon/1671152023-01-26T11:14+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/brystkreft-konferanse-podcast/toppmote-sabcs-med-de-viktigste-nyhetene-om-brystkreftmedisiner/1670682023-04-19T15:53+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/kreft/stopper-studie-med-keytruda-kombo-mot-prostatakreft-med-spredning/1670642024-01-02T11:36+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/cancer-crosslinks-konferanse-kreft/healthtalk-dekker-cancer-crosslinks-torsdag/1670472023-01-25T12:57+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/kreftsykepleiere-far-kreftforeningens-hederspris/1670372024-01-02T10:22+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/npe-har-mottatt-over-1000-erstatningskrav-for-bivirkninger-av-koronavaksine/1670232023-01-25T09:25+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/asco-gi-magekreft/forstelinje-zolbetuximab-oker-overlevelsen-hos-pasienter-med-avansert-magekreft/1670082023-01-30T14:05+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/antiinfektiva-astellas-sandoz/sandoz-kjoper-ledende-soppdrepende-medisin-fra-astellas/1669782023-01-24T14:49+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/ma-spare-penger-abc-klinikken-legges-ned/1669622024-01-02T10:12+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/bayer-brystkreft-kontrastmiddel/bayer-middel-godkjent-for-bruk-i-kontrastforsterket-mammografi/1669542023-01-24T12:17+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-inger-cathrine-bryne-nye-metoder/2023-mindre-til-sykehusene-mer-til-legemidler/1669422023-01-24T13:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/hege-edvardsen-kliniske-studier-lmi/nytt-system-for-kliniske-studier-i-eu-slik-har-industri-og-akademia-forberedt-seg/1669092023-01-24T08:51+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-gynekologisk-kreft-kristina-lindemann/gynkreft-lege-om-ja-til-immunterapi-mot-livmorkreft-forventet-fra-fagmiljoet/1668722023-01-23T15:08+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/brysthinnekreft-aslaug-helland/er-i-mal-med-rekrutteringen-til-brysthinnekreftstudie/1668622023-01-23T15:51+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-innforer-behandling-for-livmorkreft-og-svaert-sjeldent-syndrom/1668482023-01-23T11:16+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/pagaende-mangel-pa-antibiotika-i-eu-slik-jobber-ema-med-problemet/1668382023-01-23T09:32+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/kreft/fda-godkjenner-den-forste-malrettede-behandlingen-for-her2-positiv-tarmkreft/1668142024-01-02T11:46+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/kreft/immunterapikombinasjon-reduserer-risikoen-for-tilbakefall-av-leverkreft/1668002024-01-02T10:15+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/antivirale-legemidler-hiv-hiv-vaksine/fase-3-studie-pa-mulig-hiv-vaksine-stoppet-slik-reagerer-lege-og-pasientforening/1667832023-01-20T12:44+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/reagerer-pa-blaresept-nei-vi-er-overrasket/1667712023-12-18T10:02+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/helseplattformen-st-olavs-hospital/statens-helsetilsyn-apner-tilsyn-mot-st-olavs-etter-helseplattformen/1667532023-01-19T22:09+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-immunterapi/pa-mandag-skal-beslutningsforum-vurdere-fem-legemidler/1667242023-01-22T14:30+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/ny-slankemedisin-nektes-bla-resept-ber-produsenten-gi-rabatt/1666652023-12-18T10:03+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ous-planlegger-kutt-som-tilsvarer-rundt-500-arsverk/1666412023-01-19T17:58+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/barneleddgikt-revmatisme/ny-forskning-voksne-med-barneleddgikt-har-god-effekt-av-sykdomsbremsende-behandling/1666122023-01-19T13:51+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/bristol-myers-squibb-og-karolinska-universitetssjukhuset-vil-utvikle-innovative-kreftbehandlinger/1665892023-01-18T14:44+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/cecilie-daae-far-ny-sjefsjobb/1665402024-01-02T09:59+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/pfizer/pfizer-utvider-avtale-med-fattige-land-tilbyr-500-legemidler-til-innkjopspris/1665252023-01-18T11:05+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/hjerteinfarkt/norsk-legemiddel-skal-gjore-det-lettere-a-ta-akuttmedisin-mot-hjerteinfarkt/1665102023-01-19T18:06+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol-persontilpasset-medisin-veronika-barrabes/helseministeren-persontilpasset-medisin-skal-bli-en-naturlig-del-av-pasientbehandlingen/1664652023-01-17T16:37+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/bard-hoksrud/opposisjonen-reagerer-pa-kjerkols-sykehustale-et-slag-i-ansiktet-pa-pasienter-i-helseko/1664452023-01-17T14:12+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol/sykehusene-ma-bli-langt-mindre-avhengig-av-bemanningsbyraer-og-innleide-vikarer/1664332023-01-17T12:09+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol/helseministeren-varsler-strammere-okonomi-for-sykehusene/1664222023-01-17T11:58+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/american-society-of-hematology-ash-blodkreft/toppmote-ash-jeg-ble-kjempeskeptisk-da-jeg-sa-det-djerve-studiedesignet/1664182023-04-19T15:55+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/keisersnitt-gir-ikke-hoyere-risiko-for-opptak-av-sykehusbakterier/1664022023-01-21T21:25+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/takeda-karet-til-global-top-employer-for-sjette-ar-pa-rad/1663902024-01-02T11:42+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/helse-sor-ost-terje-rootwelt/223000-pasienter-motte-ikke-til-avtalt-time-en-betydelig-utfordring/1663802023-01-17T09:50+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/diabetes-type-2-rybelsus/fda-godkjenner-tablett-til-forstelinjebehandling-av-diabetes-type-2/1663542023-01-16T16:30+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/jak-hemmere-kan-gi-alvorlige-bivirkninger-slik-vil-eu-myndigheter-redusere-risikoen/1663332024-01-02T09:34+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/genterapi-zolgensma/ema-vil-varsle-leger-om-leverskade-fra-genterapi/1663032023-01-16T12:29+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/astrazeneca-celleterapi-neogene/astrazeneca-har-kjopt-neogene-styrker-satsing-pa-onkologisk-celleterapi/1662922023-01-16T11:12+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/pasientreiser/pasienter-ble-levert-feil-705-ganger-i-fjor/1662782023-01-16T08:49+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/helseplattformen/undersoker-om-helseplattformen-kan-ha-medvirket-til-at-pasient-dode/1662532023-01-14T09:52+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/sykehus-over-hele-landet-har-hevet-beredskapen/1662422024-01-02T10:15+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beredskapslagring-legemiddelgrossist/grossistene-om-betalingsniva-for-beredskapslagring-ikke-akseptabelt/1662342023-01-16T08:15+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beredskapslagring-biotilsvarende-legemidler-farma-norge/farma-norge-vil-unnga-unodvendig-kasting-av-legemidler-fra-beredskapslagrene/1662202023-01-13T12:05+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimers/soker-om-godkjenning-av-alzheimermedisin-i-europa/1662052023-12-18T09:20+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/europakommisjonen-influensa-influensalegemiddel/eu-ja-til-roche-medisin-mot-influensa-for-barn-over-ett-ar/1661672023-01-12T15:06+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beredskapslagring-grossist-legemiddelgrossist/lmi-grossistene-bor-dele-lagerstatus-for-beredskapslagring-av-medisiner/1661572023-01-12T13:40+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/apotekforeningen-beredskapslagring-horingssvar/reagerer-pa-svak-kompensasjon-til-grossist-og-apotek-for-beredskapslagring-av-medisiner/1661122023-01-11T15:30+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/apotek-beredskap-helse-og-omsorgsdepartementet/slik-vil-departementet-beredskapslagre-legemidler-i-primaerhelsetjenesten/1660902023-01-11T14:53+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-inger-cathrine-bryne-ingvild-kjerkol/beslutningsforum-sa-ja-til-rekordmange-nye-metoder-i-2022/1660872023-01-11T15:06+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/organdonasjon/flere-organdonasjoner-i-2022-takket-vaere-ny-metode/1660752023-01-11T14:16+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/helseplattformen-st-olavs-hospital/nytt-journalsystem-forer-til-store-utfordringer-for-st-olavs-hospital/1660642023-01-11T11:50+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/nyheter-og-politikk/rekordstor-legemiddelmangel-i-2022/1660532024-01-02T10:20+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/jobb-karriere-novartis/dette-er-den-nye-lederegruppen-i-novartis-norge/1660352023-01-11T11:06+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/apotek-farmasiet-knapp/farmasiet-automatiserer-plukk-og-pakk-vil-doble-omsetning-og-antall-ansatte/1660232023-01-11T09:47+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/astrazeneca-guro-bjontegaard-jobb-karriere/guro-bjontegaard-blir-ny-landssjef-i-astrazeneca-norge/1660122023-01-11T08:53+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/astrazeneca-benedikte-akre-jobb-karriere/hun-er-astrazenecas-nye-medisinske-onkologi-direktor-for-26-europeiske-land/1659762023-01-12T08:25+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/haraldsplass-lever-leversykdom/overlege-om-nye-data-pa-medisin-mot-sjelden-leversykdom-spennende-studie/1659222023-01-10T12:59+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/alzheimers-leqembi/prisen-pa-eisai-og-biogens-alzheimerlegemiddel-vil-neppe-dempe-ettersporselen-sier-analytikere/1659072023-01-10T14:03+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/novo-holdings-kjoper-seg-inn-i-genredigeringsselskap/1658902024-01-02T10:25+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/apotek-blodtrykk-blodtrykksmaling/apotek-1-tester-ut-maling-av-blodtrykk-i-apotek-60-apotek-er-med-i-piloten/1658852023-01-10T08:27+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/abbvie-antistoff-immunome/abbvie-og-immunome-inngar-strategisk-samarbeid-skal-finne-nye-kreftmal/1658752023-01-09T14:56+01:00https://image.healthtalk.no?imageId=165871&format=webp&width=1200https://www.healthtalk.no/dnv-imatis/han-er-ny-adm-dir-i-dnv-imatis-skal-vokse-selskapet-internasjonalt/1658612023-01-09T12:45+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/astrazeneca-hjerte-nyre/astrazeneca-kjoper-cincor-pharma-sikrer-mulig-ny-blodtrykkssenkende-medisin/1658522023-01-09T13:44+01:00https://image.healthtalk.no?imageId=165855&format=webp&width=1200https://www.healthtalk.no/alzheimer-alzheimers-leqembi/fda-godkjenner-ny-behandling-for-tidlig-alzheimers/1658312023-01-06T23:08+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/debatt-hemmelige-priser-legeforeningen/novartis-sjefen-tror-prisdiskusjon-beror-pa-misforstaelser/1657992023-01-06T15:16+01:00https://image.healthtalk.no?imageId=165826&format=webp&width=1200https://www.healthtalk.no/anne-karin-rime-daniel-heinrich-debatt/uenighet-om-hemmelige-priser-apenhet-gir-ikke-billigere-legemidler/1657862023-01-06T14:23+01:00https://image.healthtalk.no?imageId=165793&format=webp&width=1200https://www.healthtalk.no/bispesifikke-antistoffer-glofitamab/fda-vil-hurtigbehandle-roche-sitt-bispesifikke-antistoff-glofitamab/1657012023-01-08T17:41+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/fhi-preben-aavitsland/kraftig-okning-i-influensainnleggelser-fhi-ber-flere-eldre-vaksinere-seg/1656852023-01-05T18:25+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/eksem/dupixent-godkjent-for-behandling-av-hudsykdommen-prurigo-nodularis/1656772023-12-18T10:00+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/dnv/dnv-kjoper-enda-et-digitalt-helseselskap/1656592023-01-05T16:18+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/blodpropp-blodsykdommer-cttp/forste-fase-3-data-pa-medisin-mot-svaert-sjelden-blodpropp-sykdom/1656502023-01-05T15:24+01:00https://image.healthtalk.no?imageId=165653&format=webp&width=1200https://www.healthtalk.no/bard-hoksrud-cgrp-cgrp-hemmer/frp-hoksrud-om-cgrp-hemmere-innstramningene-var-urimelige/1656412023-01-05T12:16+01:00https://image.healthtalk.no?imageId=165644&format=webp&width=1200https://www.healthtalk.no/bors-ge-ge-healthcare/ge-healthcare-skilt-ut-i-eget-selskap/1656262023-01-05T09:52+01:00https://image.healthtalk.no?imageId=165635&format=webp&width=1200https://www.healthtalk.no/aleris-dr-dropin-karita-bekkemellem/aleris-dr-dropin-og-volvat-melder-seg-inn-i-nho-geneo/1656192023-01-05T09:43+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/aimovig-ajovy-emgality/sa-mye-brukte-staten-pa-nye-migrenemedisiner-i-2022/1656062023-01-04T14:23+01:00https://image.healthtalk.no?imageId=165609&format=webp&width=1200https://www.healthtalk.no/evoq-gilead-immunterapi/gilead-og-evoq-samarbeider-om-immunterapi-mot-leddgikt-og-lupus/1655972023-01-04T08:52+01:00https://image.healthtalk.no?imageId=165600&format=webp&width=1200https://www.healthtalk.no/cgrp-cgrp-hemmer-legemiddelverket/nye-migrenemedisiner-tilbake-til-gamle-refusjonsvilkar-spent-pa-kostnadsutviklingen/1655882023-01-03T15:26+01:00https://image.healthtalk.no?imageId=165591&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/ny-slankemedisin-pa-resept-i-norge/1655792024-01-02T10:48+01:00https://image.healthtalk.no?imageId=165582&format=webp&width=1200https://www.healthtalk.no/bispesifikke-antistoffer-lymfekreft/fda-godkjenner-lunsumio-for-behandling-av-lymfekreft-et-alternativ-til-genterapi/1655702023-01-03T08:21+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/gilead-immunterapi-jounce/gilead-kjoper-utprovende-immunterapi-fra-jounce/1655592023-01-02T15:01+01:00https://image.healthtalk.no?imageId=165562&format=webp&width=1200https://www.healthtalk.no/prostatakreft/lynparza-godkjent-i-eu-for-behandling-av-metastatisk-prostatakreft/1655442022-12-27T10:30+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/kreft/malrettet-radioaktivt-legemiddel-godkjent-i-eu/1655152024-01-02T10:12+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/immunterapi-jemperli-keytruda/lungekreft-jemperli-med-sterke-head-to-head-data-mot-keytruda/1655012022-12-22T09:12+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/gsk-immunterapi-jemperli/immunterapi-oker-overlevelsen-ved-avansert-eller-tilbakevendende-livmorkreft/1654672022-12-21T09:15+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/bimzelx-hidradenitis-suppurativa-ucb/psoriasislegemiddel-med-effekt-pa-svettekjertelbetennelse/1654402022-12-19T23:03+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/helse-sor-ost-ulleval-sykehus/styret-i-helse-sor-ost-har-vedtatt-a-legge-ned-ulleval-og-bygge-to-nye-sykehus/1654042022-12-16T14:49+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ash-fredrik-schjesvold-konferanse/dette-var-hoydepunktene-pa-american-society-of-hematology/1653512022-12-15T01:06+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ash-konferanse-mantelcellelymfom/nytt-behandlingskonsept-av-mantelcellelymfom-pasientene-slipper-unodig-behandling/1653392022-12-14T20:01+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/kreft/dyr-og-avansert-kreftpille-er-mer-kostnadseffektiv-enn-billig-kjemoterapi/1653182024-01-02T09:09+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ash-bispesifikke-antistoffer-car-t/vi-har-fatt-et-nytt-angrepsmal-mot-myelomatose-bispesifikt-antistoff-og-car-t-lykkes-i-studier/1653072022-12-13T04:36+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ash-konferanse-mantelcellelymfom/ibrutinib-pa-vei-mot-forstelinjebehandling-av-pasienter-med-mantelcellelymfom/1652732022-12-13T16:06+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-eggstokkreft/beslutningsforum-sier-ja-til-zejula-for-behandling-av-avansert-eggstokkreft/1652532022-12-12T14:41+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum/beslutningsforum-mange-fikk-nei-forhandlinger-om-spinal-muskelatrofi-legemidler-fortsetter/1652442022-12-12T17:05+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ash-beslutningsforum-bispesifikke-antistoffer/lymfekreftpasienter-som-har-komplett-remisjon-etter-endt-behandling-med-glofitamab-far-sjelden-tilbakefall/1652172023-01-12T12:25+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/brystkreft-konferanse-sabcs/norske-overleger-dette-er-hoydepunktene-pa-sabcs/1651422022-12-10T05:37+01:00https://image.healthtalk.no?imageId=165154&format=webp&width=1200https://www.healthtalk.no/bard-hoksrud-ingvild-kjerkol-legemiddelverket/statens-legemiddelverk-har-brutt-blareseptfristen-pa-viktig-hjertemedisin/1651352022-12-09T19:23+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-enhertu-konferanse/overbevisende-data-fra-studien-som-beslutningsforum-ikke-trodde-pa/1651132022-12-09T13:50+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/kreft/norsk-studie-med-ny-og-lovende-behandling-for-pasienter-med-trippelnegativ-brystkreft/1650902023-12-15T15:54+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/brystkreft-konferanse-sabcs/nytt-malrettet-legemiddel-med-lovende-effekt-pa-trippelnegativ-brystkreft/1650682022-12-08T17:26+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-enhertu-konferanse/enhertu-leverer-oppsiktsvekkende-overlevelsesfordel-hos-brystkreftpasienter-med-spredning/1650292022-12-07T23:21+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/cdk-4/6-hemmer-konferanse-sabcs/effekten-av-verzenios-etter-brystkreftoperasjon-oker-etter-fire-ar/1650182023-04-21T10:35+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/brystkreft-sabcs/malrettet-behandling-okte-overlevelsen-til-yngre-pasienter-med-aggressiv-metastatisk-brystkreft/1650052022-12-07T17:04+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/fastlegeordningen/240-millioner-kroner-til-flere-spesialister-i-allmennmedisin/1649532022-12-05T14:46+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/alexander-fossa-beslutningsforum-lymfekreft/godkjenning-av-kreftlegemiddel-ble-tre-ar-forsinket/1648442022-12-18T17:58+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ash-ash-2022-blodkreft/dette-er-de-viktigste-terapiformene-pa-hematologikonferanse-i-usa/1648262022-12-11T13:27+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/bente-hayes-kreftanbudet-sykehusinnkjop/sykehusinnkjop-fikk-medhold-na-blir-kreftavtalene-signert/1647692022-12-01T11:40+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/alzheimers-beslutningsforum-biogen/ny-medisin-mot-alzheimers-viser-lovende-resultater/1647562022-11-30T23:17+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/duchennes-muskeldystrofi-genterapi/fda-hurtigbehandler-den-forste-genterapien-mot-muskelsykdom/1647302022-12-04T06:52+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/camilla-stoltenberg-folkehelseinstituttet/vg-folkehelseinstituttet-tilbyr-sluttpakke-til-alle-ansatte/1647012022-11-28T16:16+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/crohns/banebrytende-legemiddel-mot-inflammatorisk-tarm-er-godkjent/1646752023-12-18T09:42+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/dengue-vaksine/takedas-dengue-vaksine-hurtigbehandles-av-fdas/1646652022-11-29T15:45+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/blodersykdom-genterapi-hemofili/den-forste-genterapien-mot-hemofili-b-er-godkjent-i-usa/1646562022-11-27T21:24+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol/sykehusene-far-25-milliarder-ekstra/1646472022-11-25T14:25+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/fredrik-schjesvold-gsk-myelomatose/gsk-stopper-salget-av-blodkreftmedisin-i-usa-salget-fortsetter-i-europa/1645932022-11-26T10:35+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/helse-nord-nytt-om-navn/marit-lind-konstitueres-som-direktor-i-helse-nord/1644972022-11-24T09:54+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/diabetes-novo-nordisk/novo-nordisk-investerer-75-milliarder-i-dansk-fabrikk/1644492022-11-23T11:13+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/immunterapi-livmorhalskreft/immunterapi-godkjent-for-a-behandle-livmorhalskreft/1644402022-11-29T21:16+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/bimzelx-psoriasisartritt/acr-2022-uendret-effekt-etter-52-uker-med-bimzelx/1644292022-11-25T09:29+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/boehringer-ingelheim/boehringer-ingelheim-sier-opp-20-ansatte-i-norge-ogsa-sjefen-gar/1643352022-11-21T21:49+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum/beslutningsforum-sier-ja-til-syv-av-ni-legemidler/1643052022-11-25T22:15+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/car-t-gensekvensering-immunterapi/det-kommer-store-gjennombrudd-i-persontilpasset-kreftbehandling/1642342022-11-17T14:23+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/helse-sor-ost-jan-frich-ulrich-spreng/jan-frich-gar-til-fhi-ulrich-spreng-tar-over-som-direktor-for-medisin-og-helsefag-i-helse-sor-ost/1642312022-11-17T13:58+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ge-healthcare-kontrastmiddel/ge-healthcare-satser-stort-i-norge/1642162022-11-18T09:51+01:00https://image.healthtalk.no?imageId=164221&format=webp&width=1200https://www.healthtalk.no/dapagliflozin-forebygging-forxiga/ny-medisin-pa-bla-resept-viktig-for-pasienter-med-kronisk-nyresykdom/1641572022-11-16T08:15+01:00https://image.healthtalk.no?imageId=164184&format=webp&width=1200https://www.healthtalk.no/hjertesvikt/ny-behandling-oker-overlevelsen-for-pasienter-med-hjertesvikt/1639972022-11-20T21:07+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/alzheimers-biogen-demens/alzheimermedisin-feiler-i-studier/1639882022-11-22T18:12+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/kolesterol-pcsk9-sanofi/mange-flere-vil-na-fa-avansert-kolesterolbehandling/1639272022-11-15T10:37+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/legemiddelindustrien-leif-rune-skymoen-lmi/leif-rune-skymoen-blir-ny-sjef-i-legemiddelindustrien/1639032022-11-14T12:23+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/mr-sentralnervesystemet/kan-redusere-bruken-av-kontrastmiddel-ved-mr-undersokelser/1638912022-11-15T11:16+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/apotek-apotekforeningen-ukraina/krigen-gir-stor-okning-i-salget-av-jodtabletter/1638742022-11-12T19:34+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/diabetes-insulin-twitter/twitterjuks-vi-deler-ikke-ut-gratis-insulin/1638432022-11-18T11:14+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ingrid-stenstadvold-ross-kreftforeningen-prostatakreft/hoyesterett-prostatakreft-kan-ikke-anses-som-yrkesskade-for-brannmenn/1638272022-11-12T09:54+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/insomni-kondisjonstrening-sovnapne/ny-studie-god-kondisjon-minsker-risikoen-for-sovnproblemer/1637842022-11-15T13:01+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/immunterapi-johanna-olweus/johanna-olweus-blir-radgiver-for-svensk-biotek/1637722022-11-11T21:20+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/abbott-diabetes-novo-nordisk/na-snakker-smarte-insulinpenner-med-en-app/1637082022-11-11T12:13+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/immunterapi-kreftforeningen-lungekreft/bruker-stralebehandling-for-a-forsterke-effekten-av-immunterapi/1636842022-11-11T12:14+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol-korona-koronavaksine/kjerkol-om-ny-koronabolge-kan-trappe-opp-tiltak-ved-behov/1636622022-11-11T12:14+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/koppervaksine/koppevaksine-god-butikk-for-bavarian-nordic/1636402022-11-09T12:54+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/apotek-1/kjersti-solheim-johansen-er-ny-hr-direktor-i-apotek-1/1636292022-11-10T15:28+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/fritt-behandlingsvalg-helse-sor-ost-jan-frich/positiv-til-avvikling-av-fritt-behandlingsvalg/1636182022-11-08T11:16+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/fedme-og-overvekt/rekordvekst-for-dansk-slankemedisin/1636052023-12-18T10:01+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/nyresykdom-sglt2-trond-geir-jenssen/lovende-resultater-for-pasienter-med-kronisk-nyresykdom/1635932022-11-07T15:44+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/gsk-helvetesild-vaksine/studie-ny-vaksine-mot-helvetesild-gir-minst-10-ars-beskyttelse/1635722022-11-07T09:37+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ni-av-ti-vil-vite-om-sin-risiko-for-hjernesykdom/1635512022-11-04T16:03+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/eggstokkreft-gynekologisk-kreft-kreft/okt-risiko-for-tilbakefall-av-eggstokkreft-under-pandemien/1634832022-11-09T13:00+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ingvild-kjerkol-ukraina/regjeringen-norge-fortsetter-a-hente-ukrainske-pasienter/1634302022-11-03T16:20+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/feilmedisinering/sykepleieres-vanligste-feil-ti-ganger-for-mye-medisin/1634222022-11-03T15:57+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/ingrid-stenstadvold-ross-kreftforeningen-kreftforskning/kreftforeningen-gir-186-millioner-til-forskning/1634132022-11-03T15:39+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-helse-nord/helse-nord-direktoren-gar-av/1633362022-11-02T14:55+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/migrene/ny-migrenebehandling-tilgjengelig-i-norge/1633022023-12-15T16:11+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/bjorn-guldvog-fastlege-helsedirektoratet/fortsatt-for-fa-fastleger/1632442022-11-04T16:17+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/eggstokkreft-esgo-gynkreft/hun-utvikler-miniversjoner-av-bukhinnen-for-a-finne-ut-hvordan-eggstokkreft-utvikler-seg-og-kan-behandles/1632302022-11-14T11:53+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/eggstokkreft-esgo-gynekologisk-kreft/fant-ulik-immunrespons-hos-pasienter-med-eggstokkreft-som-ble-behandlet-med-to-immunterapier/1632042022-10-30T17:49+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/esgo-kreft-livmorhalskreft/livmorhalskreft-var-nesten-glemt-pa-kort-tid-har-vi-oppnadd-store-gjennombrudd-for-pasientene-vare/1631752022-11-03T18:38+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/eggstokkreft-esgo/professor-ian-mcneish-vant-helga-salvesen-prisen/1631692022-10-30T17:49+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/eggstokkreft-esgo-kreft/gjennombruddet-har-kurert-mange-kvinner-med-eggstokkreft/1631652022-11-03T18:37+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-brystkreft-enhertu/beslutningsforum-innforer-enhertu-til-pasienter-med-aggressiv-brystkreft/1631562022-11-02T13:24+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/eggstokkreft-esgo-ingfrid-haldorsen/radiologiprofessor-a-kombinere-kunstig-intelligens-og-genanalyse-er-det-neste-store-innen-kreftdiagnostisering/1631412022-10-30T17:50+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/eggstokkreft-esgo-gynekologisk-kreft/esgo-2022-parp-hemmere-er-det-storste-medisinske-gjennombruddet-de-siste-30-arene-na-kommer-ogsa-immunterapi/1631322023-04-19T15:58+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/henrik-asheim-takeda/takedas-fabrikkansatte-tar-fagbrev-pa-jobben/1631222022-10-26T21:17+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-legemiddelverket/legemiddelverket-vil-styrke-det-nordiske-samarbeidet/1630932022-11-04T16:32+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/korona-vaksine/bare-norge-og-danmark-unngikk-okt-dodelighet-under-pandemien/1630352022-10-25T11:05+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/fhi-smertestillende-medisiner/fhi-flere-dor-av-sterke-smertestillende-medisiner-enn-av-heroinoverdoser/1629492022-10-24T10:42+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/e-helse-rune-simensen/rune-simensen-blir-ny-leder-for-nasjonalt-e-helserad-vi-ma-fa-fart-pa-leveransene/1629112022-10-21T17:53+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/fritt-behandlingsvalg-ingvild-kjerkol/regjeringen-avvikler-fritt-behandlingsvalg/1628482022-10-21T16:03+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/glucoset-hemispherean-innovasjon-norge/tre-norske-legemiddel-og-helseteknologibedrifter-far-opp-mot-300-millioner-kroner-fra-eu/1628252022-10-25T13:37+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/helse-sor-ost-nye-aker-nye-rikshospitalet/styrevedtaket-om-byggestart-av-nye-aker-og-nye-rikshospitalet-skjer-16-desember/1627782022-10-23T21:13+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-fredrik-schjesvold-jan-frich/na-far-legene-en-sterkere-rolle-i-nye-metoder/1627262022-10-19T13:26+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-car-t/skuffet-over-enda-et-nei-i-beslutningsforum/1626972022-10-18T12:22+02:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-car-t/beslutningsforum-innforer-car-t-behandling-tusen-takk-men-det-var-pa-hoy-tid/1626632022-10-31T09:30+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/tyske-sykehus-kan-matte-stenge-pa-grunn-av-energikrisen/1625862022-10-17T12:04+02:00https://image.healthtalk.no?imageId=162590&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-fhi-prostatakreft/10-000-menn-far-ny-og-bedre-provetest-ved-mistanke-om-prostatakreft/1625782022-10-25T11:22+02:00https://image.healthtalk.no?imageId=162582&format=webp&width=1200https://www.healthtalk.no/bente-hayes-immunterapi-inger-cathrine-bryne/msd-gar-til-retten-for-a-stoppe-norges-storste-legemiddelanbud/1625442022-10-17T15:04+02:00https://image.healthtalk.no?imageId=162142&format=webp&width=1200https://www.healthtalk.no/e-helse-helse-midt-norge-helseplattformen/bruker-100-millioner-for-a-redusere-ventelistene-for-oppstart-av-helseplattformen/1625142022-10-17T14:05+02:00https://image.healthtalk.no?imageId=162517&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-car-t/beslutningsforum-skal-vurdere-to-car-t-celleterapier-for-behandling-av-lymfekreft-pa-nytt/1625112022-10-13T15:11+02:00https://image.healthtalk.no?imageId=162522&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-einar-andreassen-fredrik-schjesvold/lang-ventetid-pa-nye-legemidler-men-na-tror-legemiddelverket-pa-bedring/1625032022-10-21T08:39+02:00https://image.healthtalk.no?imageId=162558&format=webp&width=1200https://www.healthtalk.no/korona-vaksine/astrazeneca-skrinlegger-koronavaksine-i-form-av-nesespray/1624922022-10-12T09:04+02:00https://image.healthtalk.no?imageId=162496&format=webp&width=1200https://www.healthtalk.no/anna-maria-hoffmann-vold-beslutningsforum-lungefibrose/norge-er-det-eneste-landet-i-norden-som-ikke-vil-tilby-denne-behandlingen-til-pasienter-med-dodelig-lungesykdom/1624842022-10-17T08:57+02:00https://image.healthtalk.no?imageId=162482&format=webp&width=1200https://www.healthtalk.no/kreft/ny-podcast-livet-med-brystkreft-med-spredning/1624292023-12-15T16:03+01:00https://image.healthtalk.no?imageId=162433&format=webp&width=1200https://www.healthtalk.no/legemiddelindustrien-lmi-statsbudsjettet/legemiddelindustrien-vi-er-i-hovedsak-tilfredse-med-arets-statsbudsjett/1623602022-10-06T15:12+02:00https://image.healthtalk.no?imageId=160292&format=webp&width=1200https://www.healthtalk.no/statsbudsjettet/regjeringen-kutter-50-millioner/1623482022-10-06T15:15+02:00https://image.healthtalk.no?imageId=162353&format=webp&width=1200https://www.healthtalk.no/statsbudsjettet/statsbudsjettet-regjeringen-ber-sykehusene-sette-i-verk-omstilling-og-utsette-investeringer/1623392022-10-06T13:35+02:00https://image.healthtalk.no?imageId=104328&format=webp&width=1200https://www.healthtalk.no/transplantasjon/vil-se-pa-muligheten-for-a-etablere-pakkeforlop-for-levende-nyredonorer/1623262022-10-11T08:25+02:00https://image.healthtalk.no?imageId=162330&format=webp&width=1200https://www.healthtalk.no/covid-19-korona/forskere-fastslar-at-covid-19-kom-fra-dyr/1623162022-10-11T14:38+02:00https://image.healthtalk.no?imageId=162469&format=webp&width=1200https://www.healthtalk.no/esmo-european-society-of-medical-oncology-kreftbehandling/ny-videopod-toppmote-esmo-dette-er-de-viktigste-kreftnyhetene/1622962023-04-19T15:56+02:00https://image.healthtalk.no?imageId=162300&format=webp&width=1200https://www.healthtalk.no/fastlegekrise-fastlegeordningen/statsbudsjettet-690-millioner-kroner-til-fastlegeordningen/1622852022-10-06T12:12+02:00https://image.healthtalk.no?imageId=160927&format=webp&width=1200https://www.healthtalk.no/beslutningsforum/vil-gi-immunterapi-fasttrack-i-beslutningsforum/1622712022-10-05T09:10+02:00https://image.healthtalk.no?imageId=162275&format=webp&width=1200https://www.healthtalk.no/hjerteinfarkt/fhi-40-prosent-nedgang-i-hjerteinfarkt-pa-ti-ar/1622182022-10-04T12:54+02:00https://image.healthtalk.no?imageId=102740&format=webp&width=1200https://www.healthtalk.no/hjemmelegene/hjemmelegene-og-norgesgruppen-apner-klinikk-i-butikk/1622012022-10-04T13:08+02:00https://image.healthtalk.no?imageId=162205&format=webp&width=1200https://www.healthtalk.no/nobelprisen/svenske-svante-paabo-far-nobelprisen-i-medisin-for-sitt-arbeide-om-neandertalerne/1621662022-10-04T09:46+02:00https://image.healthtalk.no?imageId=162170&format=webp&width=1200https://www.healthtalk.no/keytruda-legemiddelanbud-sykehusinnkjop/lekket-hemmelig-legemiddelpris-kan-stoppe-gigantavtale-om-kjop-av-kreftlegemidler-til-32-milliarder-kroner/1621382022-10-02T20:06+02:00https://image.healthtalk.no?imageId=162142&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/fordeler-oppstar-ved-langvarig-behandling-med-avansert-kolesterolsenker-haper-at-flere-pasienter-kan-fa-behandling/1621092023-12-18T10:07+01:00https://image.healthtalk.no?imageId=160123&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-bimzelx-ema/jakter-pa-to-nye-indikasjoner/1620982022-10-10T09:45+02:00https://image.healthtalk.no?imageId=114474&format=webp&width=1200https://www.healthtalk.no/forskningsparken-health2b-norway-healthtech/dette-er-en-invitasjon-til-alle-som-har-gode-ideer-og-noe-a-bidra-med/1620622022-11-04T16:48+01:00https://image.healthtalk.no?imageId=162069&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-brystkreft/beslutningsforum-sier-ja-til-brystkreftmedisin-og-seks-andre-legemidler/1620482022-11-23T09:43+01:00https://image.healthtalk.no?imageId=161580&format=webp&width=1200https://www.healthtalk.no/foflekkreft-immunterapi-melanom/ny-type-immunterapi-godkjent-for-behandling-av-foflekkreft/1620412022-09-27T13:26+02:00https://image.healthtalk.no?imageId=162046&format=webp&width=1200https://www.healthtalk.no/aktiv-mot-kreft/har-samlet-inn-250-millioner-til-persontilpasset-trening-for-kreftpasienter/1620212022-09-23T23:04+02:00https://image.healthtalk.no?imageId=162025&format=webp&width=1200https://www.healthtalk.no/persontilpasset-medisin/danmarks-forste-kvantedatamaskin-skal-utvikle-nye-typer-legemidler/1620132022-09-25T21:37+02:00https://image.healthtalk.no?imageId=162017&format=webp&width=1200https://www.healthtalk.no/helse/ny-podcastserie-det-pagar-en-revolusjon-i-kreftbehandlingen/1619562024-06-26T11:15+02:00https://image.healthtalk.no?imageId=161971&format=webp&width=1200https://www.healthtalk.no/daniel-heinrich-esmo-immunterapi/dette-er-de-viktigste-urologinyhetene/1618812022-09-22T15:14+02:00https://image.healthtalk.no?imageId=161886&format=webp&width=1200https://www.healthtalk.no/esmo-odd-terje-brustugun-sotorasib/nytt-effektivt-malrettet-legemiddel-mot-lungekreft/1618712022-09-26T12:19+02:00https://image.healthtalk.no?imageId=101110&format=webp&width=1200https://www.healthtalk.no/helse/doktor-shanu-modi-om-ny-behandling-av-her2-lav-brystkreft-jeg-er-glad-for-at-jeg-opplever-dette-i-min-tid/1618262024-09-03T13:16+02:00https://image.healthtalk.no?imageId=161831&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-esmo-immunterapi/oppsiktsvekkende-tarmkreftstudie-fikk-applaus-pa-esmo/1618112022-09-21T15:05+02:00https://image.healthtalk.no?imageId=161815&format=webp&width=1200https://www.healthtalk.no/adjuvant-behandling-esmo-lungekreft/dette-er-de-viktigste-lungekreftnyhetene-pa-esmo/1617962022-09-21T15:07+02:00https://image.healthtalk.no?imageId=161801&format=webp&width=1200https://www.healthtalk.no/esmo-kras-g12c-sotorasib/nytt-persontilpasset-legemiddel-reduserer-risiko-for-progresjon-eller-dod-med-34-prosent-hos-pasienter-med-kras-mutert-lungekreft/1617832022-09-26T09:58+02:00https://image.healthtalk.no?imageId=161789&format=webp&width=1200https://www.healthtalk.no/esmo-immunterapi-melanom/ikke-bare-hva-men-nar-immunterapi-for-operasjon-reduserer-tilbakefall-i-melanom/1617682022-09-27T12:23+02:00https://image.healthtalk.no?imageId=161772&format=webp&width=1200https://www.healthtalk.no/esmo-hode-og-halskreft-immunterapi/denne-immunterapien-feiler-i-hode-og-halskreft-overraskende-og-skuffende/1617492022-09-26T09:57+02:00https://image.healthtalk.no?imageId=161754&format=webp&width=1200https://www.healthtalk.no/esmo-presisjonsmedisin/ble-overrasket-da-jeg-sa-hva-det-koster-a-behandle-kreftpasienter-i-endestadiet-med-presisjonsmedisin/1617342022-09-21T15:11+02:00https://image.healthtalk.no?imageId=161739&format=webp&width=1200https://www.healthtalk.no/esmo-immunterapi-nyrekreft/nyrestudie-feilet-effektiv-immunterapikombinasjon-reduserte-ikke-tid-til-tilbakefall/1617262022-09-21T15:12+02:00https://image.healthtalk.no?imageId=161731&format=webp&width=1200https://www.healthtalk.no/anna-winge-main-esmo-foflekkreft/imponerende-forskning-av-vare-danske-kolleger/1617122022-09-21T15:16+02:00https://image.healthtalk.no?imageId=161662&format=webp&width=1200https://www.healthtalk.no/eggstokkreft-esmo/esmo-studie-en-del-av-pasientene-med-eggstokkreft-som-fikk-olaparib-ble-kurert/1616972022-09-21T15:18+02:00https://image.healthtalk.no?imageId=161702&format=webp&width=1200https://www.healthtalk.no/esmo-lungekreft/luftforurensning-kan-utlose-lungekreft-hos-aldri-roykere/1616442022-09-21T15:19+02:00https://image.healthtalk.no?imageId=161649&format=webp&width=1200https://www.healthtalk.no/esmo-impress-norway-inpred/presenterer-norsk-kreftinitiativ-pa-esmo/1616312022-09-21T15:20+02:00https://image.healthtalk.no?imageId=161635&format=webp&width=1200https://www.healthtalk.no/esmo-kliniske-studier/slik-skal-vi-fa-flere-legemiddelstudier-til-hele-norge/1616222022-09-21T15:21+02:00https://image.healthtalk.no?imageId=161626&format=webp&width=1200https://www.healthtalk.no/brystkreft-enhertu-esmo/dette-apner-en-helt-ny-behandlingsmulighet-for-en-gruppe-brystkreftpasienter/1616132022-09-21T15:22+02:00https://image.healthtalk.no?imageId=161618&format=webp&width=1200https://www.healthtalk.no/helse/ny-type-celleterapi-utsetter-tilbakefall-og-dod-for-pasienter-med-avansert-foflekkreft/1615892024-09-13T10:24+02:00https://image.healthtalk.no?imageId=161593&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-esmo-immunterapi/denne-immunterapien-har-flest-godkjenninger-i-beslutningsforum-pa-esmo-kommer-5-ars-overlevelsesdata/1615762022-09-21T15:25+02:00https://image.healthtalk.no?imageId=161580&format=webp&width=1200https://www.healthtalk.no/korona/over-4000-registrerte-koronadodsfall-i-norge/1615682022-09-06T14:09+02:00https://image.healthtalk.no?imageId=161572&format=webp&width=1200https://www.healthtalk.no/esmo/undersoker-om-data-fra-kreftregisteret-kan-brukes-som-ekstern-kontrollarm-i-kliniske-studier/1615582022-09-20T16:39+02:00https://image.healthtalk.no?imageId=108318&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/takeda-selger-fabrikken-i-asker-til-nextpharma/1615442024-01-02T09:36+01:00https://image.healthtalk.no?imageId=161548&format=webp&width=1200https://www.healthtalk.no/jobb-og-karriere-roche/henriette-ellefsen-jovik-forlater-melanor-tar-plass-i-ledergruppen-i-roche-norge/1615322022-09-05T22:31+02:00https://image.healthtalk.no?imageId=161536&format=webp&width=1200https://www.healthtalk.no/jobb-karriere/bent-hoies-hoyre-hand-gar-til-legemiddelindustrien/1615152022-09-02T13:52+02:00https://image.healthtalk.no?imageId=161519&format=webp&width=1200https://www.healthtalk.no/jobb-og-karriere/ahmet-olmez-tar-over-roret-i-pfizer-norge/1615012022-09-02T13:20+02:00https://image.healthtalk.no?imageId=161505&format=webp&width=1200https://www.healthtalk.no/korona-koronavaksine/eus-legemiddelbyra-godkjenner-to-vaksiner-mot-omikronvarianten/1614912022-09-01T20:59+02:00https://image.healthtalk.no?imageId=161495&format=webp&width=1200https://www.healthtalk.no/kreftforeningen-livmorhalskreft/3-av-10-sjekker-seg-ikke-kreftforeningen-vil-ha-nye-grep-i-kampen-mot-livmorhalskreft/1614742022-09-01T20:44+02:00https://image.healthtalk.no?imageId=161478&format=webp&width=1200https://www.healthtalk.no/fastlegekrise-ingvild-kjerkol/fastlegekrisen-verre-enn-antatt/1614642022-08-31T23:20+02:00https://image.healthtalk.no?imageId=161468&format=webp&width=1200https://www.healthtalk.no/korona-koronavaksine/fda-godkjenner-videreutviklede-koronavaksiner-rettet-mot-omikron-varianter/1614542022-08-31T23:24+02:00https://image.healthtalk.no?imageId=107260&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-bjorn-egil-vikse/helsevesenet-er-helt-avhengig-av-at-vi-har-kontroll-pa-kostnadene/1614322022-09-20T16:39+02:00https://image.healthtalk.no?imageId=161437&format=webp&width=1200https://www.healthtalk.no/ema-markedsforingstillatelse/det-forste-bispesifikke-antistoffet-mot-benmargskreft-er-godkjent-i-eu/1614152022-08-30T12:30+02:00https://image.healthtalk.no?imageId=161419&format=webp&width=1200https://www.healthtalk.no/ahus/sorgarbeideren/1614032022-09-07T20:22+02:00https://image.healthtalk.no?imageId=161409&format=webp&width=1200https://www.healthtalk.no/beslutningsforum/sa-nei-til-behandling-av-sjelden-lunge-og-skjoldbruskkjertelkreft-og-ja-til-beinmargskreft/1613942022-08-31T11:26+02:00https://image.healthtalk.no?imageId=161398&format=webp&width=1200https://www.healthtalk.no/esc-sglt2/esc-pasienter-med-hjertesvikt-har-nytte-av-forxiga-uavhengig-av-hjertepumpefunksjon/1613862022-08-27T21:42+02:00https://image.healthtalk.no?imageId=161390&format=webp&width=1200https://www.healthtalk.no/korona-koronavaksine-moderna/moderna-saksoker-pfizer-for-patentbrudd-pa-koronavaksine/1613742022-08-26T15:29+02:00https://image.healthtalk.no?imageId=161378&format=webp&width=1200https://www.healthtalk.no/apekopper/regjeringen-klassifiserer-apekopper-som-allmennfarlig-smittsom-sykdom/1613622022-08-26T12:43+02:00https://image.healthtalk.no?imageId=161368&format=webp&width=1200https://www.healthtalk.no/fhi-statsbudsjettet/kraftig-nedbemanning-i-fhi/1613542022-08-26T09:46+02:00https://image.healthtalk.no?imageId=161358&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-kreftlegemidler/fem-kreftlegemidler-skal-opp-i-beslutningsforum/1613412022-08-26T10:10+02:00https://image.healthtalk.no?imageId=100513&format=webp&width=1200https://www.healthtalk.no/genterapi-hemofili/den-forste-genterapien-for-behandling-av-hemofili-er-godkjent-i-europa/1613112022-08-29T21:49+02:00https://image.healthtalk.no?imageId=161315&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-eksem/beslutningsforum-skal-avgjore-om-jak-hemmer-kan-tas-i-bruk-av-pasienter-med-atopisk-eksem/1612962022-08-25T14:21+02:00https://image.healthtalk.no?imageId=103935&format=webp&width=1200https://www.healthtalk.no/forskning/45-millioner-kroner-fra-forskningsradet-til-a-redusere-ulikhet-i-helse/1612882022-08-28T19:43+02:00https://image.healthtalk.no?imageId=161292&format=webp&width=1200https://www.healthtalk.no/jobb-karriere-pr/redaktor-fra-dagens-medisin-gar-til-pr-bransjen/1612782022-08-26T09:26+02:00https://image.healthtalk.no?imageId=161282&format=webp&width=1200https://www.healthtalk.no/diagnostikk/gentian-diagnostics-rigger-seg-for-milliardomsetning/1612312022-08-25T09:38+02:00https://image.healthtalk.no?imageId=161235&format=webp&width=1200https://www.healthtalk.no/alzheimer-kunstig-intelligens/skal-utvikle-ny-medisin-mot-alzheimer-ved-hjelp-av-kunstig-intelligens/1612222022-08-24T12:25+02:00https://image.healthtalk.no?imageId=161226&format=webp&width=1200https://www.healthtalk.no/screening-av-kreft-tarmkreft/na-starter-masseundersokelse-av-tarmkreft/1612042022-08-24T11:19+02:00https://image.healthtalk.no?imageId=161209&format=webp&width=1200https://www.healthtalk.no/levealder/norsk-studie-unge-voksne-med-nedsatt-funksjonsevne-har-okt-risiko-for-tidlig-dod/1611692022-08-22T14:37+02:00https://image.healthtalk.no?imageId=161173&format=webp&width=1200https://www.healthtalk.no/arendalsuka-oslo-myelomatosesenter/kliniske-studier-kan-spare-helsevesenet-for-millionbelop/1611522022-08-23T11:40+02:00https://image.healthtalk.no?imageId=161156&format=webp&width=1200https://www.healthtalk.no/arendalsuka-lungekreft-screening-av-kreft/forskere-masseundersokelse-av-storroykere-er-effektivt-og-bor-innfores/1611382022-08-18T19:52+02:00https://image.healthtalk.no?imageId=103239&format=webp&width=1200https://www.healthtalk.no/anbud-arendalsuka-terapeutisk-bytte/jeg-er-skeptisk-til-terapeutisk-bytte/1611182022-08-18T19:54+02:00https://image.healthtalk.no?imageId=161077&format=webp&width=1200https://www.healthtalk.no/arendalsuka-digital-hjemmeoppfolging/helse-allianse-mener-regjeringen-somler-med-digital-hjemmeoppfolging/1610972022-08-18T19:53+02:00https://image.healthtalk.no?imageId=161101&format=webp&width=1200https://www.healthtalk.no/arendalsuka-beslutningsforum/vil-oke-tilliten-til-systemet-for-nye-metoder-leverer-tiltakspakke-til-helseministeren-i-oktober/1610842022-08-17T16:15+02:00https://image.healthtalk.no?imageId=161088&format=webp&width=1200https://www.healthtalk.no/arendalsuka-beslutningsforum-legemidler/vi-ma-stille-sporsmal-om-norge-skal-kreve-legemiddelpriser-pa-niva-med-fattigere-land-i-sor-europa/1610732022-08-17T11:47+02:00https://image.healthtalk.no?imageId=161077&format=webp&width=1200https://www.healthtalk.no/arendalsuka-ingvild-kjerkol-nullprofittutvalget/for-tidlig-a-spekulere-om-hvilke-konsekvenser-nullprofittutvalget-vil-fa-for-private-helseaktorer/1610462022-08-25T14:35+02:00https://image.healthtalk.no?imageId=161050&format=webp&width=1200https://www.healthtalk.no/arendalsuka-menon-sjeldne-sykdommer/ny-menon-rapport-sjeldne-sykdommer-er-sjeldent-dyrt/1610292022-08-17T07:54+02:00https://image.healthtalk.no?imageId=161034&format=webp&width=1200https://www.healthtalk.no/arendalsuka-kreftstrategi/hvordan-flytte-hoyspesialisert-kreftbehandling-ut-av-sykehusene-og-dit-pasientene-bor/1610142022-08-16T22:15+02:00https://image.healthtalk.no?imageId=161018&format=webp&width=1200https://www.healthtalk.no/arendalsuka-nho-geneo-nullprofittutvalget/et-ideologisk-og-politisk-angrep-vi-ikke-tidligere-har-opplevd-i-norge/1610032022-08-23T11:06+02:00https://image.healthtalk.no?imageId=161008&format=webp&width=1200https://www.healthtalk.no/arendalsuka-vaksine-voksenvaksinasjon/na-starter-hod-arbeidet-med-a-vurdere-om-det-skal-innfores-en-voksevaksinasjonsprogram/1609922022-08-16T11:13+02:00https://image.healthtalk.no?imageId=160996&format=webp&width=1200https://www.healthtalk.no/arendalsuka-beslutningsforum/beslutningsforum-sjefen-inviterer-til-samarbeid-for-a-innfore-legemidler-raskere/1609612022-08-15T18:09+02:00https://image.healthtalk.no?imageId=160965&format=webp&width=1200https://www.healthtalk.no/korona-vaksine/moderna-vaksine-mot-omikron-godkjent-i-storbritannia/1609512022-08-15T16:25+02:00https://image.healthtalk.no?imageId=160955&format=webp&width=1200https://www.healthtalk.no/arendalsuka-fastlegekrise-fastlegeordningen/fastlegekrisen-er-blitt-en-pasientkrise/1609232022-08-15T14:31+02:00https://image.healthtalk.no?imageId=160927&format=webp&width=1200https://www.healthtalk.no/arendalsuka-helsenaeringen-lmi/karita-bekkemellem-forlater-lmi-blir-administrerende-direktor-i-nho-geneo/1609042022-08-15T11:15+02:00https://image.healthtalk.no?imageId=160879&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-genterapi-zolgensma/to-barn-dode-etter-a-ha-fatt-genterapi-mot-spinal-muskelatrofi/1608832022-08-14T21:39+02:00https://image.healthtalk.no?imageId=160888&format=webp&width=1200https://www.healthtalk.no/helsenaeringen-nho/gar-hardt-ut-mot-regjeringen/1608752022-08-23T12:00+02:00https://image.healthtalk.no?imageId=160879&format=webp&width=1200https://www.healthtalk.no/helsenaeringen-nho-geneo/lena-veras-eriksen-32-blir-kommunikasjonsdirektor-i-nho-geneo/1608602022-08-12T16:54+02:00https://image.healthtalk.no?imageId=159797&format=webp&width=1200https://www.healthtalk.no/apekopper-legemidler-vaksine/de-forste-vaksinene-mot-apekopper-kommer-til-norge-i-dag/1608522022-08-12T15:54+02:00https://image.healthtalk.no?imageId=160856&format=webp&width=1200https://www.healthtalk.no/fastlegeordningen-ks/ks-vi-ma-fa-tilbake-troen-pa-fastlegeordningen/1608292022-08-11T17:38+02:00https://image.healthtalk.no?imageId=160833&format=webp&width=1200https://www.healthtalk.no/arendalsuka-hjernen-hjerneradet/se-deg-i-speilet-hjernen-er-deg/1608092022-08-15T15:18+02:00https://image.healthtalk.no?imageId=160815&format=webp&width=1200https://www.healthtalk.no/arendalsuka-duarte-marchand-kronikk/kronikk-det-kan-ikke-bare-handle-om-lavest-mulig-pris/1607992022-08-12T10:41+02:00https://image.healthtalk.no?imageId=160803&format=webp&width=1200https://www.healthtalk.no/fastlegeordningen-ingvild-kjerkol-legeforeningen/varsler-store-endringer-i-fastlegeordningen-nedsetter-ekspertutvalg/1607882022-08-11T12:03+02:00https://image.healthtalk.no?imageId=160792&format=webp&width=1200https://www.healthtalk.no/dignio-helse-tech/norsk-helse-tech-gjor-storoppkjop-priser-selskapet-til-300-millioner/1607762022-08-10T19:39+02:00https://image.healthtalk.no?imageId=160780&format=webp&width=1200https://www.healthtalk.no/jobb-og-karriere-pr/tidligere-toppsjef-i-sykehusinnkjop-gar-til-pr-bransjen/1607462022-08-11T14:07+02:00https://image.healthtalk.no?imageId=160750&format=webp&width=1200https://www.healthtalk.no/kreftbehandling-kunstig-intelligens-tarmkreft/bruker-kunstig-intelligens-som-forutsier-hvordan-tarmkreftceller-reagerer-pa-presisjonsmedisin/1607092022-08-23T10:51+02:00https://image.healthtalk.no?imageId=160719&format=webp&width=1200https://www.healthtalk.no/fhi-legger-ned-smittestopp-appen/1607012022-08-10T11:16+02:00https://image.healthtalk.no?imageId=160705&format=webp&width=1200https://www.healthtalk.no/oslo-byrad-gar-hardt-ut-mot-statens-sykehusplaner/1606852022-08-10T08:54+02:00https://image.healthtalk.no?imageId=160689&format=webp&width=1200https://www.healthtalk.no/arendalsuka-kreftoverlever/arendalsuka-kreftoverleverne-fortjener-bedre-oppfolging/1606772022-08-12T09:10+02:00https://image.healthtalk.no?imageId=160681&format=webp&width=1200https://www.healthtalk.no/kreftbehandling/immunforsvaret-som-vapen/1606652022-08-09T13:45+02:00https://image.healthtalk.no?imageId=160671&format=webp&width=1200https://www.healthtalk.no/psykiske-lidelser/medisinbruk-for-psykiske-lidelser-oker/1606592022-08-09T13:52+02:00https://image.healthtalk.no?imageId=160663&format=webp&width=1200https://www.healthtalk.no/enhertu-kreft-malrettet-behandling/historisk-fda-ja-til-behandling-av-her2-lav-brystkreft/1606502022-10-10T09:59+02:00https://image.healthtalk.no?imageId=160502&format=webp&width=1200https://www.healthtalk.no/adhd/voksne-med-adhd-sliter-oftere-med-angst-og-depresjon-enn-andre/1606402022-08-10T16:12+02:00https://image.healthtalk.no?imageId=160643&format=webp&width=1200https://www.healthtalk.no/styringsgruppe-anbefaler-nytt-sykehus-i-moelv/1606312022-08-09T09:17+02:00https://image.healthtalk.no?imageId=160634&format=webp&width=1200https://www.healthtalk.no/dansk-forskning-en-av-ti-kvinner-kan-ha-endometriose/1606242022-08-08T13:19+02:00https://image.healthtalk.no?imageId=160627&format=webp&width=1200https://www.healthtalk.no/na-begynner-vaksinasjonen-mot-apekopper-i-norge/1606172022-08-08T13:17+02:00https://image.healthtalk.no?imageId=160620&format=webp&width=1200https://www.healthtalk.no/forskning-kjolige-forhold-kan-dempe-vekst-av-kreftceller/1606102022-08-08T13:15+02:00https://image.healthtalk.no?imageId=160613&format=webp&width=1200https://www.healthtalk.no/fhi-kan-ta-i-bruk-beredskapslager-til-vaksinasjon-av-apekopper/1606032022-08-08T13:14+02:00https://image.healthtalk.no?imageId=160606&format=webp&width=1200https://www.healthtalk.no/poliosmitte-oppdaget-i-new-york/1605942022-08-08T13:12+02:00https://image.healthtalk.no?imageId=160597&format=webp&width=1200https://www.healthtalk.no/pharma-og-biotek/novo-nordisk-oppjusterer-forventningene/1605872024-01-02T09:24+01:00https://image.healthtalk.no?imageId=160590&format=webp&width=1200https://www.healthtalk.no/klarsignal-for-ny-type-immunterapi-studie-pagar-i-norge/1605802022-08-08T13:08+02:00https://image.healthtalk.no?imageId=160583&format=webp&width=1200https://www.healthtalk.no/fhi-kondomer-beskytter-ikke-mot-apekopper/1605732022-08-08T13:06+02:00https://image.healthtalk.no?imageId=160576&format=webp&width=1200https://www.healthtalk.no/onsker-flere-pasienter-til-impress-studien/1605642022-08-08T13:05+02:00https://image.healthtalk.no?imageId=160567&format=webp&width=1200https://www.healthtalk.no/nordmenn-flest-har-overvekt-eller-fedme/1605472022-08-08T13:00+02:00https://image.healthtalk.no?imageId=160550&format=webp&width=1200https://www.healthtalk.no/legemiddelverket-na-kan-du-ta-mer-paracetamol/1605392022-08-08T12:56+02:00https://image.healthtalk.no?imageId=160542&format=webp&width=1200https://www.healthtalk.no/voksne-med-adhd-sliter-oftere-med-angst-og-depresjon-enn-andre/1605312022-08-08T12:53+02:00https://image.healthtalk.no?imageId=160534&format=webp&width=1200https://www.healthtalk.no/dr-google-hele-verdens-fastlege/1605222022-08-08T12:51+02:00https://image.healthtalk.no?imageId=160525&format=webp&width=1200https://www.healthtalk.no/en-enkel-test-kan-forutsi-hvor-lenge-du-lever/1605152022-08-08T12:48+02:00https://image.healthtalk.no?imageId=160518&format=webp&width=1200https://www.healthtalk.no/svaert-liten-sannsynlighet-for-en-epidemi-av-apekopper-i-norge/1605082022-08-08T12:47+02:00https://image.healthtalk.no?imageId=160511&format=webp&width=1200https://www.healthtalk.no/fikk-ny-brystkreftindikasjon-sier-beslutningsforum-ja-denne-gangen/1604972022-10-10T09:58+02:00https://image.healthtalk.no?imageId=160500&format=webp&width=1200https://www.healthtalk.no/nakstad-ma-forberede-oss-pa-nye-smittebolger/1604902022-08-08T12:39+02:00https://image.healthtalk.no?imageId=160493&format=webp&width=1200https://www.healthtalk.no/ny-leder-for-norsk-selskap-for-hematologi/1604832022-08-08T12:37+02:00https://image.healthtalk.no?imageId=160486&format=webp&width=1200https://www.healthtalk.no/vidar-lever-med-waldenstoms/1604762022-08-08T12:36+02:00https://image.healthtalk.no?imageId=160479&format=webp&width=1200https://www.healthtalk.no/statsforvalteren-mener-amk-oslo-ikke-er-gode-nok-pa-henvendelser-fra-publikum/1604692022-08-08T12:34+02:00https://image.healthtalk.no?imageId=160472&format=webp&width=1200https://www.healthtalk.no/impress-studien-apner-for-blodkreftpasienter/1604602022-08-08T12:32+02:00https://image.healthtalk.no?imageId=160463&format=webp&width=1200https://www.healthtalk.no/mange-blir-kvitt-tvangslidelser-i-lopet-av-fire-dager/1604532022-08-08T12:28+02:00https://image.healthtalk.no?imageId=160456&format=webp&width=1200https://www.healthtalk.no/livskvalitet-etter-bekkeneksentrasjon/1604442022-08-08T12:26+02:00https://image.healthtalk.no?imageId=160447&format=webp&width=1200https://www.healthtalk.no/diabetes-og-hjerte-og-karsykdommer-oker-risikoen-for-demens/1604352022-08-08T13:24+02:00https://image.healthtalk.no?imageId=160438&format=webp&width=1200https://www.healthtalk.no/statsforvalteren-i-agder-fastlegesituasjonen-er-alvorlig/1604282022-08-08T12:18+02:00https://image.healthtalk.no?imageId=160431&format=webp&width=1200https://www.healthtalk.no/who-koronapandemien-er-langt-fra-over/1604212022-08-08T12:17+02:00https://image.healthtalk.no?imageId=160424&format=webp&width=1200https://www.healthtalk.no/statsforvalter-pilotstreiken-gir-svaert-alvorlig-situasjon-for-helsetilbudet-i-nord/1604142022-08-08T12:14+02:00https://image.healthtalk.no?imageId=160417&format=webp&width=1200https://www.healthtalk.no/samliv-og-naerhet-etter-toff-kreftbehandling/1604012022-08-08T12:12+02:00https://image.healthtalk.no?imageId=160404&format=webp&width=1200https://www.healthtalk.no/ntb/hoy-utskiftning-av-ansatte-i-legemiddelverket-bekymrer-ledelsen-koen-av-legemidler-som-skal-metodervurderes-vokser/1603942022-08-08T12:03+02:00https://image.healthtalk.no?imageId=160397&format=webp&width=1200https://www.healthtalk.no/ny-vaksine-mot-flatt-ventet-i-2025/1603872022-08-08T12:00+02:00https://image.healthtalk.no?imageId=160390&format=webp&width=1200https://www.healthtalk.no/legemiddeldistributorer-frikjent-for-ansvar-for-opioid-krisen-i-amerikansk-delstat/1603802022-08-08T11:58+02:00https://image.healthtalk.no?imageId=160383&format=webp&width=1200https://www.healthtalk.no/ntb/helse-bergen-og-sykehusapoteket-far-millionforelegg-etter-alvorlig-feilmedisinering/1603732022-08-08T11:55+02:00https://image.healthtalk.no?imageId=160376&format=webp&width=1200https://www.healthtalk.no/duplikat/bevilger-1-million-til-radgivning-om-spiseforstyrrelser/1603662022-08-08T13:22+02:00https://image.healthtalk.no?imageId=160369&format=webp&width=1200https://www.healthtalk.no/helse-sor-ost-jan-frich/bevilger-1-million-til-radgivning-om-spiseforstyrrelser/1603102022-08-08T09:26+02:00https://image.healthtalk.no?imageId=160314&format=webp&width=1200https://www.healthtalk.no/norgesgruppen-kjoper-seg-inn-i-hjemmelegene-skal-teste-ut-hjemmelege-i-butikk/1602992022-08-08T09:27+02:00https://image.healthtalk.no?imageId=160303&format=webp&width=1200https://www.healthtalk.no/legemiddelverket-legemidler-lmi/na-starter-det-aller-forste-anbudet-pa-blareseptlegemidler/1602832022-08-02T15:13+02:00https://image.healthtalk.no?imageId=110913&format=webp&width=1200https://www.healthtalk.no/hun-er-ny-generalsekretaer-i-sanitetskvinnene/1602752022-08-02T13:51+02:00https://image.healthtalk.no?imageId=160279&format=webp&width=1200https://www.healthtalk.no/novartis-omorganiserer-og-sier-opp-8-000-ansatte-usikkert-hva-det-betyr-for-novartis-norge/1602652022-08-02T13:44+02:00https://image.healthtalk.no?imageId=160269&format=webp&width=1200https://www.healthtalk.no/fhi-frykter-like-mange-koronainnleggelser-som-i-vinter/1602572022-08-02T13:26+02:00https://image.healthtalk.no?imageId=160261&format=webp&width=1200https://www.healthtalk.no/ny-vaksinekandidat-beskytter-mot-denguefeber/1602482022-08-02T13:19+02:00https://image.healthtalk.no?imageId=160253&format=webp&width=1200https://www.healthtalk.no/psykiske-lidelser-er-en-stor-sykdomsbyrde-for-skoleungdom/1602382022-08-02T12:54+02:00https://image.healthtalk.no?imageId=160242&format=webp&width=1200https://www.healthtalk.no/flere-pasienter-skal-fa-sin-sak-vurdert-av-ekspertpanelet/1602142022-08-02T12:33+02:00https://image.healthtalk.no?imageId=101320&format=webp&width=1200https://www.healthtalk.no/ambulanseflyberedskapen-forelopig-ikke-pavirket-av-flytekniker-lockout/1602022022-08-02T12:40+02:00https://image.healthtalk.no?imageId=160112&format=webp&width=1200https://www.healthtalk.no/helse-sor-ost-kritiseres-for-utsetting-av-byggeprosjekter/1601922022-08-02T12:36+02:00https://image.healthtalk.no?imageId=160196&format=webp&width=1200https://www.healthtalk.no/pasienter-er-stort-sett-fornoyd-med-fastlegen/1601782022-08-02T12:41+02:00https://image.healthtalk.no?imageId=160181&format=webp&width=1200https://www.healthtalk.no/pasientoppropet-overleverte-102-000-underskrifter-til-helseministeren/1601602022-08-02T12:38+02:00https://image.healthtalk.no?imageId=160164&format=webp&width=1200https://www.healthtalk.no/norsk-kreftvaksine-godkjent-til-bruk-i-kliniske-studier-i-usa/1601342022-06-28T13:35+02:00https://image.healthtalk.no?imageId=160137&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/ny-avansert-kolesterolsenkende-medisin-kan-tas-i-bruk-i-norge/1601182023-12-18T10:07+01:00https://image.healthtalk.no?imageId=160123&format=webp&width=1200https://www.healthtalk.no/nfo-soker-dispensasjon-fra-lockout-for-ambulansefly-teknikere/1601072022-06-28T13:18+02:00https://image.healthtalk.no?imageId=160112&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek-helseteknologi-spinal-muskelatrofi/nyfodtscreening-av-spinal-muskelatrofi-har-kjort-seg-fast-i-helsebyrakratiet/1417522021-01-05T00:00+01:00https://www.healthtalk.no/helseteknologi-slitasjegikt/ny-behandling-hjelper-pasienter-med-artrose/1413242019-05-27T00:00+02:00https://www.healthtalk.no/cpap-garmin-garmin-health/kunstig-intelligens-finner-farlig-sovnsykdom/1401272019-12-10T00:00+01:00https://www.healthtalk.no/ema-legemidler-og-biotek-lemtrada/ms-legemidlet-lemtrada-har-fatt-ny-indikasjon-i-samsvar-med-hvordan-vi-allerede-har-brukt-lemtrada-sier-ms-professor/1395392020-01-31T00:00+01:00https://www.healthtalk.no/hjemmekontor-skulderplager-smertelindring/effektiv-smertelindring-ved-skulderplager/1384922020-04-07T00:00+02:00https://www.healthtalk.no/hjemmekontor-ryggplager-smertelindring/effektiv-smertelindring-ved-ryggplager/1384192020-04-07T00:00+02:00https://www.healthtalk.no/genterapi-legemidler-og-biotek-zolgensma/20-millioner-kroner-for-en-kur-bestillerforum-sier-nei-til-hurtig-metodevurdering-av-genterapien-zolgensma/1367782020-11-30T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/svenske-legemiddelverket-genterapien-zolgensma-er-kostnadseffektiv/1354932021-03-26T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/volumbasert-prisavtale-apnet-veien-for-at-nydiagnostiserte-pasienter-med-smacellet-lungekreft-for-forste-gang-kan-behandles-med-immunterapi/1333252021-09-27T00:00+02:00https://www.healthtalk.no/esmo-2021-legemidler-og-biotek/xtandi-reduserer-risiko-for-dod-med-34-prosent-hos-menn-med-metastatisk-hormonfolsom-prostatakreft/1333072021-09-30T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/msd-sier-at-antiviral-pille-er-effektiv-mot-covid-19-halverer-sykehusinnleggelser-og-dodsfall-er-i-samtaler-med-norske-myndigheter-for-a-sikre-tilgang/1332892021-10-01T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-forskning/vektreduksjon-pa-minst-15-prosent-bor-bli-det-sentrale-behandlingsmalet-for-personer-med-diabetes-type-2/1332772021-10-04T00:00+02:00https://www.healthtalk.no/forskning/nerveforskning-belonnes-med-nobelpris-i-medisin/1332622021-10-04T00:00+02:00https://www.healthtalk.no/10-tips-for-hvordan-du-lager-engasjerende-webinarer/1332542021-10-11T00:00+02:00https://www.healthtalk.no/coronaviruset/fhi-vil-forske-pa-om-blodninger-har-sammenheng-med-koronavaksinering-60000-kvinner-med-i-undersokelse-for-a-finne-svaret/1332472021-10-05T00:00+02:00https://www.healthtalk.no/jobb-karriere/tidligere-krf-representant-blir-kommunikasjonsdirektor-ved-sykehuset-telemark/1332192021-10-05T00:00+02:00https://www.healthtalk.no/coronaviruset/astrazeneca-soker-nodgodkjenning-for-medisin-som-forebygger-covid/1332122021-10-06T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-forskning/starter-stor-studie-biomarkorer-i-blodet-kan-forutsi-hvilke-legemidler-som-har-storst-effekt-pa-prostatakreftpasienter-med-spredning/1331972021-10-11T00:00+02:00https://www.healthtalk.no/fant-nye-genetiske-varianter-som-oker-risikoen-for-bipolar-lidelse-malet-er-a-utvikle-treffsikre-medikamenter/1331302021-10-15T00:00+02:00https://www.healthtalk.no/allcan-video/lungekreftforeningen-cecilie-brathen/1308322022-01-01T02:57+01:00https://www.healthtalk.no/allcan-video/hjernesvulstforening-lars-bestum/1308232022-01-01T02:57+01:00https://www.healthtalk.no/allcan-video/carcinor-erik-hansen/1308202022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-nevroendokrin-kreft/hva-er-nevroendokrin-kreft/1308112022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-nevroendokrin-kreft/tid-for-trening-ogsa-for-kreftpasienter/1308082022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-nevroendokrin-kreft/mestringsmedisin-i-praksis/1307982022-01-01T02:57+01:00https://www.healthtalk.no/photocure-undervisningsfilmer-video/photocure-hvordan-bruke-fleksibelt-skop-med-hexvix-i-poliklinikk/1307952022-01-01T02:57+01:00https://www.healthtalk.no/myelomatose-undervisningsfilmer-video/takeda-nasjonale-retningslinjer-for-myelomatosebehandling/1307922022-01-01T02:57+01:00https://www.healthtalk.no/fedme-video/hvordan-behandle-pasienter-med-fedme-episode-2/1307832022-01-01T02:57+01:00https://www.healthtalk.no/fedme-video/hvordan-behandle-pasienter-med-fedme-episode-1/1307802022-01-01T02:57+01:00https://www.healthtalk.no/parkinsons-video/espen-dietrichs-om-fremskreden-parkinsons-sykdom/1307712022-01-01T02:57+01:00https://www.healthtalk.no/hjerteamyloidose-video/hva-er-amyloidose/1307652022-01-01T02:57+01:00https://www.healthtalk.no/hjerteamyloidose-video/hjerteamyloidose/1307592022-01-01T02:57+01:00https://www.healthtalk.no/hjerteamyloidose-video/nytteverdien-av-skjelettscintigrafi-ved-hjerte-amyloidose/1307562022-01-01T02:57+01:00https://www.healthtalk.no/fedme-navamedic-undervisningsfilmer/fastlegens-utfordringer-innen-fedmebehandling/1307492022-01-01T02:57+01:00https://www.healthtalk.no/alexander-fossa-lymfekreft-video/cell-talk-ep-1-overlege-alexander-fossa-om-pasienter-med-lymfekreft/1307352022-01-01T02:57+01:00https://www.healthtalk.no/video/olea-studien-ved-emelie-rotbain/1307302022-01-01T02:57+01:00https://www.healthtalk.no/osteoporose-ucb-undervisningsfilmer/flsdxa-kurs-hvordan-oppdager-utreder-og-behandler-vi-bruddpasienter/1307212022-01-01T02:57+01:00https://www.healthtalk.no/pharmacosmos-undervisningsfilmer-video/hvordan-handteres-jernmangel-og-jernmangelanemi-hos-pasienten-med-inflammatorisk-tarmsykdom/1307182022-01-01T02:57+01:00https://www.healthtalk.no/video/ekspertmote-ny-behandling-av-avansert-urotelial-cancer/1307092022-01-01T02:57+01:00https://www.healthtalk.no/alexander-fossa-lymfekreft-takeda/systemisk-anaplastisk-storcellet-lymfom-salcl/1307002022-01-01T02:57+01:00https://www.healthtalk.no/brystkreft-video/blir-det-alltid-bedre-av-a-snakke-om-det/1306952022-01-01T02:57+01:00https://www.healthtalk.no/brystkreft-video/hvordan-finne-den-beste-kreftbehandlingen-for-den-finnes/1306922022-01-01T02:57+01:00https://www.healthtalk.no/brystkreft-video/brystkreft-med-spredning-hva-na/1306872022-01-01T02:57+01:00https://www.healthtalk.no/blodsykdommer-video/sentrale-lymfom-studier-pa-ash-2020-overlege-marianne-brodtkorb/1306842022-01-01T02:57+01:00https://www.healthtalk.no/net-kreft-video/net-kreft-26-takk/1306742022-01-01T02:57+01:00https://www.healthtalk.no/net-kreft-video/net-kreft-25-finne-informasjon/1306652022-01-01T02:57+01:00https://www.healthtalk.no/net-kreft-video/net-kreft-24-livet-med-net-gjenvaerende-kreft/1306502022-01-01T02:57+01:00https://www.healthtalk.no/net-kreft-video/net-kreft-23-livet-med-net-ikke-gjenvaerende-kreft/1306452022-01-01T02:57+01:00https://www.healthtalk.no/net-kreft-video/net-kreft-22-leveutsikter/1306422022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-21-ernaering-og-kreft-generelt/1306352022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-20-arvelig-net-kreft/1306302022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-19-forskning/1306272022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-18-alternativ-behandling/1306182022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-17-cellegift-ved-nevroendokrin-kreft/1306142022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-16-molekylaert-rettet-behandling-med-afinitor-og-sutent/1306112022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-15-peptid-reseptor-radionuklid-terapi-prrt/1306012022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-14-behandling-av-net-kreft-leverembolisering/1305982022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-13-behandling-av-net-kreft-somatostatinanaloger/1305892022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-12-behandling-av-net-kreft-kirurgi/1305822022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-11-lunge/1305772022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-10-bukspyttkjertel-net/1305712022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-9-tynntarms-net/1305662022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-8-typer-net-kreft/1305632022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-7-pavisning-av-nevroendokrine-svulster-detaljert-oversikt/1305542022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-6-hva-er-nevroendokrin-kreft/1305512022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-5-generell-behandling-av-net-kreft/1305482022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-4-symptomer-ved-nevroendokrin-kreft/1305382022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-3-pavisning-av-nevroendokrine-svulster-kort-oversikt/1305332022-01-01T02:57+01:00https://www.healthtalk.no/carcinor-net-kreft-video/net-kreft-2-hva-er-nevroendokrin-kreft-kortversjon/1305302022-01-01T02:57+01:00https://www.healthtalk.no/immunterapi-video/immunterapi-har-bedre-effekt-nar-kreftcellene-far-mindre-sukker/1298292022-01-01T02:57+01:00https://www.healthtalk.no/immunterapi-video/rna-legemidler-gir-nye-og-unike-muligheter-for-persontilpasset-behandling/1298242022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/nytt-malrettet-legemiddel-mot-lungekreft/1298192022-01-01T02:57+01:00https://www.healthtalk.no/alzheimers-video/kreftmedisin-viser-effekt-hos-alzheimerspasienter/1298082022-01-01T02:57+01:00https://www.healthtalk.no/ms-video/kunstig-intelligens-hjelper-forskerne-forsta-mer-av-ms-pasienters-immunsystem/1298002022-01-01T02:57+01:00https://www.healthtalk.no/lymfekreft-video/hodgins-lymfom/1297952022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/sotorasib-har-lovende-effekt-pa-kras-mutert-lungekreft-kan-bli-det-forste-godkjente-kras-legemidlet/1297912022-01-01T02:57+01:00https://www.healthtalk.no/video/enuresedagen-2022-hvordan-pavirker-problemet-barna-og-hvilken-sammenheng-har-fedme-med-utviklingen-av-enurese/1297852022-01-01T02:57+01:00https://www.healthtalk.no/analfissur-video/analfissur-diagnostikk-og-behandling/1297672022-01-01T02:57+01:00https://www.healthtalk.no/hjerteamyloidose-video/hva-ma-du-vite-om-transtyretin-amyloid-kardiomyopati/1297622022-01-01T02:57+01:00https://www.healthtalk.no/revmatisme-scr2021-video/scr2021-dette-er-de-viktigste-leddgiktstudiene-na/1297582022-01-01T02:57+01:00https://www.healthtalk.no/myelomatose-video/myelomatose-venetoclax-cobimetinib-gir-storre-respons-enn-venetoclax-alene-med-fredrik-schjesvold/1297542022-01-01T02:57+01:00https://www.healthtalk.no/esmo2020-video/toppmoteesmo-hilde-enserink-anne-bee-hegge-marijana-stjepanovic-cathrine-notland-og-ali-areffard/1297442022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/lovende-studie-med-immunterapi-for-operasjon-av-lungekreft/1297312022-01-01T02:57+01:00https://www.healthtalk.no/blodkreft-video/dette-er-blodkreft/1297272022-01-01T02:57+01:00https://www.healthtalk.no/asco-keftforskning-video/asco202-oppsummert/1297232022-01-01T02:57+01:00https://www.healthtalk.no/esmo-video/toppmote-esmo-2021/1297132022-08-24T15:14+02:00https://image.healthtalk.no?imageId=161265&format=webp&width=1200https://www.healthtalk.no/video/praksisendrende-studier-der-overlevelsesgevinsten-males-i-ar/1297012022-01-01T02:57+01:00https://www.healthtalk.no/esmo-video/bor-ogsa-pasienter-med-foflekkreft-som-ikke-har-spredd-seg-bor-fa-immunterapi-etter-operasjon/1296972022-08-24T15:10+02:00https://image.healthtalk.no?imageId=161260&format=webp&width=1200https://www.healthtalk.no/esmo-video/immunterapien-har-imponerende-effekt-pa-pasienter-med-livmorhalskreft-som-har-kort-tid-igjen-a-leve/1296932022-08-24T15:08+02:00https://image.healthtalk.no?imageId=102514&format=webp&width=1200https://www.healthtalk.no/asco-asco2020-video/dette-er-forskningsfronten-i-kreftbehandlingen/1296862022-01-01T02:57+01:00https://www.healthtalk.no/esmo-video/toppmote-esmo-hilde-enserink-anne-bee-hegge-marijana-stjepanovic-cathrine-notland-og-ali-areffard/1296792022-08-24T15:16+02:00https://image.healthtalk.no?imageId=161268&format=webp&width=1200https://www.healthtalk.no/asco-asco2020-video/healthtalk-toppmote-asco20/1296752022-01-01T02:57+01:00https://www.healthtalk.no/myelomatose-video/ny-studie-om-immunterapien-bite-gis-som-subkutan-injeksjon-med-overlege-fredrik-schjesvold/1296652022-01-01T02:57+01:00https://www.healthtalk.no/eha25-video/fredrik-schjesvold-om-gsk-sin-innovative-dreamm-studie-under-eha25/1296552022-01-01T02:57+01:00https://www.healthtalk.no/eha25-video/fredrik-schjesvold-en-ny-standardbehandling-for-myelomatose/1296492022-01-01T02:57+01:00https://www.healthtalk.no/eha25-myelomatose-video/fredrik-schjesvold-ny-behandlingsmulighet-for-pasienter-med-al-amyloidose/1296452022-01-01T02:57+01:00https://www.healthtalk.no/foflekkreft-video/hoydepunkter-asco-2021-foflekkreft/1296352022-01-01T02:57+01:00https://www.healthtalk.no/foflekkreft-video/kreftvaksine-sammen-med-immunterapi-har-effekt-pa-60-prosent-av-pasientene-med-avansert-foflekkreft/1296262022-01-01T02:57+01:00https://www.healthtalk.no/foflekkreft-video/overlege-anna-winge-main-summerer-opp-de-viktigste-esmo-studiene-innen-melanom/1296162022-01-01T02:57+01:00https://www.healthtalk.no/foflekkreft-video/pasienter-med-foflekkreft-uten-spredning-har-like-darlig-overlevelse-som-de-med-spredning/1296112022-01-01T02:57+01:00https://www.healthtalk.no/brystkreft-video/hoydepunkter-asco21-brystkreft/1295942022-01-01T02:57+01:00https://www.healthtalk.no/brystkreft-video/ny-brystkreftbehandling-gjor-lite-skade-pa-hjertehelsen/1295812022-01-01T02:57+01:00https://www.healthtalk.no/brystkreft-video/kisqali-forbedrer-overlevelsen-uavhengig-av-alder-hos-brystkreftpasienter/1295772022-01-01T02:57+01:00https://www.healthtalk.no/brystkreft-video/professor-hans-petter-eikesdal-om-esmo-2020/1295732022-01-01T02:57+01:00https://www.healthtalk.no/kronikk/biologi-i-hoyere-opplosning/1295622022-06-21T00:00+02:00https://www.healthtalk.no/brystkreft-video/aslaug-helland-om-asco20/1295582022-01-01T02:57+01:00https://www.healthtalk.no/foflekkreft-video/anna-k-winge-main-om-asco20/1295542022-01-01T02:57+01:00https://www.healthtalk.no/urologi-video/hoydepunkter-asco-2021-urologi/1295502022-01-01T02:57+01:00https://www.healthtalk.no/blaerekreft-urologi-video/daniel-heinrich-om-asco20/1295462022-01-01T02:57+01:00https://www.healthtalk.no/blaerekreft-video/jan-oldenburg-om-asco20/1295422022-01-01T02:57+01:00https://www.healthtalk.no/benmargskreft-video/fredrik-schjesvold-om-asco20/1295342022-01-01T02:57+01:00https://www.healthtalk.no/tykk-og-endetarmskreft-video/eva-hofsli-om-asco20/1295302022-01-01T02:57+01:00https://www.healthtalk.no/tykk-og-endetarmskreft-video/stadig-flere-yngre-rammes-av-tarmkreft-ga-til-legen-om-du-har-disse-symptomene/1295232022-01-01T02:57+01:00https://www.healthtalk.no/hemataologi-video/eha25-oppsummert-av-fredrik-schjesvold/1295192022-01-01T02:57+01:00https://www.healthtalk.no/hode-og-halskreft-video/hoydepunkter-asco-2021-hode-og-halskreft/1295152022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/hoydepunkter-asco-2021-lungekreft/1295112022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/immunterapiene-yervoy-og-keytruda-i-kombinasjon-oker-ikke-overlevelsen-gir-bare-okte-bivirkninger/1295072022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/aslaug-helland-oppsummerer-world-congress-on-lung-cancer-2021/1295032022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/dart-studie-skal-finne-biomarkorene-som-forklarer-hvorfor-noen-lungekreftpasienter-far-tilbakefall/1294992022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/lungekreft-professor-aslaug-helland-oppsummerer-esmo-2020/1294952022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/hoy-straledose-gir-lungekreftpasienter-50-prosent-okt-overlevelse/1294912022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/asco-2020-norsk-studie-lungekreftpasienter-lever-50-prosent-lenger-nar-de-far-hoyere-straledose/1294872022-01-01T02:57+01:00https://www.healthtalk.no/lungekreft-video/asco-2020-astrazeneca-med-studie-som-kan-endre-behandlingen-av-en-gruppe-lungekreftpasienter/1294832022-01-01T02:57+01:00https://www.healthtalk.no/brysthinnekreft-video/aslaug-helland-leder-brysthinnekreftstudie-der-pasientene-far-to-immunterapier-og-en-kreftvaksine/1294792022-01-01T02:57+01:00https://www.healthtalk.no/nyrecellekreft-video/immunterapi-etter-operasjon-reduserer-risiko-for-tilbakefall-ved-nyrecellekreft/1294752022-01-01T02:57+01:00https://www.healthtalk.no/prostatakreft-video/malrettet-radioaktivt-legemiddel-forlenger-livet-til-prostatakreftpasienter-som-har-provd-alt/1294712022-01-01T02:57+01:00https://www.healthtalk.no/prostatakreft-video/daniel-heinrich-oppsummerer-de-viktigste-esmo-2020-studiene-innenfor-urologi/1294672022-01-01T02:57+01:00https://www.healthtalk.no/prostatakreft-video/professor-jan-erik-damber-om-esmo-studie/1294562022-01-01T02:57+01:00https://www.healthtalk.no/prostatakreft-video/daniel-heinrich-om-asco2020/1294522022-01-01T02:57+01:00https://www.healthtalk.no/kll-video/ash-konferansen-oppsumert-med-sigrid-skanland/1294452022-01-01T02:57+01:00https://www.healthtalk.no/car-t-immunterapi-video/fredrik-schjesvold-forlarer-hvorfor-car-t-virker-bedre-en-tradisjonell-immunterapi/1294372022-01-01T02:57+01:00https://www.healthtalk.no/car-t-immunterapi-video/fredrik-schjesvold-forklarer-bite-teknologien-og-celgene-sin-bite/1294332022-01-01T02:57+01:00https://www.healthtalk.no/eggstokkreft-video/ga-ny-dose-presisjonsmedisin-til-pasienter-med-eggstokkreft-resultatet-overrasket-kreftlegen/1294252022-01-01T02:57+01:00https://www.healthtalk.no/kardiologi-video/den-forste-studien-som-har-effekt-pa-hjertesviktpasienter-med-bevart-hjertepumpefunksjon-hfpef/1291692022-01-01T02:57+01:00https://www.healthtalk.no/kardiologi-video/banebrytende-hjertestudier-kan-endre-norsk-behandlingspraksis/1291632022-01-01T02:57+01:00https://www.healthtalk.no/kardiologi-video/esc-2020-dette-er-de-nye-rettningslinjene-for-behandling-av-hjerteflimmer-med-professor-dan-atar/1291592022-01-01T02:57+01:00https://www.healthtalk.no/kardiologi-video/professor-dan-atar-om-emperor-reduced-studien-pa-esc-2020/1291472022-01-01T02:57+01:00https://www.healthtalk.no/kardiologi-video/hvert-fjerde-hjerneslag-skyldes-hjerteflimmer/1291372022-01-01T02:57+01:00https://www.healthtalk.no/helsdata-og-digitalisering-video/healthtalk-debatten-hvordan-kan-helsedata-gi-bedre-tjenester-for-pasienter-med-sjeldne-diagnoser/1291272022-08-10T16:44+02:00https://image.healthtalk.no?imageId=160740&format=webp&width=1200https://www.healthtalk.no/helsdata-og-digitalisering-video/healthtalk-debatten-digitalisering-av-det-norske-helsevesenet/1291232022-08-10T16:44+02:00https://image.healthtalk.no?imageId=160737&format=webp&width=1200https://www.healthtalk.no/sykdom-og-livsstil-video/slik-kan-personer-med-hjertesykdom-trene-trygt/1291192022-01-01T02:57+01:00https://www.healthtalk.no/sykdom-og-livsstil-video/healthtalk-debatten-hvor-lenge-ma-vi-vente-egentlig-ventetider-innen-kreftbehandling/1291042022-08-10T16:44+02:00https://image.healthtalk.no?imageId=160731&format=webp&width=1200https://www.healthtalk.no/presisjonsmedisin-video/healthtalk-debatten-hvordan-lykkes-vi-med-presisjonsmedisin-for-kreft/1290982022-08-10T16:44+02:00https://image.healthtalk.no?imageId=160734&format=webp&width=1200https://www.healthtalk.no/helsdata-og-digitalisering-video/kardiologiprofessor-dan-atar-dette-er-de-viktigste-studiene-pa-hjertekongressen-acc/1290872022-01-01T02:57+01:00https://www.healthtalk.no/video/funksjonell-presisjonsmedisin/1290822022-01-01T02:57+01:00https://www.healthtalk.no/video/liv-ekeberg-moen-57-far-behandlingen-beslutningsforum-sa-nei-til-betalt-av-helseforsikringen/1290782022-01-01T02:57+01:00https://www.healthtalk.no/video/arendalsuka-2021-helseindustri-en-verdiskaper-for-samfunnet/1290742022-01-01T02:57+01:00https://www.healthtalk.no/video/direkte-fra-arendalsuka-digital-inspirasjon-fra-koronaens-tid/1290702022-01-01T02:57+01:00https://www.healthtalk.no/video/arendalsuka-2021-hvor-lenge-ma-vi-vente-egentlig/1290662022-01-01T02:57+01:00https://www.healthtalk.no/video/arendalsuka-2021-helsenaering-og-kliniske-studier-vertskapsattraktivitet/1290622022-01-01T02:57+01:00https://www.healthtalk.no/video/tilgang-til-genterapi-i-norge-har-vi-noe-a-laere-fra-andre-land/1290582022-01-01T02:57+01:00https://www.healthtalk.no/arendalsuka2021-video/fremtidens-kreftbehandling-evaluering-av-nye-metoder/1290542022-01-01T02:57+01:00https://www.healthtalk.no/video/digital-arrangement-bedre-kreftomsorg-med-prehabilitering-og-trygg-utskrivning/1290492022-01-01T02:57+01:00https://www.healthtalk.no/arendalsuka2021-video/arendalsuka-2021-privat-offentlig-samarbeid-og-tillit-i-helsenaeringen/1290452022-01-01T02:57+01:00https://www.healthtalk.no/arendalsuka2021-video/genterapi-og-evalueringen-av-nye-metoder/1290032022-01-01T02:57+01:00https://www.healthtalk.no/arendalsuka2021-video/er-det-nok-oksygen-i-rommet-ehelseambisjonenes-mote-med-virkeligheten/1289952022-01-01T02:57+01:00https://www.healthtalk.no/arendalsuka2021-video/som-om-vi-har-et-valg-debatt-om-felles-kommunal-journal/1289872022-01-01T02:57+01:00https://www.healthtalk.no/video/helsenaeringen-kan-bli-en-de-viktigste-norske-vekstnaeringene-fremover/1289832022-01-01T02:57+01:00https://www.healthtalk.no/video/sjefen-i-norges-mest-verdifulle-biotekselskap-mener-vi-bor-hylle-grnderne-som-gar-konkurs/1289522022-01-01T02:57+01:00https://www.healthtalk.no/podcast/may-britt-har-testet-tusenvis-for-benskjorhet/1288552022-01-01T02:57+01:00https://www.healthtalk.no/podcast/ny-norsk-immunterapi-bruker-virus-for-a-sla-ut-kreften/1288422022-01-01T02:57+01:00https://www.healthtalk.no/podcast/nye-legemidler-oker-overlevelsen-til-pasienter-med-benmargskreft/1288372022-01-01T02:57+01:00https://www.healthtalk.no/podcast/en-gamechanger-diabeteslegemidlet-som-ogsa-hjelper-hjertesviktpasienter/1288282022-01-01T02:57+01:00https://www.healthtalk.no/podcast/fastlegen-gar-digitalt/1288072022-01-01T02:57+01:00https://www.healthtalk.no/podcast/toppmote-asco20-dette-er-forskningsfronten-i-kreftbehandlingen/1287982022-01-01T02:57+01:00https://www.healthtalk.no/podcast/blodkreftforeningen-nodvendig-a-endre-beslutningsforum/1287812022-01-01T02:57+01:00https://www.healthtalk.no/podcast/helse-norge-kollaps-eller-baerekraft/1287722022-01-01T02:57+01:00https://www.healthtalk.no/podcast/esc-2020-jardiance-reduserer-risikoen-for-cv-dod-og-sykehusinnleggelser-hos-hjertesviktpasienter-med-25-prosent/1287632022-01-01T02:57+01:00https://www.healthtalk.no/podcast/ntnu-studie-kondisen-avslorer-risiko-for-hjerteinfarkt-hos-friske/1287542022-01-01T02:57+01:00https://www.healthtalk.no/podcast/norsk-coronastudie-hoy-dodelighet-blant-pasienter-med-hoy-alder-og-kroniske-sykdommer/1287412022-01-01T02:57+01:00https://www.healthtalk.no/podcast/vare-ledere-duarte-marchand-takeda/1287362022-01-01T02:57+01:00https://www.healthtalk.no/podcast/toppmote-esmo-de-viktigste-forskningsnyhetene-innen-kreftbehandling-og-diagnostisering/1287312022-01-01T02:57+01:00https://www.healthtalk.no/podcast/inven2-star-bak-selskaper-som-er-verd-over-30-milliarder-na-er-vaccibody-alene-priset-til-17-milliarder/1287262022-01-01T02:57+01:00https://www.healthtalk.no/podcast/sotorasib-har-lovende-effekt-pa-kras-mutert-lungekreft-kan-bli-det-forste-godkjente-kras-legemidlet/1287132022-01-01T02:57+01:00https://www.healthtalk.no/podcast/norges-leger-har-fatt-sin-egen-tv-serie/1287082022-01-01T02:57+01:00https://www.healthtalk.no/podcast/rene-amundsen-global-sjef-for-innovasjon-i-merck/1287032022-01-01T02:57+01:00https://www.healthtalk.no/podcast/de-storste-legemiddelfirmaene-og-mest-solgte-legemidlene-i-2020/1286862022-01-01T02:57+01:00https://www.healthtalk.no/podcast/kunstig-intelligens-blir-et-kraftig-verktoy-i-hendene-pa-kardiologene/1286652022-01-01T02:57+01:00https://www.healthtalk.no/podcast/ny-brystkreftbehandling-gjor-lite-skade-pa-hjertehelsen/1286602022-01-01T02:57+01:00https://www.healthtalk.no/podcast/dette-er-de-viktigste-studiene-pa-hjertekongressen-acc-kardiologiprofessor-dan-atar/1286552022-01-01T02:57+01:00https://www.healthtalk.no/podcast/malrettet-radioaktivt-legemiddel-forlenger-livet-til-prostatakreftpasienter-som-har-provd-alt/1286502022-01-01T02:57+01:00https://www.healthtalk.no/podcast/hoydepunkter-asco21-brystkreft/1286272022-01-01T02:57+01:00https://www.healthtalk.no/podcast/bor-spedbarn-gentestes-for-spinal-muskelatrofi-sma/1286222022-01-01T02:57+01:00https://www.healthtalk.no/podcast/de-viktigste-studiene-pa-den-europeiske-hjertekongressen-esc/1286032022-01-01T02:57+01:00https://www.healthtalk.no/podcast/lederen-i-norsk-onkologisk-forening-tannlos-evaluering-av-beslutingsforum/1285942022-01-01T02:57+01:00https://www.healthtalk.no/podcast/knut-smeland-er-arets-unge-kreftforsker/1285892022-01-01T02:57+01:00https://www.healthtalk.no/podcast/dette-proteinet-kan-vaere-nokkelen-til-a-utvikle-nye-legemidler/1285682022-01-01T02:57+01:00https://www.healthtalk.no/podcast/blodkreftsykdommen-som-kan-gjore-blodet-tykt-og-seigt/1285632022-01-01T02:57+01:00https://www.healthtalk.no/podcast/helse-kan-bli-den-tredje-store-norske-eksportnaeringen-men-da-ma-norge-bli-bedre-til-a-tiltrekke-seg-investeringer-fra-legemiddelindustrien/1285582022-01-01T02:57+01:00https://www.healthtalk.no/podcast/ep-1-genene-avslorer-kreftsvulstens-hemmeligheter/1285532022-01-01T02:57+01:00https://www.healthtalk.no/podcast/ep-3-malrettet-behandling-angriper-kreftens-genetiske-drivere/1285442022-01-01T02:57+01:00https://www.healthtalk.no/podcast/vil-lofte-de-svakeste-og-sette-dem-pa-en-gulltrone/1283152022-01-01T02:57+01:00https://www.healthtalk.no/podcast/kreftprotonsenter-til-3-milliarder-har-gatt-under-radaren/1283102022-01-01T02:57+01:00https://www.healthtalk.no/podcast/norske-sykehus-er-for-sene-med-a-ta-i-bruk-ny-genteknologi-som-diagnostiserer-kreft/1282972022-01-01T02:57+01:00https://www.healthtalk.no/podcast/kunstig-intelligens-finner-farlig-sovnsykdom/1282922022-01-01T02:57+01:00https://www.healthtalk.no/podcast/en-politisk-entreprenor-i-oslos-utstillingsvindu/1282872022-01-01T02:57+01:00https://www.healthtalk.no/podcast/informert-om-helsenaeringsmeldingen-hiv-og-demens/1282822022-01-01T02:57+01:00https://www.healthtalk.no/podcast/24-immunterapi-frigjor-kreftpasienter-fra-frykten-om-tilbakefall/1282612022-01-01T02:57+01:00https://www.healthtalk.no/podcast/23-alle-kan-na-sin-topp/1282562022-01-01T02:57+01:00https://www.healthtalk.no/podcast/20-ehin-2019-na-smelter-persontilpasset-medisin-og-e-helse-sammen/1282432022-01-01T02:57+01:00https://www.healthtalk.no/podcast/19-ehin-2019-kunstig-intelligens-nar-terminator-blir-fastlegen-din/1282382022-01-01T02:57+01:00https://www.healthtalk.no/podcast/18-ehin-2019-roboten-e300-gir-oss-medisin-pa-direkten-i-studio/1282332022-01-01T02:57+01:00https://www.healthtalk.no/podcast/17-ehin-2019-mot-norges-e-helselokomotiv/1282282022-01-01T02:57+01:00https://www.healthtalk.no/podcast-video/16-ehin-2019-na-kan-leger-trygt-dele-bilder-og-video-fra-mobiltelefonen/1282232022-01-01T02:57+01:00https://www.healthtalk.no/podcast/13-ehin-2019-kry-moter-stengte-dorer-men-bare-i-norge/1282102022-01-01T02:57+01:00https://www.healthtalk.no/podcast/11-bedre-helse-med-digital-oppfolging-i-hjemmet/1282012022-01-01T02:57+01:00https://www.healthtalk.no/podcast/10-dan-borge-akero-slik-overvant-jeg-hjerteinfarkten/1281962022-01-01T02:57+01:00https://www.healthtalk.no/podcast/04-viktige-innspill-til-stortingsmeldingen-om-helsenaeringen/1281712022-01-01T02:57+01:00https://www.healthtalk.no/podcast/02-sveinung-stensland-om-helsenaeringen/1281622022-01-01T02:57+01:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/mandag-avgjor-beslutningsforum-om-400-norske-pasienter-med-lungefibrose-skal-fa-ny-medisin/1281382022-06-28T18:06+02:00https://www.healthtalk.no/fhi-dodelig-bakterieutbrudd-pa-sykehusene-er-over/1281312022-06-17T00:00+02:00https://www.healthtalk.no/sykdommer-smitter-i-okende-grad-fra-dyr-til-mennesker-apekopper-og-covid-er-blant-eksemplene/1281222022-06-16T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/nytt-forskningssenter-far-52-millioner-kroner-for-a-gi-diabetespasienter-mer-presis-diagnose-og-behandling/1281152022-06-20T00:00+02:00https://www.healthtalk.no/svaert-fa-med-alkoholproblemer-far-behandling/1281082022-06-15T00:00+02:00https://www.healthtalk.no/kronikk/helsenaeringen-kan-bli-norges-viktigste-naering-i-fremtiden/1280932022-06-17T00:00+02:00https://www.healthtalk.no/coronaviruset/fhi-norge-trolig-pa-vei-inn-i-en-ny-smittebolge/1280772022-06-14T00:00+02:00https://www.healthtalk.no/immunterapi-legemidler-og-biotek/immunterapi-godkjent-i-europa-for-pasienter-med-tidlig-ikke-smacellet-lungekreft/1280682022-06-13T00:00+02:00https://www.healthtalk.no/overraskende-mange-dode-av-hjerte-og-karsykdommer-i-fjor/1280522022-06-09T00:00+02:00https://www.healthtalk.no/37-000-nordmenn-ble-diagnostisert-med-kreft-i-fjor-stor-okning-av-brystkreft/1280472022-06-24T12:38+02:00https://image.healthtalk.no?imageId=159819&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek/gravide-som-gar-pa-epilepsimedisiner-har-okt-risiko-for-a-fa-barn-med-autisme/1280362022-06-07T00:00+02:00https://www.healthtalk.no/politikk/vil-at-stortinget-setter-maksgrense-for-hvor-lenge-legemiddelverket-kan-vente-for-de-starter-metodevurderingene/1280312022-06-24T12:41+02:00https://image.healthtalk.no?imageId=159848&format=webp&width=1200https://www.healthtalk.no/asco-2022-legemidler-og-biotek/enhertu-oker-overlevelsen-dramatisk-for-brystkreftpasienter/1280202022-06-05T00:00+02:00https://www.healthtalk.no/asco-2022-legemidler-og-biotek/asco-anbefaler-at-pasienter-med-oyemelanon-behandles-med-kimmtrak/1280042022-06-04T00:00+02:00https://www.healthtalk.no/hoyre-vil-styrke-fastlegeordningen-med-200-millioner-kroner/1279912022-06-04T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/bristol-myers-squibb-kjoper-turning-point-for-40-milliarder-kroner-for-a-fa-medisiner-rettet-mot-sjeldne-kreftmutasjoner/1279772022-06-04T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/eu-har-godkjent-immunterapi-kombinasjon-for-operasjon-av-trippel-negativ-brystkreft/1279692022-06-03T00:00+02:00https://www.healthtalk.no/vestlig-apekopp-respons-avslorer-markant-forskjellsbehandling-av-afrikanere/1279532022-06-02T00:00+02:00https://www.healthtalk.no/fhi-e-sigaretter-med-nikotin-kan-gi-flere-helseskader-regjeringen-vil-folge-opp-i-en-ny-tobakksstrategi/1279382022-06-01T00:00+02:00https://www.healthtalk.no/kreftforeningen-ber-helseministeren-vurdere-a-outsource-metodevurderingene-og-forskriftsfeste-nar-legemiddelverket-skal-starte-saksbehandlingen/1279322022-06-24T12:49+02:00https://image.healthtalk.no?imageId=159932&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek/car-t-behandling-har-fatt-eu-godkjenning-til-behandling-av-myelomatose/1279252022-05-27T00:00+02:00https://www.healthtalk.no/politikk/frp-far-ikke-flertall-i-stortinget-for-a-avvikle-beslutningsforum-men-enighet-om-behov-for-reform/1279112022-06-27T16:03+02:00https://image.healthtalk.no?imageId=160091&format=webp&width=1200https://www.healthtalk.no/politikk/kan-ga-mot-slutten-for-regelverket-som-sier-at-homofile-menn-i-et-partnerforhold-ikke-far-gi-blod/1278962022-05-24T00:00+02:00https://www.healthtalk.no/politikk/lange-ventelister-i-legemiddelverket-8-nye-legemidler-har-ventet-lengre-enn-180-dager-pa-saksbehandler/1278882022-10-05T15:47+02:00https://www.healthtalk.no/lar-brukere-skal-fa-bestemme-mer-selv/1278622022-06-15T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/her-er-legemidlene-som-beslutningsforum-kan-innfore-pa-mandag/1278482022-05-20T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/lanserer-unikt-privat-offentlig-samarbeid-for-a-fa-flere-kliniske-studier-til-norge/1278412022-05-23T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/rhf-direktorene-vil-ha-mer-effektiv-og-raskere-saksbehandling-av-legemidler/1278342022-05-20T00:00+02:00https://www.healthtalk.no/apekopper-pavist-i-sverige-fhi-folger-situasjonen-noye/1278242022-05-19T00:00+02:00https://www.healthtalk.no/politikk/rapport-stadig-flere-star-uten-fastlege/1278172022-05-19T00:00+02:00https://www.healthtalk.no/podcast/dette-er-podcastene-for-deg-som-er-parorende/1278002022-05-19T00:00+02:00https://www.healthtalk.no/norge-blir-ikke-kvitt-koronavaksiner-ma-kaste-titusener/1277772022-05-13T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/nykode-med-lovende-fase-2-data-pa-avansert-livmorhalskreft/1277642022-05-11T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/pfizer-legger-112-milliarder-kroner-pa-bordet-i-gigantoppkjop-av-migreneselskap/1277512022-05-16T00:00+02:00https://www.healthtalk.no/na-er-det-enighet-om-definisjonen-av-en-intensivseng/1277422022-05-11T00:00+02:00https://www.healthtalk.no/helse-sor-ost-med-stor-pasientpagang-i-barne-og-ungdomspsykiatrien-jobber-for-a-redusere-ventetidene/1277312022-05-13T00:00+02:00https://www.healthtalk.no/podcast/5-helse-podcaster-du-bor-sjekke-ut-om-sjeldne-sykdommer/1277112022-05-10T00:00+02:00https://www.healthtalk.no/sykehus-og-kommune-ilagt-forelegg-pa-12-millioner-etter-at-pasient-dode/1277042022-05-09T00:00+02:00https://www.healthtalk.no/eksem/ny-vaksine-mot-helvetesild-er-na-i-norge/1276892023-12-18T09:59+01:00https://image.healthtalk.no?imageId=101377&format=webp&width=1200https://www.healthtalk.no/ny-styreleder-i-lungekreftforeningen-vil-jobbe-for-at-pasientene-skal-fa-raskere-tilgang-til-legemidler/1276822022-05-04T00:00+02:00https://www.healthtalk.no/politikk/kreftforeningen-krever-strakstiltak-for-pasienter-som-venter-pa-legemidler-som-skal-godkjennes-av-beslutningsforum/1276622022-06-24T12:54+02:00https://image.healthtalk.no?imageId=159968&format=webp&width=1200https://www.healthtalk.no/47-pasienter-far-erstatning-for-behandling-av-tiltalt-overlege/1276352022-04-27T00:00+02:00https://www.healthtalk.no/politikk/uakseptabelt-at-legemiddelverkets-effektiviseringstiltak-oker-tiden-det-tar-a-innfore-nye-legemidler-i-norge/1276192022-04-28T00:00+02:00https://www.healthtalk.no/coronaviruset/koronakomisjoen-samlet-sett-god-handtering-av-pandemien-men-barn-og-unge-ble-hardt-rammet/1276032022-04-26T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/biogen-trekker-eu-soknaden-for-alzheimerlegemiddel/1275962022-04-26T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/innforer-omstridt-legemiddel-for-behandling-av-cystisk-fibrose/1275742022-06-24T13:11+02:00https://image.healthtalk.no?imageId=160088&format=webp&width=1200https://www.healthtalk.no/studie-vazkepa-reduserer-risiko-for-alvorlige-kardiovaskulaere-hendelser-hos-pci-pasienter/1275662022-04-26T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/eu-godkjenner-presisjonslegemidlet-padcev-til-behandling-av-blaerekreft/1275522022-04-27T00:00+02:00https://www.healthtalk.no/politikk/presidenten-i-legeforeningen-ikke-godt-nok-at-norge-bruker-nesten-tre-ganger-lengre-tid-pa-a-ta-i-bruk-nye-legemidler-enn-danmark/1275402022-06-27T16:06+02:00https://image.healthtalk.no?imageId=160094&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek/statssekretaer-det-bor-absolutt-vaere-mulig-a-redusere-tiden-det-tar-a-godkjenne-nye-legemidler/1275332022-06-27T16:11+02:00https://image.healthtalk.no?imageId=160097&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek/bruken-av-smertestillende-legemidler-har-okt-kraftig/1275262022-04-21T00:00+02:00https://www.healthtalk.no/ny-nho-forening-samler-aktorer-innen-helse-legemidler-barnehager-og-omsorg/1275182022-04-18T00:00+02:00https://www.healthtalk.no/influensabolgen-fortsetter-a-vokse/1275042022-04-14T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/verzenios-far-eu-godkjenning-som-tilleggsbehandling-etter-operasjon-av-pasienter-med-tidlig-hoyrisiko-brystkreft/1274862022-04-19T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/eu-godkjenner-immunterapi-til-behandling-av-pasienter-som-er-operert-for-blaerekreft/1274672022-04-11T00:00+02:00https://www.healthtalk.no/helse/ny-genterapi-mot-leukemi-skal-snart-testes-pa-mennesker/1274582024-06-26T12:06+02:00https://www.healthtalk.no/jobb-karriere/kristin-svanqvist-gar-fra-amgen-til-merck/1274362022-05-03T00:00+02:00https://www.healthtalk.no/digitallegen-eyr-gar-inn-i-sverige-med-et-ess-i-ermet/1274232022-04-07T00:00+02:00https://www.healthtalk.no/osteopater-naprapater-og-paramedisinere-kan-soke-om-autorisasjon-som-helsepersonell/1274032022-04-06T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/over-halvparten-vet-ikke-at-de-bor-friske-opp-vaksiner-i-voksen-alder/1273942022-04-08T00:00+02:00https://www.healthtalk.no/alle-svensker-over-65-ar-tilbys-en-fjerde-vaksinedose/1273692022-04-04T00:00+02:00https://www.healthtalk.no/politikk/aksjon-krever-folkeavstemning-om-ulleval-sykehus/1273492022-04-04T00:00+02:00https://www.healthtalk.no/blodkreft/norske-forskere-har-behandlet-den-forste-leukemipasienten-med-funksjonell-presisjonsmedisin/1273322022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/refuel-studien-onsker-a-finne-ut-om-livsstilsendringer-pavirker-kronisk-fatigue/1273252022-04-19T00:00+02:00https://www.healthtalk.no/blodkreft/annen-kreftbehandling-oker-risikoen-for-akutt-myelogen-leukemi/1273132022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/ny-studie-pa-seneffekter-etter-kreftbehandling/1273062022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/proteinet-galectin-1-kan-vaere-nokkelen-til-a-utvikle-nye-legemidler/1272872022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/blodkreftsykdommen-som-kan-gjore-blodet-tykt-og-seigt/1272782022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/toff-behandling-transplantasjon-oker-toksisiteten/1272572022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/revlimid-gar-av-patent-og-tas-i-bruk-flere-ar-for-sent-mener-kreftforeningen/1272462022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft-legemidler-og-biotek-blodkreft/gront-lys-for-car-t-behandling-av-benmargskreft-i-eu-men-vil-beslutningsforum-si-ja/1272362022-04-04T00:00+02:00https://www.healthtalk.no/helseministeren-utbyggingen-av-sykehus-pa-gaustad-og-aker-gar-som-planlagt/1272282022-04-01T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/malrettet-radioaktivt-legemiddel-godkjent-for-behandling-av-avansert-prostatakreft/1272072022-03-31T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/fda-har-godkjent-ny-type-immunterapi-til-behandling-av-pasienter-med-avansert-foflekkreft-studie-pagar-i-norge/1271992022-03-30T00:00+02:00https://www.healthtalk.no/blodkreft-legemidler-og-biotek-blodkreft/polivy-anbefales-som-forstelinjebehandling-av-lymfom/1271882022-03-29T00:00+02:00https://www.healthtalk.no/flyktninger-kan-fa-tuberkulose-undersokelse-raskere-etter-nytt-lovforslag/1271812022-03-28T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/nye-data-underbygger-lynparzas-effekt-pa-behandling-av-brystkreft-i-tidlig-stadium/1271642022-03-28T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/stopper-nyrestudie-med-sglt2-hemmer-pa-grunn-av-stor-effekt/1271572022-03-22T00:00+01:00https://www.healthtalk.no/helseteknologi/google-oyner-et-stort-marked-for-medisinsk-programvare-inngar-avtale-med-ledende-journalleverandor/1271502022-03-24T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/fire-nei-og-to-ja-i-dagens-mote-i-beslutningsforum/1271412022-03-21T00:00+01:00https://www.healthtalk.no/kliniske-studier/rekordmange-nye-kliniske-studier-pa-sykehusene-men-langt-igjen-til-regjeringens-mal/1271292022-03-21T00:00+01:00https://www.healthtalk.no/coronaviruset/moderna-soker-om-godkjennelse-for-en-fjerde-vaksinedose-i-usa/1271222022-03-18T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/usa-godkjenner-lynparza-til-pasienter-med-arvelig-brystkreft-i-tidlig-stadium/1270872022-03-15T00:00+01:00https://www.healthtalk.no/coronaviruset/to-ar-siden-pandemien-traff-norge-na-handteres-en-ny-krise/1270792022-03-13T00:00+01:00https://www.healthtalk.no/kreft/tarmfloraen-kan-snart-avslore-dodelig-kreft-i-bukspyttkjertelen/1270712023-12-18T10:10+01:00https://image.healthtalk.no?imageId=104358&format=webp&width=1200https://www.healthtalk.no/pasient-som-fikk-banebrytende-hjertetransplantasjon-dor-etter-to-maneder/1270632022-03-09T00:00+01:00https://www.healthtalk.no/jobb-karriere/stein-gunnar-bondevik-blir-ny-kommunikasjonsdirektor-i-helsedirektoratet/1270562022-03-10T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/jardiance-far-bred-hjertesviktindikasjon-i-et-sjeldent-gjennombrudd-i-vart-fag/1270362022-03-10T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-kliniske-studier/norske-forskere-har-behandlet-den-forste-leukemipasienten-med-funksjonell-presisjonsmedisin/1270192022-03-09T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/immunterapi-i-kombinasjon-med-kjemoterapi-naermer-seg-godkjenning-som-forstelinjebehandling-av-avansert-spiserorskreft/1270042022-03-03T00:00+01:00https://www.healthtalk.no/jobb-karriere/grete-herlofson-blir-ny-generalsekretaer-i-redningsselskapet/1269972022-03-02T00:00+01:00https://www.healthtalk.no/stor-okning-i-unges-bruk-av-antidepressiva/1269802022-03-01T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/ny-genterapi-tilbys-barn-i-storbritannia-snart-starter-fellesnordiske-prisforhandlinger-som-avgjor-om-behandlingen-skal-tilbys-norske-barn/1269722022-03-07T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/ema-godkjenner-legemiddel-mot-oyekreft-og-12-andre-nye-legemidler/1269642022-03-01T00:00+01:00https://www.healthtalk.no/helseteknologi/hun-har-laget-et-diagnostisk-verktoy-som-oppdager-oversett-kvinnesykdom-na-testes-den-i-en-studie-pa-fem-sykehus/1269552022-02-27T00:00+01:00https://www.healthtalk.no/asco-gu-legemidler-og-biotek/lynparza-pluss-abirateron-oker-tid-til-sykdomsprogresjon-for-pasienter-med-prostatakreft/1269482022-02-23T00:00+01:00https://www.healthtalk.no/helseteknologi/ny-digital-poliklinikk-har-fatt-sine-forste-pasienter/1269312022-02-21T00:00+01:00https://www.healthtalk.no/ambulanseflyene-med-et-underskudd-pa-132-millioner-kroner-men-na-forventer-babcock-bedring/1269222022-02-17T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/pfizers-nye-pneumokokkvaksine-er-godkjent-na-skal-fhi-utrede-hvem-som-skal-fa-vaksinen/1269142022-02-18T00:00+01:00https://www.healthtalk.no/coronaviruset/fhi-kvinner-har-hoyere-risiko-for-senskader-ved-koronasykdom/1269002022-02-15T00:00+01:00https://www.healthtalk.no/coronaviruset/studie-ostrogen-kan-beskytte-mot-alvorlig-koronasykdom/1268872022-02-15T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-innforer-cibinqo-til-behandling-av-alvorlig-atopisk-eksem/1268802022-02-15T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/beslutningsforum-innforer-fem-legemidler-til-behandling-av-pasienter-med-covid-19/1268652022-02-14T00:00+01:00https://www.healthtalk.no/helseteknologi/christen-sveaas-gar-inn-med-55-millioner-i-hjemmelegene/1268452022-02-11T00:00+01:00https://www.healthtalk.no/vil-bygge-ut-sykehuset-ostfold-kalnes-med-somatikkbygg-og-straleterapienhet-prislappen-er-over-500-millioner/1268372022-02-11T00:00+01:00https://www.healthtalk.no/helse-sor-ost-gir-sykehusene-400-millioner-kroner-i-koronakompensasjon/1268282022-02-10T00:00+01:00https://www.healthtalk.no/bransjenytt-jobb-karriere/bjorn-egil-vikse-er-den-nye-fagdirektoren-i-helse-vest/1268032022-02-09T00:00+01:00https://www.healthtalk.no/jobb-karriere/to-nye-toppledere-pa-plass-i-sykehusinnkjop/1267962022-02-08T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/de-nordiske-landene-undersoker-mulighetene-for-vaksineproduksjon/1267742022-02-06T00:00+01:00https://www.healthtalk.no/helse-kan-bli-den-tredje-store-norske-eksportnaeringen-men-da-ma-norge-bli-bedre-til-a-tiltrekke-seg-investeringer-fra-legemiddelindustrien/1267622022-02-07T00:00+01:00https://www.healthtalk.no/benskjorhet/nytt-beinbyggende-legemiddel-mot-beinskjorhet-har-fatt-refusjon/1267382023-12-18T09:55+01:00https://image.healthtalk.no?imageId=105380&format=webp&width=1200https://www.healthtalk.no/forskning/storsatsing-pa-regenerativ-medisin/1267122022-02-01T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/chmp-anbefaler-at-jardiance-far-utvidet-indikasjon-for-behandling-av-voksne-med-kronisk-hjertesvikt/1267012022-02-01T00:00+01:00https://www.healthtalk.no/podcast/ny-podcast-blodkreftsykdommen-som-kan-gjore-blodet-tykt-og-seigt/1266922022-02-03T00:00+01:00https://www.healthtalk.no/politikk/legeforeningen-avblaser-blareseptaksjonen-helseministeren-har-svart-oss/1266682022-01-28T00:00+01:00https://www.healthtalk.no/politikk/leger-risikerer-boter-for-feil-utskriving-av-bla-resept-na-vil-kjerkol-endre-reglene/1266602022-01-27T00:00+01:00https://www.healthtalk.no/politikk/legeforeningen-ser-rodt-ber-legene-begrense-blareseptforskrivningen/1266422022-01-26T00:00+01:00https://www.healthtalk.no/nye-redningshelikoptre-kan-kun-lande-pa-sju-av-femti-akuttsykehus/1266342022-01-27T00:00+01:00https://www.healthtalk.no/politikk/helsenaeringen-kan-bli-en-av-de-viktigste-norske-vekstnaeringene-fremover/1266272022-01-26T00:00+01:00https://www.healthtalk.no/helse-vest-suspenderer-to-vikarbyraer/1266202022-01-25T00:00+01:00https://www.healthtalk.no/helseteknologi/ibm-selger-genierklaerte-doktor-watson/1266132022-01-25T00:00+01:00https://www.healthtalk.no/coronaviruset/legenes-nye-vapen-slik-behandler-de-covid-19/1266032022-01-23T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/sjefen-i-norges-mest-verdifulle-biotekselskap-mener-vi-bor-hylle-grnderne-som-gar-konkurs/1265912022-01-24T00:00+01:00https://www.healthtalk.no/politikk/lederen-av-stortingets-helse-og-omsorgskomit-vil-ikke-akseptere-at-norske-pasienter-far-tilgang-til-medisiner-senere-enn-i-andre-land/1265832022-01-20T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/advarer-mot-et-a-lag-og-et-b-lag-i-helsevesenet-jeg-blir-sa-sint-og-fortvilet/1265732022-01-19T00:00+01:00https://www.healthtalk.no/beslutningsforum-brystkreft-legemidler-og-biotek/liv-ekeberg-moen-57-har-uhelbredelig-brystkreft-na-far-hun-behandlingen-som-beslutningsforum-sa-nei-til-betalt-av-helseforsikringen/1265622022-09-01T09:40+02:00https://image.healthtalk.no?imageId=104289&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-godkjenner-evrysdi-til-sma-barn-mellom-2-maneder-og-18-ar-beslutter-om-voksne-skal-fa-behandling-i-lopet-av-varen/1265532022-01-17T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sa-ja-til-alle-10-metoder-innforer-immunterapi-for-tarmkreft-og-behandling-for-barn-opp-til-18-ar-med-alvorlig-arvelig-muskelsykdom/1265462022-01-17T00:00+01:00https://www.healthtalk.no/datasystem-ute-av-drift-pa-oslo-universitetssykehus-har-satt-kriseledelse/1265292022-01-15T00:00+01:00https://www.healthtalk.no/helsedepartementet-barn-mellom-5-og-11-ar-tilbys-vaksine/1265152022-01-14T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/regjeringen-vil-bruke-fem-milliarder-kroner-pa-koronatest-kjop/1265082022-01-13T00:00+01:00https://www.healthtalk.no/helseteknologi/helse-sor-ost-kjoper-ny-teknologi-som-skal-gi-pasienter-og-helsepersonell-digitale-losninger-raskere/1264992022-01-13T00:00+01:00https://www.healthtalk.no/politikk/kraftige-reaksjoner-pa-at-kjerkol-vil-skrote-fritt-behandlingsvalg/1264802022-01-11T00:00+01:00https://www.healthtalk.no/politikk/regjeringen-vil-gi-15-milliarder-kroner-i-ekstra-stotte-til-sykehusene/1264732022-01-11T00:00+01:00https://www.healthtalk.no/politikk/hoye-forventninger-til-kjerkols-sykehustale-en-sektor-med-betydelig-endringsbehov-og-stort-handlingsrom-streames-live-her-kl-1300/1264662022-01-11T00:00+01:00https://www.healthtalk.no/coronaviruset/ingen-friske-og-fullvaksinerte-pa-respirator-i-helse-vest-de-siste-manedene/1264532022-01-10T00:00+01:00https://www.healthtalk.no/politikk/na-innfores-gebyr-for-regelstridig-forskriving-av-legemidler/1264462022-01-07T00:00+01:00https://www.healthtalk.no/oslo-apner-for-vaksine-drop-in-for-alle-mellom-18-og-44-ar/1264312022-01-05T00:00+01:00https://www.healthtalk.no/barn-under-16-ar-kan-na-fa-prevensjon-fra-helsesykepleier/1264242022-01-04T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/forskere-haper-at-nye-proteinbaserte-korona-vaksiner-gir-lengre-antistoffbeskyttelse-enn-mrna-vaksinen/1264152022-01-04T00:00+01:00https://www.healthtalk.no/coronaviruset/akutt-plassmangel-pa-sykehus-i-stockholm-samtlige-dognplasser-er-i-bruk/1263962022-01-02T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-podcast/ny-podcast-proteinet-galectin-1-kan-vaere-nokkelen-til-a-utvikle-nye-legemidler/1263862022-01-10T00:00+01:00https://www.healthtalk.no/helse-sor-ost-far-55-nye-intensivsykepleiere-fra-nyttar/1263782021-12-30T00:00+01:00https://www.healthtalk.no/politikk/forbund-krever-100000-mer-i-lonn-til-intensivsykepleiere/1263502021-12-26T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/nytt-malrettet-legemiddel-mot-lungekreft-far-klarsignal/1263352021-12-23T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/biogens-alzheimerlegemiddel-far-nei-i-europa/1263162021-12-21T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/norge-sa-nei-sverige-innforer-ny-presisjonsmedisin-til-pasienter-med-aggressiv-brystkreft/1262942021-12-20T00:00+01:00https://www.healthtalk.no/politikk/ny-kommisjon-skal-se-pa-bemanningen-i-helsevesenet-de-neste-20-arene/1262852021-12-17T00:00+01:00https://www.healthtalk.no/ash-ash-2021-ash2021/ash-2021-polivy-kombinasjon-gir-okt-progresjonsfri-overlevelse-hos-nydiagnostiserte-med-diffust-storcellet-b-celle-lymfom/1262562022-11-15T09:22+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/norge-far-koronamedisinen-lagevrio-for-jul/1262332021-12-15T00:00+01:00https://www.healthtalk.no/coronaviruset/faerre-blir-operert-ved-sykehusene-i-helse-sor-ost/1262252021-12-15T00:00+01:00https://www.healthtalk.no/coronaviruset/sorafrikanske-studier-to-pfizer-doser-gir-70-prosent-beskyttelse-mot-omikron/1262082021-12-14T00:00+01:00https://www.healthtalk.no/coronaviruset/over-halvparten-av-de-sykeste-koronapasientene-i-helse-sor-ost-er-uvaksinerte/1262012021-12-14T00:00+01:00https://www.healthtalk.no/coronaviruset/helseministeren-vedgar-for-lavt-vaksinetempo/1261872021-12-13T00:00+01:00https://www.healthtalk.no/coronaviruset/fhi-slar-alarm-venter-betydelig-okt-smittespredning/1261802021-12-13T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/norske-kreftpasienter-kan-for-forste-gang-behandles-med-et-tumoragnostisk-legemiddel/1261692021-12-13T00:00+01:00https://www.healthtalk.no/coronaviruset/eu-avgjorelse-om-ny-koronavaksine-kommer-i-lopet-av-noen-uker/1261222021-12-09T00:00+01:00https://www.healthtalk.no/coronaviruset/ema-sa-langt-fremstar-omikrontilfellene-i-hovedsak-som-milde/1261152021-12-09T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-forskning/ny-storsatsing-tre-nye-sentre-skal-drive-klinisk-forskning-pa-kreft-revmatisme-og-hodepine-i-verdensklasse/1260842021-12-07T00:00+01:00https://www.healthtalk.no/rekordlav-dodelighet-i-nyfodtperioden/1260692021-12-07T00:00+01:00https://www.healthtalk.no/coronaviruset/fhi-sammensatt-arsak-til-overrepresentasjon-av-koronasmittede-i-noen-innvandrergrupper/1260462021-12-06T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/transplanterte-som-far-potensielt-dodelig-virusinfeksjon-ma-vente-minst-to-ar-pa-ny-medisin-det-er-for-lang-tid-mener-infeksjonsmedisiner/1260352021-12-06T00:00+01:00https://www.healthtalk.no/helse-og-livsstil/svensk-studie-hoy-hvilepuls-er-forbundet-med-okt-risiko-for-demens/1260272021-12-07T00:00+01:00https://www.healthtalk.no/coronaviruset/leger-varsler-om-at-kommuner-ma-avbestille-vaksinedoser/1260142021-12-04T00:00+01:00https://www.healthtalk.no/fdas-ekspertpanel-anbefaler-den-forste-antivirale-koronapillen-med-knapp-margin/1260072021-12-02T00:00+01:00https://www.healthtalk.no/coronaviruset/forskere-mener-a-ha-funnet-arsak-til-blodpropper-knyttet-til-koronavaksine/1260002021-12-02T00:00+01:00https://www.healthtalk.no/bransjenytt-jobb-karriere/gro-bogen-nilsen-forlater-merck-og-blir-ny-kommunikasjonsdirektor-i-aleris/1259922021-12-02T00:00+01:00https://www.healthtalk.no/nyheter-og-politikk/gar-i-partnerskap-med-persontilpassede-kreftstudier-i-norden-og-nederland/1259842024-06-26T12:18+02:00https://image.healthtalk.no?imageId=108959&format=webp&width=1200https://www.healthtalk.no/stort-press-pa-haukeland-universitetssjukehus-har-redusert-kirurgi-med-20-prosent/1259772021-12-01T00:00+01:00https://www.healthtalk.no/coronaviruset/fhi-anbefaler-kjop-av-koronapiller/1259632021-11-30T00:00+01:00https://www.healthtalk.no/coronaviruset/regjeringen-innforer-nye-koronatiltak-for-a-begrense-omikron-smitten/1259562021-11-29T00:00+01:00https://www.healthtalk.no/stoltenberg-vi-bor-vaere-bekymret/1259482021-11-29T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/forskningsradet-trekker-stotte-til-norsk-vaksinefabrikk/1259412021-11-29T00:00+01:00https://www.healthtalk.no/coronaviruset/who-kan-vaere-okt-fare-for-reinfeksjon-med-omikron/1259342021-11-28T00:00+01:00https://www.healthtalk.no/line-vold-blir-ekspedisjonssjef-i-helse-og-omsorgsdepartementet/1259222021-11-27T00:00+01:00https://www.healthtalk.no/coronaviruset/fhi-barn-over-fem-ar-med-alvorlig-sykdom-vil-bli-tilbudt-koronavaksine/1259142021-11-26T00:00+01:00https://www.healthtalk.no/coronaviruset/biontech-utvikler-ny-koronavaksine-kan-vaere-klar-i-lopet-av-seks-uker/1259072021-11-26T00:00+01:00https://www.healthtalk.no/coronaviruset/trondheim-og-st-olav-innforer-pabud-om-munnbind/1259002021-11-24T00:00+01:00https://www.healthtalk.no/coronaviruset/msds-koronapille-kan-bli-godkjent-i-europa-for-jul/1258932021-11-24T00:00+01:00https://www.healthtalk.no/coronaviruset/flertall-i-tyskland-for-vaksinepabud/1258862021-11-24T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/amerikanske-apotekkjeder-ma-betale-erstatning-for-storstilt-salg-av-opioider/1258792021-11-24T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/blareseptanbud-kan-spare-600-millioner-arlig-legemiddeltopp-ber-helseministeren-bruke-pengene-til-a-gi-flere-pasienter-behandling-med-innovative-legemidler/1258682021-11-30T00:00+01:00https://www.healthtalk.no/forskning-podcast/ny-podcast-knut-smeland-er-arets-unge-kreftforsker/1258612021-11-24T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/vaccibody-inngar-milliardavtale-med-regeneron-og-bytter-navn/1258462021-11-23T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sier-nei-til-a-innfore-presisjonsmedisinen-enhertu-til-pasienter-med-aggressiv-brystkreft/1258282021-11-22T00:00+01:00https://www.healthtalk.no/koronapille-kan-anvendes-til-nodbruk-i-norge/1258202021-11-20T00:00+01:00https://www.healthtalk.no/skal-bruke-norske-helsedata-for-a-lage-avatarer-til-kliniske-studier/1258112021-11-19T00:00+01:00https://www.healthtalk.no/podcast/podcast-lederen-i-norsk-onkologisk-forening-tannlos-evaluering-av-beslutingsforum/1258042021-11-19T00:00+01:00https://www.healthtalk.no/onkologisk-forum-21-professor-emerita-sophie-fossa-80-forsker-og-formidler-gjennom-50-ar/1257952021-11-18T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/biogens-alzheimerlegemiddel-far-neppe-europeisk-markedsforingstillatatelse/1257832021-11-22T00:00+01:00https://www.healthtalk.no/foreslar-at-apotekene-skal-fa-sette-koronavaksiner-ogsa-i-2022/1257702021-11-17T00:00+01:00https://www.healthtalk.no/coronaviruset/pfizer-inngar-global-lisensavtale-for-sin-antivirale-koronapille/1257632021-11-16T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/fa-store-forskjeller-blant-sykehusene-i-kreftbehandlingen-men-det-er-ett-viktig-unntak/1257412021-11-18T00:00+01:00https://www.healthtalk.no/helt-fullt-pa-intensiven-pa-ahus-og-smitterekord-i-bergen/1257342021-11-16T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/demens-dobbelt-sa-mange-rammes-om-20-ar/1257252021-11-16T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/norske-selskaper-gar-sammen-for-a-trenge-inn-i-det-amerikanske-helsemarkedet/1257112021-11-17T00:00+01:00https://www.healthtalk.no/coronaviruset/regjeringen-innforer-nye-nasjonale-tiltak/1257032021-11-12T00:00+01:00https://www.healthtalk.no/coronaviruset/faglig-uenighet-i-fhi-om-behovet-for-tredje-dose-til-personer-under-65-ar/1256962021-11-12T00:00+01:00https://www.healthtalk.no/coronaviruset/ansatte-pa-sykehusene-i-helse-sor-ost-far-tredje-vaksinedose/1256892021-11-11T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/lungekreftpasienter-far-okt-respons-nar-kras-hemmer-kombineres-med-immunterapi/1256732021-11-11T00:00+01:00https://www.healthtalk.no/coronaviruset/fhi-epidemien-fortsetter-a-oke-i-omfang-vurderer-nye-tiltak/1256652021-11-10T00:00+01:00https://www.healthtalk.no/coronaviruset/kjerkol-vil-folge-opp-rad-om-tiltak-raskt-nar-de-kommer/1256512021-11-09T00:00+01:00https://www.healthtalk.no/helse-og-livsstil/flere-unge-sliter-med-sovnen-og-bruker-sovemedisiner/1256312021-11-09T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/pfizers-koronapille-er-89-prosent-effektiv-mot-sykdom-og-dod/1256172021-11-05T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/immunterapi-far-gront-lys-som-forstelinjebehandling-av-avansert-kreft-i-magesekken-i-kombinasjon-med-kjemoterapi/1256092021-11-05T00:00+01:00https://www.healthtalk.no/flere-er-mer-fornoyde-med-helsetjenestene-ogsa-fastlegeordningen/1255772021-11-03T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/glede-og-skuffelse-nar-danmark-innforer-nytt-legemiddel-til-barn-med-arvelige-muskelsykdom-ny-spenning-for-beslutningsforums-mote/1255662021-11-04T00:00+01:00https://www.healthtalk.no/artie-artrieflimmer-hjerte/3000-nordmenn-far-blodpropp-i-hjernen-hvert-ar-som-folge-av-hjerteflimmer-artrieflimmer/1255562021-11-09T00:00+01:00https://www.healthtalk.no/coronaviruset/cdc-radgivere-anbefaler-covid-19-vaksine-til-barn-i-alderen-5-11-ar/1255482021-11-02T00:00+01:00https://www.healthtalk.no/coronaviruset/koronautbrudd-pa-ahus-oker-driftssituasjonen-er-krevende/1255412021-11-02T00:00+01:00https://www.healthtalk.no/pfizer-fortsetter-a-oke-overskuddet/1255342021-11-02T00:00+01:00https://www.healthtalk.no/coronaviruset/st-olavs-hospital-hever-beredskapen-til-gult-niva/1255262021-11-02T00:00+01:00https://www.healthtalk.no/bransjenytt/robot-apnet-eitri-helseinkubator-malet-er-a-eksportere-helseforskning-for-milliarder-fra-vestlandet/1255192021-11-02T00:00+01:00https://www.healthtalk.no/politikk/faerre-private-sykehjemsplasser/1255112021-11-01T00:00+01:00https://www.healthtalk.no/stor-pagang-av-akuttpasienter-ahus-innforer-ekstratiltak/1255032021-11-01T00:00+01:00https://www.healthtalk.no/bransjenytt-jobb-karriere/cecilie-roksvag-er-ny-leder-i-diabetesforbundet/1254962021-10-31T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/nettapoteket-farmasiet-dobler-bade-omsetning-og-underskudd/1254802021-11-01T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/msd-gir-gront-lys-for-at-legemiddelprodusenter-i-fattige-land-produserer-deres-covid-19-pille/1254702021-10-29T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/schizofrenipasienter-som-kutter-medisinene-har-hoyere-risiko-for-a-do/1254622021-10-28T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/immunterapi-far-markedsforingstillatelse-for-behandling-av-trippel-negativ-brystkreft/1254462021-10-27T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sa-nei-na-kan-hjertepasientene-fa-behandling-pa-et-privat-sykehus/1254332021-10-26T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/sier-ja-til-genterapi-for-nyfodte-for-forste-gang-ma-et-legemiddelselskap-betale-tilbake-penger-dersom-legemidlet-ikke-virker/1254212021-10-25T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-avgjor-na-om-verdens-dyreste-legemiddel-skal-tilbys-norske-spedbarn/1254032021-10-22T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/for-forste-gang-er-immunterapi-godkjent-for-a-behandle-kvinner-med-nyoppdaget-livmorhalskreft/1253622021-10-19T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-forskning/kongen-tildelte-bjorn-tore-gjertsen-kreftforskningspris/1253532021-10-18T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/bente-hayes-er-ny-administrerende-direktor-i-sykehusinnkjop/1253462021-10-18T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/ultimovacs-tester-ut-prostakreftvaksine-utviklet-pa-ny-kreftvaksineplattform/1253322021-10-20T00:00+02:00https://www.healthtalk.no/psykologspesialist-om-kongsberg-drapene-mindre-tvangsbehandling-kan-fore-til-vold/1253252021-10-18T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/ultimovacs-med-lovende-2-ars-overlevelsesdata-80-prosent-av-pasientene-lever-etter-2-ar/1253052021-10-14T00:00+02:00https://www.healthtalk.no/politikk/store-endringer-dette-blir-store-regjeringens-nye-helsepolitikk/1252982021-10-13T00:00+02:00https://www.healthtalk.no/politikk/sp-fikk-ikke-ap-med-pa-a-redde-ulleval-sykehus/1252872021-10-13T00:00+02:00https://www.healthtalk.no/statsbudsjettet-2022/apotekkutt-pa-100-millioner-kroner-vil-gi-pasientene-darligere-tilbud/1252692021-10-12T00:00+02:00https://www.healthtalk.no/politikk-statsbudsjettet-2022/legeforeningen-skuffet-over-regjeringens-satsing-pa-fastlegeordningen/1252622021-10-12T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-statsbudsjettet-2022/kvinner-som-ikke-har-testet-seg-for-livmorhalskreft-pa-8-10-ar-far-tilbud-om-hjemmetest/1252542021-10-12T00:00+02:00https://www.healthtalk.no/coronaviruset/eus-legemiddelbyra-vurderer-ny-koronamedisin/1252352021-10-12T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/oddbjorn-tysnes-gar-av-som-direktor-for-naeringspolitikk-i-apotekforeningen/1252012021-10-12T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/fda-mener-enhertu-kan-vaere-et-gjennombrudd-i-behandlingen-av-her2-positiv-brystkreft/1251922021-10-13T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/msd-soker-nodgodkjenning-for-covid-pille/1251842021-10-11T00:00+02:00https://www.healthtalk.no/legemiddelfirmaene-ville-ikke-gi-mer-rabatt-beslutningsforum-sier-nei-til-tre-hoyeffektive-ms-legemidler/1251762021-09-27T00:00+02:00https://www.healthtalk.no/esmo-2021-hoydepunktene-legemidler-og-biotek/studien-er-et-argument-for-at-ogsa-pasienter-med-foflekkreft-som-ikke-har-spredd-seg-bor-fa-immunterapi-etter-operasjon/1251652021-09-27T00:00+02:00https://www.healthtalk.no/esmo-2021-hoydepunktene-legemidler-og-biotek/immunterapien-har-imponerende-effekt-pa-pasienter-med-livmorhalskreft-som-har-kort-tid-igjen-a-leve-kreftlegen-mener-dette-vil-endre-hvordan-vi-behandler-pasientene/1251482021-09-24T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/spurkland-vinner-prestisjetung-pris/1251342021-09-22T00:00+02:00https://www.healthtalk.no/coronaviruset/ni-positive-koronaprover-pavist-hos-ansatte-pa-oslo-universitetssykehus/1251172021-09-21T00:00+02:00https://www.healthtalk.no/esmo-2021-forskning/pasienter-med-sjelden-kreft-i-fordoyelsessystemet-kan-fa-hjelp-med-persontilpasset-medisin/1250852021-09-22T00:00+02:00https://www.healthtalk.no/esmo-2021-legemidler-og-biotek/ny-intensiv-kombinasjonsbehandling-med-eksisterende-legemidler-oker-overlevelsen-hos-pasienter-med-prostatakreft/1250722021-09-20T00:00+02:00https://www.healthtalk.no/esmo-2021-forskning/norsk-studie-stralebehandling-av-hele-hjernen-bor-forbeholdes-yngre-pasienter/1250642021-09-20T00:00+02:00https://www.healthtalk.no/esmo-2021-legemidler-og-biotek/5-arsdata-viser-langvarig-overlevelsesfordel-for-nyrekreftpasienter-med-darlig-prognose-som-behandles-med-opdivo-yervoy/1250572021-09-19T00:00+02:00https://www.healthtalk.no/esmo-2021-legemidler-og-biotek/amgen-gar-for-fase-3-studie-med-kras-kombinasjon-etter-lovende-tarmkreftresultater/1250442021-09-18T00:00+02:00https://www.healthtalk.no/esmo-2021-legemidler-og-biotek/praksisendrende-studie-immunterapi-oker-overlevelsen-for-pasienter-med-livmorhalskreft/1250272021-09-18T00:00+02:00https://www.healthtalk.no/esmo-2021-legemidler-og-biotek/immunterapi-etter-operasjon-reduserer-risikoen-for-tilbakefall-hos-pasienter-med-foflekkreft-uten-spredning/1250182021-09-18T00:00+02:00https://www.healthtalk.no/esmo-2021-legemidler-og-biotek/trearsdata-viser-at-opdivo-sammen-med-yervoy-forbedrer-overlevelsen-til-pasienter-med-brysthinnekreft/1250052021-09-17T00:00+02:00https://www.healthtalk.no/forskning/det-tok-forskerne-20-ar-a-motbevise-etablert-sannhet-om-immunforsvaret/1249932021-10-01T00:00+02:00https://www.healthtalk.no/politikk/sv-regner-det-som-sikkert-at-store-redder-ulleval-sykehus/1249852021-09-15T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/to-nye-ledere-ved-sykehuset-ostfold/1249772021-09-15T00:00+02:00https://www.healthtalk.no/politikk/jonas-gahr-store-ap-na-kan-vi-endelig-si-vi-klarte-det/1249702021-09-13T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/30-norske-pasienter-med-i-internasjonal-studie-cellegift-oker-progresjonsfri-overlevelse-for-myelomatosepasienter/1249572021-09-15T00:00+02:00https://www.healthtalk.no/esmo-2021-kreftforskning-legemidler-og-biotek/dette-er-hoydepunktene-du-ma-fa-med-deg-under-arets-esmo/1249412021-09-14T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/scr2021-dette-er-de-viktigste-leddgiktstudiene-na/1249322021-09-13T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/photocure-utnevner-anders-neijber-til-konserndirektor-for-global-medical-affairs-og-clinical-development/1249252021-09-13T00:00+02:00https://www.healthtalk.no/helseteknologi-forebygging/vil-gi-nyfodte-bedre-helsehjelp-med-varmekameraer-og-kunstig-intelligens/1248932021-10-05T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/eu-godkjenner-evrenzo-til-behandling-av-anemi-hos-voksne-med-kronisk-nyresvikt-na-er-det-opp-til-beslutningsforum/1248842021-09-09T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/terje-rootwelt-er-ny-administrerende-direktor-i-helse-sor-ost/1248772021-09-07T00:00+02:00https://www.healthtalk.no/jordmodre-varsler-om-krise-pa-fodeavdelingene-flere-slutter/1248702021-09-07T00:00+02:00https://www.healthtalk.no/ablasjon-helseteknologi-hjerteflimmer/esc-oppsummert-er-screening-av-hjerteflimmer-en-darlig-id/1248452021-09-06T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/gunnar-morne-gar-fra-sopra-steria-til-medtronic/1248382021-09-07T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/kreftoverlegen-er-glad-for-at-han-na-kan-gi-blaerekreftpasientene-immunterapi-for-kreften-kommer-tilbake/1248332021-09-06T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/kreftforskningsprisen-til-bjorn-tore-gjertsen/1248252021-09-02T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/200000-kvinner-i-norge-har-ikke-tatt-livmorhalsprove-pa-ti-ar-eller-mer/1248172021-09-02T00:00+02:00https://www.healthtalk.no/esc-oppsummert-legemidler-og-biotek-kliniske-studier/esc-oppsummert-den-forste-studien-med-effekt-pa-hjertesviktpasienter-med-bevart-hjertepumpefunksjon-hfpef/1248032021-09-02T00:00+02:00https://www.healthtalk.no/esc2021-kliniske-studier/influensavaksine-etter-hjerteinfarkt-reduserer-risiko-for-dod-hos-pasienter-med-hjertesykdom/1247902021-09-01T00:00+02:00https://www.healthtalk.no/esc-2021-forskning/ny-norsk-registerstudie-ser-pa-fordelene-ved-blodfortynnende-medisiner-hos-pasienter-med-middels-stor-risiko-for-hjerneslag/1247832021-09-01T00:00+02:00https://www.healthtalk.no/helsedirektoratet-overdosebildet-blant-unge-i-endring/1247632021-08-30T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sier-ja-til-ny-immunterapi-ved-behandling-av-ikke-smacellet-lungekreft/1247562021-08-30T00:00+02:00https://www.healthtalk.no/esc-2021-kliniske-studier/a-bytte-ut-vanlig-salt-med-salt-som-har-mindre-natrium-forebygger-hjerte-og-karsykdommer-og-dod/1247492021-08-31T00:00+02:00https://www.healthtalk.no/esc2021-forskning/ny-norsk-studie-vil-spare-mye-tid-og-kostnader-ved-a-ta-i-bruk-ny-hjerteinfarkt-algoritme-pa-legevaktene/1247322021-08-30T00:00+02:00https://www.healthtalk.no/esc-2021-forskning/master-dapt-en-maned-med-dobbel-blodplatehemming-er-nok-for-pasienter-med-hoy-blodningsrisiko-etter-pci/1247222021-08-30T00:00+02:00https://www.healthtalk.no/esc-2021-kliniske-studier/flere-overlever-hjertestans-nar-sms-livreddere-tilkalles/1247082021-08-29T00:00+02:00https://www.healthtalk.no/esc-2021-forskning/dette-kan-gi-pasientene-syv-gode-levear-etter-et-hjerteinfarkt/1247012021-08-29T00:00+02:00https://www.healthtalk.no/esc-2021-legemidler-og-biotek/kerendia-reduserer-risiko-for-alvorlige-kardiovaskulaere-hendelser/1246912021-08-29T00:00+02:00https://www.healthtalk.no/esc-2021-legemidler-og-biotek/edoxaban-nar-primaert-endepunkt-men-overbeviser-ikke-helt-i-tavi-setting/1246792021-08-29T00:00+02:00https://www.healthtalk.no/esc-2021-kliniske-studier/tannkjottsykdom-er-arsak-hjertesykdom/1246712021-08-28T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/bjorn-atle-bjornbeth-gar-inn-i-styret-til-oslo-cancer-cluster/1246552021-08-30T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/bimzelx-far-tommelen-opp-fra-eu-for-behandling-av-plakkpsoriasis/1246482021-08-31T00:00+02:00https://www.healthtalk.no/esc-2021-forskning/omega-3-er-ikke-effektivt-for-a-forebygge-hjerteinfarkt-men-kan-oke-risikoen-for-hjerteflimmer-viser-ny-norsk-studie/1246322021-08-28T00:00+02:00https://www.healthtalk.no/esc-2021-forebygging/viktig-a-gjore-bildediagnostikk-pa-covid-syke-med-etablert-hjertesykdom-og-de-i-risikosonen/1246152021-08-27T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/prisforhandlingene-om-genterapi-til-sma-barna-trekker-ut-men-forhandlingsklimaet-er-godt/1246022022-08-10T16:44+02:00https://www.healthtalk.no/legemidler-og-biotek/astmainhalator-med-digital-sensor-minner-pasientene-pa-a-ta-medisinen/1245932021-08-27T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/eu-godkjenner-den-forste-jak-hemmeren-til-behandling-av-barn-og-voksne-med-moderat-til-alvorlig-atopisk-eksem/1245782021-08-26T00:00+02:00https://www.healthtalk.no/studie-koronavaksiner-svekkes-merkbart-over-tid/1245702021-08-25T00:00+02:00https://www.healthtalk.no/coronaviruset-jobb-karriere/han-er-ny-medisinsk-direktor-i-biotek-raketten-vaccibody/1245612021-08-26T00:00+02:00https://www.healthtalk.no/coronaviruset/pfizer-oker-vaksineproduksjonen-i-europa-med-461-millioner-doser/1245542021-08-24T00:00+02:00https://www.healthtalk.no/forsvaret-det-norske-feltsykehuset-i-kabul-legges-ned-innen-31-august/1245462021-08-24T00:00+02:00https://www.healthtalk.no/bransjenytt/hoie-la-ned-grunnsteinen-for-nytt-klinikk-og-protonbygg-pa-radiumhospitalet/1245312021-08-24T00:00+02:00https://www.healthtalk.no/coronaviruset/pfizerbiontechs-koronavaksine-har-fatt-endelig-godkjenning-i-usa/1245132021-08-24T00:00+02:00https://www.healthtalk.no/coronaviruset/danmarks-helseminister-alle-vil-fa-tilbud-om-tredje-vaksinedose/1245062021-08-23T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/toppsjefen-i-bergenbio-gar-pa-dagen-inn-kommer-martin-olin/1244902021-08-23T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/den-forste-car-t-terapien-mot-benmargskreft-er-godkjent/1244822021-08-25T00:00+02:00https://www.healthtalk.no/arendalsuka/healthtalk-debatten-hvor-lenge-ma-vi-vente-for-trening-blir-en-del-av-kreftbehandlingen/1244532022-08-10T16:44+02:00https://www.healthtalk.no/generalsekretaer-i-kreftforeningen-ingrid-stenstadvold-ross-og-helseminister-bent-hoie-gikk-stafett-for-livet/1244242021-08-18T00:00+02:00https://www.healthtalk.no/trening-politikk/sykler-til-arendal-vil-ha-trening-inn-i-pasientforlopet-for-kreft/1244142021-08-15T00:00+02:00https://www.healthtalk.no/politikk/far-ikke-utvide-innovasjonsparken-grensen-er-nadd-sier-sjefen-i-radforsk/1244022021-08-16T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/ultimovacs-bekrefter-positive-data-pa-behandling-av-foflekkreft/1243942021-08-13T00:00+02:00https://www.healthtalk.no/helsedirektoratet-sender-ut-n-million-hurtigtester-til-landets-kommuner/1243812021-08-11T00:00+02:00https://www.healthtalk.no/forskning/samfunnet-tar-bedre-vare-pa-eldre-menn-enn-eldre-kvinner/1243562021-08-08T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/sanofi-kjoper-amerikansk-mrna-partner/1243492021-08-06T00:00+02:00https://www.healthtalk.no/kliniske-studier/ny-studie-vil-se-pa-nytt-behandlingsalternativ-for-pasienter-med-deformitet-i-ryggen/1243422021-08-13T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/eu-godkjenner-immunterapi-til-adjuvant-behandling-av-spiserorskreft/1243332021-08-05T00:00+02:00https://www.healthtalk.no/coronaviruset/legemiddelverket-ikke-grunnlag-for-a-endre-vaksineanbefaling/1242922021-07-29T00:00+02:00https://www.healthtalk.no/eau-2021-forskning/norsk-studie-ny-operasjonsmetode-reduserer-tilbakefall-for-pasienter-med-blaerekreft/1242462021-07-23T00:00+02:00https://www.healthtalk.no/eau-2021-kliniske-studier/vellykket-musestudie-pa-nyrecellekreft-med-to-legemidler-fra-norske-bergenbio/1242372021-07-13T00:00+02:00https://www.healthtalk.no/forskning/hormonet-dopamin-kan-i-folge-ny-studie-bade-pavirke-lidenskap-og-autisme/1242282021-07-28T00:00+02:00https://www.healthtalk.no/kliniske-studier/kunstig-intelligens-hjelper-forskerne-forsta-mer-av-ms-pasienters-immunsystem/1242212021-08-09T00:00+02:00https://www.healthtalk.no/helseteknologi/ar-briller-erstatter-leverandorbesok-fra-utlandet/1241952021-08-12T00:00+02:00https://www.healthtalk.no/helseteknologi/3d-printede-modeller-hjelper-kirurgene-pa-ous/1241842021-08-02T00:00+02:00https://www.healthtalk.no/bransjenytt/han-er-eli-lilly-company-sin-nye-medisinske-direktor-for-onkologi-i-nord-europa/1241772021-07-07T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/norsk-selskap-inngar-samarbeid-med-legemiddel-giganten-msd/1241602021-07-08T00:00+02:00https://www.healthtalk.no/forskning/fant-arsaken-til-sjeldne-syndromer/1241522021-07-26T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/nubeqa-er-anbudsvinneren-til-behandling-av-prostatakreftpasienter-med-hoy-risiko-for-spredning/1241432021-07-02T00:00+02:00https://www.healthtalk.no/leserinnlegg/regjeringen-som-ulv-i-fareklaer/1241362021-07-01T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/en-gamechanger-i-behandlingen-av-kronisk-nyresykdom-sglt2-hemmer-far-gront-lys/1241262021-07-01T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/ema-gir-gront-lys-for-den-forste-cellebaserte-genterapien-til-pasienter-med-benmargskreft/1241182021-06-30T00:00+02:00https://www.healthtalk.no/politikk/diabetesforbundet-mener-bytte-av-insuliner-i-apotek-kan-fa-alvorlige-konsekvenser/1241102021-06-29T00:00+02:00https://www.healthtalk.no/helseteknologi/dnv-kjoper-imatis-som-forste-steg-pa-vei-til-internasjonal-satsing-pa-e-helse/1240832021-06-28T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek/asco-toppmote-dette-er-forskningsfronten-i-kreftbehandlingen/1240732021-06-25T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/norges-aktuelle-zolgensma-fortsetter-a-vise-lovende-resultater/1240532021-06-24T00:00+02:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/beslutningsforum-og-legemiddelindustrien-inngar-ny-avtale-om-lovende-legemidler-for-alvorlig-syke-pasienter/1240212021-06-21T00:00+02:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/beslutningsforum-ga-gront-lys-til-fem-legemidler-seks-fikk-nei/1240092021-06-21T00:00+02:00https://www.healthtalk.no/bransjenytt/vil-gjore-det-lettere-for-parkinson-pasienter/1240002021-06-18T00:00+02:00https://www.healthtalk.no/eha-2021-legemidler-og-biotek-kliniske-studier/venclyxto-fortsetter-a-forbedre-progresjonsfri-overlevelse-hos-flertallet-av-pasienter-med-kronisk-lymfatisk-leukemi-tre-ar-etter-avsluttet-behandling/1239862021-06-17T00:00+02:00https://www.healthtalk.no/bransjenytt/lucie-aunan-er-ny-direktor-for-divisjon-samhandling-i-direktoratet-for-e-helse/1239792021-06-16T00:00+02:00https://www.healthtalk.no/politikk/det-nye-mjossykehuset-skal-ligge-i-moelv/1239712021-06-15T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-forskning/hoydepunkter-asco-2021-urologi/1239652021-06-15T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-forskning/hoydepunkter-asco-2021-foflekkreft/1239542021-06-14T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek/hoydepunkter-asco-2021-brystkreft/1239492021-06-14T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/norske-bergenbio-har-fatt-fast-track-status-i-usa-et-gjennombrudd-for-oss/1239392021-06-11T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-kliniske-studier/hoydepunkter-asco-2021-hode-og-halskreft/1239342021-06-10T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek/hoydepunkter-asco-2021-lungekreft/1239202021-06-09T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/analytiker-og-forskningssjef-ny-alzheimermedisin-kan-ogsa-bli-godkjent-i-europa/1239122021-06-08T00:00+02:00https://www.healthtalk.no/forskning/har-funnet-opp-et-mikronalsplaster-som-leverer-antibiotika-lokalt-i-huden/1239022021-06-09T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/usa-godkjenner-den-forste-nye-alzheimermedisinen-pa-20-ar-kan-bli-tilgjengelig-i-norge-om-ett-ar/1238932021-06-07T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-kliniske-studier/utfordrer-imbruvica-calquence-med-faerre-kardiovaskulaere-bivirkninger/1238792021-06-08T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-kliniske-studier/flere-pasienter-med-alvorlig-spiserorskreft-overlever-med-immunterapi-kan-bli-et-behandlingsalternativ-ogsa-for-norske-pasienter/1238682021-06-06T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-kliniske-studier/immunterapi-etter-operasjon-reduserer-risiko-for-tilbakefall-ved-nyrecellekreft-lovende-men-vi-trenger-langtidsdata-for-a-si-at-behandlingen-oker-overlevelsen/1238572021-06-07T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-forskning/malrettet-radioaktivt-legemiddel-forlenger-livet-til-prostatakreftpasienter-som-har-provd-alt/1238372021-06-05T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek/30-prosent-av-pasientene-med-foflekkreft-fikk-komplett-respons-med-norsk-kreftvaksine-i-kombinasjon-med-immunterapi/1238122021-06-05T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-kliniske-studier/lynparza-etter-operasjon-oker-sykdomsfri-overlevelse-hos-kvinner-som-har-hoy-risiko-for-brystkreft/1237962021-06-04T00:00+02:00https://www.healthtalk.no/asco-2021-kliniske-studier/cellegift-og-stralebehandling-ved-testikkelkreft-gir-storre-risiko-for-tidlig-dod/1237792021-06-08T00:00+02:00https://www.healthtalk.no/asco-2021-kliniske-studier/norsk-studie-viser-at-hoyrisikopasienter-med-sjelden-mage-tarmkreft-med-fa-mutasjoner-kanskje-ikke-trenger-tilleggsbehandling/1237712021-06-04T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-kliniske-studier/ny-norsk-studie-gir-svar-pa-sporsmal-om-mest-effektiv-behandlingstid-ved-avansert-eggstokkreft/1237642021-06-07T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek/ny-immunterapi-forbedrer-behandlingsresultatet-for-pasienter-med-avansert-foflekkreft/1237572021-06-07T00:00+02:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/beslutningsforum-sier-ja-til-a-gi-verdens-dyreste-legemiddel-resultatbasert-pris/1237512021-05-31T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek/immunterapi-tar-forste-viktige-skritt-i-behandlingen-av-lungekreft-i-tidlig-fase/1237392021-06-04T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek/norsk-asco-studie-cellegift-gjor-immunterapi-mer-effektiv-mot-uhelbredelig-tarmkreft/1237282021-06-06T00:00+02:00https://www.healthtalk.no/forskning/stor-okning-i-antall-nye-brukere-av-diabeteslegemidler/1237192021-06-02T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek/amgen-har-fatt-fda-godkjenning-for-den-forste-kras-blokkerende-lungekreftmedisinen/1237092021-05-31T00:00+02:00https://www.healthtalk.no/coronaviruset/eus-legemiddelbyra-godkjenner-koronavaksine-for-unge-ned-til-tolv-ar/1237022021-05-28T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/ja-eller-nei-til-resultatbasert-pris-pa-mandag-kommer-avgjorelsen-som-kan-avgjore-skjebnen-til-verdens-dyreste-legemiddel/1236922021-05-28T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/anbefaler-at-hjertesviktlegemidlet-vericiguat-far-eu-godkjenning/1236702021-05-26T00:00+02:00https://www.healthtalk.no/fedmeopererte-har-betydelig-lavere-dodelighet-enn-de-som-som-ikke-blir-operert-overlevelsegevinsten-klart-storst-for-de-med-diabetes/1236612021-06-03T00:00+02:00https://www.healthtalk.no/hoyres-helsetopp-alle-bor-ta-koronavaksinen-nar-de-far-tilbudet/1236512021-05-26T00:00+02:00https://www.healthtalk.no/helseteknologi-forskning/skal-utvikle-kunstig-intelligens-for-a-effektivisere-og-oke-kvaliteten-pa-brystkreftscreeningen/1236422021-05-27T00:00+02:00https://www.healthtalk.no/acc-2021/kardiologiprofessor-dan-atar-dette-er-de-viktigste-studiene-pa-hjertekongressen-acc/1236262021-05-25T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-kliniske-studier/ny-brystkreftbehandling-gjor-lite-skade-pa-hjertehelsen/1236102021-05-21T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-kliniske-studier/ultimovacs-uv1-kreftvaksine-i-kombinasjon-med-immunterapien-keytruda-har-effekt-pa-60-prosent-av-pasientene-med-avansert-foflekkreft/1236012021-05-20T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/norsk-kreftmedisin-kan-vaere-effektiv-mot-alvorlig-koronasykdom/1235812021-05-18T00:00+02:00https://www.healthtalk.no/acc-2021-helseteknologi/kunstig-intelligens-blir-et-kraftig-verktoy-i-hendene-pa-kardiologene/1235642021-05-17T00:00+02:00https://www.healthtalk.no/acc-2021-legemidler-og-biotek-kliniske-studier-forskning/norsk-studie-hjertesviktmedisin-unodvendig-for-mange-brystkreftpasienter/1235552021-05-16T00:00+02:00https://www.healthtalk.no/politikk/hoyre-har-vedtatt-screening-for-prostatakreft/1235262021-05-15T00:00+02:00https://www.healthtalk.no/acc-2021-kliniske-studier/adaptable-studien-lav-og-hoy-dose-aspirin-er-like-trygt-og-effektivt-for-a-forebygge-ny-hjertesykdom/1235172021-05-15T00:00+02:00https://www.healthtalk.no/acc-2021-legemidler-og-biotek-kliniske-studier/paradise-mi-entresto-ikke-bedre-enn-generisk-ace-hemmer-for-a-forebygge-hjertesvikt-og-dod-etter-hjerteinfarkt/1234992021-05-15T00:00+02:00https://www.healthtalk.no/politikk/hoyre-vil-gi-unge-psykiatrigaranti/1234852021-05-15T00:00+02:00https://www.healthtalk.no/esmo-breast-legemidler-og-biotek/kisqali-forbedrer-overlevelsen-saerlig-for-unge-pasienter-med-avansert-brystkreft/1234682021-05-14T00:00+02:00https://www.healthtalk.no/coronaviruset/ordforere-raser-mot-vaksine-skjevfordelingen/1234612021-05-12T00:00+02:00https://www.healthtalk.no/coronaviruset/usa-anbefaler-pfizer-vaksine-for-barn-ned-til-tolv-ar/1234542021-05-12T00:00+02:00https://www.healthtalk.no/bransjenytt/vipps-sa-ble-elisabeth-haug-ny-sjef-i-farmasiet/1234472021-05-12T00:00+02:00https://www.healthtalk.no/forskning/koronatiltakene-forer-til-mindre-influensa-og-dermed-mindre-hjertesykdom/1234392021-05-18T00:00+02:00https://www.healthtalk.no/politikk-revidert-nasjonalbudsjett/ks-mener-staten-ma-ta-fastlegeregningen/1234322021-05-12T00:00+02:00https://www.healthtalk.no/coronaviruset/studie-antistoffer-i-kroppen-minst-atte-maneder-etter-covid-19/1234252021-05-11T00:00+02:00https://www.healthtalk.no/politikk-revidert-nasjonalbudsjett/regjeringen-vil-bruke-300-millioner-mer-pa-psykisk-helse-og-rus/1234112021-05-11T00:00+02:00https://www.healthtalk.no/politikk-revidert-nasjonalbudsjett/sykehusokonomien-styrkes-i-revidert-nasjonalbudsjett/1234042021-05-11T00:00+02:00https://www.healthtalk.no/acc-2021-helse-og-livsstil-kliniske-studier/passiv-royking-oker-faren-for-hjertesvikt-saerlig-hos-menn/1233912021-05-14T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-politikk/stortinget-ber-regjeringen-sorge-for-nasjonal-beredskap-av-legemidler/1233612021-05-07T00:00+02:00https://www.healthtalk.no/bransjenytt/hun-er-helse-norges-nye-toppbyrakrat/1233472021-05-07T00:00+02:00https://www.healthtalk.no/kreft/ny-studie-brystkreftpasientene-med-darligst-prognose-har-20-40-ganger-okt-risiko-for-a-do-av-brystkreft-tidlig/1233392023-12-15T16:00+01:00https://image.healthtalk.no?imageId=103184&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/usa-stotter-plan-om-a-oppheve-patentrettigheter-pa-koronavaksiner/1233212021-05-06T00:00+02:00https://www.healthtalk.no/coronaviruset/pfizer-forventer-a-selge-koronavaksiner-for-266-milliarder-kroner-i-ar/1233062021-05-05T00:00+02:00https://www.healthtalk.no/esmo-breast-forskning/norske-forskere-har-oppdaget-en-genmarkor-med-sterk-prognostisk-effekt-ved-brystkreft/1232972021-05-05T00:00+02:00https://www.healthtalk.no/helseteknologi/norsk-lege-kan-bli-arets-oppfinner-i-europa/1232902021-05-04T00:00+02:00https://www.healthtalk.no/forskning-coronaviruset/betydelig-nedgang-i-kreftdiagnoser-som-folge-av-koronapandemien/1232702021-05-06T00:00+02:00https://www.healthtalk.no/forskning/store-kjonnsforskjeller-ved-migrenelidelser/1232612021-05-04T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/ny-myelomatosebehandling-kan-fa-stor-betydning-for-norske-pasienter/1232542021-05-03T00:00+02:00https://www.healthtalk.no/helseteknologi/forbrukerdirektoren-karer-genetiske-selvtester-til-en-av-tidenes-darligste-produkter/1232272021-04-29T00:00+02:00https://www.healthtalk.no/bransjenytt/hun-blir-trolig-ny-departementsrad-i-helse-og-omsorgsdepartementet/1232202021-04-28T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/se-analysen-av-beslutningsforums-aprilmote/1232152021-04-27T00:00+02:00https://www.healthtalk.no/forskning/sunn-tarmflora-avgjorende-for-a-unnga-livstilssykdommer/1231932021-04-30T00:00+02:00https://www.healthtalk.no/historisk-vedtak-beslutningsforum-sier-ja-til-den-forste-genterapien/1231812021-04-26T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/anbefaler-at-atte-nye-legemidler-godkjennes-i-europa/1231742021-04-27T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-politikk/legeforeningen-ber-regjeringen-skrinlegge-legemiddelreform-inntil-pasientens-legemiddelliste-er-pa-plass/1231572021-04-26T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/pa-mandag-skal-beslutningsforum-si-ja-eller-nei-til-genterapi-som-kan-forhindre-at-barn-blir-blinde/1231522021-04-23T00:00+02:00https://www.healthtalk.no/coronaviruset/83-parorende-har-fatt-erstatning-etter-koronasmitte-pa-sykehjem-og-sykehus/1231432021-04-22T00:00+02:00https://www.healthtalk.no/politikk/stortinget-legger-aps-ruskompromiss-dodt/1231352021-04-22T00:00+02:00https://www.healthtalk.no/bransjenytt/ahus-med-rekordoverskudd-i-koronaaret/1231272021-04-22T00:00+02:00https://www.healthtalk.no/forskning/demenstallene-i-norge-er-mye-hoyere-enn-tidligere-antatt/1231182021-04-23T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/roche-vokser-i-forste-kvartal/1231052021-04-21T00:00+02:00https://www.healthtalk.no/podcast/podcast-genteknologi-og-fremtidsmennesket/1230742021-04-22T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/kreftmedisin-har-effekt-pa-alzheimerpasienter/1230662021-04-20T00:00+02:00https://www.healthtalk.no/erling-ulltveit-lmi-politikk/regjeringsrapport-vil-kutte-prisen-pa-blareseptlegemidler-med-800-millioner-kroner/1230482023-11-16T16:33+01:00https://image.healthtalk.no?imageId=180240&format=webp&width=1200https://www.healthtalk.no/helseteknologi/tradlost-hjerneimplantat-fremtiden-for-pasienter-med-lammelser-og-amputasjoner/1230402021-04-19T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/ny-kras-hemmer-med-lovende-effekt-pa-lungekreft/1230312021-04-16T00:00+02:00https://www.healthtalk.no/coronaviruset/koronakommisjonen-med-hard-kritikk-regjeringen-var-ikke-forberedt/1230112021-04-14T00:00+02:00https://www.healthtalk.no/coronaviruset/johnson-johnson-utsetter-innforingen-av-vaksinen-i-europa/1230042021-04-13T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/lytix-biopharma-vil-hente-penger-og-ga-pa-bors/1229952021-04-13T00:00+02:00https://www.healthtalk.no/faerre-pasienter-pa-sykehusene-i-fjor/1229822021-04-14T00:00+02:00https://www.healthtalk.no/forskning/oppdaget-13-ukjente-gener-som-kan-forarsake-alzheimers-sykdom/1229672021-04-13T00:00+02:00https://www.healthtalk.no/migrene/menstruell-migrene-darlig-forstatt-og-ofte-feildiagnostisert/1229512023-12-15T16:11+01:00https://www.healthtalk.no/legemidler-og-biotek/flere-lungekreftpasienter-far-immunterapi/1229352021-04-08T00:00+02:00https://www.healthtalk.no/coronaviruset/eus-legemiddeltilsyn-blodpropp-en-svaert-sjelden-bivirkning-av-astrazeneca-vaksinen/1229182021-04-07T00:00+02:00https://www.healthtalk.no/antistoffer-motvirker-resmitte-av-covid-19/1229102021-04-07T00:00+02:00https://www.healthtalk.no/parkinsons/hva-vet-du-om-pasienter-med-langtkommen-parkinsons-sykdom/1228952023-12-18T09:27+01:00https://www.healthtalk.no/fhi-aavitsland-tror-vi-kan-vaere-naer-en-topp-i-antallet-coronainnlagte/1228782021-04-04T00:00+02:00https://www.healthtalk.no/kliniske-studier/regjeringen-vil-doble-antallet-kliniske-studier-det-kommer-til-a-bli-krevende/1228622021-04-07T00:00+02:00https://www.healthtalk.no/car-t-legemidler-og-biotek/usa-har-godkjent-den-forste-car-t-celleterapien-for-pasienter-med-benmargskreft/1228492021-04-02T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/eus-ekspertpanel-anbefaler-fedmelegemiddel-til-barn-og-unge/1228202021-03-30T00:00+02:00https://www.healthtalk.no/hvordan-behandle-pasienter-med-fedme-episode-2/1228122021-03-29T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/lytix-biopharma-og-norges-arktiske-universitet-har-utviklet-lovende-legemiddelkandidater-for-kreftbehandling/1228042021-03-29T00:00+02:00https://www.healthtalk.no/coronaviruset/regjeringen-skjerper-reglene-for-innreise-alle-reisende-ma-ha-mindre-enn-24-timer-gammel-test/1227862021-03-28T00:00+01:00https://www.healthtalk.no/covid-19-forskning/norsk-covid-19-studie-gir-ny-innsikt-i-langtidsvirkninger-pa-eldre-pasienter/1227752021-03-29T00:00+02:00https://www.healthtalk.no/forskning/norske-forskere-med-pa-oppdagelsen-av-genetisk-arsak-til-alvorlig-leversykdom/1227652021-03-31T00:00+02:00https://www.healthtalk.no/coronaviruset/her-er-de-nye-smitteverntiltakene-hoie-forstar-at-det-oppleves-som-vanskelig/1227532021-03-23T00:00+01:00https://www.healthtalk.no/forskning/norsk-forskningsgjennombrudd-avslorer-funksjonen-til-to-ukjente-enzymer-hos-mennesker/1227422021-04-01T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sier-ja-til-persontilpasset-lungekreftbehandling-5-ar-etter-danmark/1226742021-03-22T00:00+01:00https://www.healthtalk.no/coronaviruset/to-nye-pasienter-er-dode-av-blodpropp-etter-a-ha-mottatt-astrazeneca-vaksinen/1226612021-03-21T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/nasjonalt-screeningprogram-for-tarmkreft-er-i-rute-starter-i-ar/1226272021-03-23T00:00+01:00https://www.healthtalk.no/coronaviruset/eu-sier-at-astrazeneca-vaksinen-er-trygg-og-effektiv-opp-til-norge-a-si-ja-eller-nei-til-vaksinen/1225972021-03-18T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/ous-professor-har-funnet-arsaken-til-vaksine-bivirkninger/1225882021-03-18T00:00+01:00https://www.healthtalk.no/coronaviruset/helse-sor-ost-frykter-de-kan-fa-620-innlagte-om-fire-uker/1225802021-03-18T00:00+01:00https://www.healthtalk.no/genterapi-legemidler-og-biotek/novartis-forhandler-med-sykehusinnkjop-om-genterapi-som-kan-hindre-at-barn-blir-blinde-diskuterer-resultatbasert-prising/1225632021-03-17T00:00+01:00https://www.healthtalk.no/coronaviruset/ny-smitterekord-i-oslo-vi-er-inne-i-tredje-smittebolge/1225532021-03-16T00:00+01:00https://www.healthtalk.no/coronaviruset/helsearbeider-dode-undersoker-om-det-er-sammenheng-med-astrazeneca-vaksinering/1225452021-03-15T00:00+01:00https://www.healthtalk.no/immunterapi-legemidler-og-biotek-forskning/tarmbakterier-kan-oke-effekten-av-immunterapi/1225342021-03-18T00:00+01:00https://www.healthtalk.no/appen-som-gir-innbyggerne-en-felles-inngang-til-kommunens-helse-og-omsorgstjenester/1225292021-04-27T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-livmorhalskreft/studie-livmorhalskreft-kan-vaere-naer-utryddet-i-2039-takket-vaere-effektiv-vaksine-og-verdens-hoyeste-vaksinasjonsdekning/1225192021-03-14T00:00+01:00https://www.healthtalk.no/coronaviruset/astrazeneca-avviser-okt-fare-for-blodpropp/1225122021-03-13T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/nasjonalt-handlingsprogram-anbefaler-doak-som-forstevalg-til-lungekreftpasienter-med-blodpropp/1224832021-03-15T00:00+01:00https://www.healthtalk.no/coronaviruset/norge-pauser-astrazeneca-vaksinen-legemiddelverket-ser-etter-spor-av-blodpropp-i-alle-bivirkningsmeldinger/1224742021-03-11T00:00+01:00https://www.healthtalk.no/coronaviruset/norske-byer-setter-astrazeneca-vaksine-pa-vent/1224652021-03-11T00:00+01:00https://www.healthtalk.no/blaerekreft-legemidler-og-biotek/ny-immunterapibehandling-av-blaerekreft-er-godkjent-ber-beslutningsforum-behandle-refusjonssoknaden-raskt/1224472021-03-11T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/dansk-selskap-henter-inn-milliardbelop-til-vaksineutvikling/1224402021-03-10T00:00+01:00https://www.healthtalk.no/coronavaksine-coronaviruset/johnson-johnson-vaksinen-venter-pa-klarsignal-fra-eu-snart-klar-for-norge/1224312021-03-09T00:00+01:00https://www.healthtalk.no/coronaviruset/dansk-coronavaksine-klar-til-utproving/1224182021-03-08T00:00+01:00https://www.healthtalk.no/coronaviruset/solberg-i-tale-om-coronaaret-det-kunne-vaert-mye-verre/1224022021-03-07T00:00+01:00https://www.healthtalk.no/helse/forskere-har-laget-neandertalerliknende-minihjerner-med-crispr-og-stamcelleteknologi/1223692024-05-21T12:25+02:00https://www.healthtalk.no/coronaviruset/overlege-intensivkapasiteten-pa-ahus-er-en-skandale/1223202021-03-05T00:00+01:00https://www.healthtalk.no/coronaviruset/tillitsvalgt-kapasiteten-pa-ahus-var-sprengt-allerede-sist-helg/1223102021-03-05T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-vaccibody/vaccibody-vurderer-borsnotering-pa-nasdaq/1223032021-03-05T00:00+01:00https://www.healthtalk.no/coronavaksine-coronaviruset/danmark-og-osterrike-inngar-vaksineallianse-med-israel/1222942021-03-04T00:00+01:00https://www.healthtalk.no/start-et-samarbeid-med-ht-brand-studio/1222892021-03-04T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/klarsignal-for-pfizers-nye-pneumokokkvaksine-beskytter-mot-20-serotyper/1222732021-03-03T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-prostatakreft/hor-ny-podkast-fra-healthtalk-pasienter-med-prostatakreft-lever-lengre-med-ny-behandling/1222602021-03-03T00:00+01:00https://www.healthtalk.no/coronaviruset/johnson-johnson-vaksinen-godkjent-i-usa-norge-ma-vente-til-mars/1222532021-02-28T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-rna-spinal-muskelatrofi/rna-legemidler-gir-nye-og-unike-muligheter-for-malrettet-behandling/1222412021-03-02T00:00+01:00https://www.healthtalk.no/immunterapi-legemidler-og-biotek/immunterapi-har-bedre-effekt-nar-kreftcellene-far-mindre-sukker/1222292021-03-01T00:00+01:00https://www.healthtalk.no/blodpropp-legemidler-og-biotek/den-forste-doaken-er-godkjent-for-behandling-og-forebygging-av-blodpropp-hos-barn-et-betydelig-fremskritt/1222172021-02-25T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-ret/den-forste-behandlingen-for-avansert-lunge-og-skjoldbruskkjertelkreft-med-mutasjoner-i-ret-genet-er-godkjent/1222042021-02-24T00:00+01:00https://www.healthtalk.no/blaerekreft-legemidler-og-biotek/nytt-legemiddel-reduserer-risikoen-for-dod-med-30-prosent-hos-pasienter-med-fremskreden-eller-metastatisk-blaerekreft/1221902021-02-23T00:00+01:00https://www.healthtalk.no/kols/ny-trippelbehandling-reduserer-risiko-for-sykdomsforverring-og-dod-for-kols-pasienter/1221792023-12-18T09:49+01:00https://image.healthtalk.no?imageId=112855&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek-helseteknologi-sma/helsedirektoratet-vil-genteste-alle-nyfodte-for-spinal-muskelatrofi-hva-beslutter-bent-hoie/1221652021-02-18T00:00+01:00https://www.healthtalk.no/okning-i-bruk-av-dagkirurgi/1221542021-02-17T00:00+01:00https://www.healthtalk.no/coronaviruset/sveits-kjopte-vaksiner-selv-har-satt-flere-doser-enn-norge/1221452021-02-17T00:00+01:00https://www.healthtalk.no/coronaviruset/johnson-johnson-har-sokt-om-godkjenning-for-sin-coronavaksine-kan-bli-godkjent-i-mars/1221362021-02-16T00:00+01:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/beslutningsforum-godkjente-forste-immunterapi-for-norske-pasienter-med-leverkreft/1221242021-02-15T00:00+01:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/beslutningsforum-godkjenner-alunbrig-som-forstelinjebehandling-av-alk-positiv-ikke-smacellet-lungekreft/1221152021-02-15T00:00+01:00https://www.healthtalk.no/hiv-legemidler-og-biotek/vil-beslutningsforum-si-ja-til-den-forste-langtidsvirkende-injeksjonsbehandlingen-mot-hiv/1221042021-02-16T00:00+01:00https://www.healthtalk.no/coronaviruset/nakstad-haper-pa-mer-normal-sommer-men-frykter-ny-bolge/1220972021-02-14T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-wclc-2021/immunterapiene-yervoy-og-keytruda-i-kombinasjon-oker-ikke-overlevelsen-gir-bare-okte-bivirkninger/1220712021-02-10T00:00+01:00https://www.healthtalk.no/coronaviruset/hoie-erkjenner-at-norge-har-for-fa-intensivsykepleiere/1220622021-02-10T00:00+01:00https://www.healthtalk.no/coronaviruset/eu-i-gang-med-a-evaluere-novavax-vaksinen-men-trolig-vil-vaksinen-til-johnson-johnson-bli-godkjent-forst/1220212021-02-04T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-wclc-2021/professor-aslaug-helland-fire-sentrale-studier-pa-world-conference-on-lung-cancer/1220102021-02-05T00:00+01:00https://www.healthtalk.no/bransjenytt/karo-pharma-kjoper-kjente-internasjonale-merkevarer/1220012021-02-04T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-wclc-2021/dart-studien-skal-finne-biomarkorene-som-forklarer-hvorfor-noen-lungekreftpasienter-blir-kurert-mens-andre-far-tilbakefall/1219892021-02-04T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-wclc-2021/aslaug-helland-leder-brysthinnekreftstudie-der-pasientene-far-to-immunterapier-og-en-norsk-kreftvaksine/1219712021-02-02T00:00+01:00https://www.healthtalk.no/kras-legemidler-og-biotek-lungekreft/amgens-legemiddel-mot-kras-mutert-lungekreft-viser-effekt-i-avgjorende-studie/1219542021-01-31T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-wclc-2021/astrazenecas-egfr-inhibitor-tagrisso-reduserer-risiko-for-tilbakefall-og-dod-uavhengig-av-adjuvant-kjemoterapi/1219432021-01-31T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/eu-godkjenner-rinvoq-for-behandling-av-voksne-med-psoriasisartrit-og-ankyloserende-spondylitt/1219142021-01-29T00:00+01:00https://www.healthtalk.no/healthtalk-soker-journalister/1219072021-01-27T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-nyrekreft/usa-har-godkjent-opdivo-i-kombinasjon-med-cabometyx-som-forstelinjebehandling-av-pasienter-med-avansert-nyrekreft/1218742021-01-28T00:00+01:00https://www.healthtalk.no/cancer-crosslinks-pasientene-ma-fa-raskere-tilgang-til-presisjonsmedisin/1218692021-01-26T00:00+01:00https://www.healthtalk.no/coronavaksine-coronaviruset/msd-skrinlegger-utviklingen-av-sine-to-covid-19-vaksiner-gir-for-darlig-immunrespons/1218622021-01-25T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset/strengere-tiltak-for-ytterligere-15-ostlandskommuner-stor-risiko-for-spredning/1218552021-01-24T00:00+01:00https://www.healthtalk.no/hjertesvikt/fda-godkjenner-vericiguat-vil-mote-sterk-konkurranse/1218472021-01-25T00:00+01:00https://www.healthtalk.no/apotek-legemidler-og-biotek/apoteksalg-pa-nett-eksploderer-med-nye-restriksjoner/1218402021-01-23T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/generikaprodusenten-sandoz-er-norges-storste-legemiddelselskap/1218312021-01-25T00:00+01:00https://www.healthtalk.no/duchennes-muskeldystrofi-legemidler-og-biotek/pfizer-gar-forbi-sarepta-har-startet-fase-3-studie-med-genterapi-for-a-behandle-duchennes-muskeldystrofi/1218212021-01-22T00:00+01:00https://www.healthtalk.no/beslutningsforum-sier-ja-til-to-nye-legemidler-to-far-nei-fordi-kostnadene-tilsvarer-driftsbudsjettet-for-et-lite-sykehus/1217692021-01-18T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/dette-er-de-4-viktigste-legemidlene-som-kan-bli-godkjent-i-forste-kvartal/1217302021-01-11T00:00+01:00https://www.healthtalk.no/pfizer-vaksinen-fungerer-mot-den-muterte-virusvarianten/1217222021-01-08T00:00+01:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek-coronaviruset/fhi-fa-nordmenn-far-vaksine-i-forste-kvartal/1217132021-01-07T00:00+01:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek/det-europeiske-legemiddelbyraet-anbefaler-godkjennelse-av-coronavaksinen-fra-moderna/1217062021-01-06T00:00+01:00https://www.healthtalk.no/coronavaksine/over-4000-nordmenn-har-fatt-forste-dose-av-coronavaksinen/1216992021-01-06T00:00+01:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek-coronaviruset/om-fa-dager-kan-norge-fa-forste-forsendelse-av-coronavaksinen-fra-moderna/1216912021-01-06T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-helseteknologi-spinal-muskelatrofi/nyfodtscreening-av-spinal-muskelatrofi-har-kjort-seg-fast-i-helsebyrakratiet/1216732021-01-05T00:00+01:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek/moderna-vaksine-kan-fa-godkjenning-i-eu-og-norge-mandag/1216662021-01-04T00:00+01:00https://www.healthtalk.no/hode-og-halskreft-legemidler-og-biotek/ultimovacs-starter-fase-2-studie-for-a-undersoke-effekten-av-kreftvaksinen-uv1-i-hode-og-halskreft/1216502020-12-30T00:00+01:00https://www.healthtalk.no/immunterapi-legemidler-og-biotek/beslutningsforum-ma-innfore-ny-immunterapi-mot-blaerekreft-raskest-mulig-sier-lederen-i-norsk-onkologisk-forening/1216392020-12-29T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-bransjenytt-novo-nordisk/hans-christian-hansson-gar-fra-roche-til-novo-nordisk-blir-global-head-of-obesity-nash-policy/1216202020-12-23T00:00+01:00https://www.healthtalk.no/kreftbehandling-legemidler-og-biotek/behandler-kreft-ved-a-lamme-kreftens-kraftverk/1216062020-12-18T00:00+01:00https://www.healthtalk.no/hvordan-behandle-pasienter-med-fedme/1216012020-12-17T00:00+01:00https://www.healthtalk.no/enhertu-her2-positiv-brystkreft-legemidler-og-biotek/enhertu-ett-skritt-naermere-norsk-godkjenning-mot-brystkreft/1215902020-12-16T00:00+01:00https://www.healthtalk.no/immunterapi-legemidler-og-biotek-plateepitelkarsinom/i-dag-far-den-forste-norske-hudkreftpasienten-en-helt-ny-immunterapi/1215792020-12-15T00:00+01:00https://www.healthtalk.no/alk-legemidler-og-biotek-lungekreft/beslutningsforum-innforer-lorlatinib-til-behandling-av-avansert-alk-lungekreft/1215652020-12-14T00:00+01:00https://www.healthtalk.no/ash-2020-kronisk-lymfatisk-leukemi-legemidler-og-biotek/ibrutinib-og-venetoclax-kombo-viser-god-effekt-pa-tidligere-ubehandlede-pasienter-med-kronisk-lymfatisk-leukemi/1215372020-12-07T00:00+01:00https://www.healthtalk.no/ash-2020-car-t-legemidler-og-biotek/ny-studie-janssens-car-t-legemiddel-med-stor-effekt-pa-myelomatose/1215292020-12-07T00:00+01:00https://www.healthtalk.no/ash-2020-blodkreft/disse-studiene-bor-du-folge-med-pa-under-arets-storste-hematologikonferanse-ash-2020/1215132020-12-05T00:00+01:00https://www.healthtalk.no/ash-2020-blodkreft-legemidler-og-biotek/myelomatose-venetoclax-cobimetinib-gir-storre-respons-enn-venetoclax-alene/1215012020-12-05T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/denne-teknologien-kan-revolusjonere-kreftbehandlingen/1214912020-12-08T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/rekordvekst-i-salget-av-potenslegemidler-og-salgsrekord-for-netthandel-av-legemidler/1214502020-12-02T00:00+01:00https://www.healthtalk.no/agnete-fredriksen-legemidler-og-biotek-vaccibody/forskningsradets-innovasjonspris-gar-til-agnete-fredriksen-i-biotek-raketten-vaccibody/1214412020-11-26T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sier-ja-til-a-innfore-tre-nye-metoder-to-fikk-nei/1214342020-11-23T00:00+01:00https://www.healthtalk.no/direktoratet-for-e-helse-helseteknologi-politikk/tiden-er-moden-for-a-overlate-ledelsen-av-nasjonal-e-helse-til-andre/1213902020-11-20T00:00+01:00https://www.healthtalk.no/kronisk-lymfatisk-leukemi-legemidler-og-biotek/kunstig-intelligens-skal-gi-blodkreftpasienter-bedre-behandling-og-faerre-bivirkninger/1213842020-11-19T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-bransjenytt-podcast/podcast-hun-er-mercks-globale-innovasjonssjef-legemiddelbransjen-star-foran-store-og-raske-endringer/1213582020-11-17T00:00+01:00https://www.healthtalk.no/biologiske-legemidler-legemidler-og-biotek-psoriasis/20-ar-med-fire-store-gjennombrudd-innen-behandling-av-psoriasis-na-kommer-det-neste/1213482020-11-11T00:00+01:00https://www.healthtalk.no/corona-coronaviruset/skal-forske-pa-om-tran-kan-forebygge-coronaviruset-inkluderer-70000-deltakere-i-transtudie/1213372020-11-10T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/norske-farmasoyter-er-bekymret-for-handteringen-av-coronavaksinen/1213292020-11-10T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/lavere-omsetning-resultatfall-og-underskudd-for-photocure-i-tredje-kvartal-tror-pa-innhenting/1213212020-11-10T00:00+01:00https://www.healthtalk.no/hjertesykdom/astrazenecas-diabeteslegemiddel-forxiga-er-godkjent-til-a-behandle-hjertesviktpasienter/1213052023-12-15T16:10+01:00https://image.healthtalk.no?imageId=105240&format=webp&width=1200https://www.healthtalk.no/immunterapi-legemidler-og-biotek/immunterapi-innfores-i-behandlingen-av-hode-og-halskreft-en-merkedag-for-pasientene-vare/1212972020-11-06T00:00+01:00https://www.healthtalk.no/atopisk-eksem-eadv-2020-jak-hemmer/jak-hemmeren-rinvoq-med-god-effekt-pa-pasienter-med-atopiske-eksem/1212702020-10-30T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/helse-sor-ost-bygger-nasjonalt-pandemilager-med-smittevern-og-provetakingsutstyr/1212632020-11-02T00:00+01:00https://www.healthtalk.no/legemiddelmangel-legemidler-og-biotek-vaksine/varsler-kraftig-okt-legemiddelmangel-na-vil-ledende-naeringsorganisasjoner-at-det-etableres-en-norsk-vaksinefabrikk/1212502020-10-27T00:00+01:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/beslutningsforum-sier-ja-til-immunterapi-som-forstelinjebehandling-av-hode-og-halskreft-og-lungekreft/1212412020-10-26T00:00+01:00https://www.healthtalk.no/covid-19-legemidler-og-biotek-coronaviruset/roche-sikrer-avtale-med-atea-pharmaceuticals-for-a-utvikle-en-potensiell-behandling-for-covid-19-pasienter/1212322020-10-23T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-helseteknologi/ny-studie-dokumenterer-at-flere-atrieflimmerpasienter-vil-ha-nytte-av-ablasjonsbehandling-tidligere-i-behandlingsforlopet/1212252020-10-23T00:00+02:00https://www.healthtalk.no/slik-lyktes-fastlegekontoret-digitalt/1212192021-01-19T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/pfizers-coronavaksine-bnt162b2-kan-vaere-klar-i-slutten-av-november/1212122020-10-22T00:00+02:00https://www.healthtalk.no/kreftvaksine-legemidler-og-biotek/ultimovacs-med-positive-5-ars-overlevelsesdata-pa-kreftvaksinen-uv1/1212002020-10-20T00:00+02:00https://www.healthtalk.no/helseteknologi-forskning/podcast-mobil-helse-endrer-helsevesenet-og-helseforskningen-var-forskning-skal-bedre-folks-helse/1211932020-10-19T00:00+02:00https://www.healthtalk.no/bransjenytt/podcast-norges-leger-har-fatt-sin-egen-tv-serie/1211842020-11-04T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/generikaselskapet-sandoz-har-pa-kort-tid-blitt-norges-tredje-storste-legemiddelfirma-med-norges-tredje-storste-legemiddel/1211672020-10-16T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-malrettet-behandling-presisjonsmedisin/sotorasib-har-lovende-effekt-pa-kras-mutert-lungekreft-kan-bli-det-forste-godkjente-kras-legemidlet/1211482020-10-13T00:00+02:00https://www.healthtalk.no/covid-19-legemidler-og-biotek-vaksine/johnson-johnson-setter-coronavaksine-studie-pa-pause-etter-uforklarlig-sykdomstilfelle/1211412020-10-13T00:00+02:00https://www.healthtalk.no/inven2-legemidler-og-biotek-podcast/podcast-inven2-star-bak-selskaper-som-er-verd-nesten-30-milliarder-na-er-vaccibody-alene-priset-til-17-milliarder/1211322020-10-08T00:00+02:00https://www.healthtalk.no/politikk/regjeringen-vil-bevilge-mer-til-kliniske-studier-og-persontilpasset-medisin/1211172020-10-07T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-finans-vaccibody/vaccibody-noteres-pa-borsen-i-dag-sender-biotek-til-vaers/1211062020-10-07T00:00+02:00https://www.healthtalk.no/esmo-esmo-2020-immunterapi/toppmote-esmo-de-viktigste-forskningsnyhetene-innen-kreftbehandling-og-diagnostisering/1210612022-08-24T15:31+02:00https://image.healthtalk.no?imageId=161268&format=webp&width=1200https://www.healthtalk.no/foflekkreft-kreftvaksine-legemidler-og-biotek/ultimovacs-med-lovende-overlevelsesdata-pa-pasienter-med-foflekkreft-som-fikk-kreftvaksinen-uv1-i-kombinasjon-med-immunterapi/1210492020-10-02T00:00+02:00https://www.healthtalk.no/duarte-marchand-legemidler-og-biotek-sjeldne-sykdommer/takeda-blant-verdens-10-storste-tar-pa-seg-nordisk-og-global-lederrolle-innenfor-sykdommer-med-store-udekkede-medisinske-behov/1210382020-10-01T00:00+02:00https://www.healthtalk.no/esmo-2020-foflekkreft-immunterapi/to-lovende-tidligfasestudier-innen-behandling-av-foflekkreft-med-spredning/1210292020-09-28T00:00+02:00https://www.healthtalk.no/esmo-2020-gentest-legemidler-og-biotek/lungekreft-professor-aslaug-helland-oppsummerer-esmo-2020/1210152020-09-24T00:00+02:00https://www.healthtalk.no/esmo-esmo-2020-gentest/daniel-heinrich-vi-ma-genteste-alle-prostatapasienter-som-har-kreft-med-spredning/1210082022-08-24T15:47+02:00https://image.healthtalk.no?imageId=102469&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/beslutningsforum-sier-ja-til-fem-nye-legemidler-ett-far-nei/1209962020-09-21T00:00+02:00https://www.healthtalk.no/esmo-2020-immunterapi-legemidler-og-biotek/nyrekreft-opdivo-i-kombinasjon-med-cabometyx-reduserer-risikoen-for-dod-med-40/1209842020-09-20T00:00+02:00https://www.healthtalk.no/alk-esmo-2020-legemidler-og-biotek/pfizers-lorviqua-med-overbevisende-effekt-pa-forstelinjebehandling-av-pasienter-med-avansert-alk-lungekreft/1209762020-09-20T00:00+02:00https://www.healthtalk.no/esmo-2020-kreftvaksine-legemidler-og-biotek/foflekkreft-immunterapien-opdivo-og-dansk-eksperimentell-kreftvaksine-gir-hoy-responsrate-i-tidligfasestudie/1209682020-09-19T00:00+02:00https://www.healthtalk.no/immunterapi-legemidler-og-biotek-lungekreft/trippelbehandlingen-opdivo-yervoy-og-kjemoterapi-mot-ikke-smacellet-lungekreft-blir-snart-godkjent-i-europa-og-norge/1209592020-09-22T00:00+02:00https://www.healthtalk.no/kreft/pasienter-med-foflekkreft-uten-spredning-har-like-darlig-overlevelse-som-de-med-spredning-bor-de-fa-immunterapi-etter-operasjon/1209512023-12-15T15:53+01:00https://www.healthtalk.no/egfr-esmo-2020-forskning/stor-norsk-registerstudie-flere-gentestes-for-egfr-mutert-ikke-smacellet-lungekreft-og-far-anbefalt-behandling/1209372020-09-20T00:00+02:00https://www.healthtalk.no/esmo-esmo-2020-forskning/norsk-studie-20-prosent-av-unge-kreftoverlevere-har-betydelig-frykt-for-tilbakefall-15-ar-etter-diagnose/1209232022-08-24T15:46+02:00https://www.healthtalk.no/esmo-esmo-2020-kliniske-studier/for-esmo-den-skandinaviske-thora-studien-leger-frem-pasientrapporterte-bivirkninger-av-hoyere-straledose/1209122022-08-24T15:46+02:00https://www.healthtalk.no/legemidler-og-biotek-prostatakreft/fikk-ja-fra-beslutningsforum-legemiddel-utsetter-spredning-av-prostatakreft-og-forlenger-livet-med-14-maneder/1209052020-09-18T00:00+02:00https://www.healthtalk.no/esmo-esmo-2020-kreft/for-esmo-kreftoverlege-med-store-forventninger-til-gjennombruddsstudier-innen-nyrekreft-blaerekreft-og-testikkelkreft/1208992022-08-24T15:45+02:00https://image.healthtalk.no?imageId=161273&format=webp&width=1200https://www.healthtalk.no/corona-coronavaksine-legemidler-og-biotek-coronaviruset/coronaimmunitet-varer-kanskje-ikke-mer-enn-ett-ar/1208922020-09-15T00:00+02:00https://www.healthtalk.no/esmo-2020-kliniske-studier-lungekreft/hoy-straledose-gir-lungekreftpasienter-50-prosent-okt-overlevelse-men-ikke-flere-eller-sterkere-bivirkninger/1208832020-09-17T00:00+02:00https://www.healthtalk.no/bent-hoie/bent-hoie-derfor-var-det-pa-tide-a-slutte/1208762020-09-11T00:00+02:00https://www.healthtalk.no/farmastat-immunterapi-legemidler-og-biotek/immunterapien-keytruda-er-norges-storste-legemiddel/1208632020-09-11T00:00+02:00https://www.healthtalk.no/corona-coronaviruset/solberg-varsler-innstramninger-kan-bli-aktuelt-a-frarade-reiser-til-spesielt-smitteutsatte-omrader-i-norge/1208562020-09-10T00:00+02:00https://www.healthtalk.no/corona-klinisk-studie-kliniske-studier-coronaviruset/norsk-coronastudie-hoy-dodelighet-blant-pasienter-med-hoy-alder-og-kroniske-sykdommer/1208432020-09-08T00:00+02:00https://www.healthtalk.no/beslutningsforum-brystkreft-legemidler-og-biotek/beslutningsforum-sier-ja-til-nytt-behandlingsprinsipp-av-brystkreft/1208132020-08-31T00:00+02:00https://www.healthtalk.no/esc-legemidler-og-biotek-nyresykdom/esc-forxiga-nar-alle-endepunkter-i-stor-nyrestudie-reduserer-risiko-forbundet-med-nyresykdom-med-39/1208012020-08-31T00:00+02:00https://www.healthtalk.no/esc-hjerteflimmer-legemidler-og-biotek/esc-nye-behandlingsretningslinjer-hjerteflimmer-handteres-best-nar-pasienten-blir-lyttet-til/1207962020-08-29T00:00+02:00https://www.healthtalk.no/politikk/ingvild-kjerkol-valgt-til-ny-leder-av-trondelag-ap-etter-svaert-opphetet-debatt/1207892020-08-29T00:00+02:00https://www.healthtalk.no/esc-hjertevikt-jardiance/esc-2020-jardiance-reduserer-risikoen-for-cv-dod-og-sykehusinnleggelser-hos-hjertesviktpasienter-med-25-prosent/1207812020-08-29T00:00+02:00https://www.healthtalk.no/esc-hjerteflimmer-hjerteinfarkt/ntnu-studie-kondisen-avslorer-risiko-for-hjerteinfarkt-hos-friske/1207742020-08-30T00:00+02:00https://www.healthtalk.no/bransjenytt/philipp-maerz-blir-ny-sjef-i-merck-norge-rene-c-amundsen-gar-inn-i-selskapets-globale-toppledergruppe/1207662020-08-28T00:00+02:00https://www.healthtalk.no/apotek-farmasoyt-legemidler-og-biotek/studie-avdekker-nar-feilmedisinering-oppstar-pa-norske-sykehus/1207452020-08-25T00:00+02:00https://www.healthtalk.no/apoek-apotek1-influensavaksine/apotekene-vil-vaksinere-uten-legens-godkjennelse-venter-pa-hoies-ja/1207372020-08-24T00:00+02:00https://www.healthtalk.no/esc-hjerneslag-hjerteflimmer/hvert-fjerde-hjerneslag-skyldes-hjerteflimmer-forsker-er-bekymret-for-at-antall-hjerneslag-som-skyldes-hjerteflimmer-ikke-gar-ned/1207262020-08-28T00:00+02:00https://www.healthtalk.no/corona-coronaviruset-donald-trump/usa-har-hastegodkjent-en-ny-behandlingsform-for-covid-19-far-kritikk-av-fagfolk/1207192020-08-24T00:00+02:00https://www.healthtalk.no/pharma-og-biotek/fda-godkjenner-kesimpta-den-forste-injiserbare-ms-medisinen-pasientene-selv-kan-ta-hjemme/1207092024-01-02T09:29+01:00https://image.healthtalk.no?imageId=111228&format=webp&width=1200https://www.healthtalk.no/bransjenytt/bjorn-erik-reinseth-er-ny-sjef-i-forskningsparken/1207022020-08-21T00:00+02:00https://www.healthtalk.no/coronavirus-covid-19-legemidler-og-biotek-coronaviruset/roche-og-regeneron-forener-krefter-for-a-utvikle-legemiddel-mot-covid-19/1206942020-08-20T00:00+02:00https://www.healthtalk.no/blodermedisin-genterapi-hemofili/fda-sier-nei-til-biomarins-genterapi-mot-hemofili-etterspor-mer-data-om-varighet/1206872020-08-19T00:00+02:00https://www.healthtalk.no/bransjenytt-politikk-john-arne-rottingen/john-arne-rottingen-blir-norges-globale-helseambassador/1206802020-08-19T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-ms-sanofi/sanofi-kjoper-principia-for-33-milliarder-kroner-for-a-sikre-seg-viktig-ms-legemiddel/1206722020-08-19T00:00+02:00https://www.healthtalk.no/forxiga-legemidler-og-biotek-sglt2/forxiga-nar-alle-endepunkter-i-stor-nyrestudie/1206652020-08-18T00:00+02:00https://www.healthtalk.no/apotek-farmasiet-legemidler-og-biotek/landets-storste-nettapotek-setter-omsetningsrekord/1206582020-08-17T00:00+02:00https://www.healthtalk.no/coronavaksine-coronaviruset/eu-inngar-vaksineavtale-med-astrazeneca-kjoper-opp-til-400-millioner-doser/1206512020-08-14T00:00+02:00https://www.healthtalk.no/coronaviruset-munnbind/anbefaler-munnbind-pa-fulle-busser-og-tog-i-oslo-og-i-indre-ostfold-legeforeningen-prisene-ma-ned/1206432020-08-14T00:00+02:00https://www.healthtalk.no/alzheimer-legemidler-og-biotek-forskning/ny-studie-kroppsvekten-har-overraskende-og-alarmerende-innvirkning-pa-hjernefunksjonen/1206342020-08-17T00:00+02:00https://www.healthtalk.no/coronaviruset/munnbindrad-for-kollektivtransport-pa-trappene/1206272020-08-14T00:00+02:00https://www.healthtalk.no/novo-nordisk-gir-blodermedisin-en-ny-sjanse-gjenopptar-fase-3-studier/1206192020-08-13T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-lytix-biopharma/lytix-biopharma-inngar-milliardavtale-med-amerikansk-biotekgigant/1206122020-08-12T00:00+02:00https://www.healthtalk.no/covid-19-legemidler-og-biotek-coronaviruset-vaksine/putin-russland-er-det-forste-landet-som-godkjenner-en-corona-vaksine/1206052020-08-11T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-fhi/fhi-anbefaler-seks-nye-land-og-flere-omrader-i-sverige-og-danmark-som-rode/1205902020-08-10T00:00+02:00https://www.healthtalk.no/bransjenytt/vil-bli-best-pa-helse-og-legemiddel-pr-og-ansetter-mette-nilstad-fra-helse-midt-norge/1205832020-08-10T00:00+02:00https://www.healthtalk.no/alzheimer-blodprove-demens/blodprove-som-kan-diagnostisere-alzheimer-er-innen-rekkevidde/1205652020-08-07T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-munnbind/hoie-ikke-aktuelt-med-pabud-om-munnbind-na/1205582020-08-07T00:00+02:00https://www.healthtalk.no/karsten-bruins-slot-legemidler-og-biotek-ntrk/roche-har-fatt-markedsforingstillatelse-for-sitt-forste-tumoragnostiske-legemiddel-men-fravaeret-av-gentesting-kan-hindre-at-norske-pasienter-far-ta-det-i-bruk/1205412020-08-04T00:00+02:00https://www.healthtalk.no/coronavaksine-coronaviruset-who/who-ikke-sikkert-det-blir-en-endelig-losning-pa-coronapandemien/1205342020-08-03T00:00+02:00https://www.healthtalk.no/coronaviruset/trumps-coronaradgiver-sier-usa-er-i-ny-alvorligere-fase-viruset-er-svaert-utbredt/1205262020-08-03T00:00+02:00https://www.healthtalk.no/forxiga-hjertesvikt-jardiance/ny-studie-diabeteslegemidlet-jardiance-reduserer-risikoen-for-dod-og-sykehusinnleggelser-hos-hjertesviktpasienter/1205182020-07-31T00:00+02:00https://www.healthtalk.no/antistoff-legemiddel-konjugat-her2-legemidler-og-biotek/astrazeneca-inngar-ny-stor-kreftavtale-med-daiichi-sankyo/1205002020-07-29T00:00+02:00https://www.healthtalk.no/blodprove-helseteknologi-kreft/blodprove-kan-oppdage-fire-typer-kreft-fire-ar-for-symptomene-viser-seg/1204932020-07-28T00:00+02:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek-coronaviruset/usa-fastsetter-global-referansepris-pa-coronavaksiner-til-prisen-for-en-influensavaksine/1204792020-07-24T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-erna-solberg/solberg-krevende-a-fa-unge-folk-til-a-folge-smitteradene-i-sommerferien/1204722020-07-23T00:00+02:00https://www.healthtalk.no/ahus-coronavirus-legemidler-og-biotek-helseteknologi/dette-har-legene-laert-om-coronapasientene-ahus-har-overlevelsestall-som-ligger-helt-i-toppsjiktet-internasjonalt/1204652020-07-23T00:00+02:00https://www.healthtalk.no/helseteknologi-koloskopi-tarmkreft/tarmkreft-rammer-flere-kunstig-intelligens-gjor-koloskopi-bedre-og-billigere/1204542020-07-22T00:00+02:00https://www.healthtalk.no/brystkreft-daiichi-sankyo-enhertu/det-europeiske-legemiddelbyraet-gir-enhertu-rask-vurdering-for-behandling-av-pasienter-med-her2-positiv-metastatisk-brystkreft/1204382020-07-20T00:00+02:00https://www.healthtalk.no/coronavirus-legemidler-og-biotek-coronaviruset-vaksine/vaksinasjon-av-barn-faller-kraftig-som-folge-av-coronapandemien/1204312020-07-17T00:00+02:00https://www.healthtalk.no/covid-19-legemidler-og-biotek-plaquenil/fa-endringer-i-behandlingen-av-covid-19-gjennom-pandemien/1204192020-07-16T00:00+02:00https://www.healthtalk.no/norsk-luftambulanse-politikk/sivilt-ambulansehelikopter-er-na-pa-plass-i-kirkenes/1204122020-07-16T00:00+02:00https://www.healthtalk.no/helseteknologi-uniqon-as-andedrettsvern/na-skal-andedrettsvern-produseres-i-norge/1203982020-07-15T00:00+02:00https://www.healthtalk.no/antibiotika-antibiotikaresisten-legemidler-og-biotek/legemiddelindustrien-etablerer-milliardfond-for-a-bekjempe-antibiotikaresistens/1203752020-07-10T00:00+02:00https://www.healthtalk.no/n-av-fire-far-smertestillende-pa-resept/1203672020-07-09T00:00+02:00https://www.healthtalk.no/coronavirus-legemidler-og-biotek-coronaviruset-novavax/usas-regjering-gir-novavax-16-milliarder-dollar-for-a-utvikle-en-coronavaksine/1203482020-07-08T00:00+02:00https://www.healthtalk.no/coronaviruset/flertallet-mener-norge-var-darlig-forberedt-pa-en-pandemi/1203242020-07-06T00:00+02:00https://www.healthtalk.no/dignio-erik-fosse-helseteknologi/skal-bygge-en-digital-poliklinikk-med-stotte-fra-forskningsradet/1203152020-07-06T00:00+02:00https://www.healthtalk.no/endetarmskreft-eva-hofsli-keytruda/fda-har-godkjent-den-forste-immunterapien-mot-tarmkreft-norsk-kreftlege-bor-vurderes-som-den-foretrukne-behandlingen-ogsa-for-norske-pasienter/1203082020-07-03T00:00+02:00https://www.healthtalk.no/blodkreft-blodkreftforeningen-legemidler-og-biotek/blodkreftforeningen-nodvendig-a-endre-beslutningsforum/1202752020-07-01T00:00+02:00https://www.healthtalk.no/bransjenytt-finnmarkssykehuset-siri-tau-ursin/hun-blir-ny-direktor-i-finnmarkssykehuset/1202602020-06-29T00:00+02:00https://www.healthtalk.no/bransjenytt-ikt-norge-oyvind-husby/oyvind-husby-ny-administrerende-direktor-i-ikt-norge/1202532020-06-29T00:00+02:00https://www.healthtalk.no/bent-hoie-politikk-coronaviruset-ventelister/stor-okning-i-ventetider-pa-sykehusene-helseministeren-vil-oke-bruken-av-fritt-behandlingsvalg/1202412020-06-26T00:00+02:00https://www.healthtalk.no/nytt-behandlingstilbud-for-kvinner-i-overgangsalderen/1202362020-07-03T00:00+02:00https://www.healthtalk.no/coronaviruset-covid-19-folkehelseinstituttet/bare-1-prosent-av-befolkningen-har-vaert-smittet-av-coronaviruset/1202282020-06-26T00:00+02:00https://www.healthtalk.no/covid-19-gilead-legemidler-og-biotek/forste-covid-19-behandling-godkjent-i-europa/1202192020-06-26T00:00+02:00https://www.healthtalk.no/car-t-eha25-immunterapi/derfor-virker-car-t-bedre-en-tradisjonell-immunterapi-pa-myelomatosepasienter/1202142020-06-26T00:00+02:00https://www.healthtalk.no/bite-car-t-eha25/dette-er-forskjellen-pa-car-t-og-bite/1202092020-06-25T00:00+02:00https://www.healthtalk.no/keytruda-legemidler-og-biotek-oncos-102/norske-targovax-inngar-immunterapi-samarbeid-med-legemiddelgigant/1202012020-06-24T00:00+02:00https://www.healthtalk.no/belantamab-eha25-fredrik-schjesvold/myelomatose-gsk-med-sterke-data-pa-kombinasjonsbehandlinger-med-belantamab/1201882020-06-24T00:00+02:00https://www.healthtalk.no/brysthinnekreft-immunterapi-legemidler-og-biotek/ny-studie-targovax-melder-om-okt-immunaktivering-og-overlevelse-blant-forstelinjepasienter-med-brysthinnekreft-som-far-oncos-102/1201702020-06-22T00:00+02:00https://www.healthtalk.no/de-som-jobber-med-psykisk-helse-fikk-digitalt-sjokk/1201202020-06-12T00:00+02:00https://www.healthtalk.no/asco20-eva-hofsli-immunterapi/endelig-en-god-nyhet-for-pasienter-med-tarmkreft-immunterapi-fordobler-tiden-for-sykdomsprogresjon/1201122020-06-12T00:00+02:00https://www.healthtalk.no/asco20-blaerekreft-daniel-heinrich/asco-oppsummert-sentrale-studier-innen-blaerekreft-og-prostatakreft/1201052020-06-12T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-norges-farmaceutiske-forening-oslo-economics/lite-samarbeid-mellom-fastleger-og-farmasoyter-oker-faren-for-feil-legemiddelbruk/1201002020-06-10T00:00+02:00https://www.healthtalk.no/asco20-avelumab-bavencio/blaerekreftpasientene-som-fikk-immunterapi-levde-50-prosent-lengre/1200902020-06-10T00:00+02:00https://www.healthtalk.no/anna-winge-main-foflekkreft-legemidler-og-biotek/flere-unge-far-foflekkreft-her-er-kreftlegens-solrad/1200812020-06-18T00:00+02:00https://www.healthtalk.no/anna-winge-main-asco20-legemidler-og-biotek/foflekkreft-behandling-med-immunterapi-for-operasjon-er-svaert-lovende-kan-endre-behandlingspraksis/1200742020-06-09T00:00+02:00https://www.healthtalk.no/ali-areffard-asco20-karsten-bruins-slot/toppmote-asco20-dette-er-forskningsfronten-i-kreftbehandlingen/1200692020-06-08T00:00+02:00https://www.healthtalk.no/asco20-blue-667-legemidler-og-biotek/hun-starter-en-studie-med-et-eksperimentelt-legemiddel-som-har-effekt-pa-nesten-alle-lungekreftpasienter-med-et-sjeldent-gen/1200622020-06-04T00:00+02:00https://www.healthtalk.no/adt-asco20-erleada/erleada-forlenger-livet-til-prostatapasienter-med-14-maneder/1200462020-06-01T00:00+02:00https://www.healthtalk.no/alecensa-asco20-legemidler-og-biotek/6-av-10-lungekreftpasienter-pa-alecensa-lever-etter-5-ar/1200352020-05-31T00:00+02:00https://www.healthtalk.no/asco20-covid-19-kreft/kreft-gir-betydelig-okt-risiko-for-a-do-av-covid-19/1200282020-05-30T00:00+02:00https://www.healthtalk.no/asco20-bjorn-henning-gronberg-legemidler-og-biotek/norsk-studie-lungekreftpasienter-lever-50-prosent-lenger-nar-de-far-hoyere-straledose/1200212020-05-30T00:00+02:00https://www.healthtalk.no/asco20-legemidler-og-biotek-lungekreft/dette-er-de-viktigste-lungekreftstudiene-pa-asco20/1200162020-05-29T00:00+02:00https://www.healthtalk.no/bristol-myers-squibb-hilde-bech-legemidler-og-biotek/bristol-myers-squibbs-nye-ms-legemiddel-er-godkjent-vil-beslutningsforum-ogsa-si-ja/1199912020-05-27T00:00+02:00https://www.healthtalk.no/coronavirus-hydroksyklorokin-legemidler-og-biotek-coronaviruset/siste-who-stanser-utproving-av-malariamedisin-mot-corona/1199842020-05-25T00:00+02:00https://www.healthtalk.no/benmargskreft-beslutningsforum-eggstokkreft/beslutningsforum-innforer-legemidler-til-behandling-av-eggstokkreft-og-benmargskreft/1199762020-05-25T00:00+02:00https://www.healthtalk.no/asco20-bjorn-henning-gronberg-kjemoterapi/ny-norsk-studie-lungekreftpasienter-lever-mye-lengre-med-ny-stralebehandlingsmetode/1199632020-05-26T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-novartis-risdiplam/novartis-sin-genterapi-zolgensma-pa-vei-mot-godkjenning-i-europa-og-norge/1199532020-05-25T00:00+02:00https://www.healthtalk.no/beslutningsforum-beta-thalassemi-legemidler-og-biotek/de-nordiske-landene-skal-forhandle-pris-pa-genterapien-zynteglo/1199462020-05-25T00:00+02:00https://www.healthtalk.no/asco-2020-asco20-immunterapi/roche-presenterer-forste-data-om-sin-nye-immunterapi-i-ny-lungekreftstudie/1199392020-05-23T00:00+02:00https://www.healthtalk.no/camilla-stoltenberg-coronavirus-coronaviruset/fhi-direktoren-advarer-mot-ny-nedstengning-av-norge/1199322020-05-22T00:00+02:00https://www.healthtalk.no/astrazeneca-legemidler-og-biotek-lynparza/astrazenecas-lynparza-far-fda-godkjenning-for-behandling-av-prostatakreft/1199232020-05-20T00:00+02:00https://www.healthtalk.no/asco-asco20-lungekreft/roykeslutt-selv-kort-tid-for-en-lungekreftdiagnose-oker-sjansen-for-a-overleve/1199162020-05-20T00:00+02:00https://www.healthtalk.no/coronaviruset-donald-trump-who/trump-til-who-sjefen-mange-liv-kunne-vaert-spart-om-du-hadde-fulgt-doktor-brundtlands-eksempel/1199092020-05-19T00:00+02:00https://www.healthtalk.no/asco20-bristol-myers-squibb-immunterapi/trippelbehandlingen-opdivo-yervoy-og-kjemoterapi-reduserer-risikoen-for-dod-med-opp-til-38-prosent/1199012020-05-30T00:00+02:00https://www.healthtalk.no/allcan-legemidler-og-biotek-pasientorganisasjon/lanserer-allcan-norge-pasientorganisasjoner-og-industrien-i-tverrfaglig-samarbeid-for-en-mer-effektiv-kreftbehandling/1198822020-05-19T00:00+02:00https://www.healthtalk.no/abbvie-allergan-humira/abbvie-vokser-i-norge-etter-allergan-oppkjopet/1198752020-05-18T00:00+02:00https://www.healthtalk.no/asco-asco20-bristol-myers-squibb/fda-ja-til-immunterapikomboen-opdivo-yervoy-pa-sterke-tre-ars-data/1198582020-05-19T00:00+02:00https://www.healthtalk.no/covid-19-dan-atar-diabetes/norges-fremste-leger-ingen-grunn-til-a-endre-forskrivningspraksis-eller-bruk-av-blodtrykksmedisiner-under-coronapandemien/1198482020-05-15T00:00+02:00https://www.healthtalk.no/coronatest-coronaviruset-folkehelseinstituttet/folkehelseinstituttet-vil-sjekke-spyttprover-for-coronavirus-kan-sprare-enorme-ressurser/1198412020-05-15T00:00+02:00https://www.healthtalk.no/legemiddelproduksjon-legemidler-og-biotek/flertall-pa-stortinget-krever-nasjonal-produksjon-av-medisiner/1198342020-05-15T00:00+02:00https://www.healthtalk.no/sol-og-sommervarme-tar-ikke-knekken-pa-coronaviruset/1198262020-05-14T00:00+02:00https://www.healthtalk.no/asco-asco20-astrazeneca/lynparza-oker-overlevelsen-for-kvinner-med-eggstokkreft-med-13-maneder/1198172020-05-18T00:00+02:00https://www.healthtalk.no/bent-hoie-erna-solberg-politikk-coronaviruset/sykehusene-far-55-milliarder-kroner-i-coronatilskudd/1198092020-05-12T00:00+02:00https://www.healthtalk.no/ace-hemmere-ace2-arb-hemmere/ny-studie-menn-har-hoye-nivaer-av-et-enzym-kan-forklare-hvorfor-menn-blir-sykere-av-covid-19-enn-kvinner/1197992020-05-12T00:00+02:00https://www.healthtalk.no/bent-hoie-fastlegeordningen-ingvild-kjerkol/regjeringen-vil-gi-fastlegene-faerre-oppgaver-og-16-nye-milliarder/1197902020-05-11T00:00+02:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek-coronaviruset-preben-aavitsland/aavitsland-tror-pa-coronavaksine-tidligst-hosten-2021/1197832020-05-10T00:00+02:00https://www.healthtalk.no/astrazeneca-forxiga-hjertevikt/astrazenecas-diabeteslegemiddel-far-usa-ja-til-a-behandle-hjertesviktpasienter-norge-i-tenkeboksen/1197722020-05-11T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/ny-studie-medisinmiks-kan-korte-ned-sykdomsforlopet-hos-coronapasienter/1197652020-05-09T00:00+02:00https://www.healthtalk.no/coronaviruset-smittetallet/smittetallet-har-steget-til-055/1197582020-05-08T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-erna-solberg/na-slik-skal-norge-gjenapnes/1197512020-05-07T00:00+02:00https://www.healthtalk.no/antistoffer-folkehelseinstituttet-helseteknologi-coronaviruset/undersokelse-2-av-100-har-antistoffer-mot-coronavirus-fhi-tror-svaert-fa-har-vaert-smittet/1197362020-05-07T00:00+02:00https://www.healthtalk.no/erik-jakobsen-helsenaeringens-verdi-helseteknologi-politikk/svak-tilgang-til-hjemmemarkedet-og-kapital-bremser-veksten-i-helsenaeringen/1197302020-05-08T00:00+02:00https://www.healthtalk.no/innlegg-kvinnehelse-nimo-klinikken/ta-vare-pa-kroppen-din-kvinne/1197192020-05-06T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-knut-arild-hareide/nye-rad-for-reisende-busser-tog-og-trikker-far-maksimalt-vaere-halvfulle/1197122020-05-05T00:00+02:00https://www.healthtalk.no/antistofftest-daniel-malarek-elecsystesten/roche-har-fatt-usa-godkjenning-for-antistofftest-kommer-til-norge-denne-uken/1197022020-05-05T00:00+02:00https://www.healthtalk.no/christine-koht-ingrid-stenstadvold-ross-kreftforeningen/christine-koht-far-kreftforeningens-hederspris/1196942020-05-04T00:00+02:00https://www.healthtalk.no/coronavirus-gilead-legemidler-og-biotek-coronaviruset/usa-godkjenner-bruk-av-remdesivir-mot-corona-eu-og-norge-kan-folge-etter/1196782020-05-02T00:00+02:00https://www.healthtalk.no/bemcentinib-bergenbio-covid-19/norsk-legemiddelselskap-til-vaers-pa-borsen-skal-teste-kreftmedisin-mot-covid-19/1196632020-04-29T00:00+02:00https://www.healthtalk.no/coronatest-coronaviruset/na-skal-alle-med-symptomer-pa-corona-testes/1196522020-04-29T00:00+02:00https://www.healthtalk.no/anette-storstein-helse-og-livsstil-forebygging-hjerneradet/merck-gar-sammen-med-magnus-carlsen-og-hjerneforskere-for-a-bedre-hjernehelsen/1196442020-04-28T00:00+02:00https://www.healthtalk.no/cepi-coronavaksine-legemidler-og-biotek-coronaviruset/cepi-haper-a-ha-coronavaksine-klar-innen-utgangen-av-aret/1196302020-04-27T00:00+02:00https://www.healthtalk.no/coronaviruset/spedbarn-har-fatt-pavist-coronasmitte-i-trondheim/1196172020-04-26T00:00+02:00https://www.healthtalk.no/akson-bent-hoie-christine-bergland/hoie-vil-ha-fortgang-i-arbeidet-med-en-felles-kommunal-helsejournal/1196102020-04-26T00:00+02:00https://www.healthtalk.no/coronavaksine-coronavirus-legemidler-og-biotek-coronaviruset/coronavaksine-de-forste-pasientene-er-injisert-i-en-vaksinestudie-i-storbritannia/1195972020-04-24T00:00+02:00https://www.healthtalk.no/bent-hoie-camilla-hansen-steinum-coronaviruset/stor-okning-i-arbeidsledige-og-helt-permitterte-tannleger/1195812020-04-20T00:00+02:00https://www.healthtalk.no/coronavirus-covid-19-gilead/covid-19-pasienter-blir-raskt-bedre-med-ebolamedisinen-remdesivir-testes-na-i-norge/1195732020-04-18T00:00+02:00https://www.healthtalk.no/coronaviruset-det-europeiske-smittevernbyraet-folkehelseinstituttet/ber-norske-helsemyndigheter-anbefale-bruk-av-munnbind/1195542020-04-15T00:00+02:00https://www.healthtalk.no/christian-probst-covid-19-emma-walmsley/sanofi-og-gsk-gar-sammen-for-a-utvikle-coronavaksine/1195472020-04-15T00:00+02:00https://www.healthtalk.no/astrazeneca-calquence-covid-19/astrazeneca-tester-kreftlegemidlet-calquence-pa-pasienter-med-coronavirus-viser-lovende-resultater/1195402020-04-15T00:00+02:00https://www.healthtalk.no/kondisjon/tren-ute-6-gode-ovelser-for-rumpe-og-ben/1195352020-04-14T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-espen-rostrup-nakstad/helsemyndighetene-vil-coronateste-barna-for-gjenapning-av-barnehagene/1195212020-04-11T00:00+02:00https://www.healthtalk.no/coronatest-coronavirus-helsedirektoratet/helsedirektoratet-haper-a-teste-100000-nordmenn-hver-uke-fra-mai/1195142020-04-09T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-helsedirektoratet/250-coronainnlagte-pa-sykehus-27-faerre-enn-i-gar/1195032020-04-08T00:00+02:00https://www.healthtalk.no/bent-hoie-coronavirus-coronaviruset/regjeringen-delapner-norge/1194962020-04-07T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-erna-solberg/mot-delvis-apning-av-skoler-og-barnehager-senere-i-april/1194892020-04-07T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-folkehelseinstituttet/fhi-topp-coronagrepet-ma-losnes-faerre-innlagte-og-faerre-pa-respirator/1194822020-04-07T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-erling-holmoy/samfunnsokonomer-stotter-de-strenge-coronatiltakene/1194752020-04-06T00:00+02:00https://www.healthtalk.no/bent-hoie-camilla-stoltenberg-coronavirus/hoie-vi-har-epidemien-under-kontroll-hver-coronasmittet-smitter-na-i-snitt-07-personer/1194672020-04-06T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-ulleval-sykehus/overlege-frykter-lemping-pa-coronatiltak/1194542020-04-06T00:00+02:00https://www.healthtalk.no/forebygging-hjemmekontor-ryggsmerter/forebygging-av-ryggsmerter-mer-bevegelig-pa-10-minutter/1193572020-04-07T00:00+02:00https://www.healthtalk.no/helse-og-livsstil-forebygging-hjemmekontor-nakkesmerter/slik-forebygger-du-nakkesmerter-pa-hjemmekontoret/1193142020-04-07T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-respirator/89-far-respiratorbehandling-laveste-tall-siden-28-mars/1192972020-04-05T00:00+02:00https://www.healthtalk.no/gs1-lovisenberg-sykehus-medisinsk-utstyr/sporing-av-medisinsk-utstyr-gir-okt-effektivitet-og-bedret-pasientsikkerhet/1192722020-04-07T00:00+02:00https://www.healthtalk.no/cathrine-m-lofthus-coronaviruset-helse-sor-ost/na-smittevernutstyr-pa-vei-ut-i-hele-landet/1192582020-04-03T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-respirator/nye-tall-318-koronasmittede-innlagt-pa-norske-sykehus-sju-faerre-enn-onsdag/1192442020-04-02T00:00+02:00https://www.healthtalk.no/coronaviruset-legeforeningen-marit-hermansen/legeforeningen-urolig-ber-syke-folk-ga-til-legen/1192302020-04-01T00:00+02:00https://www.healthtalk.no/bent-hoie-erna-solberg-helseteknologi/bred-kritikk-av-erna-respirator-sykepleierforbundet-uegnet/1192212020-04-01T00:00+02:00https://www.healthtalk.no/acc-caravaggio-eliquis/caravaggio-studien-eliquis-er-like-effektiv-og-trygg-som-fragmin-i-behandlingen-av-kreftpasienter-med-venos-tromboembolisme/1192092020-03-31T00:00+02:00https://www.healthtalk.no/brystkreft-karsten-bruins-slot-legemidler-og-biotek/beslutningsforum-sier-ja-til-forste-immunterapi-mot-brystkreft-ingen-andre-immunterapier-er-tilgjengelig-for-denne-pasientgruppen/1191992020-03-30T00:00+02:00https://www.healthtalk.no/dan-atar-hjertesvikt-legemidler-og-biotek/hjertesviktlegemidlet-vericiguat-med-gode-fase-3-resultater-gledelig-resultat-ogsa-for-norske-pasienter/1191672020-03-29T00:00+01:00https://www.healthtalk.no/acc-legemidler-og-biotek-voyager/voyager-pad-studien-xarelto-sammen-med-aspirin-gir-god-effekt-for-pasienter-med-roykebein/1191622020-03-28T00:00+01:00https://www.healthtalk.no/acc-american-college-of-cardiology-legemidler-og-biotek/na-hjertekongressen-acc-gar-digitalt-det-er-gratis-adgang/1191512020-03-28T00:00+01:00https://www.healthtalk.no/bristol-myers-squibb-bristol-myers-squibb-fda/bristol-myers-squibbs-ms-legemiddel-far-ja-fra-usa/1191192020-03-26T00:00+01:00https://www.healthtalk.no/camilla-stoltenberg-corona-vaksine-coronaviruset/camilla-stoltenberg-tror-coronatiltak-vil-vare-i-18-maneder/1191122020-03-25T00:00+01:00https://www.healthtalk.no/camilla-stoltenberg-tror-coronatiltak-vil-vare-i-18-maneder/1191052020-03-25T00:00+01:00https://www.healthtalk.no/karita-bekkemellem-legemiddelindustrien-legemidler-og-biotek-coronaviruset/lmi-brev-til-naerings-og-helseministeren-etterlyser-signaler-om-a-starte-nasjonal-produksjon-av-viktige-legemidler/1190982020-03-25T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset-digital-konsultasjon/20-000-digitale-konsultasjoner-daglig-pasientene-rommer-fastlegekontorene/1190882020-03-25T00:00+01:00https://www.healthtalk.no/barn-coronaviruset/fhi-fa-barn-blir-smittet-og-de-far-mildere-symptomer-enn-voksne-knapt-registrert-dodsfall/1190812020-03-24T00:00+01:00https://www.healthtalk.no/stadig-flere-yngre-rammes-av-tarmkreft-ga-til-legen-om-du-har-disse-symptomene/1190702020-03-24T00:00+01:00https://www.healthtalk.no/innlegg/annen-pasientbehandling-ma-ikke-stoppe-opp-norske-e-helseselskaper-kan-bidra/1190602020-03-24T00:00+01:00https://www.healthtalk.no/benmargskreft-blodkreftforeningen-fredrik-schjesvold/nye-legemidler-oker-overlevelsen-til-pasienter-med-benmargskreft/1190482020-03-23T00:00+01:00https://www.healthtalk.no/cozaar-legemidler-og-biotek-malariapille/legemiddelselskaper-oker-produksjonen-av-malariapillen-som-trump-vil-ha-som-coronavirusbehandling/1190412020-03-22T00:00+01:00https://www.healthtalk.no/legemiddelslekskaper-oker-produksjonen-av-malariapillen-som-trump-vil-ha-som-coronavirusbehandling/1190272020-03-22T00:00+01:00https://www.healthtalk.no/cathrine-m-lofthus-coronavirus-coronaviruset/kritisk-mangel-pa-smittevernutstyr-ber-om-hjelp-fra-tannlegekontorer-veterinaerer-og-hudpleiesalonger/1190202020-03-21T00:00+01:00https://www.healthtalk.no/bent-hoie-coronavirus-coronaviruset/enorm-interesse-for-coronaforskning-114-norske-fagmiljoer-kappes-om-30-millioner/1190132020-03-20T00:00+01:00https://www.healthtalk.no/coronavirus-cozaar-legemidler-og-biotek-coronaviruset/billig-hjertemedisin-testes-i-kapplopet-for-a-finne-en-behandling-for-coronaviruset/1190052020-03-20T00:00+01:00https://www.healthtalk.no/haukeland-starter-forsok-med-corona-legemidlet-remdesivir/1189762020-03-19T00:00+01:00https://www.healthtalk.no/coronaviruset-universitetet-i-oslo/uio-forskere-vil-bruke-mobildata-for-a-forutse-smittespredning/1189692020-03-18T00:00+01:00https://www.healthtalk.no/geelmuyden-kiese-geir-ove-harnes-innlegg/moter-pandemien-med-penn-og-papir/1189612020-03-18T00:00+01:00https://www.healthtalk.no/ibux-legemidler-og-biotek-coronaviruset-paracet/legemiddelverket-ingen-dokumentasjon-pa-at-ibux-forverrer-covid-19-sykdom/1189542020-03-18T00:00+01:00https://www.healthtalk.no/coronaviruset/arbeidsminister-torbjorn-roe-isaksen-er-corona-smittet/1189472020-03-18T00:00+01:00https://www.healthtalk.no/bjorn-atle-bjornbeth-cathrine-m-lofthus-coronaviruset/6000-sykehusansatte-i-karantene-68-coronapasienter-er-innlagt-pa-sykehus/1189382020-03-17T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset-lothar-wieler/det-tyske-folkehelseinstituttet-sier-at-coronapandemien-kan-vare-i-to-ar/1189212020-03-17T00:00+01:00https://www.healthtalk.no/coronavirus-covid-19-legemidler-og-biotek-coronaviruset/legemiddelverket-innforer-rasjonering-av-lovende-coronamedisin-stor-studie-starter-i-spania/1189122020-03-17T00:00+01:00https://www.healthtalk.no/coronavirus-covid-19/sa-lenge-kan-coronaviruset-leve-i-luften-pa-pakker-metall-og-plast/1188952020-03-16T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset-helsedirektoratet/helsedirektoratet-fysioterapeuter-kiropraktorer-psykologer-og-optikere-ma-stenge-dorene-for-a-stoppe-coronaspredning/1188802020-03-15T00:00+01:00https://www.healthtalk.no/bjorn-atle-bjornbeth-coronavirus-coronaviruset/ous-14-ansatte-er-smittet-og-1081-i-karantene-vil-bli-nodvendig-a-fravike-karantenereglene/1188722020-03-15T00:00+01:00https://www.healthtalk.no/ebola-gilead-legemidler-og-biotek-coronaviruset/oslo-universitetssykehus-vil-teste-ut-ebolamedisinen-remdesivir-pa-coronasmittede/1188632020-03-16T00:00+01:00https://www.healthtalk.no/coronaviruset/1-av-4-som-er-smittet-har-fatt-viruset-i-norge/1188552020-03-15T00:00+01:00https://www.healthtalk.no/cobas-coronavirus-coronaviruset/ny-coronavirus-test-som-er-10-ganger-raskere-er-na-godkjent/1188452020-03-15T00:00+01:00https://www.healthtalk.no/bjorn-guldvog-bjorn-inge-larsen-coronavirus/helsedirektoren-ga-karantenefritak-til-helsetopp-na-er-40-helsebyrakrater-i-karantene/1188382020-03-14T00:00+01:00https://www.healthtalk.no/diabetes-diabetes-type-2-legemidler-og-biotek-coronaviruset/apotek-gar-tomme-innforer-rasjonering-av-diabetes-2-legemiddel/1188312020-03-14T00:00+01:00https://www.healthtalk.no/diabetes-diabetes-type-1-insulin/pasienter-hamstrer-livsviktig-insulin-legemiddelverket-innforer-rasjonering/1188092020-03-14T00:00+01:00https://www.healthtalk.no/cathrine-m-lofthus-coronavirus-coronaviruset/helse-sor-ost-22-pasienter-innlagt-med-coronasmitte-fire-i-respirator/1188002020-03-13T00:00+01:00https://www.healthtalk.no/bent-hoie-coronavirus-coronaviruset/helseministeren-helsepersonell-som-driver-pasientbehandling-forbys-a-reise-utenlands/1187932020-03-13T00:00+01:00https://www.healthtalk.no/apotek-audun-haga-coronavirus/rasjonering-av-paracet-frykt-for-mangel-pa-livsviktige-legemidler/1187852020-03-13T00:00+01:00https://www.healthtalk.no/bent-hoie-coronavirus-coronaviruset/den-forste-har-dodd-av-corona-i-norge-var-innlagt-pa-oslo-universitetssykehus/1187602020-03-12T00:00+01:00https://www.healthtalk.no/bent-hoie-bjorn-guldvog-folkehelseinstituttet/kraftig-okning-i-antall-smittede-vil-nekte-innreise-fra-smitterammede-land/1187272020-03-11T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-sats/corona-smitte-pa-sats/1187132020-03-11T00:00+01:00https://www.healthtalk.no/coronavirus-legemidler-og-biotek-oslo-kommune/pa-tide-med-drastiske-tiltak-oslo-kommune-hever-beredskapsnivaet-og-forbyr-arrangementer/1187062020-03-11T00:00+01:00https://www.healthtalk.no/bent-hoie-bjorn-guldvag-coronavirus/helsedirektoren-situasjonen-er-alvorlig-vi-er-over-i-en-ny-fase-avlys-alle-arrangementer-med-mer-enn-500-deltakere/1186982020-03-10T00:00+01:00https://www.healthtalk.no/corona-vaksine-coronavirus-covid-19/hvor-lenge-ma-vi-vente-pa-en-coronavaksine-test-pa-mennesker-starter-i-april/1186872020-03-11T00:00+01:00https://www.healthtalk.no/coronavirus-erna-solberg-jan-tore-sanner/erna-solberg-om-coronaviruset-vil-kjope-inn-mere-legemidler/1186812020-03-10T00:00+01:00https://www.healthtalk.no/coronavirus-covid-19-inkubasjonstid/ny-studie-coronaviruset-har-en-inkubasjonstid-pa-fem-dager/1186742020-03-10T00:00+01:00https://www.healthtalk.no/coronavirus-covid-19-folkehelseinstituttet/192-coronasmittet-55-er-blitt-smittet-i-norge-5-innlagt-pa-sykehus/1186652020-03-09T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset-covid-19/na-169-personer-smittet-i-norge-fodeavdeling-stenges-etter-coronasmitte/1186582020-03-08T00:00+01:00https://www.healthtalk.no/coronavirus-covid-19-einar-magnus-strand/coronasmitte-pa-sunnaas-sykehus/1186502020-03-08T00:00+01:00https://www.healthtalk.no/bjorn-guldvag-coronavirus-helsedirektoratet/155-smittet-helsedirektoratet-skjerper-tiltakene-for-a-hindre-smitte/1186422020-03-07T00:00+01:00https://www.healthtalk.no/kreft/flere-far-og-flere-lever-lengre-med-benmargskreft/1186322023-12-15T16:02+01:00https://image.healthtalk.no?imageId=109955&format=webp&width=1200https://www.healthtalk.no/113-coronasmittet-i-norge-27-nye-siste-dogn-frykter-at-eldre-og-syke-skal-bli-smittet/1186202020-03-06T00:00+01:00https://www.healthtalk.no/coronaviruset/pressemote-folkehelseinstituttet-coronavirus-live/1186112020-03-06T00:00+01:00https://www.healthtalk.no/bent-hoie-coronavirus-covid-19/norge-kan-ga-tom-for-viktige-legemidler-regjeringen-stanser-all-eksport/1186042020-03-06T00:00+01:00https://www.healthtalk.no/e-helsedagen-2020-healthtalkno-live/1185942020-03-06T00:00+01:00https://www.healthtalk.no/cold-response-coronavirus-legemidler-og-biotek/100-i-coronakarantene-stenger-skjold-leir-militaerovelsen-bor-avlyses-sier-soldater/1185872020-03-05T00:00+01:00https://www.healthtalk.no/coronavirus-covid-19-folkehelseinstituttet/25-personer-i-norge-er-coronasmittet-epidemien-kan-ga-over-i-en-ny-fase/1185802020-03-02T00:00+01:00https://www.healthtalk.no/coronavirus-legemidler-og-biotek-ulleval-sykehus/23-ansatte-ved-ulleval-sykehus-har-testet-negativt-for-coronaviruset/1185662020-03-02T00:00+01:00https://www.healthtalk.no/kreft/stadig-flere-yngre-rammes-av-tarmkreft-ga-til-legen-om-du-har-disse-symptomene/1185412023-12-15T15:49+01:00https://image.healthtalk.no?imageId=162464&format=webp&width=1200https://www.healthtalk.no/coronavirus-legemidler-og-biotek-oslo-universitetssykehus/tre-ulleval-ansatte-smittet-av-coronaviruset-50-i-karantene-400-pasienter-skal-testes/1185342020-02-29T00:00+01:00https://www.healthtalk.no/blodpropp-hjerteflimmer-legemidler-og-biotek/blodfortynner-til-hjerteflimmerpasienter-star-til-eksamen/1185132020-02-27T00:00+01:00https://www.healthtalk.no/coronavirus-folkehelseinstituttet-legemidler-og-biotek/fhi-coronaviruset-pavist-i-norge-liten-smitterisiko/1185062020-02-26T00:00+01:00https://www.healthtalk.no/bjorn-erikstein-bransjenytt-christine-sagen-helgo/bjorn-erikstein-er-ny-styreleder-i-helse-stavanger/1184852020-02-26T00:00+01:00https://www.healthtalk.no/bransjenytt-einar-stromsvag-foto-svein-lunde/inger-cathrine-bryne-blir-ny-direktor-i-helse-vest-rhf/1184702020-02-21T00:00+01:00https://www.healthtalk.no/apotek-apotekforeningen-legemiddelmangel/har-laget-felles-standard-for-apotekenes-handtering-av-legemiddelmangel/1184542020-02-25T00:00+01:00https://www.healthtalk.no/gs1-helse-sor-ost-helseteknologi/pa-vei-mot-det-heldigitale-sykehuset-helse-sor-ost-tidlig-ute-med-bruk-av-standarder/1184462020-03-09T00:00+01:00https://www.healthtalk.no/kreft/maria-sodahl-fikk-lungekreft-laget-nadelos-film-om-kreft-og-kjaerlighet/1184352023-12-15T15:57+01:00https://image.healthtalk.no?imageId=106598&format=webp&width=1200https://www.healthtalk.no/bent-hoie-beslutningsforum-legemidler-og-biotek-politikk/hoie-vil-ha-din-mening-om-beslutningsforum/1184202020-02-19T00:00+01:00https://www.healthtalk.no/blaerekreft-cysview-hexvix/photocure-far-nytt-patent-i-usa-apner-muligheter-for-ny-indikasjon/1184042020-02-17T00:00+01:00https://www.healthtalk.no/barnekreft-barnekreftforeningen-legemidler-og-biotek/barnekreftforeningen-deler-ut-19-millioner-til-forskning-vi-trenger-mer-forskning-og-star-klare-med-pengesekken/1183742020-02-14T00:00+01:00https://www.healthtalk.no/bjorn-arild-gram-bransjenytt-ks/bjorn-arild-gram-ny-styreleder-i-ks/1183612020-02-12T00:00+01:00https://www.healthtalk.no/apotek-apotekforeningen-farmasistudenter/norge-trenger-flere-farmasoyter-apotekforeningen-starter-rekrutteringskampanje/1183522020-02-12T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset-covid-19/na-har-coronaviruset-fatt-et-navn-vaksine-tidligst-klar-om-18-maneder/1183452020-02-11T00:00+01:00https://www.healthtalk.no/bransjenytt-ingrid-stenstadvold-ross-kreftforeningen/her-er-kreftforeningens-nye-generalsekretaer-en-nodvendig-fornying/1183232020-02-10T00:00+01:00https://www.healthtalk.no/bivirkninger-fastlege-legemiddelindustrien/fastleger-far-ikke-lenger-bivirkningsinformasjon-pa-papir/1182842020-02-05T00:00+01:00https://www.healthtalk.no/beslutningsforum-blodermedisin-foreningen-for-blodere-i-norge/blodermedisin-fikk-nei-av-beslutningsforum-darlig-nytt-for-barn/1182662020-02-05T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-forskning/oslo-var-moteplassen-for-flere-av-verdens-ledende-kreftforskere/1182612020-02-04T00:00+01:00https://www.healthtalk.no/arbeidsskadedodsfall-arbeidstilsynet-helse-og-livsstil/29-arbeidsskadedodsfall-i-2019-7-av-10-skjedde-ved-bruk-av-kjoretoy/1182532020-02-06T00:00+01:00https://www.healthtalk.no/bent-hoie-bransjenytt-politikk-froydis-hoyem/froydis-hoyem-blir-ny-statssekretaer-i-helse-og-omsorgsdepartementet/1182402020-02-03T00:00+01:00https://www.healthtalk.no/leserinnlegg-politikk/et-oppgjor-om-verdier/1182322020-02-03T00:00+01:00https://www.healthtalk.no/bayer-darolutamide-legemidler-og-biotek/bayer-naermere-eu-godkjenning-for-nytt-legemiddel-mot-prostatakreft/1182192020-02-04T00:00+01:00https://www.healthtalk.no/dignio-helseteknologi-lars-christian-dahle/fullt-hus-da-dignio-inviterte-til-dypdykk-om-avstandsoppfolging/1182112020-02-03T00:00+01:00https://www.healthtalk.no/bransjenytt-direktoratet-for-samfunnssikkerhet-og-beredskap-dsb/elisabeth-sorboe-aarsaether-54-skal-lede-direktoratet-for-samfunnssikkerhet-og-beredskap-dsb/1181972020-01-31T00:00+01:00https://www.healthtalk.no/bent-hoie-coronavirus-legemidler-og-biotek/regjeringen-forbereder-norge-coronavirus-blir-meldepliktig-sykdom/1181902020-01-31T00:00+01:00https://www.healthtalk.no/ema-legemidler-og-biotek-lemtrada/ms-legemidlet-lemtrada-har-fatt-ny-indikasjon-i-samsvar-med-hvordan-vi-allerede-har-brukt-lemtrada-sier-ms-professor/1181702020-01-31T00:00+01:00https://www.healthtalk.no/coronavirus-helse-og-livsstil-who/coronaviruset-sprer-seg-raskt-who-erklaerer-internasjonal-folkehelsekrise/1181612020-01-30T00:00+01:00https://www.healthtalk.no/ledig-stilling/er-du-var-nye-digitale-markedssjef/1181542020-01-29T00:00+01:00https://www.healthtalk.no/digitale-innkallingsbrev-direktoratet-for-e-helse-ellen-pettersen/digitale-innkallingsbrev-tas-na-i-bruk-i-helse-sor-ost/1181402020-01-28T00:00+01:00https://www.healthtalk.no/argus-syn-bransjenytt-marianne-pettersen/volvat-kjoper-opp-argus-syn-og-vokser-innen-syn-og-oyehelse/1181192020-01-30T00:00+01:00https://www.healthtalk.no/direktoratet-for-e-helse-folkehelseinstituttet-helsedata/na-far-forskere-lettere-tilgang-til-helsedata/1180912020-01-28T00:00+01:00https://www.healthtalk.no/bent-hoie-helgeland-politikk/regjeringen-sier-ja-til-to-akuttsykehus-pa-helgeland/1180842020-01-27T00:00+01:00https://www.healthtalk.no/blogg-ewings-sarkom-kreftkompasset/ville-jeg-vaert-kreften-foruten/1180752022-10-10T11:44+02:00https://www.healthtalk.no/aterosklerose-compass-studien-dan-atar/fikk-endelig-blaresept-flere-overlever-med-komboen-aspirin-og-blodfortynnende-medisin/1180652020-01-27T00:00+01:00https://www.healthtalk.no/bent-hoie-eldre-og-folkehelseminister-politikk/ble-ingen-suksess-hoie-tar-tilbake-eldre-og-og-folkehelsepolitikken/1180442020-01-24T00:00+01:00https://www.healthtalk.no/biogen-karsten-bruins-slot-legemidler-og-biotek/ny-studie-bekrefter-effekten-av-risdiplam-roche-gjor-seg-klar-til-sma-duell-mot-biogen-og-novartis/1180332020-01-23T00:00+01:00https://www.healthtalk.no/helse-og-livsstil-politikk-podcast/hor-podcast-vil-lofte-de-svakeste-og-sette-dem-pa-en-gulltrone/1180262020-01-23T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-helseteknologi/may-britt-har-testet-tusenvis-for-benskjorhet/1180062020-01-31T00:00+01:00https://www.healthtalk.no/anne-lise-ryel-bukspyttkjertelkreft-forskning/kreftforeningen-med-22-millioner-til-forskning-pa-bukspyttkjertelkreft/1179982020-01-21T00:00+01:00https://www.healthtalk.no/demensvennlige-kommune-loten-marte-larsen-tonseth/loten-er-norges-mest-demensvennlige-kommune/1179852020-01-20T00:00+01:00https://www.healthtalk.no/bjorn-atle-bjornbeth-bransjenytt-gunnar-bovim/bjorn-atle-bjornbeth-er-ny-administrerende-direktor-ved-ous/1179762020-01-17T00:00+01:00https://www.healthtalk.no/bransjenytt-dignio-john-creed/dignio-vil-inn-pa-sykehusene-ansetter-tidligere-ceo-i-pasientsky/1179672020-01-17T00:00+01:00https://www.healthtalk.no/anna-winge-main-cancer-crosslinks-car-t/disse-to-star-i-fronten-av-internasjonal-kreftforskning/1179562020-01-16T00:00+01:00https://www.healthtalk.no/aleris-anne-kari-bratten-civita/her-er-kristin-clemet-i-tankesmien-civita-sine-rad-til-den-norske-helsenaeringen/1179502020-01-15T00:00+01:00https://www.healthtalk.no/helseteknologi-politikk-ingeborg-hagerup-jensen-protonsenter/kreftprotonsenter-til-3-milliarder-har-gatt-under-radaren/1179402022-10-10T11:44+02:00https://www.healthtalk.no/abbvie-bla-resept-dopamin/viktig-parkinsonsmedisin-pa-bla-resept/1179162020-01-11T00:00+01:00https://www.healthtalk.no/bms-de-storste-legemiddelselskapene-farmastat/novartis-er-norges-storste-legemiddelfirma-gar-forbi-pfizer-og-msd/1179032020-01-20T00:00+01:00https://www.healthtalk.no/slik-vil-du-merke-at-terje-soviknes-har-blitt-eldre-og-folkehelseminister/1178982020-01-10T00:00+01:00https://www.healthtalk.no/akson-direktoratet-for-e-helse-helseteknologi/journaljungel-gjor-at-helsepersonellet-i-kommunene-mangler-viktig-pasientinformasjon/1178902020-01-10T00:00+01:00https://www.healthtalk.no/apeland-artell-bransjenytt/carl-fredrik-bo-gar-fra-apeland-blir-ny-byraleder-for-artell/1178822020-01-08T00:00+01:00https://www.healthtalk.no/apotek-apotekforeningen-helsedepartementet/apotekforeningen-slakter-regjeringens-forslag-for-a-trygge-legemiddelforsyningen/1178722020-01-07T00:00+01:00https://www.healthtalk.no/jobb-i-healthtalk/er-du-var-nye-digitale-markedsforer/1178632020-01-07T00:00+01:00https://www.healthtalk.no/hege-lundin-kuhle-helseteknologi-organdonasjon/rekordar-for-organdonasjon-aldri-for-har-flere-sagt-ja/1178482020-01-06T00:00+01:00https://www.healthtalk.no/avonova-bransjenytt-eskild-larsen/stamina-group-ma-gjennom-en-omfattende-snuoperasjon-toppsjefene-i-norge-og-sverige-gar/1178372020-01-06T00:00+01:00https://www.healthtalk.no/babcock-bent-hoie-helseminister/slik-vil-hoie-gjenreise-tilliten-til-luftambulansetjenesten/1178302020-01-04T00:00+01:00https://www.healthtalk.no/bransjenytt-helse-nord-trondelag-ingrid-finboe-svendsen/tor-am-er-ny-toppsjef-helse-nord-trondelag/1178232020-01-03T00:00+01:00https://www.healthtalk.no/ai-brystkreft-google-health/ai-er-bedre-enn-leger-til-a-diagnostisere-brystkreft/1178112020-01-06T00:00+01:00https://www.healthtalk.no/beslsutningsforum-legemidler-og-biotek-lungekreft/englands-beslutningsforum-sier-nei-til-kreftlegemiddel-fra-roche-prisen-er-for-hoy/1178032020-01-03T00:00+01:00https://www.healthtalk.no/helse-og-livsstil/fem-tips-for-a-oppna-en-sunnere-livsstil/1177962020-01-02T00:00+01:00https://www.healthtalk.no/crispr-helseteknologi/kinesisk-domstol-dommer-genredigeringsforsker-til-tre-ars-fengsel/1177752019-12-31T00:00+01:00https://www.healthtalk.no/astrazeneca-bukspyttkjertelen-eggstokkreft/astrazenecas-lynparza-far-fda-ja-for-behandling-av-kreft-i-bukspyttkjertelen/1177592019-12-30T00:00+01:00https://www.healthtalk.no/arendal-kommune-christine-bergland-direktoratet-for-e-helse/arendal-er-forste-kommune-med-kjernejournal/1177512019-12-30T00:00+01:00https://www.healthtalk.no/cathrine-m-lofthus-helse-sor-ost-rhf-helse-sor-ost/helse-sor-ost-skal-kjope-inn-selvbetjeningslosninger-for-innsjekking-og-betaling/1177442019-12-30T00:00+01:00https://www.healthtalk.no/alzheimer-beslutningsforum-foflekkreft/her-er-de-10-mest-leste-sette-og-horte-sakene-pa-healthtalk-i-2019/1177312019-12-28T00:00+01:00https://www.healthtalk.no/amg-510-amgen-biotilsvarende-legemidler/mot-marco-forestiere-amgens-nye-toppsjef-i-norge/1177242019-12-23T00:00+01:00https://www.healthtalk.no/trening-styrke/atte-basisovelser-for-hele-kroppen/1176932019-12-20T00:00+01:00https://www.healthtalk.no/fagradet-for-persontilpasset-medisin-helsedirektoratet-legemidler-og-biotek/disse-er-med-i-fagradet-for-persontilpasset-medisin/1176772019-12-19T00:00+01:00https://www.healthtalk.no/brystkreft-kreftregisteret-legemidler-og-biotek-forskning/screening-og-bedre-behandling-gjor-at-langt-faerre-dor-av-brystkreft/1176682019-12-18T00:00+01:00https://www.healthtalk.no/aimovig-anne-christine-poole-avjoy/migrenemedisinen-ajovy-kommer-pa-bla-resept/1176502019-12-18T00:00+01:00https://www.healthtalk.no/fastlege-ks-legeforeningen/legeforeningen-bryter-ks-forhandlingene-om-saeravtalen/1175962019-12-11T00:00+01:00https://www.healthtalk.no/bransjenytt-gisle-nodtvedt-nina-roland/stiftelsen-organdonasjon-har-fatt-ny-styreleder-har-et-brennende-engasjement/1175882019-12-11T00:00+01:00https://www.healthtalk.no/gaba-a-reseptorer-legemidler-og-biotek-sage-therapeutics/studie-om-nytt-legemiddel-mot-depresjon-feilet-borsverdien-halvert/1175732019-12-11T00:00+01:00https://www.healthtalk.no/farmasiet-hans-kristian-furuseth-legemidler-og-biotek-bransjenytt/farmasietno-er-arets-apotek-og-helsekost-2019/1175652019-12-10T00:00+01:00https://www.healthtalk.no/immunterapi-legemidler-og-biotek-radiumhospitalet/kreftoverlege-pasientene-far-livet-i-gave/1175502019-12-09T00:00+01:00https://www.healthtalk.no/diabetes-eva-gerdts-hjertesvikt/ny-forskning-halvparten-av-kvinner-med-hjertesvikt-far-ikke-tilstrekkelig-behandling/1175422019-12-09T00:00+01:00https://www.healthtalk.no/cpap-garmin-garmin-health/kunstig-intelligens-finner-farlig-sovnsykdom/1175292019-12-10T00:00+01:00https://www.healthtalk.no/aimovig-bla-resept-legemidler-og-biotek/migrenemedisinen-aimovig-kommer-pa-bla-resept-fra-mandag/1175182019-12-06T00:00+01:00https://www.healthtalk.no/helseteknologi-politikk/en-politisk-entreprenor-i-oslos-utstillingsvindu/1175092019-12-04T00:00+01:00https://www.healthtalk.no/alvorlig-astma-astma-atopisk-eksem/ny-behandling-av-alvorlig-astma-er-na-godkjent/1174662019-12-03T00:00+01:00https://www.healthtalk.no/bent-hoie-helseomsorg21-politikk/nytt-helseomsorg21-rad/1174532019-11-29T00:00+01:00https://www.healthtalk.no/arctic-nutritions-innovasjon-norge-legemidler-og-biotek/silderogn-mot-psoriasis-innovasjon-norge-stotter-arctic-nutritions-med-14-millioner-kroner/1174462019-11-27T00:00+01:00https://www.healthtalk.no/havard-aagesen-kreft-kreftoverlever/havard-53-overlevde-kreften-men-livet-blir-aldri-det-samme/1174322019-11-26T00:00+01:00https://www.healthtalk.no/immunterapi-james-p-allison-jan-vincents-johannesen/immunterapi-frigjor-kreftpasienter-fra-frykten-for-tilbakefall/1173972019-11-21T00:00+01:00https://www.healthtalk.no/mintopp-cecilie-braten-legemidler-og-biotek-lev-med/alle-kan-na-sin-topp/1173902019-11-21T00:00+01:00https://www.healthtalk.no/helse/nobelprisvinneren-i-medisin-til-tromso-og-onkologisk-forum/1173602023-12-06T15:11+01:00https://www.healthtalk.no/lev-med-lungekreft-lungekreftforeningen/mistet-moren-i-lungekreft-skal-lope-opp-og-ned-kilimanjaro-pa-24-timer-til-stotte-for-lungekreftforeningen/1173252019-11-15T00:00+01:00https://www.healthtalk.no/flatiron-health-helseteknologi-ketil-widerberg/na-smelter-persontilpasset-medisin-og-e-helse-sammen-nar-vil-helsebransjen-mote-sin-tesla/1173162019-11-13T00:00+01:00https://www.healthtalk.no/ai-computas-ehin/kunstig-intelligens-nar-terminator-blir-fastlegen-din/1173072019-11-13T00:00+01:00https://www.healthtalk.no/ehin-evondos-helseteknologi/roboten-e300-gir-oss-medisin-pa-direkten-i-studio/1172982019-11-13T00:00+01:00https://www.healthtalk.no/dips-ehin-epic/mot-norges-e-helselokomotiv/1172892019-11-13T00:00+01:00https://www.healthtalk.no/aasmund-rinde-aspit-envision/na-kan-leger-trygt-dele-bilder-og-video-fra-mobiltelefonen/1172822019-11-13T00:00+01:00https://www.healthtalk.no/anne-gunvor-nystrom-helseteknologi-iver-olav-sunnset/bedre-helse-med-digital-oppfolging-i-hjemmet-pasientene-er-kjempefornoyde/1172682019-11-11T00:00+01:00https://www.healthtalk.no/feiringklinikken-helge-istad-hjerteinfarkt/hjerteinfarktpasienter-folges-ikke-godt-nok-opp-av-fastlegen-ansvaret-ma-flyttes-til-sykehusene/1172562019-11-11T00:00+01:00https://www.healthtalk.no/ablasjon-dag-kullerud-dan-atar/dan-borge-akero-slik-overvant-jeg-hjerteinfarkten/1172442019-11-08T00:00+01:00https://www.healthtalk.no/apotek-apotekforeningen-astma/astma-og-kolspasienter-har-fatt-200-000-inhalasjonsveiledninger-i-apotek/1172272019-11-05T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/forste-legemiddel-som-kan-bremse-alzheimer/1172062019-11-05T00:00+01:00https://www.healthtalk.no/beslutningsforum-imfinzi-immunterapi/nytt-hap-for-lungekreftpasienter-kan-bli-kurert-med-ny-immunterapi/1171502019-10-30T00:00+01:00https://www.healthtalk.no/alunbrig-beslutningsforum-brystkreftforeningen/ja-til-fem-nye-kreftlegemidler-og-norges-forste-genprofiltest/1171042019-10-21T00:00+02:00https://www.healthtalk.no/benbrudd-benskjorhet-hofteleddsbrudd/benskjore-brudd-er-norges-skjulte-folkesykdom/1170822019-10-20T00:00+02:00https://www.healthtalk.no/lev-med/hver-tredje-kvinne-over-55-ar-sjekker-seg-ikke-for-livmorhalskreft/1170722019-10-18T00:00+02:00https://www.healthtalk.no/kreftforeningen-ole-alexander-opdalshei-politikk/kreftforeningen-tarmkreftscreening-vil-kunne-spare-300-liv-i-aret/1170202019-10-07T00:00+02:00https://www.healthtalk.no/apotek-apotekforeningen-legemidler/apotekene-far-ikke-dekket-utgifter-til-nye-statlige-oppgaver/1170132019-10-07T00:00+02:00https://www.healthtalk.no/bent-hoie-egnandel-politikk/na-blir-det-dyrt-om-du-ikke-moter-til-avtalt-time-pa-sykehuset/1169992019-10-07T00:00+02:00https://www.healthtalk.no/bent-hoie-camilla-steinum-politikk/regjeringen-fjerner-stotten-til-kosmetisk-tannregulering/1169922019-10-07T00:00+02:00https://www.healthtalk.no/aker-sykehus-bent-hoie-helse-sor-ost/ulleval-sykehus-blir-nedlagt-29-milliarder-til-nytt-oslo-sykehus/1169852019-10-07T00:00+02:00https://www.healthtalk.no/apotek-apotekforeningen-legemiddelpris/prisene-pa-legemidler-faller-kraftig/1169762019-10-06T00:00+02:00https://www.healthtalk.no/bransjenytt-karsten-bruins-slot-nytt-om-navn/karsten-bruins-slot-41-er-ny-medisinsk-direktor-i-roche-jeg-vil-jobbe-for-at-pasientene-far-raskere-tilgang-til-persontilpasset-medisin/1169502019-09-30T00:00+02:00https://www.healthtalk.no/blodprove-kreft-legemidler-og-biotek/ny-blodprove-kan-oppdage-flere-enn-20-krefttyper/1169432019-10-11T00:00+02:00https://www.healthtalk.no/hudkreft-immunterapi-kreft/ny-studie-over-halvparten-som-far-hudkreft-med-spredning-overlever/1169362019-10-10T00:00+02:00https://www.healthtalk.no/aktiv-mot-kreft-bristol-myers-squibb-helle-aanesen/alle-kreftpasienter-ma-fa-tilbud-om-tilpasset-trening-pa-sykehusene/1169262019-09-28T00:00+02:00https://www.healthtalk.no/beslutningsforum-kreft-legemidler-og-biotek/derfor-ma-norske-kreftpasienter-vente-i-to-ar-pa-de-nye-kreftlegemidlene/1169132019-09-30T00:00+02:00https://www.healthtalk.no/bayer-gensekvensering-legemidler-og-biotek/ny-gentilpasset-kreftmedisin-lansert-norske-sykehus-ma-starte-genetisk-testing-for-persontilpasset-medisin/1169042019-10-02T00:00+02:00https://www.healthtalk.no/psoriasis/na-kommer-en-ny-effektiv-medisin-mot-psoriasis/1168602023-12-18T09:43+01:00https://image.healthtalk.no?imageId=106340&format=webp&width=1200https://www.healthtalk.no/babylon-gp-bent-hoie-eyr/hvorfor-er-bent-hoie-en-teknologisinke/1168332019-09-22T00:00+02:00https://www.healthtalk.no/ambulanse-amk-gjenoppliving/vestre-viken-best-i-landet-pa-gjenoppliving-etter-hjertestans/1168262019-10-09T00:00+02:00https://www.healthtalk.no/astrazeneca-diabetes-hjertesvikt/kan-diabetesmedisin-hjelpe-16-000-nordmenn-med-hjertesvikt/1168012019-09-18T00:00+02:00https://www.healthtalk.no/podcast-politikk/ny-podcast-fastlegeordningen-er-i-krise-hvor-blir-det-av-den-digitale-livboyen/1167942019-09-17T00:00+02:00https://www.healthtalk.no/podcast-politikk-stortingsmeldingen-om-helsenaeringen/ny-podcast-viktige-innspill-til-stortingsmeldingen-om-helsenaeringen/1167872019-09-17T00:00+02:00https://www.healthtalk.no/brystkreft-brystkreftforeningen-ellen-harris-utne/betalte-220-000-ut-av-egen-lomme-for-livsviktig-brystkreftmedisin-na-sloss-hun-mot-beslutningsforum/1167552019-09-11T00:00+02:00https://www.healthtalk.no/apotek-apotekforeningen-behandlingsfarmasoyter/na-kan-danske-farmasoyter-skrive-ut-resept-pa-legemidler/1167412019-09-09T00:00+02:00https://www.healthtalk.no/beslsutningsforum-beslutningsforum-brystkreft/krever-ny-brystkreftmedisin-na/1167312019-09-06T00:00+02:00https://www.healthtalk.no/bransjenytt-cecilie-daae-helse-nord/hun-blir-ny-helse-nord-direktor/1167232019-09-02T00:00+02:00https://www.healthtalk.no/beslutningsforum-bransjenytt-helse-sor-ost/jan-frich-blir-ny-viseadministrerende-direktor-i-helse-sor-ost/1166812019-08-30T00:00+02:00https://www.healthtalk.no/helseteknologi-kathrine-myhre-norway-health-tech/helseteknologisjef-kathrine-myhre-norske-grndere-er-pionerer-na-ma-investorene-ta-sjansen/1166672019-08-29T00:00+02:00https://www.healthtalk.no/finans-oljefondet-statens-pensjonsfond-utland/norge-er-storeier-i-internasjonale-legemiddelselskaper/1166602019-08-27T00:00+02:00https://www.healthtalk.no/adjuvant-behandling-beslsutningsforum-bristol-myers-squibb/beslutningsforum-sier-ja-til-adjuvant-foflekkreftbehandling/1166412019-08-26T00:00+02:00https://www.healthtalk.no/helsenaeringsmeldingen-legemidler-og-biotek-politikk-persontilpasset-medisin/roche-tilbyr-norge-partnerskap-for-a-bygge-en-sterk-helsenaering/1166322019-08-25T00:00+02:00https://www.healthtalk.no/helse-og-livsstil-krefoverlevere-kreft/kreftoverlevere-far-egne-mentorer-fra-naeringslivet/1166102019-08-22T00:00+02:00https://www.healthtalk.no/apotek-legeforeningen-per-t-lund/vil-ha-mer-samarbeid-mellom-leger-og-farmasoyter/1166022019-08-21T00:00+02:00https://www.healthtalk.no/helseteknologi-politikk-kommunehelsetjenesten-nina-mevold/sykehusdirektor-i-sor-trenger-kriseforstaelse-for-a-lykkes-med-pasientens-helsetjeneste/1165852019-08-22T00:00+02:00https://www.healthtalk.no/leder-politikk/helse-norge-ma-gjennom-en-kulturell-hestekur/1165782019-08-22T00:00+02:00https://www.healthtalk.no/cannabis-epidiolex-epidyolex/gront-lys-for-cannabismedisin/1165712019-08-19T00:00+02:00https://www.healthtalk.no/arendalsuka-bent-hoie-hoyre/helse-blir-overkjort-av-bompenger-slik-vil-hoie-far-helse-inn-i-valgkampen/1165542022-08-10T16:48+02:00https://www.healthtalk.no/arendalsuka-politikk-stordata/hoyre-dominerer-helsedebatten-i-valgkampen/1165372019-08-12T00:00+02:00https://www.healthtalk.no/astrazeneca-egfr-legemidler-og-biotek-kliniske-studier/astrazenecas-tagrisso-hjelper-lungekreftpasienter-til-a-leve-lenger-viser-ny-studie/1165262019-08-12T00:00+02:00https://www.healthtalk.no/diabetes-dodfodsler-helse-og-livsstil/kvinner-med-diabetes-har-hoyere-risiko-for-dodfodsler/1164982019-08-09T00:00+02:00https://www.healthtalk.no/foflekkreft-immunterapi-legemidler-og-biotek/ny-podcast-kari-anne-hadde-uhelbredelig-foflekkreft-ble-reddet-av-immunterapi/1164892019-08-05T00:00+02:00https://www.healthtalk.no/folkehelseinstituttet-helse-og-livsstil-malaria/resistent-malaria-sprer-seg-i-sorost-asia-folkehelseinstituttet-ta-malaria-forebyggende-medisin-og-unnga-a-bli-bitt/1164792019-08-01T00:00+02:00https://www.healthtalk.no/blindhet-crispr-genredigering/genredigering-skal-kurere-blindhet/1164562019-08-08T00:00+02:00https://www.healthtalk.no/asco-immunterapi-keytruda/legemiddel-oker-femars-overlevelse-markant-for-alvorlig-lungekreft/1164402019-07-27T00:00+02:00https://www.healthtalk.no/cannabis-danmark-legemidler-og-biotek/danske-pasienter-bruker-medisinsk-cannabis-som-aldri-for/1164162019-07-31T00:00+02:00https://www.healthtalk.no/kosthold-livsstil-trening/ny-studie-velvaereprogrammer-pa-jobben-gir-liten-helseeffekt/1164082019-07-24T00:00+02:00https://www.healthtalk.no/e-sigareetter-helseteknologi-snus/ny-bolge-av-nikotinslaver-san-francisco-forbyr-salg-av-e-sigaretter-fra-2020/1163902019-07-22T00:00+02:00https://www.healthtalk.no/cysview-daniel-schneider-hexvix/photocure-star-ved-et-vannskille/1163812019-07-20T00:00+02:00https://www.healthtalk.no/elon-musk-helseteknologi-neuralink/elon-musks-nye-selskap-gar-inn-i-hjernen-din/1163722019-07-19T00:00+02:00https://www.healthtalk.no/helseteknologi-laerdalmedical-laeerdal/laerdal-medical-gar-i-skyen/1163642019-07-20T00:00+02:00https://www.healthtalk.no/bedriftehelsetjeneste-bedriftshelse-daniel-sorli/drdropin-har-behandlet-50-tusen-kunder-satser-pa-bedriftsmarkedet/1163552019-07-18T00:00+02:00https://www.healthtalk.no/livsstil-og-forebygging/sverige-har-fatt-strengere-roykelov-forbudt-a-royke-ute/1163372024-01-02T09:14+01:00https://image.healthtalk.no?imageId=108136&format=webp&width=1200https://www.healthtalk.no/apple-blodsukkermaler-dabetes/apple-store-selger-blodsukkermalere-fra-inntrengeren-one-drop/1163232019-07-16T00:00+02:00https://www.healthtalk.no/henrik-nilssen-dale-legemidler-og-biotek-roche/henrik-nilssen-dale-24-blir-sosiale-medier-radgiver-i-roche/1163152019-07-13T00:00+02:00https://www.healthtalk.no/brus-dyrnesutvalget-fedme/juice-og-brus-oker-risikoen-for-a-fa-kreft/1163022019-07-13T00:00+02:00https://www.healthtalk.no/bruntfett-hvittfett-legemidler-og-biotek/kommer-slankepillen-som-bade-reduserer-matinntaket-og-oker-fettforbrenningen/1162772019-07-09T00:00+02:00https://www.healthtalk.no/apotek-borrelia-flatt/flatt-vaksinering-er-doblet-pa-ett-ar/1162632019-07-11T00:00+02:00https://www.healthtalk.no/helseteknologi-organ-organdonasjon/flere-sier-ja-til-organdonasjon-men-ventelistene-oker/1162542019-07-08T00:00+02:00https://www.healthtalk.no/demens/nye-studie-mye-brukte-legemidler-oker-risikoen-for-demens/1162442023-12-18T09:26+01:00https://image.healthtalk.no?imageId=108524&format=webp&width=1200https://www.healthtalk.no/asieres-cevira-cysview/photocure-inngar-milliardavtale-med-kinesiske-asieris/1162272019-07-02T00:00+02:00https://www.healthtalk.no/apotek-apotek-1-apotekforeningen/stovsuger-markedet-for-legemidler-apotek-1-har-etablert-et-mangelteam/1162172019-07-03T00:00+02:00https://www.healthtalk.no/disiplinaersak-dr-droppin-legeforeningen/bli-syk-besok-legen-fa-billigere-flyreiser/1162082019-06-30T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/kreftlegens-solrad-slik-unngar-du-a-fa-foflekkreft/1161962019-06-28T00:00+02:00https://www.healthtalk.no/aimovig-anne-christine-poole-bent-hoie/legemiddelverket-gir-ny-migrenemedisin-gront-lys-vil-bent-hoie-ga-for-bla/1161862019-06-27T00:00+02:00https://www.healthtalk.no/livsstil-og-forebygging/mange-tusen-barn-og-unge-med-autisme-kan-fa-hjelp-mot-sovnloshet/1161782024-01-02T09:15+01:00https://image.healthtalk.no?imageId=108586&format=webp&width=1200https://www.healthtalk.no/livsstil-og-forebygging/godkjenner-legemiddel-som-oker-kvinners-sexlyst/1161702024-01-02T09:13+01:00https://image.healthtalk.no?imageId=108595&format=webp&width=1200https://www.healthtalk.no/andr-bregard-diabetes-legemidler-og-biotek/novo-nordisk-norge-er-arets-datterselskap/1161432019-06-21T00:00+02:00https://www.healthtalk.no/apotek-apotekforeningen-lege/legemiddelmangel-rammer-en-halv-million-ganger-i-aret-men-de-fleste-av-situasjonene-loses-i-apoteket/1161312019-06-20T00:00+02:00https://www.healthtalk.no/als-beslutningsforum-edaravone/far-dekket-ny-millionmedisin-gjennom-privat-helseforsikring/1160892019-06-17T00:00+02:00https://www.healthtalk.no/ali-areffard-foflekkreft-immunsystemet/dette-ma-du-vite-om-immunterapi/1160782019-10-24T00:00+02:00https://www.healthtalk.no/beslutningsforum-foflekk-foflekkreft/nektes-immunterapi-kreftpasienter-betaler-12-millioner-kroner-for-medisinen-pa-privat-sykehus/1160682019-06-14T00:00+02:00https://www.healthtalk.no/aimovig-anne-christine-poole-bent-hoie/danske-migrenepasienter-reiser-til-norge-for-a-kjope-ny-dyr-medisin/1160512019-06-10T00:00+02:00https://www.healthtalk.no/fastlege-legemiddel-legemidler-og-biotek/32000-rammes-nar-slagmedisiner-tas-av-markedet/1160432019-06-08T00:00+02:00https://www.healthtalk.no/fordoyelse-gronnsaker-kosthold/tre-tips-for-bedre-fordoyelse/1160162019-05-31T00:00+02:00https://www.healthtalk.no/30-om-dagen-gaing-gatur/fa-opp-pulsen-i-hverdagen/1160032019-05-31T00:00+02:00https://www.healthtalk.no/aktiv-livsstil-aktivitet-gaing/slik-far-du-mer-tid-til-a-vaere-i-aktivitet/1159962019-05-31T00:00+02:00https://www.healthtalk.no/aktivitet-folkehelse-ga/gaing-er-undervurdert-som-trening/1159822019-05-28T00:00+02:00https://www.healthtalk.no/bioteknologi-daniel-schneider-kvartalsrapport/photocure-med-sterk-topplinjevekst-etter-kraftig-loft-i-usa/1159522019-05-20T00:00+02:00https://www.healthtalk.no/behandling-beslutningsforum-drammen-sykehus/sykehusleger-starter-medisinske-studier-for-a-gi-pasientene-persontilpasset-medisin/1159442019-05-15T00:00+02:00https://www.healthtalk.no/astrup-digitale-verktoy-digitaliseringen/vil-ha-mer-innovative-offentlige-anskaffelser/1156262019-04-02T00:00+02:00https://www.healthtalk.no/digital-helse-digitalisering-digitalisering-av-helsesektoren/sjokkmaling-for-norsk-e-helse-lav-tillit-og-fa-brukere/1155492019-03-25T00:00+01:00https://www.healthtalk.no/digitalisering-digitalisering-helse-e-helse/ai-vil-revolusjonere-helsevesenet-men-norge-ligger-langt-bak/1154382019-02-21T00:00+01:00https://www.healthtalk.no/bent-hoie-digital-helse-direktoratet-for-e-helse/digital-helse-vil-endre-helsebransjen/1153342018-11-29T00:00+01:00https://www.healthtalk.no/politikk/vi-kan-rett-og-slett-bli-en-av-norges-storste-naeringer/1152182022-06-24T12:36+02:00https://image.healthtalk.no?imageId=115223&format=webp&width=1200https://www.healthtalk.no/baerekraft-baerekraft-utvikling-baerekraftig/sunt-kosthold-redder-kloden/1149382019-03-04T00:00+01:00https://www.healthtalk.no/psykisk-helse/leger-og-psykiatere-advarer-om-nye-regler-for-tvang/1146912023-12-18T09:56+01:00https://image.healthtalk.no?imageId=114697&format=webp&width=1200https://www.healthtalk.no/statsforvalteren-midlertidig-helikopterlandingsplass-i-oslo-er-en-risiko-for-pasientene/1146832021-11-17T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sier-ja-til-livsforlengende-hjertemedisin-etter-tre-avslag/1146572022-06-20T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/to-psoriasis-studier-viser-at-flertallet-av-pasientene-oppnar-symptomfri-hud/1146402021-04-29T00:00+02:00https://www.healthtalk.no/coronavirus-kina-legemidler-og-biotek/viruset-sprer-seg-til-flere-kinesiske-byer-smittebegrensning-har-hoyeste-prioritet-sier-president-xi/1146152020-01-20T00:00+01:00https://www.healthtalk.no/coronavirus-legemidler-og-biotek-oslo-kommune/oslo-kommune-advarer-mot-falske-smittetestere/1146072020-03-02T00:00+01:00https://www.healthtalk.no/vil-gi-innsatte-i-fengslene-bedre-psykisk-helsehjelp-og-rusbehandling/1145592021-12-09T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sier-ja-til-alternativ-prisavtale-for-banebrytende-kreftbehandling/1145502021-06-22T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/universitetet-i-bergen-deltar-i-internasjonalt-samarbeid-for-raskere-utvikling-av-nye-vaksiner/1145072021-08-12T00:00+02:00https://www.healthtalk.no/beslutningsforum-sa-ja-til-omstridt-metode-for-organdonasjon-og-til-ny-immunterapibehandling-av-blaerekreft/1144572021-08-30T00:00+02:00https://www.healthtalk.no/alzheimer-biogen-legemidler-og-biotek/fda-gir-biogen-hurtig-godkjenningsprosedyre-for-alzheimerlegemiddel/1144252020-08-10T00:00+02:00https://www.healthtalk.no/teknologien-som-ligger-bak-mrna-vaksiner-kan-i-fremtiden-brukes-mot-en-rekke-alvorlige-sykdommer/1144112021-04-06T00:00+02:00https://www.healthtalk.no/aducanumab-alzheimer-biogen/biogen-ber-fda-godkjenne-det-forste-legemidlet-som-kan-bremse-alzheimer/1143672020-07-14T00:00+02:00https://www.healthtalk.no/viagra-blir-reseptfri/1143582019-08-23T00:00+02:00https://www.healthtalk.no/evrysdi-legemidler-og-biotek-sma/roche-sitt-sma-legemiddel-evrysdi-er-godkjent-av-fda/1143482020-08-11T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-sma/oral-behandling-av-spinal-muskelatrofi-er-godkjent-i-norge/1143392021-03-31T00:00+02:00https://www.healthtalk.no/aimovig-ajovy-anne-christine-poole/ny-type-migrenemedisin-godkjent-i-usa/1143142019-10-15T00:00+02:00https://www.healthtalk.no/pharma-og-biotek/voltarol-blir-reseptbelagt/1142812024-01-02T09:39+01:00https://image.healthtalk.no?imageId=114288&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek-line-bjorge-onkologisk-forum/onkologisk-forum-norges-viktigste-fagarena-om-kreft/1142522019-11-22T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/stor-studie-remdesivir-har-ingen-effekt/1142232020-10-16T00:00+02:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek-coronaviruset/vaksinegjennombrudd-pfizer-og-biontech-sier-at-deres-vaksinekandidat-er-mer-enn-90-prosent-effektiv/1142002020-11-09T00:00+01:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek-coronaviruset/moderna-coronavaksine-er-945-prosent-effektiv/1141792020-11-16T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/pfizer-vaksinen-er-95-prosent-effektiv/1141702020-11-18T00:00+01:00https://www.healthtalk.no/covid-19-legemidler-og-biotek-coronaviruset-roactemra/leddgiktlegemidlet-til-roche-hadde-ikke-effekt-mot-covid-19/1141322020-07-30T00:00+02:00https://www.healthtalk.no/korona/norge-har-bestilt-41000-doser-av-pfizers-nye-koronapille/1141062021-12-29T00:00+01:00https://www.healthtalk.no/norske-forskere-omtaler-blodproppfunn-som-ekstremt-alvorlig/1140562021-04-10T00:00+02:00https://www.healthtalk.no/baqsimi-chmp-ema/syv-nye-medisiner-anbefales-for-godkjenning-i-eu/1140102019-10-20T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/blir-forxiga-det-forste-sglt2-legemidlet-for-behandling-av-pasienter-med-kronisk-nyresykdom/1140012021-01-12T00:00+01:00https://www.healthtalk.no/baby-pia-legemidler-og-biotek-novartis/baby-pia-nesten-1-million-belgiere-betaler-for-livreddende-medisin/1139012019-09-26T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-orifarm-takeda/takeda-selger-ut-deler-av-virksomheten-til-orifarm-for-670-millioner-dollar/1138932020-04-27T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-lytix-biopharma/fikk-ja-fra-fda-lytix-biopharma-starter-fase-2-studie-i-usa/1138592021-01-20T00:00+01:00https://www.healthtalk.no/bjorn-atle-bjornbeth-coronavirus-legemidler-og-biotek/nye-coronaregler-for-helsepersonell/1138402020-03-01T00:00+01:00https://www.healthtalk.no/alliance-healthcare-norge-anders-larsson-boots-norge/vant-gigantisk-legemiddelanbud/1138302020-01-28T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/eu-kommisjonen-har-godkjent-ny-behandling-for-kronisk-hjertesvikt/1137652021-08-24T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/rekordstor-legemiddelmangel-legemiddelindustrien-vil-gi-pasientene-innsyn-i-apotekenes-lagerbeholdning/1137512019-10-22T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-who/who-covid-19-en-pandemi/1137422020-03-11T00:00+01:00https://www.healthtalk.no/ahus-utvider-kapasiteten-med-ny-sengepost-for-kreftpasienter/1136952022-01-12T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-navamedic/navamedic-fortsetter-veksten/1136862019-08-31T00:00+02:00https://www.healthtalk.no/alzheimer-legemidler-og-biotek/ny-studie-legemiddel-fra-eli-lilly-bremser-utviklingen-av-alzheimer/1136422021-01-14T00:00+01:00https://www.healthtalk.no/fedme-og-overvekt/kraftig-vekst-i-salget-av-slankelegemidler/1135902023-12-18T10:04+01:00https://image.healthtalk.no?imageId=113601&format=webp&width=1200https://www.healthtalk.no/britt-robertsen-helse-og-livsstil-smabarns-psykiske-helse/spedbarnspsykiatri-vi-kan-ikke-vente-og-se/1135412019-09-13T00:00+02:00https://www.healthtalk.no/helse-og-livsstil-innlegg/inne-er-noe-annet-enn-ute/1135332019-09-16T00:00+02:00https://www.healthtalk.no/fedme-og-overvekt/1-million-nordmenn-har-fedme-nye-slankelegemidler-hjelper-mange/1135202023-12-18T09:32+01:00https://www.healthtalk.no/kliniske-studier/crispr-basert-genterapi-demper-kroniske-smerter-hos-mus/1135082021-04-08T00:00+02:00https://www.healthtalk.no/kliniske-studier/arctic-rewind-ny-norsk-studie-kan-endre-hvordan-vi-behandler-leddgikt/1134992021-05-20T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-kliniske-studier/ema-har-godkjent-aubagio-til-barn-med-ms/1134792021-07-06T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/fda-gir-kreftvaksinen-til-ultimovacs-dobbel-fast-track-i-kombinasjon-med-immunterapi/1134612021-10-21T00:00+02:00https://www.healthtalk.no/ehin-2019-helseteknologi/ehin-dag-1-slik-er-norges-e-helse/1134532019-11-12T00:00+01:00https://www.healthtalk.no/heart-reset-helseteknologi-hjertestarter/900-solgt-i-norge-ikke-bruk-denne-hjertestarteren/1134152019-12-10T00:00+01:00https://www.healthtalk.no/akson-helseteknologi/kommune-norge-vil-ha-akson/1133712020-07-14T00:00+02:00https://www.healthtalk.no/coronatest-helseteknologi-coronaviruset-roche-diagnostics/er-det-corona-eller-influensa-ny-kombinasjonstest-fra-roche-gir-svaret/1133542020-09-10T00:00+02:00https://www.healthtalk.no/helseteknologi/medisinsk-hologram-startup-henter-inn-fersk-kapital/1132982021-03-09T00:00+01:00https://www.healthtalk.no/helseteknologi/bedre-pasientbehandling-med-strekkoder/1132822022-08-31T10:44+02:00https://www.healthtalk.no/helse/forskere-har-laget-neandertalerliknende-minihjerner-med-crispr-og-stamcelleteknologi/1132062024-05-21T12:24+02:00https://www.healthtalk.no/demens/forskere-har-funnet-genetisk-sammenheng-mellom-lewy-body-demens-parkinsons-og-alzheimers-sykdom/1131932023-12-18T09:25+01:00https://image.healthtalk.no?imageId=113202&format=webp&width=1200https://www.healthtalk.no/forskning/eksperimentell-hiv-vaksine-viser-lovende-resultater-i-studier/1131252021-04-15T00:00+02:00https://www.healthtalk.no/forskning/nyoppdaget-genvariant-styrer-dosebehov-av-antidepressive-legemidler/1131172021-04-21T00:00+02:00https://www.healthtalk.no/kliniske-studier-forskning/ny-studie-kan-potensielt-endre-hvordan-vi-behandler-eggstokkreft/1130782021-05-08T00:00+02:00https://www.healthtalk.no/forskning/ny-studie-skal-forutsi-risiko-for-hjerte-og-karsykdommer-blant-innvandrere/1130582021-05-26T00:00+02:00https://www.healthtalk.no/forskning/ny-forskning-gir-oss-innsikt-om-gridcellenes-relasjon-til-fart-og-retning/1130502021-06-01T00:00+02:00https://www.healthtalk.no/forskning/kreftforeningens-pionerprosjekter-vil-hjelpe-nyeskapende-ideer-i-kreftforskningen/1130172021-07-05T00:00+02:00https://www.healthtalk.no/forskning/hjernehinnebetennelse-og-demens-to-forskjellige-sykdommer-med-flere-likheter/1130092021-07-21T00:00+02:00https://www.healthtalk.no/eau-2021-forskning/testosteronbehandling-reduserer-hjerteinfarkt-og-hjerneslag/1130012021-07-22T00:00+02:00https://www.healthtalk.no/forskning/oppdaget-molekyler-i-blodet-som-kan-diagnostisere-lungekreft-tidlig/1129692021-08-04T00:00+02:00https://www.healthtalk.no/forskning/flere-pasienter-opplever-kognitiv-svikt-etter-hjerneslag-ny-norsk-studie-vil-gi-dem-bedre-behandling/1129582021-08-06T00:00+02:00https://www.healthtalk.no/forskning/ny-teknologi-kan-skreddersy-medisiner/1129352021-08-11T00:00+02:00https://www.healthtalk.no/forskning/fant-stemmene-i-hodet/1129122021-07-30T00:00+02:00https://www.healthtalk.no/msd-msd-norge/mindre-enn-tre-prosent-av-pasientene-i-norge-inngar-i-kliniske-studier/1128682021-12-22T00:00+01:00https://www.healthtalk.no/kols-legemidler-og-biotek/astrazenecas-kols-legemiddel-er-godkjent-i-usa/1128592020-07-27T00:00+02:00https://www.healthtalk.no/arendalsuka-helseteknologi/kunstig-intelligens-i-helsevesenet/1128262019-08-14T00:00+02:00https://www.healthtalk.no/helse-og-livsstil-innlegg/dette-er-veldig-viktig-for-god-livskvalitet/1127662019-07-29T00:00+02:00https://www.healthtalk.no/folsyre-helse-og-livsstil-john-hopkins/kosttilskudd-og-vitaminer-gir-ingen-helseeffekt/1127572019-07-29T00:00+02:00https://www.healthtalk.no/beslsutningsforum-biktarvy-dovato/gsks-nye-hiv-legemiddel-godkjent-kan-bli-en-storselger/1127062019-07-18T00:00+02:00https://www.healthtalk.no/brystkreft-cassie-trewin-nybraten-giske-ursin/kraftig-forbedring-i-overlevelse-av-avansert-brystkreft-men-bare-for-de-mest-ressurssterke/1126822020-07-06T00:00+02:00https://www.healthtalk.no/hamstring-i-dagligvarebutikker-i-oslo-det-er-nok-mat-sier-naeringsministeren/1126152020-03-12T00:00+01:00https://www.healthtalk.no/helsedirektoratet-sender-ut-n-million-hurtigtester-til-landets-kommuner/1125912021-08-11T00:00+02:00https://www.healthtalk.no/moderna-starter-testing-av-boostervaksine-rettet-mot-omikron/1125832022-01-27T00:00+01:00https://www.healthtalk.no/et-sjeldent-perspektiv-sanofi/hvordan-leter-man-etter-sjeldne-diagnoser-hos-barn-hvorfor-er-det-vanskelig-a-stille-en-sjelden-diagnose/1125372021-10-12T00:00+02:00https://www.healthtalk.no/helseteknologi/akson-kan-skape-en-global-norsk-e-helseindustri/1125192019-12-13T00:00+01:00https://www.healthtalk.no/helseteknologi/krever-en-digital-helsemilliard-i-revidert-nasjonalbudsjett/1125092020-04-22T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/svenske-legemiddelverket-genterapien-zolgensma-er-kostnadseffektiv/1124492021-03-26T00:00+01:00https://www.healthtalk.no/coronaviruset-legeforeningen-marit-hermansen/legeforeningen-sikkerheten-til-helsepersonell-ma-ivaretas/1124392020-03-16T00:00+01:00https://www.healthtalk.no/coronaviruset-korona-luftambulansen/varsler-at-luftambulansetjenesten-kan-bli-satt-delvis-ut-av-spill/1123932020-03-24T00:00+01:00https://www.healthtalk.no/coronaviruset-korona-legemiddelindustrien/legemiddelindustrien-tilbyr-sitt-helsepersonell-til-koronadugnaden/1123682020-03-27T00:00+01:00https://www.healthtalk.no/cathrine-m-lofthus-coronaviruset-helse-sor-ost-rhf/ny-forsendelse-med-smittevernutstyr-til-norge/1123602020-03-28T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset/flere-coronapasienter-har-utviklet-nevrologiske-symptomer/1123432020-04-04T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-klorokin/svenske-sykehus-stopper-bruk-av-malariamedisin-mot-corona/1123272020-04-06T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-gilead/remdesivir-feilet-i-klinisk-studie-viste-ingen-effekt-mot-coronaviruset/1122892020-04-24T00:00+02:00https://www.healthtalk.no/coronavirus-gilead-legemidler-og-biotek-coronaviruset/viktig-studie-gileads-covid-19-medisin-har-effekt-pa-alvorlig-syke-pasienter/1122802020-05-01T00:00+02:00https://www.healthtalk.no/coronaviruset/regjeringen-varsler-de-sterkeste-tiltakene-vi-har-hatt-i-fredstid-i-norge/1122582020-03-12T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset/folk-i-hjemmekarantene-skal-ikke-lenger-testes/1122512020-03-13T00:00+01:00https://www.healthtalk.no/antibiotika-frode-forland-legemidler-og-biotek-coronaviruset/rasjonering-av-vaksine-mot-lungebetennelse-kun-de-mest-utsatte-blir-vaksinert/1122232020-03-14T00:00+01:00https://www.healthtalk.no/bjorn-guldvog-camilla-stoltenberg-coronaviruset/hele-norges-helseledelse-er-i-karantene/1122132020-03-14T00:00+01:00https://www.healthtalk.no/coronavaksine-coronaviruset/johnson-johnsons-vaksine-er-85-prosent-effektiv-i-a-forebygge-alvorlig-sykdom/1121452021-01-29T00:00+01:00https://www.healthtalk.no/coronavaksine-coronaviruset/astrazenecas-vaksine-godkjent-for-bruk-i-norge-og-eu/1121332021-01-29T00:00+01:00https://www.healthtalk.no/coronaviruset/sykehusledere-vi-er-verre-stilt-enn-i-mars/1121112021-02-06T00:00+01:00https://www.healthtalk.no/coronaviruset/minst-seks-eu-land-stanser-bruk-av-astrazeneca-vaksine-etter-mulig-alvorlig-bivirkning/1120742021-03-11T00:00+01:00https://www.healthtalk.no/coronaviruset/johnson-johnsons-vaksine-er-godkjent-for-bruk-i-norge-og-eu/1120492021-03-11T00:00+01:00https://www.healthtalk.no/helseteknologi-coronaviruset/astrazeneca-vaksinerte-advares-om-mulige-farer/1120412021-03-13T00:00+01:00https://www.healthtalk.no/coronaviruset/who-anbefaler-videre-bruk-av-astrazenecas-vaksine/1119682021-03-19T00:00+01:00https://www.healthtalk.no/coronaviruset/ema-topp-ser-sammenheng-mellom-astrazenecas-vaksine-og-blodpropp/1119252021-04-06T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-opersjon/sykehus-venter-lange-kirurgiske-ventelister-etter-pandemien/1118762020-05-18T00:00+02:00https://www.healthtalk.no/feilmedisinering-legemidler-og-biotek-lukket-legemiddelsloyfe/babyer-og-eldre-oftest-feilmedisinert/1118432020-07-10T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/stor-dansk-studie-fant-ingen-sammenheng-mellom-hpv-vaksine-og-me/1117532020-09-04T00:00+02:00https://www.healthtalk.no/corona-coronaviruset/fhi-fortsatt-frykt-for-at-coronapandemien-kommer-ut-av-kontroll/1117112020-11-30T00:00+01:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek/coronavaksinen-er-i-norge-en-veldig-viktig-dag/1117002020-12-26T00:00+01:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek/vaksinene-inneholder-en-liten-genetisk-kode-fra-coronaviruset-som-aktiverer-immunforsvaret/1116922021-01-02T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/svensk-studie-p-piller-minsker-risikoen-for-eggstokk-og-livmorkreft/1116462021-01-11T00:00+01:00https://www.healthtalk.no/coronaviruset/nakstad-nedgangen-i-smitte-har-flatet-ut/1116302021-02-07T00:00+01:00https://www.healthtalk.no/coronaviruset/who-med-ny-vurdering-av-astrazeneca-vaksinen/1116212021-02-08T00:00+01:00https://www.healthtalk.no/coronavaksine-legemidler-og-biotek/sputnik-vaksinen-vurderes-for-godkjenning-i-eu-norge-kan-fa-en-halv-million-doser/1115722021-03-04T00:00+01:00https://www.healthtalk.no/coronaviruset/koronakommisjonen-er-ferdig-med-arbeidet/1115302021-03-07T00:00+01:00https://www.healthtalk.no/coronaviruset/erna-solberg-venter-med-ny-nedstengning/1115142021-03-09T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset-unn/40-sykehusansatte-i-narvik-i-karantene-etter-kontakt-med-coronapasient/1114832020-04-16T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-donald-trump/trump-regjeringen-vil-granske-hvor-viruset-stammer-fra/1114752020-04-17T00:00+02:00https://www.healthtalk.no/coronavirus-coronaviruset-kina/pompeo-enorme-bevis-for-at-coronaviruset-kom-fra-kinesisk-laboratorium/1114432020-05-03T00:00+02:00https://www.healthtalk.no/coronavirus-legemidler-og-biotek-coronaviruset-remdesivir/japan-godkjenner-bruk-av-remdesivir-mot-corona/1114362020-05-07T00:00+02:00https://www.healthtalk.no/pfizer-vil-tilby-en-tredje-vaksinedose-og-produsere-egen-delta-vaksine/1113882021-07-09T00:00+02:00https://www.healthtalk.no/nakstad-fikk-sin-egen-jobb/1113802021-08-03T00:00+02:00https://www.healthtalk.no/jordmorforbundet-varsler-vikarkrise/1113722021-08-04T00:00+02:00https://www.healthtalk.no/helseministeren-etter-kongsberg-drapene-vi-har-utfordringer/1113572021-10-16T00:00+02:00https://www.healthtalk.no/kjerkol-bevilger-100-millioner-ekstra-til-fastlegeordningen-legeforeningen-er-skuffet/1113312021-11-07T00:00+01:00https://www.healthtalk.no/podcast-politikk/podcast-statsbudsjettet-med-first-house/1113212019-10-09T00:00+02:00https://www.healthtalk.no/bent-hoie-coronavirus-erna-solberg/de-mest-dramatiske-grep-i-fredstid-skal-bremse-coronaepidemien/1113022020-03-12T00:00+01:00https://www.healthtalk.no/bent-hoie-beredskapsproduksjon-hanne-mette-dyrlie-kristensen/helseindustrien-ber-helseministeren-forberede-produksjon-av-livsviktige-legemidler-i-norge/1112782020-03-23T00:00+01:00https://www.healthtalk.no/bent-hoie-corona-vaksine-covid-19/opptil-1000-norske-pasienter-i-ny-coronastudie-skal-teste-ut-malaria-og-ebolamedisin/1112702020-03-27T00:00+01:00https://www.healthtalk.no/diabetes-glp-1-legemidler-og-biotek/eus-ekspertpanel-anbefaler-at-novo-nordisk-nye-diabetes-tablett-godkjennes/1112062020-02-06T00:00+01:00https://www.healthtalk.no/covid-19-legemidler-og-biotek-sanofi/sanofi-investerer-65-milliarder-kroner-i-to-vaksinefabrikker-signaliserer-okt-fokus-pa-vaksiner/1110882020-06-16T00:00+02:00https://www.healthtalk.no/astrazeneca-corona-vaksine-legemidler-og-biotek-coronaviruset/oxford-vaksine-viser-lovende-resultater-gir-immunrespons/1110302020-07-21T00:00+02:00https://www.healthtalk.no/astrazeneca-legemidler-og-biotek-coronaviruset-monoklonale-antistoffer/astra-zeneca-starter-fase-1-studier-av-antistoffer-som-kan-beskytte-mot-covid-19/1110222020-08-25T00:00+02:00https://www.healthtalk.no/astrazeneca-coronavaksine-legemidler-og-biotek-coronaviruset/test-av-coronavaksine-stoppes-etter-mulige-alvorlige-bivirkninger/1110152020-09-09T00:00+02:00https://www.healthtalk.no/karsten-bruins-slot-kevzara-legemidler-og-biotek-coronaviruset/roche-tester-roactemra-i-coronapasienter-med-lungebetennelse/1109952020-03-19T00:00+01:00https://www.healthtalk.no/blaerekreft-legemidler-og-biotek/photocure-overtar-salget-av-hexvix-i-europa-forventer-en-tredobling-av-inntektene-i-2021/1109672020-10-06T00:00+02:00https://www.healthtalk.no/erik-skaaheim-haug-giske-ursin-helse-og-livsstil/prostataoperasjon-halverer-seksualfunksjonen-anbefaler-at-lavrisikopasienter-ikke-opereres/1108562019-10-14T00:00+02:00https://www.healthtalk.no/blaerekreft-legemidler-og-biotek-nyrekreft/et-enkelt-karrierevalg-tok-spranget-fra-ibm-watson-til-innovativ-kreftbehandling/1108352020-10-06T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-prostatakreft/eus-ekspertpanel-anbefaler-xtandi-til-behandling-av-metastatisk-hormonsensitiv-prostatakreft/1108112021-03-31T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-magesekkreft-malrettet-behandling/magesekkreft-fda-hurtgigvurderer-enhertu/1107792020-10-29T00:00+01:00https://www.healthtalk.no/eksem/rinvoq-er-mer-effektiv-enn-dupixent-blant-voksne-pasienter-med-atopisk-eksem/1107722023-12-18T09:46+01:00https://image.healthtalk.no?imageId=103935&format=webp&width=1200https://www.healthtalk.no/bimekizumab-legemidler-og-biotek-psoriasis/psoriasis-ucbs-bimekizumab-bedre-enn-stelara-i-fase-3-studie/1107622020-06-30T00:00+02:00https://www.healthtalk.no/hepatitt-c-legemidler-og-biotek-nobelprisen/nobelprisen-i-medisin-for-oppdagelsen-av-hepatitt-c/1107502020-10-05T00:00+02:00https://www.healthtalk.no/crispr-helseteknologi/genredigering-reverserte-mutasjon-hos-mus-med-duchennes-muskeldystrofi/1107322021-04-13T00:00+02:00https://www.healthtalk.no/car-t-legemidler-og-biotek/abbvie-og-caribou-biosciences-skal-utvikle-neste-generasjons-kreftbehandling-med-crispr-genredigeringsteknologi/1107022021-02-11T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/forxiga-er-godkjent-i-usa-for-behandling-av-kronisk-nyresykdom/1106472021-05-13T00:00+02:00https://www.healthtalk.no/cancer-crosslinks-car-t-checkpoint-inhibitor/professor-michel-sadelain-how-car-t-cell-therapy-is-revolutionizing-oncology/1106222022-06-24T12:47+02:00https://image.healthtalk.no?imageId=159908&format=webp&width=1200https://www.healthtalk.no/anne-karin-kolstad-asbjorn-ellingsen-biktarvy/alle-nye-hiv-legemidler-er-na-tilgjengelig-for-norske-pasienter/1106002019-12-01T00:00+01:00https://www.healthtalk.no/covid-19-ebola-gilead/ny-studie-to-av-tre-covid-19-pasienter-blir-bedre-med-ebola-medisinen-remdesivir/1105902020-04-12T00:00+02:00https://www.healthtalk.no/cancer-cancer-crosslinks-immune-checkpoint-blocking/professor-jason-j-luke-the-cancer-treatment-landscape-is-exploding-with-possibilities/1105752021-10-01T00:00+02:00https://www.healthtalk.no/fedme-fedmekirurgi-gastric-bypass/livsstilsbehandling-av-barn-og-unge-med-alvorlig-fedme-gir-liten-vektreduksjon-vil-tilby-legemiddelbehandling-og-vektreduserende-kirurgi/1105392020-07-02T00:00+02:00https://www.healthtalk.no/fedme-og-overvekt/ny-studie-viser-lovende-resultater-for-nytt-fedmelegemiddel/1105022023-12-18T09:34+01:00https://image.healthtalk.no?imageId=110508&format=webp&width=1200https://www.healthtalk.no/forskning/kreftcellene-kan-bli-resistente-mot-cellegift/1104942021-09-08T00:00+02:00https://www.healthtalk.no/ahus-helseteknologi-video/ahus-starter-med-videokonsultasjoner/1104752020-04-02T00:00+02:00https://www.healthtalk.no/helseteknologi-hologram-inven2/rigger-norske-helsehologrammer-for-global-satsning/1104312020-02-05T00:00+01:00https://www.healthtalk.no/dignio-helseteknologi/dignio-i-kreftsamarbeid-med-det-offentlige-helsevesenet-i-storbritannia-hvor-blir-det-av-norge/1104232019-09-03T00:00+02:00https://www.healthtalk.no/dignio-ewa-truchanowicz-helseteknologi/dignio-vant-startup-pris-i-england/1104032020-02-18T00:00+01:00https://www.healthtalk.no/deloitte-technology-fast-50-dignio-frode-vik-jensen/disse-7-helsebedriftene-er-blant-norges-50-raskest-voksende-teknologiselskaper/1103942020-02-27T00:00+01:00https://www.healthtalk.no/drammen-sykehus-helseteknologi-martin-polacek/drammen-sykehus-har-redusert-ventetiden-for-bruddpasienter-med-ny-behandlingsmodell/1103622019-09-04T00:00+02:00https://www.healthtalk.no/adjuvant-beslutningsforum-foflekkreft/melanomforeningen-jubler-over-adjuvant-behandling/1103552019-08-27T00:00+02:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek-lungekreft/alle-gode-ting-er-ikke-tre-ocrevus-fikk-nei-i-beslutningsforum/1103322019-11-18T00:00+01:00https://www.healthtalk.no/helseteknologi-kathrine-myhre-norway-health-tech/helseteknologisjef-kathrine-myhre-norske-grndere-er-pionerer-na-ma-investorene-ta-sjansen/1103112019-08-29T00:00+02:00https://www.healthtalk.no/coronavirus-deconx-helseteknologi/norsk-teknologi-kan-bekjempe-corona-viruset/1103032020-02-29T00:00+01:00https://www.healthtalk.no/ablasjon-atrieflimmer-coronaviruset/har-personer-med-hjerteflimmer-okt-risiko-for-a-bli-alvorlig-syke-av-covid-19/1102882020-03-19T00:00+01:00https://www.healthtalk.no/astma-astmaspray-gsk/astmaspray-gir-stort-klimaavtrykk/1102502019-11-04T00:00+01:00https://www.healthtalk.no/aimovig-bent-hoie-blaresepetordningen/helse-lekkasjer-fra-statsbudsjettet-for-2020/1102432019-10-06T00:00+02:00https://www.healthtalk.no/apotekforeningen-farmasistudiet-farmasoyt/gode-jobbmuligheter-etter-farmasistudiet/1102362019-12-29T00:00+01:00https://www.healthtalk.no/apotek-apotekbarometer-apotekforeningen/1-av-3-pasienter-er-bekymret-for-legemiddelmangel/1102292019-11-26T00:00+01:00https://www.healthtalk.no/apotek-coronavirus-coronaviruset/nettapotek-tar-av-salget-opp-700-prosent/1102042020-03-17T00:00+01:00https://www.healthtalk.no/apotek-apotek-1-coronaviruset/apotekene-sliter-med-bemanningen-under-coronakrisen/1101972020-03-19T00:00+01:00https://www.healthtalk.no/beslutningsforum-brystkreft-impassion130-studien/roche-sin-immunterapi-tecentriq-er-godkjent-i-europa-for-brystkreft/1101532019-09-01T00:00+02:00https://www.healthtalk.no/abelia-gensekvensering-kreftforeningen/arbeiderpartiet-norge-skal-bli-den-foretrukne-partner-for-internasjonal-legemiddelindustri/1101412019-09-26T00:00+02:00https://www.healthtalk.no/apotekforeningen-legemiddelindustrien-legemidler-og-biotek/apotekforeningen-raser-mot-regjeringen-kaller-lovforslag-inngripende-reguleringer/1101072019-10-23T00:00+02:00https://www.healthtalk.no/bayer-kreft-legemidler-og-biotek-kliniske-studier/bayers-presisjonsmedisin-mot-kreft-snart-godkjent-i-eu-og-norge/1100742019-08-21T00:00+02:00https://www.healthtalk.no/andreas-stensvold-helseminister-bent-hoie-immunterapi/kreftlegen-som-endret-kreftpolitikken/1100102019-11-21T00:00+01:00https://www.healthtalk.no/avastin-bayer-imbrave150/tecentriqavastin-kombo-forlenger-overlevelsen-betydelig-for-pasienter-med-alvorlig-leverkreft/1100012019-12-05T00:00+01:00https://www.healthtalk.no/benmargskreftpasienter-beslutningsforum-eisai/beslutningsforum-sa-ja-til-ninlaro-for-benmargskreftpasienter/1099672019-12-16T00:00+01:00https://www.healthtalk.no/alexa-amazon-digital-helse/alexa-hvordan-behandler-jeg-migrene/1099412019-07-17T00:00+02:00https://www.healthtalk.no/alzheimer-berit-kvalvaag-gronnestad-demens/35-000-vet-ikke-at-de-har-demens/1099332019-11-29T00:00+01:00https://www.healthtalk.no/bent-hoie-karita-bekkemellem-karsten-bruins-slot/vil-ha-flere-kliniske-studier-til-norge-ser-en-sterk-politiske-vilje-men-etterlyser-konkrete-tiltak/1098832019-10-08T00:00+02:00https://www.healthtalk.no/ali-areffard-bristol-myers-squibb-immunterapi/cancer-crosslinks-norsk-kreftkonferanse-samler-nasjonal-og-internasjonal-kreftekspertise/1098732020-01-13T00:00+01:00https://www.healthtalk.no/alzheimers/hvorfor-kvinner-har-mer-alzheimer-enn-menn/1098132023-12-18T09:18+01:00https://image.healthtalk.no?imageId=109819&format=webp&width=1200https://www.healthtalk.no/coronavirus-folkehelseinstituttet-legemidler-og-biotek/folkehelseinstituttet-nordmann-bosatt-i-italia-skal-ha-blitt-smittet-av-coronavirus/1097942020-02-26T00:00+01:00https://www.healthtalk.no/coronavirus-folkehelseinstituttet-legemidler-og-biotek/ny-risikovurdering-70-prosent-kan-bli-corona-smittet-i-norge/1097852020-02-26T00:00+01:00https://www.healthtalk.no/camilla-stoltenberg-coronavirus-coronaviruset/fhi-rapport-733000-blir-syke-og-5500-vil-trenge-intensivbehandling/1097432020-03-13T00:00+01:00https://www.healthtalk.no/coronavirus-coronaviruset-folkehelseinstituttet/fhi-alle-som-har-luftveisinfeksjon-bor-holde-seg-hjemme/1097352020-03-16T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/ny-nasjonal-veileder-skal-hindre-at-pasienter-utvikler-legemiddelavhengighet/1096092021-10-28T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sier-ja-til-ny-kombinasjonsbehandling-med-immunterapi-for-avansert-nyrecellekreft/1095082021-11-23T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/ny-podcast-fda-med-gode-nyheter-til-ultimovacs/1094732021-12-08T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/sabcs-enhertu-forbedrer-overlevelsen-hos-pasienter-med-her2-positiv-brystkreft-som-har-spredd-seg-til-hjernen/1094632021-12-10T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-prostatakreft/lynparza-godkjent-for-behandling-av-brca-mutert-metastatisk-kastrasjonsresistent-prostatakreft/1094232020-11-16T00:00+01:00https://www.healthtalk.no/nyresykdom/forxiga-godkjent-i-norge-for-behandling-av-kronisk-nyresykdom/1094072023-12-18T09:30+01:00https://image.healthtalk.no?imageId=100709&format=webp&width=1200https://www.healthtalk.no/bayer-starter-studie-med-1500-pasienter-som-har-kronisk-nyresykdom-uten-diabetes-men-ingen-norske-pasienter-deltar/1093992021-10-06T00:00+02:00https://www.healthtalk.no/bent-hoie-helse-og-livsstil-helsedirektoratet/10-millioner-ekstra-til-hjelpetelefoner-for-selvmordsforebygging/1093932020-01-06T00:00+01:00https://www.healthtalk.no/helse-og-livsstil/slik-skal-norge-stanse-coronaviruset-her-er-planen-til-helsemyndighetene/1093862020-01-29T00:00+01:00https://www.healthtalk.no/fedmekirurgi-helse-og-livsstil-joran-hjelmesaeth/fedmeprofessor-ber-fastlegene-hjelpe-flere-pasienter-det-finnes-effektive-behandlingsmetoder/1093282022-10-10T11:39+02:00https://www.healthtalk.no/helse-og-livsstil/psykiske-lidelser-mindre-utbredt-blant-innvandrere-men-det-finnes-noen-unntak/1093192021-05-11T00:00+02:00https://www.healthtalk.no/alzheimer-demens-livsstil/demens-kan-forebygges-gjennom-sunn-livsstil/1092862019-07-30T00:00+02:00https://www.healthtalk.no/trening-helse-og-livsstil-kondisjon/slik-klarer-du-10-000-skritt-hver-dag/1092472019-12-30T00:00+01:00https://www.healthtalk.no/trening-helse-og-livsstil/hvordan-komme-i-gang-med-trening/1092402020-01-02T00:00+01:00https://www.healthtalk.no/sats-sondre-gravir-trening-helse-og-livsstil/ansetter-ny-sjef-i-sats-norge/1092312020-01-22T00:00+01:00https://www.healthtalk.no/hjemmekontor-skulderplager-smertelindring/effektiv-smertelindring-ved-skulderplager/1092162020-04-07T00:00+02:00https://www.healthtalk.no/forebygging-hjemmekontor-skuldersmerter/slik-forebygger-du-skuldersmerter-og-styrker-skuldrene/1091992020-04-07T00:00+02:00https://www.healthtalk.no/hjemmekontor-ryggplager-smertelindring/effektiv-smertelindring-ved-ryggplager/1091612020-04-07T00:00+02:00https://www.healthtalk.no/blogg-ida-oye-bjorkvold-kreft/hodet-vil-men-kroppen-stopper-meg/1091532019-08-28T00:00+02:00https://www.healthtalk.no/blogg-helle-heia-eiborg-kreft/ta-telefonen-mamma/1091462019-09-10T00:00+02:00https://www.healthtalk.no/ida-oye-bjorkvold-kreft-kreftkontroll/jeg-trodde-kreften-var-tilbake/1091382019-09-25T00:00+02:00https://www.healthtalk.no/cellegift-ikke-smacellet-lungekreft-immunterapi/immunterapi-reddet-livet-mitt/1091082019-11-07T00:00+01:00https://www.healthtalk.no/lev-med-livmorhalskreft-sarkom/ragnhild-lever-med-livmorhalskreft-og-er-evig-optimist/1090832020-01-02T00:00+01:00https://www.healthtalk.no/akutt-lymfoblastisk-leukemi-amund-vold-benmargstransplantasjon/fra-vm-tittel-til-blodkreftdiagnose/1090592020-04-07T00:00+02:00https://www.healthtalk.no/hjertesykdom/tone-fikk-hjerteamyloidose-trodde-symptomene-skyldtes-stress-ble-lettet-da-hun-fikk-rett-diagnose/1090332023-12-15T16:05+01:00https://image.healthtalk.no?imageId=109047&format=webp&width=1200https://www.healthtalk.no/fusjon-legemidler-og-biotek-finans-lipitor/pfizer-i-milliardfusjon-med-mylan/1090262019-07-29T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-finans/photocure-vokser-kraftig-omsetningen-opp-60-prosent/1090002021-05-19T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-kliniske-studier/ny-studie-rinvoq-reduserer-sykdomstegn-og-symptomer-hos-pasienter-med-ankyloserende-spondylitt/1089672021-10-25T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-kliniske-studier/han-skal-lede-lungekreftstudie-som-kombinerer-immunterapi-med-norsk-kreftvaksine/1089632021-11-29T00:00+01:00https://www.healthtalk.no/kliniske-studier/en-ny-vaksine-kan-gi-bedre-og-raskere-behandling-av-tuberkulose/1089432022-02-14T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-helseteknologi/unge-kreftpasienter-kan-ta-cellegift-hjemme/1089162021-07-12T00:00+02:00https://www.healthtalk.no/helseteknologi/opererer-hjernen-med-navigert-kirurgi/1088852021-08-03T00:00+02:00https://www.healthtalk.no/helseteknologi/vekstraketten-epiguard-vinner-oslo-innovation-award-2021/1088672021-09-27T00:00+02:00https://www.healthtalk.no/helseteknologi/sykehuset-flytter-inn-i-hjemmene-jon-fikk-livet-tilbake-med-hjemmedialyse/1088402021-11-08T00:00+01:00https://www.healthtalk.no/helseteknologi/ny-teknikk-oppdager-langt-flere-brystkreftsvulster/1088162022-02-04T00:00+01:00https://www.healthtalk.no/forskning/har-dokumentert-at-fatigue-ikke-er-latskap/1087972021-09-16T00:00+02:00https://www.healthtalk.no/forskning/35-515-nye-krefttilfeller-i-2020-og-det-er-faktisk-en-god-nyhet/1087832021-09-21T00:00+02:00https://www.healthtalk.no/forskning/store-geografiske-forskjeller-i-tvangsinnleggelse/1087302021-10-07T00:00+02:00https://www.healthtalk.no/forskning/disse-vaktcellene-aktiverer-immuncellene-som-angriper-kreft-virus-og-bakterier/1087012021-11-10T00:00+01:00https://www.healthtalk.no/forskning/ny-studie-harvard-forskere-knytter-ms-til-kyssesyke/1086802022-01-25T00:00+01:00https://www.healthtalk.no/brystkreft-hormonrelatert-kreft-lev-med/livet-etter-brystkreften/1086592019-11-04T00:00+01:00https://www.healthtalk.no/annonsorinnhold-fra-garmin-health/behandlingen-av-diabetes-og-kols-flytter-seg-inn-i-svenske-hjem/1086312019-06-18T00:00+02:00https://www.healthtalk.no/aldring-og-helse-alzheimer-demens/kommunene-svikter-de-demente-bare-halvparten-blir-utredet-og-diagnostisert/1086222019-06-19T00:00+02:00https://www.healthtalk.no/hudkreft-kreftforeningen-kreftlegen/solarium-er-kreftfremkallende-men-solariumkjeden-brun-og-blid-kjorer-reklamekampanje/1085062019-07-05T00:00+02:00https://www.healthtalk.no/aleris-helseteknologi-triton/1-100-norske-aleris-ansatte-far-ny-arbeidsgiver/1084522019-07-12T00:00+02:00https://www.healthtalk.no/adjuvant-adjuvant-behandling-aleris/bonnfaller-beslutningsforum-si-ja-til-forebyggende-immunterapi-slik-at-flere-pasienter-med-ondartet-foflekkreft-kan-overleve/1084322019-05-27T00:00+02:00https://www.healthtalk.no/leddgikt/ny-behandling-hjelper-pasienter-med-artrose/1084142024-01-02T09:10+01:00https://image.healthtalk.no?imageId=108428&format=webp&width=1200https://www.healthtalk.no/asco-forskning-kliniske-studier/asco-2019-biotech-i-rampelyset-mens-pharma-inntar-baksetet/1084052019-05-28T00:00+02:00https://www.healthtalk.no/beslutningsforum-fda-genterapi/novartis-nye-genterapi-til-185-millioner-kroner-er-verdens-dyreste-legemiddel/1083992019-05-29T00:00+02:00https://www.healthtalk.no/livsstil-og-forebygging/slik-klarer-du-10-000-skritt-hver-dag/1083922024-01-02T09:11+01:00https://image.healthtalk.no?imageId=108395&format=webp&width=1200https://www.healthtalk.no/30-om-dagen-aktivitet-bedriftshelse/gir-ansatte-en-fridag-hvis-de-trener/1083712019-05-31T00:00+02:00https://www.healthtalk.no/adjuvant-beslutningsforum-brystkreft/norske-brystkreftpasientar-far-revolusjonerende-medisin/1083222019-06-17T00:00+02:00https://www.healthtalk.no/asco-immunterapi-keynote-001/lungekreftpasienter-lever-lenger-med-immunterapi-helt-fantastisk-sier-ledende-norsk-kreftlege/1083012019-06-10T00:00+02:00https://www.healthtalk.no/agnostisk-kreftmedisin-ehelse-ehin/ehin-2019-persontilpasset-medisin-og-e-helse-smelter-sammen/1082642019-10-20T00:00+02:00https://www.healthtalk.no/computas-direktoratet-for-e-helse-e-helse/computas-vant-stor-rammeavtale-hos-direktoratet-for-e-helse-og-norsk-helsenett/1082562020-01-30T00:00+01:00https://www.healthtalk.no/beslutningsforum-gilenya-legemiddelindustrien/beslutningsforum-utfordrer-pasientsikkerheten-til-mange-tusen-norske-ms-pasienter/1081472019-11-21T00:00+01:00https://www.healthtalk.no/abelia-akson-direktoratet-for-e-helse/sterk-kritikk-av-regjeringens-e-helsepolitikk/1081402019-11-29T00:00+01:00https://www.healthtalk.no/bent-hoie-helseminister-opiodkrisen/helseministeren-jeg-er-bekymret-over-overdoser-av-smertestillende-medisiner/1080642019-08-31T00:00+02:00https://www.healthtalk.no/fastlegeordningen-finn-henry-hansen-helse-nord-rhf/nord-norge-mister-fastlegene-frykter-sykehuskrise/1080222019-09-16T00:00+02:00https://www.healthtalk.no/helsepartiet-kreft-kreftpasienter/4-av-10-far-ikke-kreftbehandling-i-tide/1079982019-09-19T00:00+02:00https://www.healthtalk.no/ambulansefly-babcock-helse-nord-rhf/ambulanseflykrisen-helse-nord-har-satt-krisestab/1079922019-12-09T00:00+01:00https://www.healthtalk.no/beslutningsforum-kirsti-nyhus-legemiddelindustrien/beslutningsforum-vil-ta-17-desembervedtaket-opp-til-ny-vurdering/1079742019-12-17T00:00+01:00https://www.healthtalk.no/bente-angell-hansen-efta-esa/esa-stevner-norge-for-regler-som-nekter-norske-pasienter-sykehusbehandling-i-utlandet/1079642019-12-18T00:00+01:00https://www.healthtalk.no/ambulansefly-babcock-politikk/babcock-anker-ikke-dommen-om-virksomhetsoverdragelse/1078942020-04-01T00:00+02:00https://www.healthtalk.no/cathrine-m-lofthus-helse-sor-ost-politikk/270-millioner-ekstra-til-oppgraderinger-ved-sykehusene/1078552020-07-07T00:00+02:00https://www.healthtalk.no/donald-trump-politikk-who/usa-har-levert-who-oppsigelsen-til-fn/1078482020-07-07T00:00+02:00https://www.healthtalk.no/politikk/streik-planlegges-for-fastlegene-kan-ramme-kommunale-legevakter/1078092020-10-15T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-politikk/vi-trenger-bedre-samarbeid-for-tilgang-til-avanserte-legemidler/1077892021-03-30T00:00+02:00https://www.healthtalk.no/kliniske-studier-politikk/ikke-overrasket-over-riksrevisjonens-kritikk-av-sykehusenes-kliniske-studier/1077482021-05-06T00:00+02:00https://www.healthtalk.no/politikk-revidert-nasjonalbudsjett/revidert-nasjonalbudsjett-styrker-basistilskuddet-for-fastleger/1077312021-05-11T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-politikk/jubler-for-at-et-enstemmig-storting-sier-ja-til-norsk-legemiddelproduksjon/1076872021-05-20T00:00+02:00https://www.healthtalk.no/politikk/alvorlig-kritikk-mot-psykisk-helsevesen-i-riksrevisjonen-rapport/1076792021-06-03T00:00+02:00https://www.healthtalk.no/helseteknologi-politikk/knusende-dom-riksrevisjonen-mener-direktoratet-for-e-helse-har-brutt-flere-regler-i-anskaffelsesregelverket/1076642021-06-22T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-politikk/kongressen-og-fda-vil-granske-godkjenningen-av-biogens-alzheimerlegemiddel/1076472021-07-19T00:00+02:00https://www.healthtalk.no/politikk/vi-tar-helsedebatten-slik-dekker-healthtalk-arendalsuka/1076402021-08-11T00:00+02:00https://www.healthtalk.no/politikk/evaluering-av-fritt-behandlingsvalg-har-i-liten-grad-redusert-ventetidene/1076052021-08-24T00:00+02:00https://www.healthtalk.no/politikk/jubel-hos-pasientfokus-i-finnmark/1075982021-09-13T00:00+02:00https://www.healthtalk.no/politikk/riksrevisoren-lite-hjelp-til-familier-med-barn-med-funksjonsnedsettelser/1075752021-09-30T00:00+02:00https://www.healthtalk.no/politikk-statsbudsjettet-2022/regjeringen-vil-styrke-fastlegeordningen/1075682021-10-12T00:00+02:00https://www.healthtalk.no/politikk-statsbudsjettet-2022/vil-sette-i-gang-sykehusutbygging-i-skien-ahus-og-haugesund/1075612021-10-12T00:00+02:00https://www.healthtalk.no/nyheter-og-politikk/ingvild-kjerkol-blir-helseminister-tar-over-et-av-de-aller-tyngste-departementene/1075302024-01-02T09:16+01:00https://image.healthtalk.no?imageId=104625&format=webp&width=1200https://www.healthtalk.no/politikk/kjerkol-vil-ha-mer-penger-til-fastlegeordningen/1075232021-10-30T00:00+02:00https://www.healthtalk.no/bristol-myers-squibb-cabometyx-daniel-heinrich/legemiddelkombo-fra-bristol-myers-squibb-og-exelixis-forlenger-overlevelsen-for-nyrekreftpasienter/1074712020-04-30T00:00+02:00https://www.healthtalk.no/coronaviruset/regjeringen-coronavirus-blir-meldepliktig-sykdom/1074532020-01-31T00:00+01:00https://www.healthtalk.no/coronaviruset/usa-vil-midlertidig-stanse-bruk-av-j-j-vaksinen/1074232021-04-13T00:00+02:00https://www.healthtalk.no/helseteknologi-coronaviruset/utvikler-ny-og-billig-koronavaksine/1074002021-04-20T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/ema-mulig-sammenheng-mellom-janssen-vaksinen-og-sjeldne-blodpropper-legemiddelverket-for-tidlig-a-si-hva-dette-betyr-for-norge/1073902021-04-20T00:00+02:00https://www.healthtalk.no/coronaviruset/johnson-johnson-starter-opp-igjen-utrullingen-av-vaksinen-til-eu-norge-og-island/1073822021-04-20T00:00+02:00https://www.healthtalk.no/coronaviruset/ekspertutvalg-ikke-bruk-astrazeneca-og-janssen-vaksinene-i-koronavaksinasjonsprogrammet/1073342021-05-10T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/over-13000-meldinger-om-mistenkte-bivirkninger-av-koronavaksiner/1073022021-05-21T00:00+02:00https://www.healthtalk.no/kliniske-studier-coronaviruset/bemcentinib-med-effekt-god-effekt-i-behandling-av-covid-19-kan-bli-et-verdifullt-behandlingsaternativ/1072862021-07-15T00:00+02:00https://www.healthtalk.no/coronaviruset/pfizer-og-moderna-skrur-opp-vaksineprisene/1072712021-08-01T00:00+02:00https://www.healthtalk.no/coronaviruset/regjeringen-anbefaler-tredje-vaksinedose-til-alle-over-65-ar-men-fhi-er-usikre-pa-om-nar-det-rette-tidspunktet-er/1072102021-10-05T00:00+02:00https://www.healthtalk.no/coronaviruset/sverige-og-danmark-stanser-moderna-vaksinen-for-de-yngre/1071942021-10-06T00:00+02:00https://www.healthtalk.no/coronaviruset/tall-fra-fhi-langt-flere-tilfeller-av-hjertebetennelse-med-moderna/1071782021-10-11T00:00+02:00https://www.healthtalk.no/coronaviruset/helseministeren-nasjonale-koronatiltak-kan-bli-aktuelt-men-ikke-na/1071622021-10-27T00:00+02:00https://www.healthtalk.no/coronaviruset/england-krever-at-helsepersonell-fullvaksineres/1071112021-11-09T00:00+01:00https://www.healthtalk.no/coronaviruset/fhi-varsler-ny-risikovurdering-av-omikron/1070632021-12-05T00:00+01:00https://www.healthtalk.no/coronaviruset/fda-har-godkjent-astrazenecas-antistoffbehandling-mot-korona-for-personer-med-svekket-immunsystem-og-den-skal-produseres-i-sverige/1070482021-12-10T00:00+01:00https://www.healthtalk.no/corona-vaksine-coronaviruset-covid-19/alle-landets-skoler-og-barnehager-stenges/1070142020-03-12T00:00+01:00https://www.healthtalk.no/coronaviruset-korona-usa/usas-helsevesen-vakler-under-koronapress/1069872020-03-27T00:00+01:00https://www.healthtalk.no/coronaviruset/fhi-tror-ny-deltavariant-i-trondheim-vil-ta-over-i-hele-landet/1069572021-11-16T00:00+01:00https://www.healthtalk.no/fortsatt-mangelfull-rekruttering-av-fastleger/1069282021-11-23T00:00+01:00https://www.healthtalk.no/verdens-aidsdag/koronapandemien-er-blitt-en-alvorlig-snublestein-i-kampen-mot-hiv-og-aids/1068472021-12-01T00:00+01:00https://www.healthtalk.no/coronaviruset/regjeringen-framskynder-tredje-dose-for-alle-over-45/1068132021-12-06T00:00+01:00https://www.healthtalk.no/pfizer-oppfriskningsdose-gir-god-beskyttelse-mot-omikronsmitte/1068052021-12-08T00:00+01:00https://www.healthtalk.no/coronaviruset/klarsignal-til-kommunene-kan-bruke-apotekene-til-koronavaksinering/1067582021-12-18T00:00+01:00https://www.healthtalk.no/regjeringen-vil-ha-500-nye-studieplasser-for-sykepleiere/1067492021-12-18T00:00+01:00https://www.healthtalk.no/fhi-omikronvarianten-er-dominerende-i-norge/1067422022-01-03T00:00+01:00https://www.healthtalk.no/siv-jensen-nytt-styremedlem-i-patientsky-norge/1067352022-01-11T00:00+01:00https://www.healthtalk.no/diakonhjemmet-og-lovisenberg-med-kjempeunderskudd/1067012022-01-15T00:00+01:00https://www.healthtalk.no/koronavaksinen-fra-novavax-blir-tilgjengelig-i-norge/1066872022-01-28T00:00+01:00https://www.healthtalk.no/studie-sykehuspersonell-fikk-betydelige-helseplager-under-pandemien/1066802022-02-04T00:00+01:00https://www.healthtalk.no/kliniske-studier/forskere-har-funnet-over-100000-nye-rna-virus/1066712022-02-10T00:00+01:00https://www.healthtalk.no/ukraina-sier-61-sykehus-er-satt-ut-av-drift-etter-russiske-angrep/1066642022-03-09T00:00+01:00https://www.healthtalk.no/stor-studie-milde-bivirkninger-av-koronavaksine/1066572022-03-09T00:00+01:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek-novartis/medisinen-som-ble-for-dyr-for-norge-med-jan-anders-istad-i-novartis/1066502019-10-04T00:00+02:00https://www.healthtalk.no/beslutningsforum-kjersti-toppe-podcast/er-hun-den-neste-helseministeren-stortingsrepresentant-kjersti-toppe-om-folkehelse-prioritering-og-beslutningsforum/1066352019-11-19T00:00+01:00https://www.healthtalk.no/beslutningsforum-crispr-immunterapi/inspire-gir-et-bedre-og-mer-rettferdig-helsevesen/1066282019-11-22T00:00+01:00https://www.healthtalk.no/arbeiderpartiet-beslutningsforum-kjersti-toppe/flertall-i-stortinget-for-lovfesting-av-beslutningsforum/1066202019-12-03T00:00+01:00https://www.healthtalk.no/inven2-johanna-olweus-kg-jebsen-senter-for-immunterapi-mot-kreft/novo-nordisk-fondet-sponser-norsk-kreft-start-up/1066142020-02-14T00:00+01:00https://www.healthtalk.no/depresjon-langrenn-trening/ny-forskning-langrenn-halverer-risikoen-for-depresjon/1066022020-02-17T00:00+01:00https://www.healthtalk.no/btk-hemmer-legemidler-og-biotek-ms/sanofis-ms-legemiddel-viser-lovende-resultater-kan-transformere-ms-behandlingen/1065782020-02-20T00:00+01:00https://www.healthtalk.no/blodkreftforeningen-legemidler-og-biotek-olav-ljosne/beslutningsforum-stopper-bruken-av-blodkreftmedisin-blodkreftforeningen-vil-anke-saken-til-helseministeren/1065592020-06-23T00:00+02:00https://www.healthtalk.no/abbvie-beslsutningsforum-humira/abbvies-jak-hemmer-rinvoq-godkjent-for-behandling-av-revmatisme/1065472019-12-23T00:00+01:00https://www.healthtalk.no/alk-egfr-legemidler-og-biotek/beslutningsforum-sier-ja-til-ny-kreftbehandling-nytt-og-viktig-behandlingstilbud-for-pasienter-som-har-aggressiv-lungekreft-sier-lungekreftprofessor/1065422020-09-21T00:00+02:00https://www.healthtalk.no/ali-areffard-bristol-myers-squibb-immunterapi/syvmilsteg-innen-lungekreftbehandlingen-men-fremdeles-langt-fram/1065152019-11-22T00:00+01:00https://www.healthtalk.no/bjorn-henning-gronberg-immunterapi-keynote-studien/lungekreftpasienter-lever-mye-lenger-med-immunterapi-vil-endre-behandlingspraksis/1064942019-11-25T00:00+01:00https://www.healthtalk.no/anna-winge-main-foflekkreft-immunterapi/kreftlege-immunterapi-er-en-kreftrevolusjon/1064722019-10-15T00:00+02:00https://www.healthtalk.no/astellas-beslutningsforum-legemidler-og-biotek/prostatakreftmedisin-fikk-nei-av-beslutningsforum/1064562019-10-25T00:00+02:00https://www.healthtalk.no/astrazeneca-diabetes-forxiga/diabeteslegemiddel-bremser-nyresykdom-klinisk-studie-stoppes/1064202020-04-05T00:00+02:00https://www.healthtalk.no/hjerteflimmer-legemidler-og-biotek-trening-ntnu/ntnu-studie-hjerteflimmerpasienter-som-trener-lever-lenger/1064042020-07-07T00:00+02:00https://www.healthtalk.no/kreft/reddet-livet-med-immunterapi-kari-anne-fevang-ble-med-i-en-klinisk-studie/1063762023-12-18T10:08+01:00https://www.healthtalk.no/atopisk-eksem-eksem-karin-c-lodrup-carlsen/ny-studie-oljebad-forebygger-ikke-atopisk-eksem/1063442020-02-24T00:00+01:00https://www.healthtalk.no/leddgikt/revolusjon-i-leddgiktbehandlingen/1063122023-12-18T09:41+01:00https://image.healthtalk.no?imageId=106320&format=webp&width=1200https://www.healthtalk.no/genterapi-legemidler-og-biotek-zolgensma/20-millioner-kroner-for-en-kur-bestillerforum-sier-nei-til-hurtig-metodevurdering-av-genterapien-zolgensma/1062952020-11-30T00:00+01:00https://www.healthtalk.no/crispr-legemidler-og-biotek-forskning/nobelpris-til-to-kvinnelige-forskere-som-oppdaget-genredigeringsmetoden-crispr/1062852020-10-08T00:00+02:00https://www.healthtalk.no/alan-cuthbertson-bayer-jan-borge-jakobsen/radioaktiv-medisin-kan-bli-en-norsk-kreftrevolusjon/1062292019-11-01T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-ultimovacs/ultimovacs-starter-fase-2-studie-for-pasienter-med-alvorlig-eggstokkreft-rekrutterer-norske-pasienter/1061942021-01-27T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/cabometyx-og-opdivo-kombo-godkjent-i-eu-mot-avansert-nyrecellekreft/1061882021-04-14T00:00+02:00https://www.healthtalk.no/fagartikkel-forskning/legemiddelresistens-ved-kronisk-lymfatisk-leukemi-hva-er-de-underliggende-mekanismene-og-hvordan-kan-det-forebygges-og-behandles/1061782021-04-30T00:00+02:00https://www.healthtalk.no/kreft/nye-behandlingsmuligheter-for-kronisk-lymfatisk-leukemi/1061672023-12-15T15:59+01:00https://image.healthtalk.no?imageId=106174&format=webp&width=1200https://www.healthtalk.no/hjertesykdom/jardiance-godkjent-for-behandling-av-hjertesviktpasienter/1061522023-12-15T16:05+01:00https://image.healthtalk.no?imageId=106163&format=webp&width=1200https://www.healthtalk.no/kreft/kan-kurere-en-av-de-mest-alvorlige-formene-for-hjernekreft/1061252023-12-18T09:40+01:00https://image.healthtalk.no?imageId=106130&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-bristol-myers-squibb-hilde-bech/beslutningsforum-sa-ja-til-immunterapi-kombo-for-alvorlig-nyrekreft/1061142020-01-27T00:00+01:00https://www.healthtalk.no/helse-og-livsstil-politikk/kreftforeningen-vil-at-legene-skal-bruke-ekspertpanelet/1061072021-04-28T00:00+02:00https://www.healthtalk.no/benmargskreft-beslutningsforum-blodkreftforeningen/beslutningsforum-nytt-legemiddel-for-benmargskreft-godkjent-engasjement-fra-pasienter-og-leger-var-sentralt/1060802019-12-20T00:00+01:00https://www.healthtalk.no/blodkreft-legemidler-og-biotek-venetoclax/ny-studie-pasienter-med-en-aggressiv-blodkreftsykdom-lever-lenger-med-ny-behandling/1060732020-08-26T00:00+02:00https://www.healthtalk.no/car-t-legemidler-og-biotek/usa-godkjenner-ny-car-t-til-behandling-av-lymfom/1060632021-02-09T00:00+01:00https://www.healthtalk.no/bransjenytt-helen-brandstorp-helsedirektoratet/hun-tar-over-for-marte-gerhardsen-i-helsedirektoratet/1060562019-08-06T00:00+02:00https://www.healthtalk.no/bransjenytt-fagpressen-healthtalk/healthtalk-kan-juble-for-30-000-lesere-i-juli/1060522019-08-12T00:00+02:00https://www.healthtalk.no/arena-klynge-hanne-mette-dyrlie-kristensen-helseteknologi-bransjenytt/the-life-science-cluster-har-blitt-arena-klynge/1060432019-08-21T00:00+02:00https://www.healthtalk.no/amicoat-bransjenytt-georg-andreas-gundersen/skal-ta-amicoat-ut-i-verden/1060132019-10-13T00:00+02:00https://www.healthtalk.no/bms-bristol-myers-squibb-celgene/bristol-myers-squibb-og-celgene-er-fra-i-dag-ett-selskap/1060052019-11-21T00:00+01:00https://www.healthtalk.no/bransjenytt-farmastat-lena-nymo-helli/lena-nymo-helli-er-ny-styreleder-i-farmastat/1059792019-12-16T00:00+01:00https://www.healthtalk.no/ahus-bransjenytt-frode-jahren/ahus-kan-overta-og-hjertebehandlingen-til-lhl-sykehuset/1059082020-01-27T00:00+01:00https://www.healthtalk.no/anders-larsson-boots-boots-norge/anders-larsson-blir-ny-toppsjef-i-boots-norge/1059002020-01-28T00:00+01:00https://www.healthtalk.no/bransjenytt-jan-stevnsborg-mylan/mylan-styrker-den-nordiske-ledelsen/1058932020-01-28T00:00+01:00https://www.healthtalk.no/avonova-bransjenytt-max-van-eijk/max-van-eijk-blir-ny-konsernsjef-i-stamina-group/1058692020-02-03T00:00+01:00https://www.healthtalk.no/ambulansefly-babcock-bransjenytt/ambulanseflyrettssaken-starter-i-dag/1058552020-02-04T00:00+01:00https://www.healthtalk.no/bransjenytt-nytt-om-navn-sykehuset-innlandet/toril-b-ressem-blir-ny-styreleder-i-sykehuset-innlandet/1058482020-02-05T00:00+01:00https://www.healthtalk.no/bransjenytt-dignio-helseteknologi/dignio-kapret-leder-fra-vipps/1058292020-02-10T00:00+01:00https://www.healthtalk.no/bransjenytt-hilde-apold-karina-tangerud/bedre-tilbud-til-pasienter-med-vonde-skuldre/1058222020-02-11T00:00+01:00https://www.healthtalk.no/bransjenytt/fikk-prestisjetungt-internasjonalt-lederverv/1057152021-04-22T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek-bransjenytt-forskning/nytt-behandlingsalternativ-for-lungekreftpasienter-er-godkjent/1056912021-05-06T00:00+02:00https://www.healthtalk.no/bransjenytt-kliniske-studier/fant-genetisk-sammenheng-mellom-svangerskapsforgiftning-og-hjertesykdom/1056742021-05-12T00:00+02:00https://www.healthtalk.no/bransjenytt/anne-karin-rime-blir-legeforeningens-nye-president/1056592021-06-03T00:00+02:00https://www.healthtalk.no/bransjenytt/tror-kombinasjonen-venclyxto-og-azacitidin-blir-standardbehandling-for-pasienter-som-ikke-kan-motta-intensiv-cellegift/1056502021-06-04T00:00+02:00https://www.healthtalk.no/bransjenytt/fra-stortinget-til-novartis-karine-skaret-er-ny-kommunikasjonssjef/1056432021-06-08T00:00+02:00https://www.healthtalk.no/fedme-og-overvekt/usa-har-godkjent-semaglutid-til-behandling-av-fedme/1056322023-12-18T09:36+01:00https://image.healthtalk.no?imageId=105639&format=webp&width=1200https://www.healthtalk.no/bransjenytt-eha-2021/nye-data-viser-gode-resultater-ved-bruk-av-car-t-behandling-av-benmargskreft/1056062021-06-21T00:00+02:00https://www.healthtalk.no/bransjenytt/samarbeider-i-kampen-mot-fedme/1055922021-08-05T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/priser-til-fremragende-forskere-ved-oslo-universitetssykehus/1055412021-08-31T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/fratrer-fra-styret-i-helse-nord-rhf/1055252021-09-07T00:00+02:00https://www.healthtalk.no/kreft/ny-behandling-av-aggressiv-lymfekreft-er-godkjent/1055102023-12-15T16:01+01:00https://image.healthtalk.no?imageId=105514&format=webp&width=1200https://www.healthtalk.no/politikk-statsbudsjettet-2022/livsvitenskapsbygget-realiseres-prislappen-er-119-milliarder-kroner/1054992021-10-12T00:00+02:00https://www.healthtalk.no/kliniske-studier/kreftforeningen-gir-25-millioner-for-at-flere-pasienter-i-distriktene-skal-bli-med-i-kliniske-studier/1054902022-03-17T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-med-nytt-pristilbud-til-produsenten-av-cystisk-fibrose-legemiddel/1054752021-12-14T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/ema-anbefaler-to-nye-behandlinger-mot-covid-19/1054622021-12-17T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-kliniske-studier/norsk-studie-persontilpasset-behandling-med-biologisk-legemiddel-gir-bedre-sykdomskontroll-av-kroniske-betennelsessykdommer-i-ledd-tarm-og-hud/1054472021-12-22T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-coronaviruset/norge-skal-trolig-ikke-bruke-msds-koronapille/1054402021-12-26T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/fda-godkjenner-nytt-kolesterollegemiddel/1054312022-01-03T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/usa-godkjenner-keytruda-for-adjuvant-behandling-av-melanom-i-stadium-ii-bc/1054232022-01-06T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/fire-kreftbehandlinger-blant-de-10-mest-solgte-legemidlene/1053572022-02-09T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/ema-anbefalte-92-legemidler-i-fjor-det-er-35-prosent-flere-enn-i-2020/1053422022-02-17T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/mest-bruk-av-legemidler-i-innlandet-og-det-er-ikke-overraskende/1053352022-02-17T00:00+01:00https://www.healthtalk.no/pharma-og-biotek/her-er-de-7-viktigste-legemidlene-som-kan-bli-godkjent-i-2022/1053132024-01-02T09:30+01:00https://image.healthtalk.no?imageId=105322&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek/eu-godkjenner-kerendia-for-behandling-av-pasienter-som-har-kronisk-nyresykdom-og-diabetes-type-2/1052982022-02-25T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/positive-resultater-for-enhertu-i-brystkreft-med-lavt-her2-uttrykk/1052832022-03-02T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/kombinasjonsbehandling-feiler-i-stor-melanomstudie/1052162022-03-17T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/bayer-ber-om-eu-ja-for-behandling-av-nyrepasienter-i-tidlig-fase/1051932022-03-23T00:00+01:00https://www.healthtalk.no/podcast/21-er-hun-den-neste-helseministeren-stortingsrepresentant-kjersti-toppe/1051832022-01-01T02:57+01:00https://www.healthtalk.no/podcast/22-kreftlegen-som-endret-kreftpolitikken/1051782022-01-01T02:57+01:00https://www.healthtalk.no/podcast/25-inspire-gir-et-bedre-og-mer-rettferdig-helsevesen/1051632022-01-01T02:57+01:00https://www.healthtalk.no/podcast/26-syvmilsteg-innen-lungekreftbehandlingen-men-fremdeles-langt-fram/1051582022-01-01T02:57+01:00https://www.healthtalk.no/podcast/27-onkologisk-forum-norges-viktigste-fagarena-om-kreft/1051532022-01-01T02:57+01:00https://www.healthtalk.no/podcast/28-sterk-kritikk-av-regjeringens-e-helsepolitikk/1051482022-01-01T02:57+01:00https://www.healthtalk.no/podcast/informert-om-beslutningsforum-og-akson/1051242022-01-01T02:57+01:00https://www.healthtalk.no/podcast/krise-i-stamina-og-vi-intervjuer-ks-sin-akson-general/1051202022-01-01T02:57+01:00https://www.healthtalk.no/podcast/revolusjon-i-leddgiktbehandlingen/1051042022-01-01T02:57+01:00https://www.healthtalk.no/podcast/novo-nordisk-fondet-sponser-norsk-kreft-start-up/1051002022-01-01T02:57+01:00https://www.healthtalk.no/podcast/12-ehin-2019-slik-samler-vi-norge-til-ett-digitalt-helserike/1050852022-01-01T02:57+01:00https://www.healthtalk.no/podcast/13-ehin-2019-kry-moter-stengte-dorer-men-bare-i-norge/1050802022-01-01T02:57+01:00https://www.healthtalk.no/podcast/14-ehin-2019-torgeir-waterhouse-er-helseminister-for-en-dag/1050752022-01-01T02:57+01:00https://www.healthtalk.no/podcast/15-ehin-2019-svensk-helseplattform-trenger-inn-i-norge/1050702022-01-01T02:57+01:00https://www.healthtalk.no/podcast/1-million-nordmenn-har-fedme/1050382022-01-01T02:57+01:00https://www.healthtalk.no/podcast/magnus-carlsen-og-hjerneforskere-skal-bedre-hjernehelsen/1050302022-01-01T02:57+01:00https://www.healthtalk.no/podcast/legemiddelkombo-forlenger-overlevelsen-for-nyrekreftpasienter/1050262022-01-01T02:57+01:00https://www.healthtalk.no/podcast/beslutningsforum-sa-ja-til-lynparza-til-behandling-av-arvelig-eggstokkreft/1050222022-01-01T02:57+01:00https://www.healthtalk.no/podcast/den-digitale-psykologen/1050182022-01-01T02:57+01:00https://www.healthtalk.no/podcast/asco-2020-roche-bristol-myers-squibb-msd-og-astrazeneca-med-viktige-lungekreftstudier/1050102022-01-01T02:57+01:00https://www.healthtalk.no/podcast/nye-behandlingsmuligheter-for-kronisk-lymfatisk-leukemi/1050022022-01-01T02:57+01:00https://www.healthtalk.no/podcast/asco20-oppsummert/1049982022-01-01T02:57+01:00https://www.healthtalk.no/podcast/eha25-med-mange-banebrytende-studier-innen-blodkreft/1049942022-01-01T02:57+01:00https://www.healthtalk.no/podcast/vektreduksjon-er-den-viktigste-behandlingen-for-diabetes-type-2/1049862022-01-01T02:57+01:00https://www.healthtalk.no/podcast/hvert-fjerde-hjerneslag-skyldes-hjerteflimmer/1049782022-01-01T02:57+01:00https://www.healthtalk.no/podcast/esc-2020-dette-er-de-nye-rettningslinjene-for-behandling-av-hjerteflimmer/1049702022-01-01T02:57+01:00https://www.healthtalk.no/dod-dodsfall-egg/tre-eller-flere-egg-om-dagen-oker-risikoen-for-hjertesykdom-og-tidlig-dod-viser-ny-studie/1049522019-03-18T00:00+01:00https://www.healthtalk.no/digital-helse-dips-ellen-white/helseplattformen-og-epic-signerte-milliardkontrakt-om-ny-pasientjournal/1049432019-03-21T00:00+01:00https://www.healthtalk.no/anne-karin-kolstad-beslutningsforum-biktarvy/fikk-ja-fra-beslutningsforum-hivnorge-er-glad-for-ny-hivmedisin/1049352019-03-22T00:00+01:00https://www.healthtalk.no/driftsfeil-erik-vigander-featured/it-feil-i-pasientsystemene-stopper-operasjoner-i-helse-vest/1049262019-03-27T00:00+01:00https://www.healthtalk.no/anne-grethe-erlandsen-astrazeneca-beslutningsforum/forstar-at-lungekreftpasientene-demonstrerer-for-ny-medisin/1049132019-03-29T00:00+01:00https://www.healthtalk.no/featured-hjerne-kavli/norske-forskere-fant-ny-type-hjernecelle/1049042019-04-04T00:00+02:00https://www.healthtalk.no/bent-hoie-erik-fosse-featured/vil-gjore-helse-til-gull/1048932019-04-05T00:00+02:00https://www.healthtalk.no/accenture-barnefamilier-confrere/pasientene-vil-mote-fastlegen-ansikt-til-ansikt/1048832019-04-08T00:00+02:00https://www.healthtalk.no/featured-legemidler-og-biotek-helseteknologi-maria-jahrmann-bjerke/bygger-fremtidens-operasjonsstue-sammen-med-helseindustrien/1048742019-04-09T00:00+02:00https://www.healthtalk.no/beslutningsforum-featured-helsebarometer/helsebarometeret-flere-nordmenn-bekymret-for-todelt-helsevesen/1048702019-04-10T00:00+02:00https://www.healthtalk.no/featured-legemidler-og-biotek/skal-kartlegge-bruken-av-nye-kreftmedisiner/1048642019-04-11T00:00+02:00https://www.healthtalk.no/featured-legemidler-og-biotek-helseteknologi/lobbyvettreglene-slik-pavirker-du-helsenaeringsmeldingen/1048592019-04-12T00:00+02:00https://www.healthtalk.no/featured-helseteknologi/melanor-helsenaeringsmeldingen-svarer-til-forventningene/1048542019-04-15T00:00+02:00https://www.healthtalk.no/featured-helseteknologi-trening/smartklokker-forbedrer-helsen-din/1048492019-04-16T00:00+02:00https://www.healthtalk.no/featured-legemidler-og-biotek/na-blir-det-felles-nordisk-legemiddelinnkjop/1048392019-04-17T00:00+02:00https://www.healthtalk.no/featured-legemidler-og-biotek/bristol-myers-squibb-kjoper-celgene-for-647-milliarder-kroner/1048312019-04-17T00:00+02:00https://www.healthtalk.no/featured-legemidler-legemidler-og-biotek/roche-lofter-salgsforventningene/1048232019-04-23T00:00+02:00https://www.healthtalk.no/blalyscystoskopi-cystoskopi-featured/photocure-far-hexvix-refusjon-i-australia/1048152019-04-23T00:00+02:00https://www.healthtalk.no/beslutningsforum-featured-kymriah/to-nye-genterapier-til-voksne-med-lymfekreft-skal-vurderes-av-beslutningsforum/1048062019-04-24T00:00+02:00https://www.healthtalk.no/apotek-apotekforeningen-featured/tilliten-til-legene-oker/1047972019-04-25T00:00+02:00https://www.healthtalk.no/erik-jakobsen-featured-healthtalk/helse-kan-ikke-bli-en-stor-eksportnaering-uten-et-stort-hjemmemarked-sykehusene-og-norske-kommuner-ma-ta-ansvar/1047882019-04-26T00:00+02:00https://www.healthtalk.no/featured-kari-eian-korgstad-legemidler-og-biotek/medistim-stimer-frem-med-rekordinntekter/1047802019-04-29T00:00+02:00https://www.healthtalk.no/aleris-aleris-hlese-featured/aleris-skal-selges-wallenberg-kaster-kortene/1047692019-04-29T00:00+02:00https://www.healthtalk.no/behandlingstilbud-beslutningsforum-featured/beslutningsforum-sa-ja-til-keytruda-700-lungekreftpasienter-arlig-far-et-nytt-behandlingstilbud/1047642019-04-29T00:00+02:00https://www.healthtalk.no/featured-healthtalk-kreft/norge-pa-bunnplass-i-europa-det-tar-nesten-2-ar-for-norske-pasienter-far-nye-kreftmedisiner/1047542019-04-29T00:00+02:00https://www.healthtalk.no/featured-finansdepartementet-helsedepartementet/eksportpotensialet-er-naermest-ubegrenset-men-helsenaeringen-trenger-et-storre-hjemmemarked/1047452019-04-30T00:00+02:00https://www.healthtalk.no/arbeiderpartiet-featured-helsenaeringen/her-er-arbeiderpartiets-oppskrift-for-a-styrke-helsenaeringen/1047372019-05-02T00:00+02:00https://www.healthtalk.no/bent-hoie-beslutningsforum-featured/healthtalk-mener-bent-hoie-far-det-som-han-vil-beslutningsforum-blir-lovfestet/1047302019-05-03T00:00+02:00https://www.healthtalk.no/eldre-og-folkehelseminister-erna-solberg-featured/gjor-comeback-i-toppolitikken-sylvi-listhaug-blir-ny-eldre-og-folkehelseminister/1047232019-05-03T00:00+02:00https://www.healthtalk.no/antibiotika-direktoratet-for-e-helse-featured/nettleger-feilbehandler-oftere-barn/1047162019-05-06T00:00+02:00https://www.healthtalk.no/abbvie-behandling-beslutningsforum/abbvies-skyrizi-har-fatt-markedsforingstillatelse/1047092019-05-06T00:00+02:00https://www.healthtalk.no/diagnose-featured-giske-ursin/27-000-har-mer-enn-n-kreftdiagnose/1047002019-05-07T00:00+02:00https://www.healthtalk.no/beslutningsforum-featured-helseokonomi/professor-advarer-unge-dodssyke-pasienter-nektes-behandling-fordi-de-tilhorer-en-pasientgruppe-med-mange-eldre/1046892019-05-07T00:00+02:00https://www.healthtalk.no/aids-featured-healthtalk/kampen-mot-aids-kan-vaere-vunnet-ny-behandling-som-stanser-overforingen-av-hiv-viruset-er-funnet/1046792019-05-08T00:00+02:00https://www.healthtalk.no/fastlege-featured-healthtalk/fastlegenes-arbeidsbelastning-oker/1046712019-05-08T00:00+02:00https://www.healthtalk.no/featured-lege-legeforeningen/arets-lonnsoppgjor-for-sykehuslegene-er-i-boks/1046662019-05-09T00:00+02:00https://www.healthtalk.no/pharma-og-biotek/her-er-verdens-20-storste-legemiddelselskaper/1046572024-01-02T09:38+01:00https://image.healthtalk.no?imageId=104662&format=webp&width=1200https://www.healthtalk.no/allmennlegeforeningen-featured-legemidler-og-biotek/nils-kristian-klev-ble-ny-leder-for-allmennlegeforeningen/1046492019-05-09T00:00+02:00https://www.healthtalk.no/brystkreft-featured-innvandrerkvinner/innvandrerkvinner-har-hissigere-brystkreft/1046412019-05-10T00:00+02:00https://www.healthtalk.no/featured-fedme-fedmeepidemi/fersk-rapport-slar-alarm-om-fedme-i-norge-tar-livet-av-3200-arlig/1046292019-05-13T00:00+02:00https://www.healthtalk.no/arbeiderpartiet-bent-hoie-beslutningsforum/stortinget-utsetter-behandling-av-omstridt-lovforslag-kan-apne-for-individuell-vurdering-av-hvem-som-skal-fa-persontilpasset-medisin/1046182019-05-13T00:00+02:00https://www.healthtalk.no/bent-hoie-digital-helse-direktoratet-for-e-helse/digital-helse-vil-endre-helsebransjen/1045962018-11-29T00:00+01:00https://www.healthtalk.no/e-helsestrategi-e-helse-ehelse/her-er-lobbyradene-hoyretoppen-gir-helseindustrien/1045852019-03-08T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/samarbeider-med-sverige-og-danmark-om-avansert-gen-celle-og-vevsterapi/1045142022-04-05T00:00+02:00https://www.healthtalk.no/historisk-kort-barselopphold-under-pandemien/1045072022-04-05T00:00+02:00https://www.healthtalk.no/hver-femte-akuttinnleggelse-skyldes-legemiddelbruk/1045002022-04-06T00:00+02:00https://www.healthtalk.no/50000-vaksiner-mot-lungebetennelse-kan-bli-kastet/1044862022-04-06T00:00+02:00https://www.healthtalk.no/rapport-nesten-halvparten-av-verdens-graviditeter-er-utilsiktede/1044772022-04-07T00:00+02:00https://www.healthtalk.no/mange-bekymret-for-bemanning-i-helsetjenestene/1044522022-04-07T00:00+02:00https://www.healthtalk.no/en-medisinsk-revolusjon-er-pa-gang/1044382022-06-27T16:15+02:00https://image.healthtalk.no?imageId=160100&format=webp&width=1200https://www.healthtalk.no/blodkreft/avansert-hjemmesykehus-tilbys-blodkreftpasienter/1044202022-04-12T00:00+02:00https://www.healthtalk.no/jobb-karriere/han-blir-apotekbransjens-nye-sjefs-lobbyist/1044112022-04-12T00:00+02:00https://www.healthtalk.no/brystkreft-legemidler-og-biotek/ny-presisjonsmedisin-er-godkjent-for-pasienter-med-metastatisk-brystkreft/1043322020-10-05T00:00+02:00https://www.healthtalk.no/her2-legemidler-og-biotek/enhertu-er-godkjent-i-usa-for-behandling-magesekkreft-og-i-europa-for-brystkreft/1042552021-01-20T00:00+01:00https://www.healthtalk.no/politikk/profesor-jon-magnussen-skal-lede-utvalg-som-skal-utrede-styringen-av-sykehusene/1042052022-02-05T00:00+01:00https://www.healthtalk.no/politikk/regjeringen-klar-med-innstramminger-i-fritt-behandlingsvalg/1041982022-04-04T00:00+02:00https://www.healthtalk.no/politikk/frp-ber-stortinget-vedta-a-omorganisere-beslutningsforum-for-nye-metoder-etter-samme-modell-som-brukes-i-danmark/1041822022-04-11T00:00+02:00https://www.healthtalk.no/immunterapi-legemidler-og-biotek/immunterapien-tecentriq-i-kombinasjon-med-avastin-er-godkjent-for-pasienter-med-leverkreft/1041572020-11-03T00:00+01:00https://www.healthtalk.no/coronaviruset/kompensasjonsordning-for-fastleger-forlenges/1040862022-01-03T00:00+01:00https://www.healthtalk.no/coronaviruset/ema-anbefaler-pfizers-tablettbehandling-mot-covid-19/1040482022-01-31T00:00+01:00https://www.healthtalk.no/coronaviruset/pfizer-ber-fda-godkjenne-en-ekstra-boosterdose-for-eldre-amerikanere/1040072022-03-16T00:00+01:00https://www.healthtalk.no/coronaviruset/ny-studie-naturlige-antistoffer-kan-gi-beskyttelse-mot-covid-19/1039912022-04-01T00:00+02:00https://www.healthtalk.no/coronaviruset/forebyggende-koronalegemiddel-fra-astrazenca-er-godkjent/1039842022-04-01T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/kardiolog-ber-beslutningsforum-gi-tydelige-retningslinjer-for-hvilke-hjerteamyloidose-pasienter-som-skal-behandles-med-nytt-legemiddel/1039562021-10-21T00:00+02:00https://www.healthtalk.no/eksem/beslutningsforum-sa-ja-til-avansert-legemiddel-mot-alvorlig-eksem/1039292023-12-18T09:46+01:00https://image.healthtalk.no?imageId=103935&format=webp&width=1200https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek-lynparza/beslutningsforum-sa-ja-til-lynparza-til-behandling-av-arvelig-eggstokkreft/1039222020-04-27T00:00+02:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek-stig-slordahl/beslutningsforum-sier-nei-til-medisiner-for-brystkreft-og-hyperkolesterolemi/1038992020-06-23T00:00+02:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/beslutningsforum-sier-ja-til-legemidler-til-behandling-av-brystkreft-prostatakreft-nyrecellekreft-og-revmatisme/1038942020-08-31T00:00+02:00https://www.healthtalk.no/acc-henrik-sillesen-legemidler-og-biotek/voyager-pad-studien-vil-endre-behandlingspraksis-for-en-oversett-pasientgruppe/1038152020-03-29T00:00+01:00https://www.healthtalk.no/hjertesykdom/acc-forxiga-viser-effekt-hos-hjertesviktpasienter-uavhengig-av-tidligere-behandling/1037802023-12-15T16:04+01:00https://image.healthtalk.no?imageId=103786&format=webp&width=1200https://www.healthtalk.no/acc-hjertesvikt-legemidler-og-biotek/acc-2020-hjertesviktlegemidlet-vericiguat-med-gode-fase-3-resultater/1037722020-03-28T00:00+01:00https://www.healthtalk.no/asco20-endetarmkreft-immunterapi/keytruda-gir-betydelig-bedre-progresjonsfri-overlevelse-enn-kjemoterapi-hos-pasienter-med-tykk-og-endetarmskreft/1037122020-05-29T00:00+02:00https://www.healthtalk.no/asco20-astrazeneca-egfr/astrazeneca-med-studie-som-kan-endre-behandlingen-av-en-gruppe-lungekreftpasienter/1037082020-05-29T00:00+02:00https://www.healthtalk.no/asco20-astrazeneca-daiichi-sankyo/magesekkreft-enhertu-forbedret-overlevelsen-med-41-prosent-i-forhold-til-kjemoterapi/1036512020-06-01T00:00+02:00https://www.healthtalk.no/asco20-immunterapi-legemidler-og-biotek/asco-oppsummert-mange-gode-lungekreftnyheter/1036322020-06-11T00:00+02:00https://www.healthtalk.no/asco20-fredrik-schjesvold-legemidler-og-biotek/nye-studier-lovende-behandlingsresultater-av-pasienter-med-benmargskreft/1036102020-06-15T00:00+02:00https://www.healthtalk.no/asco20/asco-oppsummert/1036062020-08-06T00:00+02:00https://www.healthtalk.no/al-amyloidose-daratumumab-eha25/ny-behandlingsmulighet-for-pasienter-med-al-amyloidose-daratumumab-sammen-med-cybord/1036022020-06-22T00:00+02:00https://www.healthtalk.no/eha25-fredrik-schjesvold-ikema-studien/en-ny-standardbehandling-for-myelomatose/1035952020-06-23T00:00+02:00https://www.healthtalk.no/al-amyloidose-eha25-fredrik-schjesvold/eha25-oppsummert-dette-var-de-viktigste-nyhetene/1035792020-06-29T00:00+02:00https://www.healthtalk.no/hjertesykdom/hjerteflimmerforsker-slik-kan-du-trene-trygt-med-hjertesykdom/1035332023-12-15T16:06+01:00https://www.healthtalk.no/ablasjon-atrieflimmer-esc/hjerteprofessor-banebrytende-hjertestudier-kan-endre-norsk-behandlingspraksis/1035252020-09-07T00:00+02:00https://www.healthtalk.no/adt-esmo-2020-legemidler-og-biotek/nubeqa-forbedrer-overlevelsen-ved-kastrasjonsresistent-prostatakreft/1034552020-09-21T00:00+02:00https://www.healthtalk.no/eadv-2020-legemidler-og-biotek-psoriasis/ny-studie-bimekizumab-har-bedre-effekt-enn-humira-blant-pasienter-med-moderat-til-alvorlig-plakkpsoriasis/1034062020-11-01T00:00+01:00https://www.healthtalk.no/ash-2020-car-t-legemidler-og-biotek/to-nye-genterapier-til-behandling-av-blodkreft-kan-bli-tatt-i-bruk-i-norge/1033802020-11-24T00:00+01:00https://www.healthtalk.no/ash-2020-crispr-genterapi/en-kur-for-arvelige-blodsykdommer-lovende-behandlingsresultater-med-crispr-genredigering/1033492020-12-06T00:00+01:00https://www.healthtalk.no/ash-2020-car-t-legemidler-og-biotek/banebrytende-car-t-studie-med-t-celler-fra-friske-donorer/1033272020-12-08T00:00+01:00https://www.healthtalk.no/ash-2020-benmargskreft-legemidler-og-biotek/slik-fant-norske-forskere-en-ny-bildediagnostisk-metode-som-kan-oppdage-benmargskreft-tidligere/1033162022-10-25T11:45+02:00https://www.healthtalk.no/ash-2020-ash-2020-oppsummert-kronisk-lymfatisk-leukemi/kronisk-lymfatisk-leukemi-mange-viktige-studier-med-persontilpassede-legemidler/1033102020-12-14T00:00+01:00https://www.healthtalk.no/ash-2020-oppsummert-legemidler-og-biotek-lymfom/lymfekreft-immunterapistudier-med-car-t-og-bispesifikke-antistoffer-dominerte-ash/1033042020-12-16T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-wclc-2021/opdivo-med-nye-sterke-overlevelsesdata-i-behandlingen-av-brysthinnekreft/1032742021-02-01T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-wclc-2021/presisjonsmedisinen-enhertu-med-sterke-resultater-mot-her2-positiv-lungekreft/1032552021-02-03T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek-wclc-2021/keytruda-med-langtidsdata-lungekreftpasienter-med-spredning-lever-betydelig-lengre-med-immunterapi/1032112021-02-12T00:00+01:00https://www.healthtalk.no/esmo-breast-legemidler-og-biotek/tester-ny-kombinasjon-av-cellegift-og-immunterapi-ved-trippel-negativ-brystkreft-med-spredning/1031992021-05-05T00:00+02:00https://www.healthtalk.no/esmo-breast-kliniske-studier/vi-vil-at-alle-brystkreftpasienter-deltar-i-kliniske-studier/1031722021-05-10T00:00+02:00https://www.healthtalk.no/acc-2021-forskning/kan-moderat-alkoholinntak-virkelig-redusere-faren-for-alvorlig-hjertesykdom/1031542021-05-15T00:00+02:00https://www.healthtalk.no/acc-2021-kliniske-studier/dansk-registerstudie-over-halvparten-av-pasientene-med-hjertesvikt-utviklet-hjerteflimmer/1031462021-05-15T00:00+02:00https://www.healthtalk.no/acc-2021-legemidler-og-biotek-kliniske-studier/atlantis-studien-eliquis-ikke-bedre-enn-standardbehandling-etter-tavi/1031142021-05-16T00:00+02:00https://www.healthtalk.no/acc-2021-kliniske-studier-forskning/lukking-av-venstre-aurikkel-under-hjertekirurgi-reduserer-risiko-for-hjerneslag/1031022021-05-16T00:00+02:00https://www.healthtalk.no/acc-2021-kliniske-studier/evkeeza-kan-hjelpe-noen-pasienter-med-alvorlig-hypertriglyseridemi/1030952021-05-16T00:00+02:00https://www.healthtalk.no/acc-2021-bransjenytt-kliniske-studier/fase-3-studie-viser-fordeler-med-mavacamten-hos-pasienter-med-arvelig-hjertemuskelsykdom/1030872021-05-16T00:00+02:00https://www.healthtalk.no/acc-2021-bransjenytt-kliniske-studier/xarelto-reduserer-iskemiske-hendelser-hos-pasienter-med-nedsatt-blodsirkulasjon-i-beina/1030592021-05-18T00:00+02:00https://www.healthtalk.no/asco-2021-kliniske-studier/postmenopausale-kvinner-levde-signifikant-lenger-med-kisqali-i-kombinasjon-med-faslodex/1029852021-06-05T00:00+02:00https://www.healthtalk.no/asco-2021-legemidler-og-biotek-kliniske-studier/lovende-resultater-for-norsk-kreftmedisin-pa-lungekreft/1029782021-06-05T00:00+02:00https://www.healthtalk.no/asco-2021-gynkreft-legemidler-og-biotek-kliniske-studier/bekrefter-at-behandling-med-parp-hemmeren-zejula-er-trygg-og-effektiv-i-behandling-av-eggstokkreft/1029432022-10-04T09:36+02:00https://www.healthtalk.no/eha-2021-kliniske-studier/bergenbio-med-lovende-data-for-leukemipasienter/1028492021-06-16T00:00+02:00https://www.healthtalk.no/arendalsuka/healthtalk-debatten-fremtidens-kreftbehandling-fra-politikk-til-klinikk/1028382022-08-10T16:40+02:00https://image.healthtalk.no?imageId=160765&format=webp&width=1200https://www.healthtalk.no/arendalsuka/healthtalk-debatten-hvordan-sikre-morgendagens-helsetjeneste-med-nok-testkapasitet-i-norge/1028292022-08-10T16:46+02:00https://www.healthtalk.no/arendalsuka/healthtalk-debatten-evaluering-av-nye-metoder-og-medisinsk-genterapi/1028252022-08-10T16:42+02:00https://image.healthtalk.no?imageId=160768&format=webp&width=1200https://www.healthtalk.no/arendalsuka/healthtalk-debatten-hvordan-lykkes-vi-med-presisjonsmedisin-for-kreft/1028212022-08-10T16:46+02:00https://image.healthtalk.no?imageId=160743&format=webp&width=1200https://www.healthtalk.no/arendalsuka/healthtalk-debatten-hvor-lenge-ma-vi-vente-for-trening-blir-en-del-av-kreftbehandlingen/1028122022-08-10T16:46+02:00https://image.healthtalk.no?imageId=160771&format=webp&width=1200https://www.healthtalk.no/arendalsuka-podcast/intervju-med-radarparet-bak-podcasten-radium/1028032022-08-10T16:47+02:00https://www.healthtalk.no/arendalsuka/healthtalk-debatten-digitalisering-av-det-norske-helsevesenet/1027942022-08-10T16:44+02:00https://www.healthtalk.no/arendalsuka/healthtalk-debatten-hvordan-kan-helsedata-gi-bedre-tjenester-for-pasienter-med-sjeldne-diagnoser/1027902022-08-10T16:46+02:00https://image.healthtalk.no?imageId=160762&format=webp&width=1200https://www.healthtalk.no/esc-2021-helseteknologi/droner-leverte-hjertestartere-til-pasienter-med-hjertestans-raskere-enn-ambulansen/1027702021-08-27T00:00+02:00https://www.healthtalk.no/hjertesykdom/sglt-2-hemmerne-tas-inn-i-behandlingsretningslinjene-for-hjertesvikt/1027622023-12-15T16:07+01:00https://image.healthtalk.no?imageId=102694&format=webp&width=1200https://www.healthtalk.no/esc-2021-forskning/hjertefunksjonen-er-normal-hos-de-fleste-pasienter-som-er-kommet-seg-etter-covid-19/1026822021-08-30T00:00+02:00https://www.healthtalk.no/esc-2021-helseteknologi-forskning/screening-av-hjerteflimmer-reduserte-ikke-forekomsten-av-hjerneslag/1026692021-08-31T00:00+02:00https://www.healthtalk.no/esmo-2021-forskning/ny-norsk-studie-nyrekreftpasienter-har-bedre-sjanse-for-overlevelse-med-immunterapi/1026072021-09-17T00:00+02:00https://www.healthtalk.no/esmo-2021-forskning/ny-norsk-studie-flere-behandlingsmodaliteter-kan-forbedre-overlevelsen-ved-sjelden-hjernekreft/1026002021-09-18T00:00+02:00https://www.healthtalk.no/esmo-2021-forskning/norsk-studie-lot-pasienter-med-hjernekreft-evaluere-sin-egen-livskvalitet/1025292021-09-22T00:00+02:00https://www.healthtalk.no/esmo-2021-gynkreft-legemidler-og-biotek/ga-ny-dose-med-parp-hemmer-resultatet-overrasket-kreftlegen/1025182022-10-04T09:33+02:00https://www.healthtalk.no/legemidler-og-biotek/store-fremskritt-i-kreftbehandlingen/1024852021-09-29T00:00+02:00https://www.healthtalk.no/onkologisk-forum-21-rolf-j-ledal-hjernesvulstforeningen-skuffet-over-evalueringsrapporten-om-systemet-for-nye-metoder/1024812021-11-18T00:00+01:00https://www.healthtalk.no/onkologisk-forum-21-odd-terje-brustugun-om-evalueringsrapporten-av-nye-metoder/1024772021-11-18T00:00+01:00https://www.healthtalk.no/norsk-dansk-samarbeid-om-protonterapi-studier/1024582021-11-19T00:00+01:00https://www.healthtalk.no/kreft/dette-er-blodkreft/1024072023-12-15T15:58+01:00https://www.healthtalk.no/ash-2021-legemidler-og-biotek/ash-2021-to-studier-viser-at-celleterapi-kan-bli-den-nye-standardbehandlingen-av-lymfompasienter-i-2-linje/1023962021-12-11T00:00+01:00https://www.healthtalk.no/ash-2021-legemidler-og-biotek/ash-2021-vil-nye-langtidsdata-gi-genterapi-mot-sjelden-blodsykdom-en-ny-sjanse-i-norge/1023812021-12-12T00:00+01:00https://www.healthtalk.no/beslutningsforum-car-t-gilead/beslutningsforum-sa-nei-til-to-nye-genterapier-til-voksne-med-lymfekreft/1023702019-09-23T00:00+02:00https://www.healthtalk.no/beslutningsforum-legemidler-og-biotek/polivy-fikk-ja-fra-beslutningsforum-et-gjennombrudd-for-norske-lymfompasienter/1023592021-01-19T00:00+01:00https://www.healthtalk.no/legemidler-og-biotek/to-kombinasjonsbehandlinger-mot-benmargskreft-fikk-ja-to-fikk-nei-det-er-jo-som-forventet/1023512022-02-14T00:00+01:00https://www.healthtalk.no/blodkreft-legemidler-og-biotek-blodkreft/har-oppdaget-ny-type-immunterapi-mot-leukemi/1023422021-12-13T00:00+01:00https://www.healthtalk.no/bransjenytt-jobb-karriere/onkolog-og-lungekreftforsker-odd-terje-brustugen-er-ansatt-som-professor/1023192021-09-13T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/aksel-tunold-blir-business-development-director-i-medhouse/1022952021-09-23T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/incyte-vokser-og-ansetter-david-waaseth-som-key-account-manager/1022882021-10-06T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/marianne-skjerven-martinsen-er-utnevnt-til-ekspedisjonssjef-i-helse-og-omsorgsdepartementet/1022792021-10-08T00:00+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/erik-digman-wiklund-blir-sjef-i-targovax/1022572021-10-20T00:00+02:00https://www.healthtalk.no/bransjenytt/sykepleierleder-har-ikke-brettet-ned-ermene/1022362021-11-10T00:00+01:00https://www.healthtalk.no/bransjenytt/legeforeningen-fikk-ikke-stanset-nettsted-med-legerangering/1022182021-12-08T00:00+01:00https://www.healthtalk.no/aleap-confrere-dignio/e-helsenyheter-episode-2/1022022018-12-20T00:00+01:00https://www.healthtalk.no/e-helsestrategi-e-helse-ehelse/ehelse-status-norge-inn-mot-2019/1021932018-12-10T00:00+01:00https://www.healthtalk.no/ablasjon-apple-apple-watch/apple-watch-ekg-trenger-hjertet-ditt-det/1021812019-06-07T00:00+02:00https://www.healthtalk.no/digitalisering-digitalisering-av-helsesektoren-digitalisering-av-helsetjenesten/digitaliseringen-kommer-og-det-norske-helsevesenet-ma-fa-pa-seg-skoene/1021742018-11-27T00:00+01:00https://www.healthtalk.no/e-helse-ehelse-helse-norge/e-helsenyheter-episode-1/1021652018-12-01T00:00+01:00https://www.healthtalk.no/bedriftshelse-bedriftshelsetjeneste-bedriftshelsetjeneste-oslo/fokus-pa-24-timersmennesket-hvordan-vil-fremtidens-bedriftshelsetjeneste-se-ut/1021562019-01-15T00:00+01:00https://www.healthtalk.no/astrup-digitale-verktoy-digitaliseringen/vil-ha-mer-innovative-offentlige-anskaffelser/1021382019-04-02T00:00+02:00https://www.healthtalk.no/dignio-helseteknologi-innovasjon/helse-norge-er-rammet-av-pilotsyken/1021222019-08-20T00:00+02:00https://www.healthtalk.no/bilforsikring-bilforsikringer-featured/smartforsikringer-flere-kan-fa-helseforsikring-med-ny-teknologi/1021132019-03-27T00:00+01:00https://www.healthtalk.no/behandling-brustugun-drammen-sykehus/1500-lungekreftpasienter-nektes-effektiv-kreftbehandling/1021012019-04-01T00:00+02:00https://www.healthtalk.no/bransjenytt-forbrukkeradet-gjensidige/og-norges-beste-helseforsikring-er/1020792019-11-14T00:00+01:00https://www.healthtalk.no/aleap-direktoratet-for-e-helse-e-helse-organisasjon/kathrine-myhre-om-ehelse-stortingsmeldingen/1020702019-01-15T00:00+01:00https://www.healthtalk.no/e-helse-fritt-behandlingsvalg-helse-norge/vil-ha-fritt-behandlingsvalg-i-primaerhelsetjenesten/1020612019-01-24T00:00+01:00https://www.healthtalk.no/aleris-e-helse-fritt-behandlingsvalg/hvordan-skal-fritt-behandlingsvalg-bli-den-dundrende-suksessen-som-den-fortjener-a-bli/1020522019-01-25T00:00+01:00https://www.healthtalk.no/boston-consulting-group-e-helse-ehelse/fra-boston-consulting-group-til-grunder-av-hjemmelegene/1020432019-02-12T00:00+01:00https://www.healthtalk.no/digitalisering-digitalisering-helse-e-helse/ai-vil-revolusjonere-helsevesenet-men-norge-ligger-langt-bak/1020322019-02-21T00:00+01:00https://www.healthtalk.no/baerekraft-baerekraft-utvikling-baerekraftig/sunt-kosthold-redder-kloden/1020142019-03-04T00:00+01:00https://www.healthtalk.no/apotek-apotekforeningen-blaresepetordningen/vi-bruker-legemidler-for-5200-kroner-hver/1020032019-03-12T00:00+01:00https://www.healthtalk.no/dn-helseforsikring-legemidler-og-biotek/krise-hos-helsegigant-kan-tape-en-halv-milliard/1019942019-03-13T00:00+01:00https://www.healthtalk.no/kommunikajonsteam-kommunikasjon-kommunikasjonsradgiver/roche-styrker-kommunikasjonsteamet/1019862019-03-14T00:00+01:00https://www.healthtalk.no/avtale-borsmelding-celleterapi/to-norske-biotekselskaper-inngar-lisensavtale-til-100-millioner/1019792019-03-18T00:00+01:00https://www.healthtalk.no/behandling-benmargskreft-helsedirektoratet/beslutningsforum-sa-nei-til-ny-livsforlengende-kreftmedisin/1019702019-03-18T00:00+01:00https://www.healthtalk.no/digital-helse-digitalisering-digitalisering-av-helsesektoren/sjokkmaling-for-norsk-e-helse-lav-tillit-og-fa-brukere/1019592019-03-25T00:00+01:00https://www.healthtalk.no/digital-helse-direktoratet-for-e-helse-e-helse/direktoratet-ma-sterkere-pa-banen/1019542019-03-26T00:00+01:00https://www.healthtalk.no/digital-helse-digitalisering-digitalisering-av-helsesektoren/sjokkmalingen-vi-har-en-formidabel-formidlingsoppgave/1019492019-03-27T00:00+01:00https://www.healthtalk.no/biologiske-legemidler-featured-folkehelseinstituttet/frykter-kostnadene-ikke-mulig-a-si-ja-til-alt/1019432019-04-04T00:00+02:00https://www.healthtalk.no/e-helse-ehelse-garmin/i-kjolvannet-av-garmin-health-summit-2018-fremtidens-helsebransje/1019252018-11-25T00:00+01:00https://www.healthtalk.no/blodkreft/nye-behandlingsmetoder-for-lymfekreft/1018982022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/har-oppdaget-ny-type-immunterapi-mot-leukemi/1018492021-12-13T00:00+01:00https://www.healthtalk.no/podcast/01-kreftlege-roar-johansen-i-ibm-watson/1018442022-01-01T02:57+01:00https://www.healthtalk.no/podcast/03-kari-anne-reddet-livet-med-immunterapi/1018342022-01-01T02:57+01:00https://www.healthtalk.no/podcast/05-det-er-krise-i-fastlegeordningen/1018242022-01-01T02:57+01:00https://www.healthtalk.no/podcast/06-medisinen-som-ble-for-dyr-for-norge/1018192022-01-01T02:57+01:00https://www.healthtalk.no/podcast/07-statsbudsjettet-med-first-house/1018142022-01-01T02:57+01:00https://www.healthtalk.no/podcast/08-den-skjulte-folkesykdommen/1018092022-01-01T02:57+01:00https://www.healthtalk.no/podcast/09-radioaktiv-medisin-kan-bli-en-norsk-kreftrevolusjon/1018042022-01-01T02:57+01:00https://www.healthtalk.no/podcast/hjerteflimmerforsker-slik-kan-du-trene-trygt-med-hjertesykdom/1017962022-01-01T02:57+01:00https://www.healthtalk.no/podcast/hjerteprofessor-banebrytende-hjertestudier-kan-endre-norsk-behandlingspraksis/1017922022-01-01T02:57+01:00https://www.healthtalk.no/podcast/et-enkelt-karrierevalg-tok-spranget-fra-ibm-watson-til-innovativ-kreftbehandling/1017712022-01-01T02:57+01:00https://www.healthtalk.no/podcast/mobil-helse-endrer-helsevesenet-og-helseforskningen/1017672022-01-01T02:57+01:00https://www.healthtalk.no/podcast/rene-amundsen-global-sjef-for-innovasjon-i-merck/1017552022-01-01T02:57+01:00https://www.healthtalk.no/podcast/denne-teknologien-kan-revolusjonere-kreftbehandlingen/1017482022-01-01T02:57+01:00https://www.healthtalk.no/podcast/hvordan-behandle-pasienter-med-fedme/1017442022-01-01T02:57+01:00https://www.healthtalk.no/podcast/stadig-flere-yngere-rammes-av-tarmkreft/1017402022-01-01T02:57+01:00https://www.healthtalk.no/podcast/ultimovacs-starter-fase-2-studie-mot-eggstokkreft/1017322022-01-01T02:57+01:00https://www.healthtalk.no/podcast/nytt-handlingsprogram-for-prostatakreftpasienter/1017272022-01-01T02:57+01:00https://www.healthtalk.no/podcast/kurativ-behandling-av-tykk-og-endetarmskreft/1017232022-01-01T02:57+01:00https://www.healthtalk.no/podcast/genteknologi-og-fremtidsmennesket/1017192022-01-01T02:57+01:00https://www.healthtalk.no/podcast/e-helse-i-norge/1016992022-01-01T02:57+01:00https://www.healthtalk.no/podcast/immunterapi-etter-operasjon-reduserer-risiko-for-tilbakefall-ved-nyrecellekreft/1016912022-01-01T02:57+01:00https://www.healthtalk.no/podcast/e-helse-i-norge-ep-2/1016672022-01-01T02:57+01:00https://www.healthtalk.no/podcast/toppmote-esmo-2021/1016592022-01-01T02:57+01:00https://www.healthtalk.no/podcast/stor-nasjonal-kreftstudie-med-presisjonsmedisin-er-i-gang/1016472022-01-01T02:57+01:00https://www.healthtalk.no/podcast/fda-med-gode-nyheter-til-ultimovacs/1016432022-01-01T02:57+01:00https://www.healthtalk.no/podcast/benmargskreft-car-t-med-imponerende-langtidsdata/1016382022-01-01T02:57+01:00https://www.healthtalk.no/legemidler-og-biotek/pasienter-med-benmargskreft-ble-kreftfrie-i-norsk-klinisk-studie-med-celleterapi/1016302021-05-10T00:00+02:00https://www.healthtalk.no/kreft/kisqali-har-den-lengste-overlevelsen-observert-hos-brystkreftpasienter-med-spredning/1016032023-12-18T10:09+01:00https://image.healthtalk.no?imageId=101609&format=webp&width=1200https://www.healthtalk.no/kreft/legemiddel-reduserer-risiko-for-tilbakefall-med-25-prosent-hos-pasienter-med-tidlig-brystkreft-og-to-studier-som-forundrer-kreftlegen/1015942024-01-02T09:08+01:00https://image.healthtalk.no?imageId=101599&format=webp&width=1200https://www.healthtalk.no/garmin-garmin-health-summit-garmin-health-summit-2018/smartklokker-endrer-helsevesenet/1015852018-11-06T00:00+01:00https://www.healthtalk.no/e-helse-ehelse-ehelse-og-velferdsteknologi/fremtidens-helse-global-product-lead-travis-johnson-hos-garmin-health/1015802018-11-09T00:00+01:00https://www.healthtalk.no/digitalisering-digitalisering-helse-e-helse/fremtidens-helse-er-i-hjemmet-og-pa-telefonen/1015712018-11-19T00:00+01:00https://www.healthtalk.no/blodkreft-legemidler-og-biotek-blodkreft/car-t-er-godkjent-som-andrelinjebehandling-av-lymfom/1015472022-04-19T00:00+02:00https://www.healthtalk.no/who-anbefaler-pfizers-koronapille/1015262022-04-22T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-godkjenner-immunterapier-til-behandling-av-brystkreft-og-hudkreft/1015102022-04-25T00:00+02:00https://www.healthtalk.no/rettssak-mot-svensk-skandalekirurg-starter-i-dag/1014702022-04-27T00:00+02:00https://www.healthtalk.no/coronaviruset/intensivkrangel-overrasket-koronakommisjonen/1014612022-04-27T00:00+02:00https://www.healthtalk.no/stort-presseoppbud-da-rettssaken-startet-mot-tidligere-stjernekirurg/1014522022-04-27T00:00+02:00https://www.healthtalk.no/avdekker-store-forskjeller-i-behandlingen-av-kronisk-syke-i-norge/1014202022-04-29T00:00+02:00https://www.healthtalk.no/dyrker-kreftceller-i-mininatyrlunger/1014022022-05-02T00:00+02:00https://www.healthtalk.no/blodkreft/cd37-car-immunterapi-for-norske-pasienter/1013882022-05-03T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/nasjonalt-presisjonsmedisin-initiativ-for-kreft-i-nature-medicine/1013652022-05-06T00:00+02:00https://www.healthtalk.no/kreft/smertene-i-skulderen-var-lungekreft/1013552023-12-15T15:52+01:00https://image.healthtalk.no?imageId=101361&format=webp&width=1200https://www.healthtalk.no/norge-har-overskudd-av-koronavaksiner-men-ingen-vil-ha/1013342022-05-10T00:00+02:00https://www.healthtalk.no/politikk/700-millioner-kroner-mer-til-sykehusene/1013172022-05-11T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/skal-teste-norsk-kreftvaksine-mot-ras-mutert-benmargskreft/1013012022-05-12T00:00+02:00https://www.healthtalk.no/ikke-en-krone-til-fastlegeordningen-i-revidert-nasjonalbudsjett/1012942022-05-12T00:00+02:00https://www.healthtalk.no/coronaviruset/astrazeneca-beklager-etter-vaksinebivirkningene/1012732022-05-15T00:00+02:00https://www.healthtalk.no/takker-den-engasjerte-fastlegen-for-at-kreftdiagnosen-ble-stilt-tidlig/1012542022-05-17T00:00+02:00https://www.healthtalk.no/esa-tar-ytterligere-skritt-mot-norge-om-retten-til-sykehusbehandling-i-utlandet/1012472022-05-18T00:00+02:00https://www.healthtalk.no/fhi-overlege-om-apekopper-i-oslo-ingen-fare-for-befolkningen/1012052022-05-22T00:00+02:00https://www.healthtalk.no/beslutningsforum-sa-ja-til-seks-legemidler-og-nei-til-tre/1011922022-10-12T08:46+02:00https://www.healthtalk.no/legemidler-og-biotek/beslutningsforum-sier-ja-til-ny-persontilpasset-brystkreftbehandling-men-det-tok-sin-tid/1011832022-05-23T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/pfizer-vi-selge-patenterte-legemidler-til-fattige-land-uten-profitt/1011662022-05-25T00:00+02:00https://www.healthtalk.no/beslutningsforum-brystkreft/liv-ekeberg-moen-57-har-uhelbredelig-brystkreft-na-far-hun-behandlingen-som-beslutningsforum-sa-nei-til-betalt-av-helseforsikringen/1011522022-09-01T09:43+02:00https://image.healthtalk.no?imageId=104289&format=webp&width=1200https://www.healthtalk.no/esmo-2021-legemidler-og-biotek/oppsiktsvekkende-resultater-i-behandlingen-av-brystkreft/1011232021-09-19T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/legemiddelverket-mangler-saksbehandlere-kan-forsinke-godkjenningen-av-persontilpasset-kreftlegemiddel-med-to-ar/1011012022-04-20T00:00+02:00https://www.healthtalk.no/blodkreft/tone-fikk-hjerteamyloidose-trodde-symptomene-skyldtes-stress-ble-lettet-da-hun-fikk-rett-diagnose/1010542022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/car-t-er-godkjent-som-andrelinjebehandling-av-lymfom/1010322022-04-19T00:00+02:00https://www.healthtalk.no/blodkreft/avansert-hjemmesykehus-tilbys-blodkreftpasienter/1009772022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/tone-fikk-hjerteamyloidose-trodde-symptomene-skyldtes-stress-ble-lettet-da-hun-fikk-rett-diagnose/1008862022-04-12T00:00+02:00https://www.healthtalk.no/blodkreft/cd37-car-immunterapi-for-norske-pasienter/1008112022-05-03T00:00+02:00https://www.healthtalk.no/podcast/tone-fikk-hjerteamyloidose/1008062022-01-01T02:57+01:00https://www.healthtalk.no/asco-2022-legemidler-og-biotek/astrazenea-og-daiichi-sankyo-presenterer-enhertu-fase-3-studie-i-brystkreft-med-lavt-her2-uttrykk/1007662022-05-30T00:00+02:00https://www.healthtalk.no/sykepleien-og-diabetes-hedret-med-priser/1007482022-06-01T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/na-skal-norske-pasienter-fa-prove-banebrytende-kreftbehandling-utviklet-av-norske-forskere/1007292022-06-24T12:43+02:00https://image.healthtalk.no?imageId=159873&format=webp&width=1200https://www.healthtalk.no/asco-2022-legemidler-og-biotek/cabometyx-og-opdivo-kombo-gir-dypere-respons-og-lengre-overlevelse-for-pasienter-med-avansert-nyrecellekreft/1007042022-06-04T00:00+02:00https://www.healthtalk.no/asco-2022-legemidler-og-biotek/cdk-46-hemmer-viser-overlevelsesfordel-hos-nydiagnostiserte-brystkreftpasienter-men-effekten-er-ikke-signifikant/1006742022-06-05T00:00+02:00https://www.healthtalk.no/asco-2022-legemidler-og-biotek/ny-kras-hemmer-krympet-lungekreften-hos-43-prosent-av-pasientene/1006652022-06-05T00:00+02:00https://www.healthtalk.no/podcast/ep-2-geniale-gener/1006612022-01-01T02:57+01:00https://www.healthtalk.no/podcast/ep-4-kroppens-eget-immunsystem-bekjemper-kreften/1006532022-01-01T02:57+01:00https://www.healthtalk.no/nyheter-og-politikk/den-persontilpassede-revolusjon-genterapi-en-kur-for-arvelige-sykdommer/1006492024-06-26T12:14+02:00https://image.healthtalk.no?imageId=170466&format=webp&width=1200https://www.healthtalk.no/legemidler-og-biotek/ny-immunterapi-mot-lymfekreft-godkjent-i-europa-er-et-alternativ-til-car-t-behandling/1005662022-06-15T00:00+02:00https://www.healthtalk.no/legemidler-og-biotek/hjertemedisinen-vyndaqel-skal-opp-i-beslutningsforum-for-fjerde-gang/1005482022-06-15T00:00+02:00https://www.healthtalk.no/n-milliard-kroner-til-kunnskap-for-bedre-pasientbehandling/1004622022-06-28T18:14+02:00https://www.healthtalk.no/bransjenytt-jobb-karriere/tidligere-ungdomspolitiker-bjorn-kristian-svendsrud-gar-til-sanofi/1004552022-06-16T00:00+02:00https://www.healthtalk.no/podcast/ep-5-car-t-dine-egne-t-celler-blir-omgjort-til-en-behandling/1004502022-01-01T02:57+01:00https://www.healthtalk.no/garmin-health-summit-garmin-health-summit-2018-health/yulife-banebrytende-digital-helseforsikring/1004412018-11-19T00:00+01:00https://www.healthtalk.no/blodkreft/nye-behandlingsmetoder-for-lymfekreft/1004292022-04-12T00:00+02:00https://www.healthtalk.no/asco-2022-legemidler-og-biotek/alle-pasientene-i-studien-ble-kreftfrie-da-de-fikk-immunterapi/1004192022-06-06T00:00+02:00https://www.healthtalk.no/helse/video-podcast-stor-nasjonal-kreftstudie-med-presisjonsmedisin-er-i-gang/1004152024-06-26T12:19+02:00